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ABSTRACT 
In this doctoral thesis analysis of the solvate and polymorph landscape, solvate stability and 
phase transitions of active pharmaceutical ingredients are used to approach a possibility where the 
crystal structures could be used to completely understand and rationalize driving forces for solvate 
formation, stability and desolvation mechanism. A study of the dehydration of mildronate 
dihydrate is used to rationalize its dehydration mechanism. Solvate formation, stability and phase 
transitions of droperidol and benperidol is rationalized using analysis of molecular properties, 
crystal structures and computational calculations. Droperidol isostructural solvates are used to find 
a tool for rationalization of solvate thermal stability and explain the observed different solvent 
molecule arrangement and dynamics in their crystal structures. 
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INTRODUCTION 
Solvates are essential phase type of solid phases for organic molecules, and for pharmaceuticals in 
particular. They are likely to be obtained during the active pharmaceutical ingredient (API) 
manufacturing and can even be used as the API commercial form. Solvates typically appear during 
the API purification stage or processing stages, such as mixing and blending, wet granulation, 
lyophilisation, spray drying, etc., when APIs are exposed to solvents or solvent vapours1-4. 
However, the stability of the solvates under an atmosphere without the corresponding solvent 
vapour is typically limited. Thus the solvate decomposition is likely to occur during the 
transportation or storage of the drug product. Therefore only hydrates are usually considered as a 
final drug product, although their dehydration is also possible. Moreover, high humidity during the 
transportation or storage can also lead to unexpected formation of a hydrate. 
During the desolvation, new polymorphs can form, which can make formation of the solvate either 
undesirable, if polymorphs are unstable, or advantageous, as polymorphs inaccessible by 
crystallization can be obtained in such cases5-8. 
Nevertheless, even nowadays it is not possible to predict the existence and stability of solvates for 
a particular compound, so this has to be explored during the development of an API. Moreover, 
there is not even an efficient scheme for fast and efficient detection of solvate formation and their 
stability for a given API molecule. 
If a solvate forms in a crystallization process, it is likely that it is possible to obtain its crystals and 
therefore easily characterize its crystal structure. However, determination of the stability of 
particular solvate and phase transitions occurring during its desolvation is time-consuming and 
needs human resources and various analytical techniques.  
By analysing the solvate and polymorph landscape, solvate stability and phase transitions of a well-
explored API it would be possible to use the crystal structures for understanding and rationalizing 
driving forces for their formation, rationalizing their stability and desolvation mechanism. 
Accumulation and analysis of such an information can lead to general understanding of these 
relations, leading to a possibility of solvate engineering and prediction of the desolvation 
mechanism. 
 
The aim of the study was to analyse the connection between crystal structure features of the studied 
API solvates and their stability, phase transitions and desolvation kinetics by searching for general 
regularities and the possibility to predict the formation, properties and phase transitions of the 
solvates. 
To achieve the aim, the following tasks were proposed: 
1. To determine the dehydration kinetic parameters of mildronate dihydrate from 
experiments in isothermal and nonisothermal mode. 
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2. To rationalize the dehydration mechanism of mildronate dihydrate by using qualitative and 
quantitative analysis of the crystal structure of mildronate phases, as well as data obtained 
from the study of dehydration kinetics. 
3. To explore the polymorph and solvate landscape of chemically very similar APIs droperidol 
and benperidol by rationalizing the formation of their solvates, solvate properties, stability, 
and desolvation mechanism. 
4. To characterize the desolvation kinetics and intermolecular interaction energies in 
droperidol isostructural solvates formed with water, methanol, ethanol, acetonitrile and 
nitromethane. Use this information to rationalize the relative stability of these solvates. 
5. To rationalize the differences observed in the solvent molecule arrangement and behaviour 
in the droperidol isostructural solvates formed with water, methanol, ethanol, acetonitrile 
and nitromethane. 
 
The scientific novelty of this work: 
1. Crystalline structures has been linked to the properties, stability and desolvation mechanism 
of solvates. This has been achieved for solvates with completely different crystal structure 
features (isolated site and channel solvates with different solvent molecule linkage and role 
in the crystal structure) and different relationship between crystal structures of solvates and 
polymorphs (from similar to completely different). This is the only way to achieve general 
rationalization and prediction of the solvate properties using the crystal structures. 
2. Solvate formation, stability and desolvation products has been rationalized for two APIs. 
This is a step forward to situation, where it would be possible to predict the formation, 
stability and desolvation mechanism of solvates for any particular molecule. 
3. Computational calculations has been incorporated in the data analysis, rationalization and 
explanation of results as well as validation of hypothesis. Such approach leads to more 
reliable conclusions and reduces the amount of necessary experimental work. 
4. Method for rationalization of solvate stability based on the solvent intermolecular 
interactions in the crystal structure has been developed and used for isostructural solvate 
system. By extending this to a general stoichiometric solvate systems general rationalization 
of the solvate stability would be possible. 
5. It has been shown that by analysing the effect of different sample and environmental 
factors on the dehydration kinetic parameters it is possible to achieve information about 
the dehydration mechanism. Together with the interpretation of the dehydration 
mechanism in molecular level this leads to general understanding of the dehydration 
process. 
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6. New polymorphs and solvates of benperidol and droperidol have been discovered and 
characterized. 
 
The practical significance of this work: 
1. Prediction of the solvate formation can lead to faster selection of the solvents used for the 
processing of API, by therefore allowing this step to be more efficient and cost-effective. 
2. Prediction of solvate stability and desolvation products can lead to faster and more effective 
decisions about possible complications during drug synthesis and usefulness of particular 
solvates. 
3. General understanding of the desolvation mechanism can lead to fast and reliable 
prediction of the solvate stability in a given environmental conditions. 
 
The findings of this research have been disclosed in six publications, and have been presented 
in nine international scientific conferences and four local scientific conferences. 
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1 LITERATURE REVIEW 
1.1 Solid phases 
APIs in the solid state can exist in numerous phases, which includes polymorphs (solid 
crystalline phases of the same compound with different arrangement and/or conformation of the 
molecules in the crystal lattice9), solvates (solid crystalline phases of a compound in which also 
solvent molecules are incorporated in the crystal structure10, sometimes designated as 
solvatomorphs10), co-crystals (solid crystalline phases composed of at least two solid neutral 
components present in definite stoichiometric amounts11-13) and amorphous solids (phases lacking 
three-dimensional long-range molecular order, but possibly containing short-range order over 
several molecular dimensions14), see Figure 1.1. Solvates containing water in the crystal lattice are 
known as hydrates. Such phases can exist for neutral API molecules as well as their salts. 
 
Figure 1.1. Different solid forms formed by molecular crystals (α and β are different conformers 
of API molecule, s = solvent molecules and n = molecules of neutral solid)15 
The importance of polymorphism and solvatomorphism in pharmaceutical industry is 
showed by a fact, that 57% of compounds in the European Pharmacopeia are reported to exist in 
more than one phase, with 36% existing in different polymorphic forms, 29% forming hydrates 
and 10% forming other solvates in particular16. 
It is well known that these different phases typically have different physical properties such 
as packing, thermodynamic, spectroscopic, kinetic, surface and mechanical properties, which 
therefore will affect drug stability and performance17. Under specified conditions only one phase is 
the thermodynamically stable one (except at an equilibrium conditions) 18 and it is suggested to use 
this form as a final drug product19, 20. In practice, however, due to kinetic considerations, metastable 
forms can exist21, and these sometimes are selected as final drug products due to better solubility, 
intellectual property issues, or even because thermodynamically stable form has not been 
discovered yet22. 
1.1.1 Polymorphs 
In molecular crystals there are two different types of polymorphs: conformational (pairs I-
III and II-III in Figure 1.1) and packing polymorphs (pair I-II in Figure 1.1)23, 24. Packing 
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polymorphism arises from different possible packing arrangements of conformationally rigid 
molecules24, whereas in conformational polymorphs conformationally flexible molecules adopt 
different conformations in the solid state25, although this usually also include packing into different 
characteristic ways23. Typically conformationally flexible molecules form more polymorphs than 
rigid molecules, and the number of polymorphs can reach up to ten (10 for ROY26 and 9 for 
flufenamic acid27). 
Based on the relative thermodynamic stability polymorph pairs are divided in two types: two 
polymorphs are related enantiotropically if there is a transition temperature below the melting point 
of the lower melting polymorph, and therefore both of the polymorphs have temperature range 
where they are thermodynamically stable, whereas polymorphs are related monotropically, if only 
one of the polymorphs is thermodynamically stable in whole temperature interval up to its melting 
point9, 17, 28. 
Relative stability of polymorphs is determined by the relative stability of both conformers 
present in the crystal structure (typical energy difference is 1-8 kcal·mol-1)29 as well as the relative 
lattice energy (which is affected by the presence of intermolecular interactions as conventional 
hydrogen bonds (4-15 kcal·mol-1), weak hydrogen bonds (1-4 kcal·mol-1) and van der Waals and 
dispersive interactions (0.5-1.0 kcal·mol-1))25. As the differences of intramolecular and 
intermolecular interaction energy for polymorphs are very similar, both of these aspects will affect 
the relative total energy of the polymorphs25, 30. 
1.1.2 Solvates 
Solvates typically are obtained during the API purification stage or the API processing stages, 
such as mixing and blending, wet granulation, lyophilisation, spray drying, etc., when APIs are 
exposed to solvents or solvent vapours1-4. Moreover, solvates tend to crystallize more easily than 
solvent-free polymorphs because of the more efficient packing together with solvent molecules31.  
Solvates are broadly classified as stoichiometric (where there is a definite ratio of solvent to 
molecule) and non-stoichiometric (where the ratio of solvent to molecule may vary continuously 
over a given range)10, 32. The solvent in stoichiometric solvates is usually an integral part of the 
crystal structure and is essential for its maintenance, and their desolvation always lead to a different 
crystal structure or a disordered or amorphous state16. 
In non-stoichiometric solvates solvent molecules are usually arranged in structure channels 
or other voids and does not significantly participate in the formation and stabilization of the crystal 
structure. Therefore the amount of solvent in the structure depends on the partial pressure of the 
solvent in the environment and on the temperature16. Nevertheless, the crystal structure of non-
stoichiometric solvates usually forms only in the presence of the solvent16. If the non-
stoichiometric solvate can be completely desolvated by obtaining a one-component phase with the 
same main structural characteristics, the obtained phase is called isomorphic desovate16, 33-35. 
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Although such structures can sometimes be stable36, they are typically unstable33 or even collapse 
immediately after the removal of the solvent molecules27, 110, and usually they easily binds the 
original or even another solvent molecules16, 33. 
It is common that the same host structure can incorporate different solvent molecules to 
form a set of isostructural solvates. This phenomenon is typical for non-stoichiometric channel 
solvates 37, 38, but is not limited to non-stoichiometric solvates8, 39, 40 nor to channel solvates41. The 
formation of isostructural solvates is typically driven by the presence of specific solvent-host 
interactions39, 41 or by the specific shape of the solvent molecule 37. 
1.2 Characterization of solvates and their stability 
1.2.1 Thermodynamic stability of solvates 
Solvatomorphic system consists of at least two components (the substance and the solvent) 
and therefore variables as pressure, volume, temperature, and composition should be considered 
to describe the phases present in the system. A two-component phase diagram with eutectic and 
peritectic points (see Figure 1.2a) is characteristic for solvates. It shows that the solvate is the only 
stable crystalline phase at a compositions between the eutectic and the peritectic points below the 
curve. It has been shown that such phase diagram can cause complicated desolvation process, 
which appears as the dependence of the desolvation process on the experimental procedure and 
sample preparation (see Figure 1.2b)42. Closed sample pan, fast heating and big particles will result 
to the peritectic decomposition/melting of the solvate and appearance of the corresponding peak 
(1) in thermal analysis at the peritectic temperature (P), after which evaporation of liquid water will 
occur if the sample pan is open (2). In contrast, open pan, N2 flow, slow heating and small particles 
will facilitate the nucleation and formation of the desolvate, and therefore appearance of 
conventional desolvation peak (3)42. 
 
Figure 1.2. (a) Phase diagram of water and compound A showing an incongurently melting 
hydrate H43 and (b) DSC curves of the dehydration of barbituric acid hydrate in (i) closed pan at 
10 K∙min-1, (ii) pinholed pan at 10 K∙min-1, and (iii) closed pan at 2.5 K∙min-1.42 
Biphasic equilibria implies that the thermodynamic stability of the solvate will depend on the 
corresponding solvent vapour pressure10. Equilibrium between solvate and nonsolvated form 
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(Eq. (1.1)) can be described by Eq. (1.2), and in the case of pure solids in their standard states 
stability of the solvate at a given temperature depends only on the activity of the solvent: 
A(s) + m Solv  A·mSolv(s)  (1.1) 
𝐾𝐾𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 = 𝑎𝑎�A·mSolv(s)�𝑎𝑎�𝐴𝐴(𝑠𝑠)�𝑎𝑎(𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆)𝑚𝑚 =  𝑎𝑎(𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆)−𝑚𝑚,  (1.2) 
where KSolv is the equilibrium constant between the solvate and the nonsolvated phase and a 
is the activity of the corresponding phase10, 16, 44, 45. Therefore stability of the solvates are determined 
by the temperature and the solvent activity in the surrounding medium46-49. With an exception of 
the hydrates, absence of the solvent vapour in the atmosphere makes all of the solvates 
thermodynamically unstable in ambient conditions10, 16. 
The stability of solvates at a given temperature is typically characterized by solvent sorption-
desorption isotherms, in which solvent content dependence on the solvent activity (for water: 
relative humidity) is reported. There are several different types of isotherms observed for 
pharmaceutical solids50, and two most characteristic types corresponding to stoichiometric and 
non-stoichiometric solvates are highlighted in Figure 1.3. 
 
Figure 1.3. Solvent sorption-desorption isotherms characteristic for (a) stoichiometric and (b) 
non-stoichiometric solvates. 
Isotherms of stoichiometric solvates are step-shaped with each step corresponding to well-
defined water content. Typically in these isotherms there is a hysteresis (different solvent content 
at the same solvent activity in sorption and desorption isotherms). In isotherm of non-
stoichiometric solvates, however, solvent content changes continuously within a certain solvent 
activity range and typically there is no hysteresis. However, there is no exact shape of isotherms 
corresponding to non-stoichiometric solvates, their shape depends on the crystal structure solvate 
and the strength of solvent-solvent and substance-solvent interactions. Various thermodynamic 
models describing non-stoichiometric solvents and their sorption-desorption isotherms have been 
reviewed51 and are summarized in Appendix 1. 
Stability of a stoichiometric solvate can be characterized by the solvent activity (relative 
humidity for water) at which it starts to desolvate. However, the kinetics of desolvation usually 
does not allow to reach the equilibrium in a reasonable time and it depends on many variables. In 
KSolv
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fact, this is one of the main factors responsible for the appearance of the hysteresis in the sorption-
desorption isotherms. Thermodynamic stability is related to the solubility and therefore 
determination of the solubility in a chosen solvent can be used to fully characterize the stability of 
solvates and even compare it to other phases, provided no phase transition occurs during the 
solubility determination52. Solvate stability can as well be compared by constructing a phase diagram 
of solvate Gibbs energy dependence on the solvent activity53. 
The temperature effect on the stoichiometric solvate stability can be evaluated based on the 
phase diagram in coordinates psolv – T, if the transition between the solvate and the nonsolvated 
phase occurs without significant hysteresis. In this case phase boundary between two phases can 
be found by determining the equilibrium solvent vapour pressure at various temperatures. From 
this phase boundary phase transition enthalpy can then be calculated using Gibbs-Helmholtz 
equation54, 55. 
1.2.2 Arrangement and dynamics of solvent molecules 
As already stated, solvent molecules can have different role in the crystal structure, although 
in all cases they improve the stability of the crystal lattice10. This can be accomplished in three basic 
ways: firstly, solvent molecules can occupy isolated lattice positions, secondly, solvent molecules 
can occupy channels in the structure, and thirdly, solvent molecules (usually water) can associate 
with metal ions by being a part of a coordination complex or by forming a strong ionic bond. In 
the classification of hydrates such aspects as hydrogen bond strength and hydrogen bonding motifs 
can also be taken into account, although in practice both of these classifications usually can be 
associated with already mentioned three classes10. 
In isolated site (discrete position) solvates solvent molecules (or solvent molecule clusters56) 
are isolated from each other and bridge individual molecules or sheets of molecules10. These 
solvates are typically stoichiometric and removal of the solvent (desolvation) leads to destruction 
of the crystal structure56. In TA these solvates show sharp desolvation endotherm and have narrow 
weight loss range44. 
In channels solvates solvent molecules included in the lattice are located in proximity to other 
solvent molecules in adjoining unit cells along a particular axis of the lattice10 and typically interact 
with each other44. Although these solvates are usually non-stoichiometric16, depending on the 
hydrogen bonding and the size of the channel they can as well be stoichiometric56. Removal of the 
solvent from channel solvates is easier and isostructural desolvate33, 35 or non-solvated phase with 
similar crystal structure can be obtained57, 58. These solvates usually have wide weight loss range and 
broad endothermic peak in TA44. 
Most of the metal ion associated solvates are hydrates, and the interaction between the metal 
cation and the oxygen atoms of the bound water molecules are very strong, therefore these hydrates 
are very stable10 and have high dehydration temperatures44. 
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However, picture of a static crystal structure is in fact wrong and the molecular level mobility 
should be included to gain full understanding of the crystal structure59. Molecular motion can be 
associated with solid phase stability and phase transitions, and can be relatively easily studied using 
SSNMR60. Although there are many functional groups which can exhibit intramolecular motion in 
the crystalline state (e.g. rotational diffusion of methyl group, 180° rotation of phenylene rings)59-61 
and affect the relative stability of the phase35, 62, in case of solvates more interesting is the dynamics 
of the solvent molecules. It is shown that solvent molecules tend to be particularly mobile when 
they occupy structure channels and are weakly bounded to the host molecules63-65. However, also 
water molecules forming strong hydrogen bonds tend to experience C2 flips (exchanging the 
positions of the hydrogen atoms)66-68. Moreover, exchange of solvent molecules with solvent 
molecules from nearby atmosphere and exchange of hydrogen atoms between the solvent 
molecules and labile N-H and O-H sites in the host molecule is also taking part and have been 
studied using SSNMR and also Raman spectroscopy69, 58, 59. Motion of the solvent molecules is 
typically studied by measuring relaxation time of individual 13C atoms35 or common 1H relaxation 
time70 (as the mobility of solvent molecules usually drive the 1H relaxation of the whole solid via 
spin diffusion71), line broadening65 or spectra and its temperature dependence63, 72. Another 
commonly used approach is a study of the spectra of deuterium labelled sample in which 
quadrupolar coupling parameters and T1 relaxation time of deuterium atoms provide useful 
information about the dynamics of the corresponding sites63, 65, 73, 74. 
Characterization of the arrangement and dynamics of the solvent molecules in non-
stoichiometric solvates with different solvent content is more complex10, 16. Change of the solvent 
molecule amount in the solid phase and associated changes in the solvent site occupation factor75, 
76 usually introduce some changes in the solvent molecule arrangement and in the host structure 
itself. These typically include change of the channel size by therefore altering the lattice parameters 
(identifiable by PXRD as shift of the diffraction peaks56, 77, 78, see Figure 1.4a) and unit cell volume 
(see Figure 1.4b) as well as changes in the molecular level mobility (identifiable by SSNMR)35, 79. It 
has been shown that SSNMR can be more useful than XRD methods to understand structural 
changes and solvent molecule arrangement in such solvates73, 78-80, especially if the crystal structure 
is not known81, 82, as peak positions and width directly depends on the local chemical environment 
(and therefore the solvent content) and possible local disorder (see Figure 1.4c). Moreover, solvent 
dynamics can readily be identified and characterized. Besides, 2H spectra can even allow 
discrimination between bounded and surface solvent, which helps to rationalize the solvent 
sorption-desorption isotherms74. 
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Figure 1.4. Effect of different water content in non-stoichiometric hydrate on (a) PXRD 
pattern83, (b) unit cell volume83, and (c) 13C SSNMR spectra79. 
1.2.3 Characterization of crystal structure 
Crystal structures can be characterized based on two partially separable features: molecular 
conformation and intermolecular interactions. Combination of all intermolecular interactions 
present in the structure leads to molecular packing, and this feature can be analysed separately. All 
of these features can be characterized qualitatively by comparing the geometrical parameters, as 
well as quantitatively by calculating and comparing the energy of different molecular 
conformations, intermolecular interactions or whole crystal lattices. 
Molecular conformation. Molecular conformation is easily characterizable and comparable 
but is the least informative of the crystal structure features. Molecular conformation can be 
analysed qualitatively by comparing the values of any flexible torsion (dihedral) angles in the 
molecule8, 84, or quantitavely, by calculating the energy differences between conformers30, 85 or by 
performing PES scan with respect to flexible torsion angles86, 87. Such calculations nowadays 
typically are done at ab initio or DFT level. The similarity of the molecular conformation in different 
solid forms depends on the molecule flexibility and the energy differences between different 
conformers25, 88. In general, conformational differences can appear as either significant differences 
in one or more torsion angles, or accumulation of a large number of small differences in torsion 
angles88. Although analysis of the PES scan with respect to particular torsion angles can be used to 
evaluate the possibility of a molecule to adopt some particular conformation29, 30, 85, 89, this cannot 
be used as the main factor, because the most favourable conformation can sometimes prevent the 
formation of energetically favourable intermolecular interactions90. Therefore different 
intermolecular interactions in polymorphs and particularly in solvates, in which additional different 
structure building elements are introduced, can lead to a variety of different conformers present in 
the crystal structures, see Figure 1.5a8, 84, 91. 
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Figure 1.5. (a) Molecular conformation in different polymorphs and solvates of dehydro-
aripiprazole84 and (b) intermolecular interactions in different polymorphs and solvates of 
aripiprazole34. 
Intermolecular interactions. Although identification and geometrical characterization of 
strong intermolecular interactions is straightforward and conventionally used structure 
characterization tool, complete and comprehensive characterization of intermolecular interactions 
is more challenging. There are several possibilities for performing the characterization, starting 
from simple qualitative identification of the interactions and quantitative characterization of their 
geometrical parameters92, 93, quantitative characterization using Hirshfeld surfaces94-96, and finishing 
by quantification of all interaction energies in the crystal structure97-99, which was recently 
postulated as strongly suggested method to evaluate the relative importance of cohesion factors in 
crystals100. 
The most commonly characterized intermolecular interactions are strong hydrogen bonds, 
which are typically characterized by their geometrical parameters (distance and angle) as well as 
graph sets categorizing the interaction with respect to the hydrogen-bonding pattern formed. 
Graph set analysis divides hydrogen bonds in four patterns: chains (C), rings (R), intramolecular 
hydrogen-bonded patterns (S), and other finite patterns (D). Further analysis includes identification 
of motifs and higher level graph sets in cases when more than one different hydrogen bond is 
present in the structure9, 101. This analysis is of particular interest in supramolecular chemistry and 
crystal engineering9, 101. Identification of the characteristic hydrogen bonding pattern is still one of 
the most important information about the crystal structure and is used for fast evaluation of 
structure similarity. For example, three of aripiprazole polymorphs form hydrogen bonded 
catamers with graph set notation C(4), while other two forms hydrogen bonded dimers with graph 
set notation R22(8), see Figure 1.5b. The second pattern is observed also in three of the solvates, in 
which additional hydrogen bonds with solvent molecules are present, whereas in H1 more complex 
and not easily charaterizable higher level graph sets can be identified. 
However, recently it has been emphasized99, 100 that strong hydrogen bonds does not always 
determine stability of the crystal structure and also weaker interaction (e.g., weak hydrogen bonds 
and dispersion interactions) are important and therefore should be discussed. These interactions 
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can be visualized and analysed using commonly used structure visualization softwares (e.g. 
Mercury102). Nevertheless, lately a tool, CrystalExplorer103, for identification and characterization 
of all relevant intermolecular interactions have been provided. It generates Hirshfeld surface (0.5 
isosurface where the electrone distribution of a sum of spherical atoms for the molecule of interest 
is equal to the corresponding sum over the crystal) and maps different properties on this surface 
(e.g. curvedness, shape index, distance to the atoms)94, 95. The benefit of using Hirshfeld surface lies 
in the fact that the size and the shape of the Hirshfeld surface reflects the interplay between 
different atoms and intermolecular contacts in the crystal, and hence the surfaces reflect different 
intermolecular interactions94, see Figure 1.6a. From this surface 2D Fingerprint plot can be 
generated, in which a summary of the frequency of each combination of de and di (distances from 
the surface to the nearest atoms outside and inside, respectively) across the surface is provided94, 95 
by thus providing a concise two-dimensional summary of intermolecular interactions in the 
crystal104, see Figure 1.6b. Besides, this information can be decomposed into different interaction 
types by enabling analysis of their contributions and quantification of these different intermolecular 
interactions104. 
Nevertheless, the most straightforward way for evaluating the importance of the interactions 
is quantification of their energy. Nowadays this can be done relatively easily and this information 
can be obtained from fast but not always reliable force-field methods97, slower and more limiting 
but reliable semi-empirical PIXEL methodology98, 105-107, slow but usually the most accurate DFT 
or post-Hartree–Fock ab initio methods98, 108-110, and even from the experimentally determined 
electron densities111. In this way interaction energy between individual molecule pairs and its 
importance with respect to the total lattice energy can be evaluated30, 112, 113, see Figure 1.6c. 
Comparison of pairwise interaction energy values can facilitate the understanding of formation of 
the crystal structures by analysing the occurrence frequency of molecule pairs interacting in a 
particular way99, 114-116. Sum of the intermolecular interaction energy over all of the molecule pairs 
in the crystal is the lattice energy117. Comparison of the lattice energy allows determination of the 
stability of different crystal structures, if conformation energy is also taken into account30, 118. 
However, one should not forget that these calculations represent the relative energy at 0 K100, 117 
and temperature effect can be taken into account only by the analysis of the dynamics, which is 
computationally expensive and can be done by frequency calculations119, 120 or molecular dynamics 
simulations117. 
Lately Hirshfeld sufaces, 2D fingerprint plots and interaction energy calculations has become 
a commonly used tools8, 110, 121-123 or even is the main tools in the characterization and comparison 
of crystal structure 112, 113, 124, 125. Examples of the use of these techniques for characterization of 
crystal structures of arylboronic azaester126, arjunolic acid derivative127 and 7-Hydroxy-4-methyl-
2H-chromen-2-one112 are given in Figure 1.6. Besides, more new tools for analysing crystal 
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structures are appearing, e.g., recently developed Full Interaction Maps allow visualisation of the 
intermolecular interaction preferences of a molecule in a particular conformation and qualitative 
analysis of how well interaction preferences are satisfied within the lattice128. 
 
Figure 1.6. Characterization of intermolecular interactions using (a) Hirshfeld surfaces126, (b) 2-D 
fingerprint plots127, and (c) calculation of pairwise interaction energies112. 
Molecular packing. Analysis of all intermolecular interactions in the crystal structure leads 
to characterization of the molecular packing, which fully describes the arrangement of molecules 
with respect to all other molecules in the crystal structure. Similarities of molecular packing in 
different structures will appear in the case of coinciding intermolecular interactions, and depending 
on the level of the similarity can be either 0-D (isolated units such as dimers), 1-D (differently 
bundled identical rows), 2-D (differently stacked identical sheets) or 3-D (identical frameworks, in 
the case of isostructural phases)129. The identification of such similarities can be done either by 
visually comparing crystal structures, or by using special software XPac, which searches for 
identical supramolecular constructs in the crystal structures, identifies and quantifies crystal 
structure similarity129-131. This approach has been used for identification of the packing similarities 
in polymorphs and solvates8, 89, 123, 132 as well as in phases formed by structurally similar molecules133. 
Structural similarity based on the comparison of the whole crystal structure (therefore – 
molecular packing) can be quantified also using tools as dSNAP (compare geometrical parameters 
of the structure)130, IsoQuest (compare PXRD patterns)130, 134 or Mercury102 Compack algorithm 
(compare the arrangement of the molecules surrounding the central molecule)135. 
1.2.4 Prediction of solvate formation 
Understanding of the solvate formation is important in order to enable prediction of their 
formation and even their stability. Currently, it would be the most reasonable to make solvate 
predictions based on the solvent and host properties Although structural features leading to the 
solvate formation have not been completely identified, there are two main scenarios in which 
solvent molecules tend to incorporate into the crystal lattice by forming solvates136: a) potential 
intermolecular interactions between the molecules of the compound are not well satisfied and the 
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incorporation of solvent molecules provides a strong intermolecular interaction, or b) solvent 
inclusion in the crystal decreases the void space. In the first scenario, the solvate selectivity is 
typically based on their functionality, whereas it does not have to be so for the second scenario. 
However, most solvates include contributions from both of these driving forces, which can be 
viewed as lowering the crystal free energy primarily through electrostatic and van der Waals 
interactions, respectively. In more specific cases the solvent molecules can act as bridges between 
polar and apolar structure regions and/or serve the role of ligands completing the coordination 
around a metal ion3. It has also been concluded that solvate ability to involve multi-point 
recognition through hydrogen bonds strongly facilitates its stability137. 
More challenging is to understand the reasons for the formation of isostructural solvates, 
where the same host structure can incorporate different solvent molecules. There are cases where 
the formation of isostructural solvates can occur only from solvents with some specific 
interaction39, 41 or molecular shape37, although it is common that such solvates form with very 
different solvent molecules located in structural channels8, 38, 138. 
Rationalization of the solvate formation can also be achieved by evaluating the properties of 
the solvent molecules. There are several studies in which the most commonly used solvents have 
been grouped by classifying them according to statistical analysis of four molecular descriptors139 
as well as hydrogen bond acceptor and donor propensity, polarity/dipolarity, dipole moment, and 
dielectric constant140. Solvent classification according to their properties are given in Appendix 2. 
Detailed analysis of the arrangement of water and methanol molecules in crystal structures 
deposited in the CSD has been performed by trying to understand structural features necessary for 
the crystallization of hydrates and methanol solvates, identifying the most frequent hydrogen 
bonding patterns and motifs141, 142 and the most common environments143. Also various physical 
parameters have been correlated with the hydrate formation and it have been found that increase 
in the sum of the number of average donor and acceptor hydrogen bonds in the crystal structure 
causes an increase in the frequency of hydrates144. 
Despite the pessimistic feature promises145, computational crystal structure prediction have 
evolved rapidly146-148 in the last ten years and recently it has been shown to be successful in specially 
organized tests149, 150 as well as during polymorph screening studies as a valuable tool to understand 
the formation possibility of particular polymorphs and their energetic relations132, 151-154. 
Nevertheless, computational prediction of the solvate crystal structures is more challenging and 
until now predictions have been successful only in few cases mostly for relatively simple solvate 
systems149, 155-158. 
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1.3 Desolvation process 
1.3.1 Crystal structure aspects 
It is well known that solvate stability and desolvation process is directly determined by the 
crystal structure of the solvate and the solvent molecule arrangement in particular73, 159, 160. Crystal 
structure features are related with desolvation temperature and enthalpy, desolvation product, as 
well as desolvation kinetic model and activation energy. Therefore crystal structure aspects should 
be evaluated if the stability or the desolvation process of a solvate is studied. 
Classification of solvates with respect to the desolvation mechanism. Besides 
establishing the role of the solvent molecules in the crystal structure (section 1.2.2), structural 
changes during the desolvation process are suggested as a tool for solvate classification. Although 
this has been presented only for the hydrates, the presented classification is directly transferable to 
solvates of any other solvent. From a crystallographic point of view one can arrive at a somewhat 
simplified scheme, anticipating one of the three situations: a) the crystal structure of the resulting 
anhydrous substance is identical or very similar to that of the original hydrate, b) the crystal 
collapses resulting an amorphous phase, and c) the crystal transforms into a fundamentally different 
crystal structure10, 161. The drawbacks of this classification lies in the fact that it compares only the 
initial and the final crystal structures. Two more sophisticated theories have provided classification 
schemes which deals with this drawback. Nevertheless, the main conclusions are similar to those 
of previously mentioned simplified scheme. 
First theory, so-called “Rouen 96 model”, divides hydrates into two general classes and 
several subclasses based on the changes in the structural information upon the dehydration, by 
analysing the possible release of water molecules, formation of anhydrous material and possible 
reorganization processes162, see Appendix 3. The second theory explores and reviews all possible 
structural changes during the dehydration, resulting in six water evaluation types (WET) of 
hydrates, which are based on the observed transformations163. These WETs are described in 
Appendix 3. 
Structural relation of a solvate and the corresponding desolvate. Rational outcome of 
the desolvation process commonly is the formation of structurally similar non-solvated structure. 
This can occur for stoichiometric isolated site solvates164, and in particular for non-stoichiometric 
channels solvates34. Such structural similarity of solvate and its desolvate is usually accompanied by 
relatively fast and easy solvation-desolvation process164, 165 and the particular desolvation product is 
favourable if compared with formation of any other structurally different non-solvated 
polymorph165. Such structural similarities usually are easily identifiable, although sometimes they 
can be identified only in a complex molecular packing analysis8. If there are only slight structural 
changes during the desolvation, it is possible to develop a model of the desolvation mechanism by 
identifying conformation changes and molecule rearrangement42, 166. Such model can be confirmed 
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using quantum chemistry calculations by optimizing the geometry of a solvate structure where the 
solvent molecules have been removed. If the structural changes are small enough, after 
optimization the geometry of the experimental desolvate will be obtained167, 168. Although usually 
after the removal of the solvent molecules host molecules will rearrange to pack in a more compact 
way, some exceptions are reported where the unit cell size have increased after the desolvation169. 
However, not always there are structural similarities between the solvate and its desolvate, 
especially if the solvent molecules have crucial role in the stabilization of the crystal structure170. 
This is also supported by some of the possible solvent evaluation types in which structural 
information is not retained during the desolvation162, 163. Such a route explains some of the 
experimentally observed desolvation processes, e.g., the formation of thermodynamically unstable 
polymorph after the desolvation of R-cinacalcet hydrochloride, although thermodynamically stable 
polymorph has similar structure features to that of the solvate7, and the formation of only one of 
two energetically and structurally similar polymorphs after the dehydration of nitrofurantion 
monohydrate171. 
In cases when solvent molecules in the crystal structure occupy different sites with different 
arrangement and different intermolecular interactions, desolvation can occur in multiple stages161, 
169, 172, 173. Using computational chemistry it is possible to calculate the sorption energy of the solvent 
molecules by thus evaluating the cohesion energy of each individual solvent molecule in the crystal 
structure80. Particularly different cohesion energy and thus favourable multi step desolvation 
process is observed when solvent molecules in the structure occupy completely different 
environments, e.g. solvent molecules are located in structure channels and in isolated sites174, or 
even are associated with metal ions10. 
Effect of the structure on the desolvation process and kinetics. It is stated that the 
desolvation temperature and rate is associated with the solvent interaction energy (and enthalpy) 
in the structure175. Usually the thermal stability of solvates is compared using the desolvation onset 
point or the desolvation rate at a given temperature or heating rate. In general, thermal stability 
should be a function of all the host-guest interactions, host-host interactions, and the intrinsic 
properties of the guest itself175. Although it is stated175 and shown experimentally85, 89 that the 
thermal stability of solvates correlates with the normal boiling point of the solvent, this can be true 
only if the solvent molecules are weakly bound to the host material and situated in open voids. In 
other cases the solvate stability should strongly depend on the solvent molecule accommodation 
in the host structure: the interaction energy between solvent and host molecules and the spatial 
characteristics89. This is supported by the experimentally obtained order of the isostructural solvate 
thermal stability not matching the order of solvent boiling points63, 123 and explained by the presence 
of different solvent-host intermolecular interactions41, 170, 176, 177, tight binding of the solvent 
molecules in the crystal cavities8, 38, or steric effects hindering the desolvation138. 
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This also explains the difference between the desolvation features of isolated site and channel 
solvates: desolvation rate of isolated site solvates below the desolvation temperature is very slow, 
but rapidly become fast when the desolvation temperature is reached as all of the solvent molecules 
in the structure have identical environment10, 44. In contrast, the desolvation of channel solvates is 
continuous and have an onset at relatively low temperature. This is explained by generally accepted 
idea that all the hydrogen bonds of a given solvent molecule may get stronger as subsequent 
hydrogen bonds are formed. Thus, when one solvent molecule is taken away from this 
arrangement, the remaining solvent molecules become less strongly bound to the host system10. 
Also crystal packing efficiency can be associated with solvent molecule interactions and 
therefore the solvate thermal stability138. The relative sequence of the desolvation for different host 
structures can, in principle, be rationalized using factors as the presence and size of solvent tunnels, 
compactness of the crystal packing, hydrogen bonding, and other crystal packing factors160, 178. 
The desolvation mechanism (and kinetic model) is definitely related to the crystal structure 
of the solvate, and a study of structure transformations and desolvation kinetics can establish the 
desolvation mechanism90, 179-181. In the presence of solvent channels in the structure, rate limiting 
step will be determined by the energy barrier associated with the disruption of the intermolecular 
interactions and the diffusion of solvent molecules180-182. If the solvent molecules, however, are 
involved in structurally important intermolecular interactions and there are no solvent channels, 
the rate limiting step usually is the phase boundary advance towards the centre of the crystal90. 
There also have been attempts to connect the crystal structure features and the desolvation Ea, by 
concluding that for the studied solvates Ea can be related to the solvent-host interaction energy183. 
Moreover, it has been shown that the dehydration Ea of selected hydrates correlate with the 
dehydration onset temperature and therefore could be used to estimate their physical stability184. 
The presence of the solvent channels in the structure can be confirmed, if the microscopy 
analysis confirms anisotropic desolvation, as the desolvation in the channel direction will be 
favourable160, 185, 186 and the only rational explanation for desolvation in other directions is the 
cracking of the crystal due to different unit cell volume of the corresponding desolvate185. 
1.3.2 Qualitative aspects 
Fundamentals of solid state transformations and their description. Solid state reactions 
are heterogeneous (as at least two solid phases are involved) and are more complicated than 
reactions in homogenous media, because of various possible rate limiting steps, such as nucleation, 
nuclei growth, diffusion, and interface advance187-189. Moreover, the kinetics often are affected by 
particle size and their geometrical shape190. As the reaction usually occurs on the phase boundary, 
which is initiated at the defects in the crystal lattice or at crystal surfaces, edges, or corners, 
concentration does not relate to reactivity and conversion degree (or fraction converted) α is used 
instead. α takes values from 0 (no reaction has occurred) to 1 (reagent has reacted completely)190. 
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The rate of a solid-state reaction can be described using Eq. 1.3, where k is the rate constant 
and f(α) is the differential reaction kinetic model or the rate law187, 188. 
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
= 𝑘𝑘𝑘𝑘(𝛼𝛼)  (1.3) 
Integration of Eq. 1.3 produces Eq. 1.4, where g(α) is the integral reaction kinetic model187, 
188. 
𝑔𝑔(𝛼𝛼) = 𝑘𝑘𝑘𝑘  (1.4) 
Above mentioned different rate limiting steps lead to a variety of kinetic models, the most 
common of which are summarized in Appendix 490, 171, 187, 190-192. These models are generally 
categorized by the underlying mechanistic assumptions as: a) Nucleation: the rate-limiting step is 
the formation and the growth of product nuclei. The nucleation rate is different from that of the 
nuclei growth. Nucleation models are divided in A and P models based on the relative rates of 
nucleation and nuclei growth. b) Geometrical contraction: nucleation is instantaneous throughout 
the surface and the rate-limiting step is the progression of the product layer from the surface to 
the crystal inward, which is different for various crystal morphologies. c) Diffusion: the rate-
limiting step is the diffusion of the reactants into the reaction sites or the products away from the 
reaction sites. d) Other models: there are several other models, most often used of which are 
reaction-order models (analogous to homogenous kinetics), although in the solid state they usually 
are purely empirical190. 
Desolvation process and phase boundary. Desolvation can sometimes produce different 
products or can occur in multiple steps. Besides, the appearance of particular steps can depend on 
the desolvation conditions193. Therefore the identification of the desolvation products and 
intermediates is a crucial step in characterization of the desolvation process152. 
Chemical reactions and transformations in the solid state usually occur only in the phase 
boundary between the reactant and the product187, 188. In the phase boundary changes as crystal 
structure decomposition, bond reorganization, recrystallization, diffusion of evolved gases etc. 
occurs. These processes can occur either simultaneously, or can be divided by space and/or time, 
which determine the desolvation mechanism and the desolvation products 163, 187, 188, 194. The study 
of phase boundaries are complicated as they are not accessible for direct examination in an 
undestructed form195, 196. The phase boundary progresses (moves) into the unchanged reactant from 
a particular sites of the reaction initiation – nuclei – and the rate of the reaction is directly 
proportional to the total active contact surface between the reagent and the product. In the 
desolvation reactions nucleation usually occurs on the crystal surface and the phase boundary 
progresses inwards to the centre of the crystal, while the solvent is removed through the product 
layer194. The rate of the phase boundary advance in different crystallographic directions is often 
different. 
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Nucleation is particularly important step in the desolvation process, as it is believed that it 
determines the desolvation onset temperature. Besides, this step controls the geometry (and 
therefore the kinetic model) of the desolvation process, and it often depends on the presence, 
concentration and location of the crystal defects163, 197. 
1.3.3 Quantitative aspects 
Desolvation activation energy. Complete kinetic description of the solid state 
transformation is obtained only after the quantification of the rate constant dependence on the 
temperature and determination of the kinetic model191. The dependence of the rate constant on the 
temperature is usually described using the Arrhenius equation 1.5, where A is the frequency factor, 
Ea is the activation energy, T is the absolute temperature and R is the universal gas constant195, 198. 
𝑘𝑘 = 𝐴𝐴 ∙ exp �− 𝐸𝐸𝑎𝑎
𝑅𝑅𝑅𝑅
�  (1.5) 
The most common controversy in the solid state kinetics is the fact that the energy 
distribution of solid state reactions are suggested to differ from the Maxwell–Boltzmann 
distribution which is the basis of the Arrhenius equation. This has resulted a questioning of the 
physical significance of Arrhenius equation constants Ea and A187, 189, 195, 199. However, later the bond 
reorganization and electron transitions in the reaction zone have been described with band theory, 
which takes into account that the energy in the crystal during the reaction is in the form of phonons 
and electronic energy. The description of the energy distribution for both phonons and electronic 
energy has shown that they have the same form as that of the Maxwell–Boltzmann distribution 
and therefore use of Eq. 1.5 is justified195, 196. 
Determination of the kinetic parameters. Kinetic parameters can be determined in two 
general ways: using model fitting methods and model free methods. Recent reviews emphasize that 
the model-free methods should be preferred, especially when analysing non-isothermal data190, 200. 
Model fitting methods are based on the fitting of the experimental data to various solid state 
kinetic models (see Appendix 490, 171, 187, 190-192). The kinetic model is determined from the best 
statistical fit, while the rate constant (for isothermal data) or the Ea and A (for non-isothermal data) 
are calculated from the correlation analysis. The Ea values for isothermal data are then determined 
from the Arrhenius plot. Use of these methods have been criticized, especially for the analysis of 
non-isothermal data201-203. Nevertheless, they are still the most powerful and common tool for 
determination of the kinetic model from isothermal data186, 204, 205 and are widely used in the analysis 
of APIs172, 179. 
In the model free methods Ea is calculated without any modelistic assumptions. The most 
commonly used of these methods are isoconversional methods, where Ea is calculated at 
progressive conversion degree (α) values206 using data from multiple temperatures or heating 
rates207. These methods can be divided into two types – differential (most common of which is the 
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Friedman (FR)208 method) and integral (most common of which are average linear integral method 
(ALIM)209 and advanced isoconversional method (AIC)210, 211) methods. Mathematical expressions 
used in the most common isoconversional methods are given in the Appendix 4. 
The most common approach for determination of the kinetic model when Ea is determined 
with the isoconversional methods is the use of model fitting methods4, 15, 26 or the use of an 
integrated approach where these two method groups are combined90, 180, 212. Methods from this 
integrated approach used to determine the kinetic model include but are not limted to: a) 
reconstruction of the integral or differential reaction model with independently obtained Ea (from 
isoconversional methods) and frequency factor (calculated from isokinetic relationship90, 180, 213) 
values using Eq. 1.3, 1.4 and 1.5 90, 180, 214, b) use of algorithm provided in ALIM method209, and c) 
reduced time plots for isothermal data188 and so-called “master plots” for non-isothermal data 215. 
The last two approaches, however, are less commonly used. Mathematical expressions used for 
determination of the kinetic model are given in the Appendix 4. However, one should keep in mind 
that although the choice of the kinetic model is generally based on statistical fit of the mathematical 
models to the data190, the choice of a particular model should ideally be supported by other 
complementary techniques such as microscopy, spectroscopy, XRD, etc216. 
Effect of different factors on the desolvation kinetic parameters. As already mentioned, 
the desolvation kinetic parameters can be strongly affected by various sample and experimental 
factors and in some cases these factors can even have larger impact on the desolvation parameters 
than the crystal structure itself197, 217, 218. Differences of the sample particle size180, 204, 205, 219, 220, crystal 
habit221, sample history217, distribution and concentration of crystal defect 222, and seeding with the 
product183 can result in different desolvation rate, Ea variation and even change the kinetic model. 
Besides these sample factors, all the mentioned kinetic parameters can be affected by experimental 
factors as solvent vapour pressure in the atmosphere187, 188, 204, 205, 223, 224, inert gas flow rate187, 204, 
vapour pressure of concurrent or inert solvent225, 226, and sample weight219, 227. Thus, for better 
understanding of the desolvation process and the calculated kinetic parameters, the effects of 
sample and experimental factors should be evaluated, and the kinetic parameters should be 
reported together with accurate experimental conditions and sample preparation procedure. 
Various mechanistic features and sample factors can result deflections of the kinetic curves 
from those calculated using ideal kinetic models. Besides actual deviations from the kinetic model, 
these deflections can as well can be a result of averaging of the kinetic curve from reactions in 
various crystallographic directions194, 228 or from particles with different sizes194, 229. Although 
mathematical expressions have been provided to take this into account194, 230, in the absence of a 
convincing proof for a particular complication these equations are only empirical. 
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1.4 Analytical methods for characterization of solvates and polymorphs 
Most common analytical methods for characterization and studies of API polymorphs and 
solvates are X-ray diffraction methods (SCXRD and PXRD which analyse features and changes of 
the crystal structures), thermal methods (DSC, TG and DTA which analyse the thermal effects and 
associated weight changes), vibrational spectroscopy (IR and Raman spectroscopy), solid state 
NMR spectroscopy (which analyse the magnetic environment of nuclei and the molecular level 
dynamics) and microscopic methods (which includes HSM, SEM, AFM and which characterize 
crystal shape, morphology and changes in these characteristics). Main information obtained from 
these methods is briefly summarized in Table 1.1. Basic principles of commonly used techniques 
is not reviewed and can be found in the corresponding textbooks14, 92, 231-238. However, attention is 
paid to aspects of PXRD associated with the crystal structure determination as well as to less 
commonly used and described SSNMR. 
Table 1.1. Information obtained from different analytical techniques for each type of solid phases15. 
Phase SCXRD PXRD IR/Raman spectroscopy 
SSNMR 
spectroscopy 
Thermal 
methods Microscopy 
Polymorphs 
Same chemical 
composition. 
Unique unit cell 
parameters, 
molecular 
conformation 
and packing. 
Unique 
diffraction peaks. 
Useful for 
determination of 
phase purity and 
crystallinity 
degree. 
Characteristic 
spectra. Sensitive 
to hydrogen 
bonding. 
Unique chemical 
shifts. Useful for 
determining 
phase purity, 
molecular 
mobility. 
Unique mp, heat 
capacity, heats of 
fusion/transition, 
solubility. Useful 
for determining 
relative stability 
of forms. 
Characteristic 
indices of 
refraction, 
birefringence, 
dispersion colour 
and crystal habit. 
Solvates Same as polymorphs. 
Same as 
polymorphs. 
Unique solvent 
bands. Shifted 
API bands. 
Sensitive to 
hydrogen 
bonding. 
Unique solvent 
resonances. 
Shifted API 
resonances. 
Solvent mobility 
can be 
determined. 
Low-temperature 
transitions due to 
desolvation (in 
TG – weight 
loss). 
Same as 
polymorphs. 
Desolvation 
observable by 
HSM. 
Isomorphic 
desolvates NA 
Diffraction 
pattern only 
slightly changed 
from parent 
solvates. 
Solvent bands 
disappear. API 
bands shifted. 
Solvent 
resonances 
disappear. API 
resonances shift. 
Low-temperature 
desolvation 
absent. Events 
due to 
crystallization or 
lattice relaxation. 
Birefringent 
microcrystalline 
domains, with 
cracks and 
fissures. 
Amorphous 
solids NA 
No diffraction 
peaks. 
Broadened 
spectra. 
Broadened 
spectra. 
Glass transition 
seen. Often 
followed by 
crystallization 
and melting. 
‘Fragility’ related 
to width of Tg. 
No birefringence, 
irregular particle 
shape. 
Polymorphic 
mixtures NA 
Composite 
pattern of 
crystalline 
components. 
Composite 
spectrum of all 
components. 
Nuclei-specific 
composite 
spectrum of all 
components. 
Thermal 
behaviour 
indicative of 
phase diagram 
(e.g. mp- 
depression, 
eutectic melting, 
dissolution). 
Composite of 
distinct crystalline 
and amorphous 
particles. 
 
30 
1.4.1 Crystal structure and PXRD 
Peak positions and intensity in the PXRD pattern directly depends on the unit cell parameters 
and the crystal structure. Therefore changes in the PXRD pattern of a given phase is caused by the 
crystal structure changes. To determine the changes in the lattice parameters, PXRD pattern should 
be indexed, whereas to understand the crystal structure changes, crystal structure should be known. 
Lattice parameter changes can be identified from the changes in the peak positions, while lattice 
parameter optimization gives quantitative information about these changes. The most accurate 
approach for the lattice parameter optimization is the fitting of the whole PXRD pattern using 
whole powder pattern decomposition, where besides the lattice parameters also the parameters of 
peak profile function, particle size, strain, and peak asymmetry can be optimized232. The most 
popular is the Pawley fitting, which is derived from the Rietveld refinement by removing the crystal 
structure data, and adding the possibility to refine an individual intensity for every expected Bragg 
peak239, and very similar Le Bail fitting240. These methods are implemented in lot of softwares, e.g., 
EXPO2014, TOPAS, Fox, DASH etc. 
Recently the development of XRD equipment, as well as computational power and software 
have provided an opportunity to determine the crystal structure using only PXRD pattern. 
However, this is time consuming and not straightforward task, which is typically used only if the 
SCXRD analysis cannot be performed. Nevertheless, a lot of recent studies report crystal structures 
determined in this particular way, and the complexity of structures calculated in this way is 
constantly growing58, 241-244. Two of the most commonly used structure determination algorithms 
are Monte Carlo Simulated Annealing and Parallel Tempering. The quality of the structural model 
is evaluated using Rietveld refinement: a least-squares fit of the calculated diffraction pattern to the 
experimental diffraction pattern using the weighted R-factor Rwp as a similarity quantification 
tool245-247. 
1.4.2 Solid state NMR spectroscopy 
The main differences between the NMR in the liquid state and the SSNMR is the lack of a 
rapid motion, which leads to very broad peaks due to chemical shift anisotropy (CSA) and 
unaveraged dipolar and quadrupolar (only for quadrupolar nuclei) couplings. Besides, T1 relaxation 
time in the solid state is longer and may significantly differ for different atoms in the molecule 
(leading to longer experiment times), while linewidths are generally much broader (largely due to 
the effects of dipolar coupling)71, 248. 
Nevertheless, there are three techniques of considerable importance for obtaining high-
quality, well-resolved spectra, especially from powdered samples. These are magic angle spinning 
(MAS), heteronuclear decoupling and cross polarization (CP), all of which are used to record most 
of typical SSNMR spectra71. MAS involves spinning the sample at 54.74° with respect to the 
external magnetic field Bo at rate up to 15kHz (or even 100 kHz for 1H spectra) to average the CSA 
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and scale down the dipolar couplings (elimination of the dipolar coupling can occur only if the 
spinning rate is significantly faster than the strength of the dipolar interaction). Averaging of the 
CSA results in appearance of a peak at the isotropic chemical shift, as well as appearance of spinning 
sidebands (resonances spaced at intervals of the spin rate from the isotropic resonance frequency), 
if the spinning rate is not fast enough to completely average the CSA. Quadrupolar couplings are 
too large to be averaged out by the MAS, so numerous spinning sidebands will usually be seen in 
the spectra of quadrupolar nuclei. 
13C and 15N homonuclear couplings are typically not a problem, whereas high-power 1H 
decoupling should be used to eliminate the heteronuclear couplings by therefore significantly 
narrowing the peaks in 13C and 15N SSNMR spectra. In contrast, 1H homonuclear dipolar couplings 
are problematic as they cannot be averaged out by MAS because of the strength of these 
interactions and the fact that 1H chemical shift range is limited to ~15 ppm. Therefore to obtain 
reasonable quality 1H SSNMR spectra specially designed pulse sequences for 1H homonuclear 
decoupling are used in combination with ultra-fast MAS71, 248, 249. 
Another problem in SSNMR spectroscopy is that it is difficult to record a spectra of nuclei 
with low sensitivity (e.g., 13C and 15N) with good signal-to-noise ratio in a reasonable time. This can 
be overcome by using CP, which involves a transfer of magnetization from abundant 1H (or, 
occasionally, 19F) spins to dilute X ones, where X is any other spin−½ nucleus. There are two most 
apparent benefits for using CP sequence. First, the recycle delay is limited by the recovery of the 
1H magnetization and not that of the X spins. As usually T1H << T1X, the pulse sequence can be 
repeated much more rapidly than in a direct-excitation experiment, by thus significantly increasing 
the signal-to-noise ratio. Secondly, the gyromagnetic ratio of 1H is 4 and 10 times higher than that 
of 13C and 15N, respectively, therefore the magnetization transfer results a signal enhancement by 
the same factor, which represents 16- and 100-fold reduction in experiment time71, 248, 249. 
The strength of SSNMR lies in its ability to analyse different nuclei, and in the fact that the 
chemical shift and the appearance of the signal depends on the chemical environment and the 
molecular level dynamics in the solid structure. Moreover, modern quantum chemistry calculations 
can be used to predict the chemical shift, its anisotropy, dipolar and quadrupolar couplings (most 
commonly used technique for this is GIPAW250-253, which is implemented in periodic ab initio codes 
CASTEP251 and QuantumEspresso254), as well as to predict and analyse possible molecular level 
dynamics and its effect on the NMR parameters by using molecular dynamics. In contrast to the 
diffraction methods, local changes in the chemical environment will introduce changes in the 
spectra, which makes this method particularly useful for analysing isostructural phases. Besides, 
additional information can be obtained by performing spectral editing or 2D-spectroscopy 
experiments61, 71, 249. 
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SSNMR spectra can be used to probe molecular dynamics in the timescale of the nucleus 
Larmor frequency (usually tens to hundreds of MHz), MAS and decoupling frequency (usually tens 
of kHz). Besides the spectra itself, useful information about the dynamics can also be obtained by 
measuring the relaxation times. SSNMR is particularly concerned with three types of the relaxation: 
a) spin–lattice relaxation (the process of regaining equilibrium of the z component of 
magnetization, characterized by relaxation time constant T1), b) spin–spin relaxation (the process 
of regaining equilibrium of the xy component of magnetization, characterized by relaxation time 
constant T2 and is directly related to the linewidth or lineshape of resonances), and c) spin–lattice 
relaxation in the rotating frame (which describes the return to equilibrium of transverse 
magnetization in the presence of an RF magnetic field in the same direction, is characterized by 
relaxation time constant T1ρ and is of particular interest in CP experiments). From these the first 
(T1) and the third (T1ρ) are commonly analysed and used to probe the dynamics in the 
corresponding timescale (tens to hundreds of MHz for T1 and tens of kHz for T1ρ). Although 
molecular motions in solids can be very complex and are often poorly understood, in simple cases 
T1 and T1ρ pass through a well-defined minimum as the motional rate increases, with a tendency to 
increase toward infinity for very fast motions (as in mobile liquids) or very slow motions (as for 
rigid solids)71. 
1.5 Solid state characterization of the studied compounds 
1.5.1 Mildronate 
Mildronate, 3-(1,1,1-trimethylhydrazin-1-ium-2-yl)propionate (Figure 1.7a), is a γ-
butyrobetaine analogue, inhibitor of γ-butyrobetaine hydroxylase, and used as an anti-ischemic 
drug255, 256. It is known to exist in a form of dihydrate257, monohydrate and anhydrous phase258. The 
crystal structures of all these phases are known. Dihydrate DH belongs to space group P21/c257, 259, 
the monohydrate MH crystallizes in P-1 space group260, and water molecules in both hydrates are 
located in structural channels. The anhydrous phase AP belongs to P21/n space group with empty 
channels present in the structure260. Mildronate is very hygroscopic and deliquesces if kept in high 
humidity258, which is explained by the presence of the channels in crystal structures in all of its 
crystal forms260. When heated in dry air, mildronate DH transforms into AP, whereas at elevated 
temperature and relatively high humidity it transforms into MH258. 
 
Figure 1.7. Molecular structure of (a) mildronate, (b) droperidol, and (c) benperidol with the 
numbering of non-hydrogen atoms and flexible torsion angles. 
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1.5.2 Droperidol 
Droperidol, 1-{1-[4-(4-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl}-1,3-dihy-
dro-2H-benzimidazol-2-one (Figure 1.7b), is a neuroleptic pharmaceutical. It is reported to exist in 
two polymorphic forms I and II (also labelled as z)261, 262 and three solvated forms: dihydrate DH262, 
263, non-stoichiometric hydrate NSH (also labelled as x)261, 262, 264, and ethanol solvate SEt265. NSH, 
II and I can be identified by the melting points, which are reported to be 129°, 145° and 151°C 
respectively41. The crystal structures of the DH, SEt, NSH, and polymorph II have been reported. 
It is determined that the NSH and SEt are isostructural264. Although NSH is reported as 
hemihydrate261, it is nonstoichiometric and the water content in its structure can change freely from 
0 to 1264. DH is isolated site hydrate, whereas in both isostructural solvates solvent molecules are 
situated in the structural channels oriented along the a-axis. In polymorph II and in isostructural 
solvates droperidol forms hydrogen bonded amide homodimers. Additional structural stability for 
II is provided by two weak hydrogen bonds formed by the carbonyl group, whereas the structure 
of isostructural solvates is stabilized by three weak hydrogen bonds formed by the carbonyl group, 
tertiary nitrogen and fluorine, as well as by the hydrogen bond between the amide carbonyl group 
and the solvent molecules. DH structure, however, is stabilized by network of strong hydrogen 
bonds mediated by water molecules employing all the strong hydrogen bond donor and acceptor 
sites of droperidol. Molecular conformation of droperidol molecules in isostructural solvates and 
in II is very similar256. 
1.5.3 Benperidol 
Benperidol, (1-{1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl}-1,3-dihydro-2H-benzimid-
azol-2-one) (Figure 1.7c), is butyrophenone derivative, an antipsychotic, which can be used for the 
treatment of schizophrenia266. Its molecular structure is very similar to that of droperidol. 
Benperidol is reported to exist in three polymorphic forms I, II and III, a dihydrate DH and an 
ethanol solvate SEt. These phases are characterized by PXRD peak positions and DSC traces41. 
Crystal structure has been reported only for polymorph I, which crystallizes in R-3 space group, in 
which six benperidol molecules are connected with N2-H…N3 hydrogen bonds by forming a 
hydrogen boded ring R66(48)267. Besides, later study reports the preparation procedures and IR 
spectra of benperidol crystalline forms by concluding that in part of them benperidol exists in an 
enol form, and that polymorph III actually is a mixture of polymorphs I and II268. 
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2 MATERIALS AND METHODS 
2.1 Materials 
Mildronate (purity >99%) was provided by JSC Grindeks (Riga, Latvia) and was confirmed 
as pure DH by PXRD. Droperidol (purity >99%) was obtained from JSC Grindeks. The sample 
consisted of polymorph II. Benperidol (purity >99%) was obtained from JSC Grindeks. The 
sample consisted of polymorph I. 
Inorganic compounds and organic solvents of analytical grade were purchased from 
commercial sources and used without further purification (see Appendix 5). 
2.2 Sample preparation 
Mildronate dihydrate. Four samples differing by the preparation procedure and/or storage 
conditions were used. Samples were prepared by slowly crystallizing mildronate from water at 30 °C 
or by drying a paste obtained by adding a small amount of water to mildronate in mortar. The 
obtained samples were fractionated by pushing through sieves with mesh size 1300, 700, 350, 150, 
67 and 40 μm, yielding a maximum of 7 fractions (the obtained particle size distribution for 
different fractions is given in Figure S3, Appendix 7). Part of the 150-350 μm and 350-700 μm 
fractions was slightly ground and then fractionated by pushing through sieves with mesh size 350, 
150, 67 and 40 μm, and 5 fractions were thus obtained. Samples were stored at ambient temperature 
above saturated solutions of CH3COOK (RH = 22.5%) or MgCl2 (RH = 34%). More details of 
sample preparation procedures are given in the Appendix 7. 
For studying the effect of mechanical compression on the dehydration kinetics of DH, 
approximately 30 mg of sample was inserted in a die with 13 mm diameter, and then compressed 
at 130, 370 and 740 MPa for one minute. Manual hydraulic press was used for compression of the 
samples. Right after the compression, the obtained tablet was either gently ground to obtain 
powder or divided into smaller pieces suitable for analysis with TG. Dehydration analyses were 
started immediately afterwards. 
For studying the effect of prior history of dehydration/rehydration, the initial DH sample 
was dehydrated at 50°C temperature under N2 flow. Then the dehydrated sample was stored at the 
ambient temperature in 22.5% relative humidity. 
Solvent-based polymorph and solvate screening of droperidol and benperidol. The 
most popular solvents chosen from different solvent classes139, 140 (grouped according to physical 
and physicochemical properties) were selected for the crystallization of droperidol and benperidol. 
Saturated or concentrated solutions of droperidol or benperidol in all of the solvents were prepared 
at 40−130 °C depending on the boiling point of the solvent (see Table S1, Appendix 8 and Table 
S1, Appendix 11). The obtained solutions were then cooled down to −5°C. In the cases when no 
crystallization was observed, the solutions were slowly evaporated at 40°C or 50°C, while 
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preventing a complete evaporation. The obtained products were collected by filtration, air dried 
and characterized. 
Droperidol. For studying the thermal stability of the solvates and recording their SSNMR 
spectra, samples were prepared as follows: saturated solutions of droperidol in methanol, ethanol, 
acetonitrile, and nitromethane were prepared at 60 – 90°C depending on the boiling point of the 
solvent. The solutions were then cooled down to –5 °C or –20 °C, giving SMe, SEt, SACN, and SNM, 
respectively. Small amount of water (5-10%) was added to droperidol solution in acetone and the 
resulting solution was slowly partially evaporated at 50°C temperature, giving NSH. Solvates were 
stored in the mother liquor, filtered, dried and ground in a mortar for 30 s immediately before the 
analysis. DH was prepared by dissolving droperidol in acetone at 50 oC, cooling the solution to 
~10 °C, slowly adding similar volume of water and then slowly partially evaporating the resulting 
solution at 5 oC. Droperidol polymorph II was obtained by recrystallizing the sample from acetone 
at 50 °C. The identity of all droperidol phases was confirmed using PXRD. 
For a study of the desolvation kinetics, different sample preparation procedures were used. 
Four different types of NSH samples were obtained similarly as described above. Samples labelled 
as Crystals I - IV (the size of all of the dimensions was higher than 100 μm) were obtained by slowly 
evaporating the solution in a 100 mL conical flask, samples labelled Small crystals I-III (with the size 
below 100 μm for at least one of the dimensions) were obtained by evaporating the solution in a 
250 mL conical flask, while samples labelled Powder I-II (with the size below 40 μm for all of the 
dimensions) were obtained when the solution was evaporated at 25 oC temperature from a Petri 
dish. The fourth type of samples was obtained by grinding the Crystals II in a mortar. More details 
on the preparation of each sample are given in Table S2, Appendix 9. 
Organic solvates used for the kinetic study were prepared by obtaining saturated solutions 
of droperidol in the respective solvents at 60 – 90°C (depending on the boiling point of the solvent) 
and then cooling to –10 °C either slowly (obtaining crystals with the size of at least one of the 
dimensions below 100 μm, labelled Small crystals) or rapidly (obtaining powder samples with the 
particle size below 40 μm for all of the dimensions, and labelled Powder). Alternatively, well-ground 
polymorph II was suspended in the corresponding solvent at 50°C for 24 h, producing powdered 
solvate samples labelled Suspension. For the study of the desolvation kinetics of organic solvates 
under non-isothermal conditions, Small crystals were ground in a mortar for 1 minute. 
Prior to the analysis, solvate samples were stored at ambient temperature in desiccators above 
saturated solution of K2SO4 (97% relative humidity) for NSH and 90% solution (mole fraction) of 
the corresponding solvent with glycerol (for alcohol solvates) or DMF (for acetonitrile and 
nitromethane solvates). 
Deuterium-labelled droperidol solvates were prepared by grinding and then desolvating the 
original solvate at 50 oC over P2O5. The resulting sample was then placed in a closed container with 
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saturated D2O or d1-alcohol vapour. NSH with different D2O content was obtained by storing the 
deuterium-labelled sample above D2O to obtain monohydrate stoichiometry or above a saturated 
solution of MgCl2 in D2O to obtain approximately hemihydrate stoichiometry. 
Benperiodol. For studying the phase transitions and desolvation kinetics of the solvates, 
samples were prepared as follows: SEt, SMe and SACN were prepared by obtaining saturated solutions 
of benperidol in the respective solvents at 60 – 70°C (depending on the boiling point of the solvent) 
and then cooling to –5 °C by obtaining crystals. Alternatively, well-ground polymorph I was 
suspended in the corresponding solvent at 50°C for 24 h, producing powdered solvate samples. 
Similarly, SEtOAc, SNM, SBenz, HH and SDIOX were prepared by obtaining saturated or concentrated 
solutions of benperidol in the respective solvents (o-xylene containing traces of water for HH) at 
70 – 90°C (depending on the boiling point of the solvent) and then cooling to –5 °C by obtaining 
crystals (powder for SDIOX). Fast cooling of the ethanol and methanol solutions produced small 
solvate crystals (the size of at least one of the dimensions was below 100 μm), while slow 
evaporation of these solutions at 50 °C produced large crystals (the size of all of the dimensions 
was higher than 200 μm). Polymorph I was prepared by recrystallization from isopropanol, using 
saturated solution at 70 °C and fast cooling to –5 °C. Polymorph II was prepared by slowly 
evaporating benperidol solution in isopropanol at 50 °C. DH crystals were obtained when a similar 
volume of water was slowly added to droperidol solution in acetone and the resulting solution was 
slowly evaporated at 50°C temperature. Powdered DH was obtained when droperidol solution in 
acetone or DMF was poured into a large amount of water, by stirring the obtained suspension. 
SCLF and STCC were prepared as in the crystal forms screening experiments. 
Study of solvate stability. Stability of the solvates was determined at ambient conditions, 
by storing the solvate sample in desiccator over P2O5 at 30°C, and at elevated temperatures by 
heating the samples in air thermostats. The heating temperature was selected based on the recorded 
DTA/TG curves. Phase transformations was identified using PXRD and, if necessary, DTA/TG 
as well. 
2.3 Powder X-ray Diffraction 
PXRD patterns were measured at ambient temperature on a D8 Advance (Bruker) 
diffractometer using copper radiation (CuKα) at a wavelength of 1.54180 Å. The tube voltage and 
current were set to 40 kV and 40 mA. The diffraction patterns of mildronate samples were recorded 
with a scintillation detector using a scanning speed 0.5s/0.02° from 3° to 30° in the 2θ scale, the 
divergence and antiscattering slits were set at 1.0 mm, and the receiving slit was set at 0.6 mm. The 
diffraction patterns of droperidol and benperidol samples were recorded with a LynxEye position 
sensitive detector using a 0.2s/0.02° scanning speed (for phase identification) or 0.5s/0.02° (for 
lattice parameter determination) from 3° to 35° in 2θ scale, the divergence slit was set at 0.6 mm 
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and the antiscattering slit was set at 8.0 mm. To prevent the atmospheric humidity effect and 
decomposition of the solvates, when necessary during the analysis the samples were covered with 
a 10 µm polyethylene film. 
For crystal structure determination of benperidol phases, PXRD patterns were measured on 
a D8 Discover (Bruker) diffractometer at transmission geometry using Göbel Mirrors and a 
capillary sample stage. Other settings and equipment were identical to those used for D8 Advance. 
Samples were sealed in rotating (60 rpm) borosilicate glass capillaries of 0.5 mm outer diameter 
(Hilgenberg glass No. 10), and data were collected using 22s/0.01° (III), 25s/0.01° (SBenz), or 
36s/0.01° (HH) scanning speed from 2.5° (SBenz) or 4.5° (III and HH) to 70° on 2θ scale. 
For variable temperature PXRD (VT-PXRD) of mildronate DH, D8 Advance (Bruker) 
diffractometer equipped with a MRI heating stage, Sol-X energy dispersive detector, automatically 
adjustable slits (1.0, 1.0 and 0.1 mm, respectively) and Soller collimators was used. The diffraction 
patterns were recorded using a scanning speed 4s/0.02° from 10° to 25° in the 2θ scale. Stepwise 
temperature increase 1 °C per diffraction pattern was used from 30 to 60 °C, then 5 °C per 
diffraction pattern was used up to 80 °C. For VT-PXRD of droperidol and benperidol samples, 
D8 Discover (Bruker) diffractometer equipped with a MRI heating stage and LynxEye position 
sensitive detector was used. The diffraction patterns were recorded using a scanning speed 
0.2s/0.02° from 3° to 30° in the 2θ scale. Stepwise temperature increase 2 or 5 °C per diffraction 
pattern was used. 
2.4 Single crystal X-ray diffraction 
The single-crystal X-ray diffraction data for droperidol and benperidol phases were collected 
either at 173 K or 100 K on a Nonius Kappa CCD (Bruker) diffractometer, or at 120 K or 333 K 
on a SMART CCD 6000 (Bruker) diffractometer, both using Mo-Kα radiation (graphite 
monochromator, λ=0.71073Å) and Oxford Cryostream (Oxford Cryosystems) open-flow nitrogen 
cryostat for sample temperature control. The structure was solved by direct method and refined by 
full-matrix least squares on F2 for all data using SHELXTL269 and OLEX2270 software or SHELX-
97 suite269. All non-disordered non-hydrogen atoms were refined anisotropically. For disordered 
alcohol and ethyl acetate molecules a fixed value of site occupancy factor 0.5 was used. 
The packing coefficients for crystal structures were calculated by PLATON93. Mercury 3.3 
software102 was used for crystal structure analysis and simulation of powder X-ray diffraction 
patterns based on crystal structure data. 
2.5 Thermal Analysis 
Differential scanning calorimetry. DSC patterns were recorded with a DSC 823e 
apparatus (Mettler Toledo), 5 – 10 mg of each sample was used for analysis. Samples were heated 
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in sealed aluminium pans at heating rate of 1 °C∙min-1 or 5 °C∙min-1 from 30 °C to 120 °C in static 
air atmosphere. Some of the samples were pinholed with hole diameter 0.5 mm. 
Differential thermal analysis/thermogravimetry. DTA/TG analysis was performed with 
Exstar6000 TG/DTA6300 (SII Nanotechnology). Open aluminium pans were used. Heating of 
samples from 30 to 200°C (120°C for mildronate) was performed at a 5°∙min-1 (0.5, 1, 2, 3, 4 and 
5 °∙min-1 for mildronate) heating rate. Samples of 5-10 mg mass were used, and the nitrogen flow 
rate was 100±10 mL∙min-1 (80±10 mL∙min-1 for mildronate). 
Study of the desolvation kinetics. For studying the desolvation kinetics, TG analysis in 
open aluminium pans was performed with Exstar6000 TG/DTA6300 (SII Nanotechnology). For 
studying the desolvation kinetics in non-isothermal mode, samples were heated with heating rates 
of 0.5, 1, 2, 3, 4 and 5°C∙min-1 for mildronate and with variable heating rates in the range from 0.1 
to 3°C∙min-1 for droperidol. The nitrogen flow rate was 80±10 mL∙min-1 for mildronate and 
300±20 mL∙min-1 for droperidol. The sample weight for mildronate was 7.0±0.5 mg. For 
mildronate the effects of sample size and nitrogen flow rate were determined at additional data 
points, where the sample weight was 3 or 15 mg, and nitrogen flow rate was 30 or 300 mL∙min-1. 
Desolvation kinetics were studied also in the isothermal mode at the temperature range from 
25 to 80 °C for mildronate, 20 to 125°C for droperidol and 30 to 110°C for benperidol with a step 
of 5 °C . The heater unit was preset to the required temperature before the insertion of the sample. 
For each sample, desolvation was performed at eight (for mildronate) and four to eight (for 
droperidol and benperidol) different temperatures selected according to the desolvation rate, which 
depended on the analysed solvate and the particle size. For droperidol and benperidol the nitrogen 
flow rate was 100±10 mL∙min-1. For mildronate the sample weight was 7.0±0.5 mg, and nitrogen 
flow rate was 80±10 mL∙min-1. The effects of sample weight and nitrogen flow rate were 
determined at additional data points, where the sample weight was 2, 4, 6, 8, 10 mg, and nitrogen 
flow rate was 0, 45, 200, and 300 mL∙min-1. 
For studying the dehydration at controlled water vapour pressure, a system previously 
described in the literature271 was used for providing specific water vapour activity. Dry and moist 
nitrogen gas was mixed in a Gas controller unit (SII) at selected flow rates. The combined flow rate 
was 300 mL∙min-1. The relative humidity was measured with a TFH 620 (Ebro) humidity meter, 
which was previously calibrated using saturated solutions of NaCl and MgCl2. 
Hot stage microscopy. For HSM, a Laborlux 12 PolS (Leitz) polarized light microscope 
equipped with a heating stage and a Newtronic heating control module was used. The heating rate 
was 5 °C·min-1. Images were acquired with Leica Application Suite software from a DFC450 (Leica) 
digital microscope camera. 
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2.6 Determination of desolvation kinetic parameters 
For isothermal experiments, both model-free and model-based methods were used, but for 
non-isothermal experiments only model-free kinetic analysis was performed200. For isothermal 
experiments, data sets of α – time were obtained with Δα = 0.02 at each temperature. Temperature 
stability during the reaction was evaluated and further analysis was performed in the conversion 
degree region where temperature change was smaller than 0.3 degrees for all used temperatures. 
For non-isothermal experiments, data sets of α – temperature and time were obtained with Δα = 
0.02 for each heating rate. By using results from both experimental modes, Ea was calculated with 
isoconversional methods: Friedman (FR)208, average linear integral method (ALIM)209 and advanced 
isoconversional method (AIC)210, 211. For the first two methods Ea was calculated from the slope of 
the line in corresponding coordinates for α values with step size 0.02208, 209, but for AIC method the 
parameter Φ(Ea) was minimized with MS Excel Solver, obtaining Ea for α values with step size 
0.1210, 211. Confidence intervals for the calculated Ea values were evaluated from the slope error of 
the line used for calculation of Ea with the FR method. Kinetic model determination was performed 
with ALIM209 and reaction progress was reconstructed in the coordinates g(α) – α180, 272 and f(α) – 
α90, 180, 272. Besides, kinetic model determination for isothermal experiments was performed with 
reduced time plots188, but for non-isothermal experiments from master plots using the parameter 
Z(α)215. Most often used solid-state kinetic models were included in the analysis90, 171, 190, 191. 
For isothermal experiments model fitting methods were used as well. The kinetic model was 
determined from linearization of the experimental points in coordinates g(α) – time, and model 
with the best linear fit was selected from the list of most often used solid-state kinetic models90, 171, 
190, 191. The dehydration rate constants were subsequently determined by plotting experimental data 
points in the coordinates α – time and fitting theoretical lines modelled from selected kinetic 
models to the experimental points. The sum of squared differences between experimental and 
theoretically calculated α values was minimized with MS Excel Solver. If more than one model was 
selected for this procedure, then the best model was identified by the smallest sum of least squares. 
The Ea values were then determined from the Arrhenius plot. 
More details are given in Appendix 4. 
2.7 Gravimetric determination of solvent content 
Solvent content was determined for droperidol non-stoichiometric solvates stored in 
desiccators with controlled solvent activity in the vapour phase. To provide a variety of relative 
humidity (RH) values for determination of water content in NSH, saturated salt solutions and P2O5 
were used. The salts used for this experiment and the corresponding RH values were: LiBr (6%), 
LiCl (11%), CH3CO2K (23%), MgCl2 (32%), NaBr (56%), KI (68%), NaCl (75%), KCl (84%), 
K2SO4 (97%), and also P2O5 (~0%)273. To provide a variety of ethanol, methanol, acetonitrile, and 
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nitromethane vapour activity, solutions with different compositions of the corresponding solvents 
and glycerol for methanol and ethanol, and glycerol and dimethylformamide for acetonitrile and 
nitromethane were prepared. The solvent activity in the vapour phase was estimated by the Raoult’s 
law. All desiccators were thermostated at 30.0±0.5°C and the sample containers were weighed on 
analytical balance (d=0.1 mg). Further experimental details are given in Appendix 8. 
Similar procedure was used for recording sorption-desorption isotherm of mildronate. DH 
and AP samples were placed in humidity chambers thermostated at 25±1 °C where the relative 
humidity was provided with saturated salt solutions and P2O5 (see above) and their weight was 
controlled using analytical balance (d=0.1 mg) until no notable change of weight was observed. At 
the end of the experiment, the phase composition of each sample was determined with PXRD. 
2.8 Determination of lattice parameters of solvates with different solvent 
content 
The PXRD patterns were determined for droperidol solvates with different solvent content. 
Samples identical to those used for gravimetric solvent content determination were used. Both 
samples were stored together, and thus the solvent content was assumed to be identical. The lattice 
parameters of the fully solvated non-stoichiometric solvates was determined at ambient 
temperature with LP-Search algorithm in TOPAS 4.2274 using lattice parameters determined at 173 K 
in SCXRD measurements as the initial guess. The lattice parameters of the non-stoichiometric 
solvates with different solvent content were determined by performing the Pawley refinement in 
TOPAS 4.2 by relaxing the lattice parameters and the crystallite size parameter. 
2.9 Crystal structure determination from PXRD data 
The PXRD patterns were indexed for the first 20-25 peaks, using DICVOL04275 
(implemented in WinPLOTR software276) and SVD indexing algorithms277 (implemented in 
TOPAS v4.2). Space group determination was carried out using a statistical assessment of 
systematic absences, and Z’ was determined based on density considerations. Structure solutions 
were performed by Monte Carlo/Simulated annealing technique implemented in Expo2014278, 279, 
using a rigid model, flexible about the dihedral angles τ1–6 and τBenz1 and τBenz2 (Figure S7, Appendix 
11) for benzyl alcohol molecule by also determining the center of mass location and molecular 
orientation. The initial geometries of benperidol molecule as in crystal structures of polymorph I 
(for SBenz) and SACN (for HH and III) were used. For the structure of HH, oxygen atoms of water 
molecules were kept in the special positions, and the initial unit cell with water molecules was taken 
from the CSD (Refcode AMCHCA280). The initial geometry of benzyl alcohol molecule was taken 
from the CSD (Refcode FEBCUL281). The final refinements were carried out by the Rietveld 
method, maintaining the rigid bodies introduced at the structure solution stage. The background 
was modelled by a 20th-order polynomial function of the Chebyshev type; peak profiles were 
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described by the Pearson VII function and a common (refinable) isotropic thermal factor was 
attributed to all non-hydrogen atoms, while that of hydrogen atoms was assumed to be 1.2 times 
higher. 
2.10 Fourier transform infrared spectroscopy 
The ATR-FTIR spectra were collected for neat solids on a Frontier FTIR (PerkinElmer) 
spectrometer equipped with a Universal ATR Sampling Accessory with a diamond window. The 
spectra were recorded from 650 to 4000 cm-1 at a 2 cm-1 spectral resolution with 16 scans. 
2.11 Particle size analysis 
A Mastersizer 2000 (Malvern Instruments) laser diffraction instrument was used for particle 
size analysis. Integration time was 3000 ms. The measurement range was set to 0.020 – 2000 μm, 
and 59 counting channels were used. For sample dispersion nitrogen with 1.0 bar pressure was 
used. All measurements were carried out three times and the average particle size distribution was 
calculated. 
2.12 Karl Fischer titration 
A 836 Titrando (Metrohm) Karl Fischer volumetric titrator was used for the determination 
of water content in the samples. Approximately 100–200 mg portions of each sample were weighed 
on an analytical balance (d=0.1 mg) and titrated with Hydranal Composite 5 (Fluka). 
2.13 Solid-state NMR 
High-resolution solid-state NMR spectra were obtained using either a Avance III HD 
spectrometer (Bruker) operating at 125.67 MHz for 13C (499.72 MHz for 1H) and 76.71 MHz for 
2H with a 4.0 mm (rotor o.d.) MAS probe, or a VNMRS 400 spectrometer (Varian), operating at 
40.53 MHz for 15N (399.88 MHz for 1H) with a 6.0 mm (rotor o.d.) MAS probe. 15N spectra were 
recorded at ambient temperature, whereas 13C and 2H spectra were recorded at controlled 
temperatures from 20 oC down to –45 oC. Note that these are set temperatures that do not attempt 
to correct for sample heating under magic-angle spinning; these are estimated to be of the order of 
+5, +8 and +15 °C for the 2H, 15N and 13C spectra respectively. 
13C and 15N spectra were obtained under MAS conditions using cross polarization (CP) with 
the following conditions: recycle delay 7–30 s for NSH, SMe and SEt, and 120–180 s for SACN, and 
SNM, contact time 0.5–2 ms, a sample spin rate of 13 kHz for 13C and 6.8 kHz for 15N spectra, and 
acquiring 300–1000 transients for 13C and 440–3600 transients for 15N (depending on relaxation 
delays). SPINAL64 with 78 kHz 1H nutation rate and TPPM with 55.6 kHz nutation rate were used 
for heteronuclear decoupling of the 13C and 15N spectra respectively. Spectra were referenced with 
respect to external neat TMS for 13C or neat nitromethane for 15N by setting the high-frequency 
signal from a replacement sample of adamantane to 38.4 ppm or the nitrate signal from a 
replacement sample of solid ammonium nitrate to –5.1 ppm, and typically processed with an 
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apodisation function corresponding to a 20 Hz Lorentzian line-broadening prior to Fourier 
transformation. 13C linewidths were determined by fitting the peaks to a mixed Lorentzian 
/Gaussian lineshape in the Bruker TopSpin software. 
Carbon-13 T1 values were estimated from direct-excitation spectra with recycle delays of 0.2–
180 s, while more accurate measurements were made using saturation-recovery experiments with 
recovery delays of 0.1 ms – 90 s. 12 pulses separated with a 10 ms delay were used for saturation 
of the 13C magnetization. 200–240 repetitions were accumulated, with a spinning rate of 13 kHz 
and 1H decoupling nutation rate of 71 kHz. T1 values from variable recycle delay experiments were 
calculated by fitting peak heights to a simple rising exponential function using Excel Solver. T1 
values from saturation-recovery experiments were determined in TopSpin by fitting integrated peak 
areas to a rising exponential. Note that measurement of the relaxation times for the CH3 of SEt in 
particular were complicated by transient Nuclear Overhauser effects282; this is discussed further in 
the Appendix 10. 
2H MAS spectra were acquired without proton decoupling with 10 kHz spinning rate and 10 
s recycle delay, acquiring 1000–10000 transients (depending on time available). T1 relaxation times 
were estimated with short experiments (50–100 repetitions) with the recycle delay varying up to 
10 s or 30 s using 7–9 increments. T1 values were estimated by fitting peak heights to a simple rising 
exponential function as above. Bandshape analysis of the spinning sidebands was performed in 
Gsim283 / pNMRsim284 by simultaneously fitting the peak linewidths (using a Lorentzian lineshape 
function) and quadrupolar coupling parameters from both ND and solvent sites. Flat baselines, 
which are significant for fitting, were typically obtained by discarding the data points before the 
first rotary echo for signals obtained on-resonance. Alternatively, the baseline roll was suppressed 
using spline fitting in TopSpin. 
2.14 Theoretical calculations 
Geometry optimization and energy calculation of the crystal structures. The starting 
geometries of all droperidol and benperidol phases and mildronate DH were obtained from 
SCXRD experimental data259, while that of mildronate AP was used as determined from PXRD 
data260 and then corrected in Gaussian09 at the B3LYP/6-31G level, see Appendix 6. Since the 
solvent molecules in droperidol SMe and SEt are disordered over two orientations related by 
inversion symmetry, the starting geometries of SMe and SEt without disorder were prepared by 
discarding one of the solvent molecule orientations, by thus creating a structure in the P1 space 
group with two symmetrically individual droperidol molecules. The starting geometry for 
droperidol ISD was obtained by removing the water molecules from the NSH structure. Geometry 
optimization of crystal structures were performed in CRYSTAL09285 and in CASTEP251. 
Calculations in CRYSTAL09 were performed at the B3LYP-D*277, 286 level using 6-31G(d,p) basis 
set287, 288, dispersion interactions were treated using Grimme dispersion correction model289 
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modified as described in the literature98, 286, 290. All of the obtained energies were corrected for basis 
set superposition error by the counterpoise method291. The calculations in CASTEP were 
performed with the PBE292 functional using on-the-fly generated ultrasoft pseudopotentials and 
cut-off energy of 600 eV. Dispersion interactions were treated using semiempirical dispersion 
correction schemes of Grimme (G06)289 and Tkatchenko-Scheffler (TS)293. Crystal structure 
optimization was performed by employing three different procedures – by relaxing only the 
hydrogen atoms (HO), by relaxing all atoms (ALL), and by relaxing all atoms and the unit cell 
parameters (UC) – using three different calculation methods: PBE+TS (HO, ALL and UC) and 
PBE+G06 (UC) in CASTEP, as well as B3LYP-D* (UC) in CRYSTAL09. Identical input 
geometries were used for all of the calculation methods. 
Geometry optimizations of droperidol solvate doubled unit cells (see Appendix 9 and 
Section 3.5.4) with adjacent solvent molecules in the same or opposing directions were performed 
both with the pure PBE functional and also using the TS dispersion correction scheme293. The 
orientation of the solvent molecule was inverted by manually adjusting the atomic coordinates on 
one solvent molecule prior to full geometry optimisation. Structures where adjacent alcohol 
molecules were oriented in opposite directions were used to confirm the validity of the ordered 
model of SMe and SEt by calculating the intermolecular interaction energy of the solvent molecules 
(see Appendix 9). 
Frequency calculation294, 295 was performed in CRYSTAL09 for mildronate structures after 
the full geometry optimization in order to calculate the zero-point vibration correction and thermal 
correction on the total energy. 
Calculations in Gaussian 09. Single molecule and molecular cluster energy calculation and 
geometry optimization were performed in Gaussian 09296. The potential energy surface (PES) scans 
with respect to one dihedral angle were performed at the MP2/6-31G(d,p) or B3LYP/6-311G(d,p) 
level with step size of 10°, while PES scans with respect to two dihedral angles were performed at 
the B3LYP/6-31G level with step size 15° for each dihedral angle. For this analysis mildronate 
molecule was extracted from nonoptimized DH structure with atom coordinates as in the 
literature, from AP structure corrected at the B3LYP/6-31G level (see Appendix 6), as well as from 
droperidol NSH and benperidol SACN structures optimized in CASTEP. 
The molecular volumes of selected solvent molecules were calculated in Gaussian 09296 after 
the geometry optimization at the B3LYP/6-311G(d,p) level using Grimme’s dispersion 
correction297. 
Simulation of IR spectra was performed by extracting a characteristic molecular fragment 
representing the intermolecular interactions (amide homodimers for II and SACN, six benperidol 
molecule ring for I, chain consisting of three benperidol and two alcohol molecules for SMe and 
SBenz, and a fragment of three benperidol and one water molecule for HH). Geometry optimization 
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and frequency calculation was performed at PM6 level, and the obtained freqjuencies were 
multiplied by a scale factor 0.953 298. 
Calculation of the intermolecular interaction energy. The interaction energies between 
pairs of molecules were calculated in Gaussian 09296 using the B3LYP and M06-2X299 functionals 
and 6-311G(d,p) basis set to molecular geometries directly extracted from the crystal structures 
after the geometry optimization. The basis set superposition error was corrected using the 
counterpoise method. For B3LYP calculations the Grimme dispersion correction method was 
used297. The interaction energy was calculated as the difference between the total energy of the 
dimer and the corresponding isolated molecules. The total interaction energy values were calculated 
as a sum of all pairwise interaction energies (without the correction for double counting of identical 
interactions) for molecule pairs having contacts shorter than the given cut-off distance, see Table 
3.16. 
Calculation of the lattice energy. Lattice energy calculations were performed with semi-
empirical PIXEL97 methodology (code provided in the CLP software suite), which also provides 
information about pairwise intermolecular interaction energies. This code enables decomposition 
of total lattice energy and pairwise interaction energy into electrostatic, polarization, dispersion and 
repulsion contributions. Empirical parameters for calculations were used as provided in the 
literature97, 300. The atom positions for the purposes of this calculation were obtained by standard 
procedure using RETCIF and RETCOR modules. Hydrogen atom positions were either 
renormalized or optimized by CASTEP. Molecular electron density calculations were performed 
in Gaussian 09296 at the MP2/6-31G(d,p) level using standard grid parameters. Condensation level 
4 and cutoff distance 35-45Å depending on the molecule size were used. 
Calculation of chemical shift. Chemical shift calculations were carried out using the 
GIPAW method implemented in CASTEP250-253, after geometry optimization of the droperidol 
crystal structures determined at 173 K. Since the first principles calculations cannot be applied to 
disordered structures, starting structures of SMe and SEt without disorder were prepared in two 
ways: (a) both structures were solved in the P1 space group with ordered solvent and (b) P1 
structures were derived from the reported P  structures by discarding one of the solvent molecule 
orientations. Calculations were performed with the PBE292 functional using on-the-fly generated 
ultrasoft pseudopotentials and a cut-off energy of 600 eV, with integrals taken over the Brillouin 
zone using a Monkhorst-Pack grid of a minimum k-point sampling of 0.05 Å−1. Two approaches 
were used for geometry optimization: optimization of hydrogen atom positions only and 
optimization of all atomic positions. Unit cell parameters were fixed to the values determined from 
X-ray diffraction studies in both cases. The computed 13C and 15N chemical shifts were referenced 
by linear regression of computed shielding values to the experimental shifts252.  
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3 RESULTS AND DISCUSSION 
3.1 Dehydration mechanism of mildronate dihydrate 
When heated in dry air, mildronate DH transforms into AP, whereas at high temperature 
and relatively high humidity it transforms into MH258. However, the dehydration mechanism of 
the DH, the only stable mildronate form in ambient conditions, has not yet been examined. 
Understanding the mechanism of such dehydration is important for the systematic study of the 
dehydration processes of pharmaceutical materials58. The aims of this study thus were: a) to 
determine the dehydration mechanism of mildronate DH; b) to establish the reasons for the 
observed one step dehydration process of mildronate DH directly to the AP, and c) to calculate 
the dehydration kinetic parameters and relate them to the dehydration mechanism and the crystal 
structure of DH. 
3.1.1 Characterization of mildronate dihydrate dehydration 
It was determined that at 25 oC temperature DH was stable in the relative humidity interval 
from 6 to 50%, but dehydrated to AP at humidity below 6%. Thus it was confirmed that MH was 
not thermodynamically stable at any of the examined conditions. It was observed that the 
dehydration of DH at various temperatures gave AP as the only product, implying that the 
dehydration of DH was a one step process. In order to confirm this dehydration mechanism, we 
analyzed dehydration of DH with VT-PXRD under air atmosphere. The temperature in the range 
where dehydration was observed in other experiments was raised with 1°C step size per diffraction 
pattern, until complete dehydration was observed. Diffraction patterns for those temperatures 
where phase transition was observed are given in Figure 3.1. It can be seen that at p(H2O) = 1.1 kPa, 
relative humidity 40% at 22 °C, dehydration started at 57 °C temperature, which was identified by 
appearance of the AP peaks (marked with blue triangles). Formation of MH was not observed in 
this experiment, nor in other similar experiments. The characteristic diffraction peak position for 
MH would be at 12.0 ° and 16.6 ° in 2θ scale. 
 
Figure 3.1. VT-PXRD patterns of mildronate DH dehydration. 
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Dehydration of DH samples was analyzed with DSC in closed and pinholed sample holders 
and with DTA/TG in open pans under nitrogen flow. In DTA analysis one or two overlapping 
endothermic peaks appeared with dehydration starting at 45-55 °C. The second endothermic effect 
was always observed as a relatively narrow peak at 86-88 °C and above this temperature the weight 
loss rate noticeably decreased. The temperature of first peak was affected by the heating rate and 
the particle size, whereas these parameters did not affect the temperature of the second peak (see 
Figure 3.2). When DH samples were analyzed with DSC, dehydration was observed as a narrow 
signal with peak temperature of 88-90 °C, regardless of the hole in the container (see Figure 3.2). 
From various experiments (9 scans for particle size fractions from <40 µm up to 350-700 µm) the 
enthalpy of the observed process was calculated as 31.8±0.9 kJ∙mol-1. 
 
Figure 3.2. DTA/TG curves of mildronate DH fraction 67-150 µm at various heating rates 
(on the left) and DSC curves of mildronate DH at heating rate 5 o·min-1 (on the right). 
From the obtained data it can be concluded that the observed endothermic process in the 
DSC scans under static air atmosphere was melting/peritectic decomposition of the DH. This 
explains the observed enthalpy value (31.8±0.9 kJ∙mol-1), which was too low even for the 
evaporation of two water molecules (vaporization enthalpy of water at the corresponding 
temperature is 41.6 kJ·mol-1)301. This was obvious for closed pans, and the explanation for pinholed 
pans was that the size of the hole was too small for evaporation of the evolved water during the 
analysis. However, when DH was heated in DTA/TG instrument on open pans, nucleation of AP 
started at lower temperatures and water was lost much more effectively. Thus the dehydration of 
the DH was finished before reaching the melting temperature in cases when the heating rate was 
slow enough and/or particles were small enough. By using the DTA data it was calculated that the 
dehydration enthalpy of the DH was 120±10 kJ·mol-1, corresponding to the sum of the crystal 
hydrate decomposition and water vaporization enthalpies (DTA was calibrated with substances 
having known melting and dehydration enthalpy values). 
If complete dehydration was not reached until the melting temperature in the DTA scans, 
then a melting/peritectic decomposition process was also observed. This was supported from 
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HSM study of two samples with different particle sizes (see Appendix 6) and by decrease of the 
weight loss rate. 
Phase composition of the samples obtained after and during DTA/TG analysis was 
determined with PXRD. It was found that for samples where dehydration was observed as a one 
step process (complete dehydration was reached below 86 – 88 °C), the only phase which formed 
during and after the dehydration was AP. The results of PXRD and thermal analysis thus indicated 
that AP formed as the only product in a one-step dehydration process. However, when dehydration 
was slower (and also the melting/peritectic decomposition signal appeared in DTA) during and 
after the second endothermic dehydration peak (at temperatures above 90 °C), MH was sometimes 
also detected as one of the phases. Nevertheless, after exceeding the melting temperature, 
formation of MH occurred due to the crystallization of mildronate from solution or solid phase 
transition from the AP in the presence of liquid water. This observation agreed with the previously 
reported fact that MH was stable only at elevated temperature258. 
3.1.2 The relationship between crystal structures and the observed dehydration 
mechanism 
The dehydration of DH resulted in the formation of AP instead of MH. This observation 
could be related to the similarity of the crystal structures of DH and AP. To explore this theory, 
we analyzed the structures of three crystalline phases formed by mildronate. 
Mildronate molecules in the structures of DH and MH adopted the same conformation and 
were characterized by the same hydrogen bonding motif different from that in the AP structure. 
Thus, from this analysis, crystal structures of DH and MH appeared to be similar260. 
However, analysis of molecular packing in the crystal structures of DH, AP and MH showed 
that structures of DH and AP were similar and consisted of four mildronate molecules notated A, 
B, C and D (each generated by one of four symmetry operations corresponding to P21/c or P21/n 
space group). In DH these molecules were grouped around hydrogen bonded graph set ring 𝑅𝑅44(8) 
formed by water molecules (see Figure S12 in Appendix 6). Each of the four molecules A, B, C 
and D formed a hydrogen bonded molecule pair with the molecules A′, B′, C′ and D′, respectively. 
Similarly arranged four pairs of molecules A-A′, B-B′, C-C′ and D-D′ could be identified in the 
crystal structure of AP as well (see Figure 3.3). However, in this structure between these molecules 
there was an empty channel, and molecule pairs were packed more tightly. Besides this, there were 
significant changes in molecular conformation (τ1 and τ2, see Appendix 6) and hydrogen bonds 
between the molecule pairs A and A′, B and B′ etc were lost, but new hydrogen bonds formed 
between molecules A and D, and between B and C, thus forming C(6) chains (see Figure S12 in 
Appendix 6). Therefore, inversion-related antiparallel molecule pairs occurred in the crystal 
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structures of DH and AP. Two such antiparallel pairs (A-A’ and C-C’) were situated 
perpendicularly to two other (B-B’ and C-C’). 
 
Figure 3.3. Molecular packing in the crystalline forms of mildronate (hydrogen atoms have 
been omitted for clarity). 
In the crystal structure of MH, inversion-related antiparallel molecule pairs E-F were packed 
parallel to other such pairs, resulting in layers of mildronate molecules (see Figure 3.3). These layers 
were interconnected by hydrogen bonds mediated by water molecules (see Figure S12 in Appendix 
6). Although hydrogen bonded antiparallel molecule pairs with the same molecular conformation 
were present in both hydrates, these pairs in the MH structure were packed in different way. 
Therefore, the molecule conformation can be associated with hydrogen bonding motif and/or the 
presence of the hydrogen bonds with water molecules but not with the molecule packing. 
Thus, it was shown that the transformation from DH to AP was associated with only minor 
changes in packing of the mildronate molecules. At the same time, the transformation from DH 
structure to MH was connected with important reorganization of mildronate molecular packing, 
which could occur only during destructive dehydration followed by crystallization of a new phase. 
Thus it can be seen that transition from DH to AP should be an easy one-step process, and not 
connected with formation of MH as an intermediate step. However, dehydration did not occur as 
a single crystal to single crystal transition. It can be concluded that structure reorganization was 
important enough to introduce cracking and thus AP was produced as a polycrystalline powder. 
Based on the structural analyzes, we provide a mechanism of water elimination and structure 
reorganization explaining the observed dehydration of DH to AP. Due to the presence of large 
channels containing all of the water molecules, it was likely that the first step in the dehydration 
process represented escape of water by emptying of the channels (see 1 in Figure 3.4). After this 
step, conformation change (2) and molecule translation (3) occurred, forming AP as the final 
product. Although separated in the Figure 3.4 for the clarity, most probably both of these processes 
happened simultaneously and were associated with disappearance of the hydrogen bonded 
molecule pairs and formation of new hydrogen bonds observed in AP structure. 
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Figure 3.4. Schematic representation of structural reorganizations during the transition from 
DH to AP. 
Thus, based on the dehydration process classification according to structural changes during 
the dehydration, dehydration of the DH could be classified as a) a water evolution type WET3 
with direct formation of AP crystalline phase after the dehydration163 and b) cooperative release of 
water followed by the cooperative rearrangement, thus belonging to the class II-Coop.-Reorg.162, 
according to the two systems described in literature. 
3.1.3 Kinetic parameters of dehydration 
Particle size. Dehydration of DH was studied for samples with different particle sizes. 
Particle size distribution for different DH fractions is given in Figure S1 in Appendix 6. PXRD 
was used to determine that in all of the cases AP was obtained as the only dehydration product. 
The dehydration Ea value for each fraction was calculated from isothermal experiments and are 
shown in Figure 3.5. 
From Figure 3.5 it can be seen that Ea of the samples with particle size up to 350 μm was 
75±3 kJ·mol-1, but for particles larger than 350 μm there was a significant decrease of the Ea caused 
by increasing the particle size. Most probably this decrease of the Ea for larger particles was due to 
diffusion control. When considering water vapor escape through a thick product layer, the rate 
becomes diffusion limited for some critical particle size, and this effect grows upon further increase 
in the particle size. 
 
Figure 3.5. Dehydration activation energy for different fractions of DH. 
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It was determined that the most appropriate kinetic model for dehydration of fractions with 
particle size below 150 μm was the one-dimensional phase boundary model R1, but for particle 
size above 350 μm it was the two-dimensional phase boundary model R2. Kinetic models R1 and 
R2 both describe phase boundary controlled reactions with different dimensionality. This result 
fits with the observations from hot stage microscopy where dehydration process initiated on the 
single crystal surface and then reaction boundary progressed inwards to the crystal interior. It has 
been mentioned in the literature163 that the typical thickness of the reaction interface is 10 – 150 µm, 
so for smaller particles the only rate limiting step can be formation and advance of this interface 
towards the crystal interior from only one energetically more favourable direction. However, the 
formation of the phase boundary for bigger particles (applicable in this case where the average 
particle diameter was above 350 µm) was complete when there still was a lot of DH present. Thus 
the rate limiting step could also involve reaction interface advancement from other crystal faces, 
which could be described by a two dimensional phase boundary mechanism. 
Sample weight. Dehydration of DH <40 µm fraction was studied for samples with 
different weight. It was determined that the dehydration rate decreased when the sample weight 
was increased. The reason for the decrease of the rate constant by increasing the sample weight 
can be due to the slower vapor diffusion through the sample layer, which limits the total 
dehydration rate. Dehydration Ea dependence on the sample weight was calculated as well and the 
obtained results are shown in Figure 3.6. It is apparent that the Ea decreased by increasing the 
sample weight. Such an effect can be the result of increased contribution from the bulk diffusion 
effect upon increasing the sample weight as the Ea of the diffusion step typically is smaller than 
that of the phase boundary reaction and more contribution from the diffusion would be observed 
by increasing the sample weight. 
 
Figure 3.6. Dehydration activation energy dependence on sample weight for the <40μm 
fraction. 
3.1.4 Dehydration mechanism 
There are large channels containing water molecules along the a-axis257, 259 in the DH 
structure. Thus, we suggested that during the dehydration of mildronate DH, water molecules 
escaped through these channels. It has been postulated that if the dehydration environment is 
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controlled by nitrogen flow with relative humidity close to zero, then the water molecule diffusion 
to the crystal surface should not control dehydration rate181, as it appeared for mildronate DH 
where dehydration kinetics were described by the models R1 and R2. Thus it can be concluded 
that the rate limiting step should be hydrogen bond dissociation and/or molecular conformation 
change and reorganization. From the PES analysis it was determined that the energy necessary for 
molecular conformation changes was at least three times lower than the dehydration Ea (see 
Appendix 6). Thus it can be predicted that the rate limiting step most probably is the disruption of 
the hydrogen bonding network, or separation of mildronate molecules paired through hydrogen 
bonds in the crystal structure of DH257. 
However, it was also found that besides phase boundary advance other factors limited the 
rate of dehydration: a) diffusion rate of water outside of the crystal and b) diffusion of water from 
the inside of the powder. By changing the particle size and sample weight influence of these rate 
limiting steps could be modified. However, based on the results from kinetic model determination, 
phase boundary advance was the main rate limiting step. 
Based on the crystal structure it can be suggested that for small particles the phase boundary 
advance during the dehydration of DH occurred along the a-axis and complete dehydration was 
reached by phase boundary advance only in this direction. The dehydration rate could thus be 
described with a one-dimensional phase boundary reaction model. However, for particles with 
larger size than 350 µm, dehydration most probably occurred also in the second energetically 
favourable direction. This can be described by the movement of the reaction interface also 
perpendicularly to the channels where water molecules are situated in the DH crystal structure. As 
a result the dehydration could be described by a two-dimensional phase boundary reaction model. 
It is possible that evolving of water in the direction perpendicular to the water channels is hindered, 
thus contribution from the diffusion increased in this case, and the dehydration Ea decreased as 
observed for samples where R2 was determined as the most appropriate kinetic model. Schematic 
representation of the dehydration process and the rate limiting steps are given in Figure 3.7. 
 
Figure 3.7. Schematic representation of the dehydratiom process and the rate limiting steps 
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3.1.5 Conclusions 
The mechanism of mildronate dihydrate (DH) dehydration was analyzed according to 
various experimental methods, and it was determined that dehydration of the DH is a single-step 
process leading directly to the anhydrous form (AP). By analyzing the crystal structures of the DH, 
MH and AP it was determined that, in contrast to the similar molecular conformation and 
hydrogen bonding patterns in DH and MH, molecular packing in the DH and AP structures was 
also similar, thus explaining the one-step dehydration of the DH directly to AP. 
The dehydration of the mildronate DH was linked to the escape of water molecules through 
structural channels, as molecule conformation changes and molecule translation. Thus, dehydration 
of the DH could be classified as a) WET3 with direct formation of AP crystalline phase after the 
dehydration163 and b) class II-Coop.-Reorg.162. 
The dehydration Ea of DH was 75±3 kJ·mol-1 for particles with diameter below 350 µm but 
it decreased for larger particles due to the increasing effect of water diffusion out of the particle. 
The kinetic model best describing the dehydration of particles smaller than 150 µm was R1, while 
for particles larger than 350 µm it was the R2 model. This change was associated with the altered 
dimensionality of the phase boundary movement towards the center of the crystal. 
By analyzing the sample weight effect on the dehydration, a decrease of the reaction rate and 
the dehydration Ea were observed by increasing the sample weight. This decrease was associated 
with increasing contribution from the water diffusion out of the powdered sample. 
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3.2 Rationalization of mildronate dihydrate dehydration mechanism and 
determination of kinetic parameters by analyzing the effect of 
experimental and sample factors 
The effects of various sample and experimental factors on the dehydration process of API 
hydrates have been investigated in a number of papers180, 219, 220, 271, 302-304. By studying the dehydration 
mechanism of mildronate DH (section 3.1) it was observed that dehydration kinetic parameters 
depended on particle size and sample weight. However, this represent only two sample and 
experimental factors studied for one sample in isothermal mode. 
In this section a) the possibilities of determining the dehydration kinetic parameters of 
mildronate hydrate DH by both isothermal and non-isothermal methods were explored, b) the 
effect of various sample and experimental factors on the dehydration activation energy and kinetic 
model were studied in depth, c) variations of kinetic parameters were used for understanding the 
dehydration mechanism and d) optimal conditions for determining the dehydration kinetic 
parameters were selected. 
Investigation of the sample and experimental factors in both isothermal and non-isothermal 
modes allowed us to compare the influence of each factor on the results obtained in both modes. 
Moreover, evaluation of various factors allowed the identification of the most appropriate sample 
and experimental factors for performing reliable determination of the dehydration kinetic 
parameters. 
Matching Ea values were obtained with all the calculation methods for each sample in each 
particular experiment. For representation of the model-free method results, Ea values calculated 
with Friedman’s method were used in this section. In each of the cases a certain kinetic model was 
determined as the most appropriate according to all methods, unless stated otherwise. 
PXRD was used to determine that AP was obtained as a dehydration product. However, in 
samples where the dehydration continued after the melting/peritectic decomposition point, MH 
was also detected, even though its formation was not associated with direct dehydration of the 
DH, see section 3.1. 
It was determined that sample preparation procedure and storage conditions had no effect 
on the examined kinetic parameters. For example, the similarity of the dehydration Ea for fractions 
up to 150-350 µm of all the samples can be evaluated from Figure S4 in Appendix 7. The sample 
particle size in this section is reported according to the mesh sizes used for their preparation. 
3.2.1 Particle size effects evaluated from dehydration in isothermal and non-isothermal 
modes 
To evaluate the possibility of determining the dehydration kinetics of DH under isothermal 
and non-isothermal modes, as well as for the evaluation of the particle size effects, Ea and kinetic 
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models from dehydration experiments of different DH particle size fractions in both modes were 
calculated and compared. Particle size distribution for different DH fractions is given in Figure S3 
in Appendix 7. It was observed that by increasing the particle size, the dehydration process slowed, 
and the dehydration rate constant correspondingly decreased in isothermal mode, while the 
dehydration starting and finishing temperatures increased in the non-isothermal mode. This is due 
to the fact that for smaller particles there was more surface area accessible to dehydration than that 
for larger particles. Nevertheless, it was observed that the dehydration rate expressed as fraction 
converted per one degree was similar for all sample fractions in the non-isothermal mode, whereas 
more detailed study identified that the fraction of <40 µm showed an exception from these trends 
(see Appendix 7). 
In section 3.1 it is already stated that dehydration Ea of the DH samples with particle size up 
to 350 μm is almost the same, but for particles larger than 350 μm there is a significant decrease of 
the Ea by increasing the particle size, explained by diffusion control. Here the dehydration Ea was 
calculated with isoconversional methods from both isothermal and non-isothermal experiments. 
The obtained dehydration Ea as a function of conversion degree α for samples with various particle 
sizes are shown in Figure 3.8. 
 
Figure 3.8. Dehydration activation energy – conversion degree plot for various DH 
fractions obtained (a) from isothermal experiments and (b) from non-isothermal experiments. 
From the isothermal experiments shown in the Figure 3.8(a) it was confirmed that Ea of the 
samples with particle size up to 350 μm was the same, whereas it decreased by further increasing 
the particle size. From the non-isothermal experiments shown in Figure 3.8(b), it was possible to 
identify differences in the final part of the Ea – α plots for fractions with particle size up to 350 µm. 
In Figure 3.9, the dehydration Ea – α plots calculated from isothermal and non-isothermal 
experiments for the 40-67 μm fraction are shown. It can be seen that the Ea values calculated from 
both modes were the same at the start of the reaction, within the limits of experimental error, and 
a small decrease of the values was observed by increasing the conversion degree. This decrease was 
explained by the fact that the higher dehydration Ea at the start of reaction was caused by nucleation 
of the product phase171 or by the reversibility of the dehydration reaction272. 
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Figure 3.9. An activation energy - conversion degree plot for dehydration of the 40-67 µm 
fraction calculated from isothermal and non-isothermal experiments. 
After this initial decrease, Ea values calculated from isothermal experiments in the α interval 
from 0.2 to 0.8 were almost constant. However, the Ea values obtained from non-isothermal 
experiment were constant only for a small α interval and after that started to decrease slowly by 
increasing α. This decrease became faster when the conversion degree approached 1. 
Similar results were obtained also when other fractions were compared, although there 
typically was some divergence of the Ea values at the beginning of the dehydration reaction. 
Comparison of the obtained Ea values in isothermal and non-isothermal experiments for the 
fractions from <40 μm up to 150-350 μm is given in Figure 3.10. In this diagram, the bottom and 
the top of the presented column corresponds to the lowest and highest dehydration Ea values in α 
interval from 0.2 to 0.7. The color change point corresponds to the average Ea value in this interval. 
 
Figure 3.10. Minimum, maximum and the average value of the dehydration activation energy 
calculated from non-isothermal (NI) and isothermal (I) experiments for the <40 μm, 40-67 μm, 
67-150 μm, and 150-350 μm fractions. 
The Figure 3.10 clearly illustrates that in all cases the average, minimum and maximum values 
of dehydration Ea were higher for isothermal experiments. Also, for non-isothermal experiments 
the Ea value changed more within the conversion degree interval from 0.2 to 0.7, because Ea 
decreased at higher conversion degree, as presented in Figure 3.8(b) and Figure 3.9. Moreover, in 
non-isothermal experiments the range of Ea values in this α interval became wider by increasing 
the particle size. These results can easily be connected with Figure 3.8, where the Ea values are 
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constant for fractions up to 150-350 µm in isothermal experiments and decrease in non-isothermal 
experiments. Furthermore, this decrease was faster for larger particles. 
The temperature range at which the dehydration reaction was examined in both experimental 
modes for each DH fraction is given in Table S1 in Appendix 7. It is evident that higher 
temperatures were used in non-isothermal experiments. Moreover, the Ea values for non-
isothermal experiments at high conversion degrees were calculated from data measured at higher 
temperatures, explaining the differences in Ea values presented in Figure 3.9. Thus the decrease of 
Ea by increasing α suggested that at higher temperatures the energy of the rate limiting step was 
different, or contribution from a different rate limiting step became apparent. The more 
pronounced decrease of the Ea for larger particles in non-isothermal experiments could easily be 
associated with slower dehydration, which led to higher dehydration temperature. Moreover, in 
order to reach complete dehydration at every experimentally used heating rate for the fractions 
with 67-150 μm and 150-350 μm particle size, samples were heated above the melting/peritectic 
decomposition point at 88-92 °C. The conversion degree at which this point was reached for the 
fastest heating rate is given in Table S1 in Appendix 7. It is clear that data obtained above melting 
point cannot be used for calculation of the dehydration Ea. Thus, Ea obtained above this conversion 
degree could not be considered purely as dehydration Ea, because some of the data used for its 
calculation was not actually from the dehydration process. For the 150-350 µm fraction this α value 
was as low as 0.55, thus explaining the significantly lower minimum Ea value in Figure 3.10. 
Thus, also for non-isothermal experiments Ea was not dependent on the particle size for 
fractions with particle size up to 350 μm. Unfortunately, it was not possible to reliably calculate the 
Ea of the samples with particle size above 350 μm, because the evolution of water above the melting 
point caused problems in most of the experiments. Thus, Ea decrease for fractions with particle 
size above 350 μm was not demonstrated in non-isothermal experiments. 
As can be seen from Figure 3.8(a), small decrease of the Ea by increasing the α was observed 
in isothermal experiments for the 350-700 µm and 700-1300 µm fractions. This cannot be explained 
by the higher temperature, because dehydration of the 350-700 µm fraction was examined at the 
same conditions as the fractions with smaller particle size. As already mentioned, decrease of the 
average Ea for these two fractions was associated with the increased diffusion of water out of the 
particles. Thus it was possible that the diffusion effect slightly increased during the dehydration, 
and in this way Ea decreased by increasing α, as shown in Figure 3.8(a). Therefore the decrease of 
the Ea resulting from increased contribution of water diffusion was due to the fact that water 
molecules had to travel a longer distance to leave the particle, or due to the possible phase boundary 
advance in directions perpendicular to the water channels (see Section 3.1), which was observed 
for larger particles, especially at the end of the reaction when all of the hydrate was surrounded by 
a thick AP layer. 
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The most appropriate kinetic models for the dehydration process were determined for all of 
the samples with various particle sizes under both isothermal and non-isothermal conditions, as 
well as for samples where the influence of other factors was examined. The obtained results are 
presented in Table 3.1. It is visible that the dehydration of fractions with particle size below 150 μm 
was best described by the one-dimensional phase boundary model R1, whereas that of fractions 
with particle size above 350 μm was best described by the two-dimensional phase boundary model 
R2. This is consistent with results presented in Section 3.1. The other examined experimental and 
sample factors did not change the dehydration kinetic model. However, for all of the analyzed 
samples there were deviations from the most appropriate kinetic model at the beginning and the 
end of the dehydration process. Deviations at the beginning can be associated with stabilization of 
the temperature or heating rate, while at the end there may have been actual deviations from the 
chosen model associated with either a) a certain degree of diffusion control or b) the fact that the 
escape of the last water molecules can occur in other directions rather than those associated with 
the main movement of the phase boundary180. The reason for different kinetic models determined 
for different particle size fractions is associated with change of the dimensionality of the phase 
boundary movement, see Section 3.1. Although it can be seen that the same dehydration kinetic 
model for all of the analyzed samples was found both from isothermal and non-isothermal 
experiments, determination of the kinetic model from isothermal experiments was more 
straightforward and it was possible to make a selection more convincingly. 
Table 3.1. The most appropriate dehydration kinetic model for different DH fractions, 
determined by studying the effect of various sample and experimental factors. 
Study <40 μm - 
67-150 μm 
150-350 μm 350-700 μm 700-1300 μm, 
>1300 μm 
Isothermal mode1 R1 R1/R2 R2 R2 
Non-isothermal mode1 R1 R2 R2 - 
Sample weight R1 R1 R2 - 
Atmosphere R1 - - - 
Dehydration/rehydration R1 - - - 
Mechanical compression2 R1 - - - 
1 – Study of the particle size effect, 
2 – Results from dehydration of the powdered sample under isothermal mode. 
3.2.2 Effect of the sample weight 
In Section 3.1 it was already stated that the dehydration rate of the DH decreased for larger 
samples, due to the slower vapor diffusion through the sample layer. By carrying out more detailed 
investigation it was observed that the reciprocal dehydration rate constant determined with model 
fitting methods was linearly dependent on the sample weight (see Figure 3.11). It can be seen that 
the slope was decreasing if the temperature was raised, showing that the sample weight had a more 
pronounced effect on the dehydration rate constant at lower temperatures. This probably was 
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because of slower water diffusion from the sample volume at lower temperatures. However, it was 
concluded that the particle size did not have an effect on the slope, although the slopes determined 
for 40-67 μm and 350-700 μm fractions were different than that for the rest of the fractions. For 
the 40-67 μm fraction this could be due to random errors, but for the 350-700 μm fraction this 
was due to the different kinetic model used, producing different rate constant values and thus 
changing the slope (see Table 3.1). Increase of the intercept (thus, decrease of the dehydration rate) 
by increasing the particle size was due to the slower dehydration rate of the larger particles, as 
discussed previously. 
 
Figure 3.11. Sample weight effect on the reciprocal dehydration rate constant of mildronate 
DH: (a) different fractions at 55 ºC temperature and (b) <40 µm fraction at different temperatures. 
In Section 3.1 it was also stated that the dehydration Ea determined under isothermal 
conditions decreased by increasing the sample weight due to increasing contribution from the bulk 
diffusion effect. In this work the effect of the sample weight on the dehydration Ea was measured 
in both isothermal and non-isothermal conditions, and the obtained Ea dependence on α for 
samples of various weight is shown in Figure 3.12. 
 
Figure 3.12. Dehydration activation energy dependence on (a) sample weight for the <40 
μm fraction in isothermal experiments and (b) sample weight (empty markers) and nitrogen flow 
rate (filled markers) for the <40 μm fraction in non-isothermal experiments. 
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Decrease of the dehydration Ea by increasing the sample weight was observed in both 
experimental modes. By changing the sample weight from 2 mg to 15 mg, dehydration Ea changed 
from 84 to 64 kJ·mol-1. These Ea values were in accordance with the Figure 3.6 and showed that 
larger samples gave even smaller dehydration Ea. From the obtained results it was evaluated that 
sample weights of 2, 3, and 4 mg were not appropriate for accurate study of the dehydration kinetics 
because of the elevated random error in calculated Ea values. However, by using excessively large 
samples, unacceptable diffusion effects would appear, so samples of moderate weight are 
preferable. Thus both experimental modes could easily be used for the evaluation of the sample 
weight effect on the dehydration rate and Ea, although results obtained under non-isothermal mode 
were complicated by the sample weight unrelated Ea changes, the reason for which is already 
discussed. 
3.2.3 Effect of the atmosphere 
Experiments with dehydration of DH <40μm fraction were carried out under nitrogen gas 
flow at various flow rates. It was determined that by increasing the N2 flow rate increased the 
dehydration reaction rate. This is because the rate of reversible dehydration was enhanced 
noticeably when the evolved vapor was promptly removed from the sample. The same effect was 
found in non-isothermal mode as well. However, changes of the nitrogen flow had less effect on 
the dehydration rate, compared to changes in other factors (like particle size, sample weight and 
water vapor content in the atmosphere). From the results obtained under non-isothermal 
conditions, dehydration Ea was calculated and the obtained results are shown in Figure 3.12 (b). 
Although the increase of the nitrogen flow resulted in faster dehydration, it did not noticeably 
reduce the contribution from the step associated with the water diffusion out of the sample which 
would result in a lower Ea value. On the contrary, the dehydration Ea decreased when the N2 flow 
rate was increased. The magnitude of the Ea changes was similar to that introduced by the sample 
weight variation. These results suggested that the increased N2 flow provided for a more efficient 
removal of water from the bulk of DH particles, most probably resulting in an increase of the 
contribution from the water vapor diffusion from the DH particles. Thus, the observed total 
dehydration Ea decreased because the Ea of water vapor diffusion from the particles was lower 
than that of the phase boundary advance. The Figure 3.12 (b) indicates that with 300 mL·min-1 N2 
flow the calculated dehydration Ea values did not show initial decrease at low α values as observed 
in all the other cases. This initial decrease was therefore most probably associated with the 
reversibility of the dehydration reaction, and faster nitrogen flow precluded this effect. 
The effect of variable water vapor pressure on the dehydration of DH was evaluated as well. 
It was observed that the dehydration rate decreased with increasing water vapor pressure at a given 
temperature, and the rate constant dependence on water vapor pressure could be approximated 
with straight line. This observation can be associated with the reversibility of the dehydration 
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reaction. The observation of a linear dehydration rate decrease suggested that the presence of water 
in the vapor phase did not change the dehydration mechanism. By using dehydration curves 
recorded at different temperatures for a particular relative humidity, the dehydration Ea dependence 
on the relative humidity was calculated, and the results are shown in Figure 3.13. It is visible that 
the dehydration Ea did not depend on the relative humidity. This confirms that the presence of 
water did not change the dehydration mechanism and did not introduce any changes in the 
dehydration rate limiting step energy at the reaction interface. However, the three highest relative 
humidity levels used had a high uncertainty, which could be related to slow dehydration where 
other factors could play a major role in the determination of the dehydration rate and the fact that 
the AP and DH phase boundary has a slight temperature dependence258. 
 
Figure 3.13. The dependence of the dehydration activation energy on the relative humidity 
for the <40 µm fraction. 
3.2.4 Effect of the sample history 
The considered aspects of sample history were a) previous dehydration/rehydration of the 
sample and b) mechanical compression. It was observed that repeated dehydration of previously 
dehydrated/rehydrated samples occurred faster and the dehydration Ea was lower. This effect could 
result from the cracking of the crystals and formation of channels through which water escape was 
facilitated during the repeated dehydration as well as due to the formation of internal defects 
allowing for an easier phase boundary advance. Also it was possible that previous 
dehydration/rehydration reduced the particle size, allowing faster dehydration in the second 
dehydration cycle304. However, reduction of the particle size alone would not explain the decrease 
of the dehydration Ea. 
It was observed that the mechanical compression (in terms of enhanced crystal defects and 
stress) had no effect on the dehydration Ea and the kinetic model. However, these defects 
promoted the initiation of the dehydration process, which was clearly observed as lower 
dehydration starting temperatures in non-isothermal experiments. When dehydration of 
compressed tablets was performed, water evolution from samples was more difficult compared to 
powdered samples, thus the dehydration rate was reduced, as observed both in isothermal and non-
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isothermal experiments. Extended discussion about the obtained results for mechanically 
compressed samples can be found in the Appendix 7. 
3.2.5 Conclusions 
It was possible to obtain comparable Ea values and the same kinetic model for the 
dehydration of mildronate DH in both isothermal and non-isothermal mode. However, both the 
obtained results and experimental procedures were more complicated when experiments were 
performed in non-isothermal mode. Firstly, there was a decrease of dehydration Ea at high 
conversion degree values, either due to different contributions from various rate limiting steps at 
different temperatures, or due to altered Ea of rate limiting step at high temperatures. Secondly, 
dehydration process should be complete before reaching the melting/peritectic decomposition 
point for every employed heating rate. Thus in non-isothermal mode it was possible to analyse only 
sufficiently small particles, therefore the possibility to study the particle size effect was limited. 
Moreover, obtained results were complicated by the Ea changes not directly caused by the change 
of the particle size. For fast identification of the possible complications and for setting up the 
dehydration kinetic study, results obtained from thermal analysis should be used to get insight 
about the appropriate temperature interval for the study. 
Particle size influenced both the dehydration rate and Ea. This factor should therefore be 
controlled and sample with narrow particle size distribution would be preferred for the dehydration 
kinetic study. Although in isothermal mode it was possible to study the dehydration of all prepared 
fractions, small variation in dehydration Ea was observed for particles with size above 350 µm, 
because of the changing diffusion contribution, and <40 µm fraction showed deviation from typical 
dehydration behaviour. 
Study of the experimental factor effects revealed that very low sample weight resulted in 
elevated random error for dehydration Ea, whereas very high sample weight increased the diffusion 
contribution. Increase in the nitrogen flow decreased the dehydration Ea suggesting that the 
contribution from water diffusion out of the particles was possibly increased by this change. 
Relative humidity did not affect the dehydration Ea, thus the presence of water at the reaction 
interface did not change the energy of the dehydration rate limiting step. 
Although sample preparation and storage did not show an effect on the examined 
dehydration parameters, sample history did. Thus, in order to perform a kinetic study, the sample 
should be handled carefully prior to dehydration experiments, in order not to induce any physical 
changes. 
As the dehydration Ea is affected by the diffusion of the water out of the particle and the 
kinetic model is affected by the phase boundary advance in other directions than those along the 
water channels, the particle morphology can be an important factor affecting these kinetic 
parameters. In this study we used samples with particles lacking a characteristic morphology, which 
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had crystallized as a particle aggregate. However, it is possible that other crystallization procedures 
can produce particles with different characteristic morphologies showing different dehydration 
kinetics. 
For the determination of diffusion-independent kinetic parameters characterizing the main 
DH dehydration mechanism, an isothermal experimental mode should be selected, with moderate 
particle size (narrow range within 40-150 µm) and sample weight (6-8 mg), and nitrogen flow 
providing effective removal of the evolved water (~100 mL·min-1) should be used. Sample 
preparation and handling should be done carefully. Such conditions would preclude the detection 
of the sample property and experimental factor effects, thus limiting the study of the dehydration 
mechanism. However, parameters obtained through such approach would be characteristic of the 
DH dehydration. Nevertheless, if one wants to study the dehydration mechanism, effects of 
various sample and experimental factors should be investigated. 
Of course, the study of dehydration mechanisms through the influence of various sample 
and experimental factors on the kinetic parameters is not limited to mildronate DH. Thus, a similar 
study could easily reveal essential information about the dehydration mechanism of other organic 
and inorganic hydrates, as well as provide conditions for determining the main dehydration 
mechanism characterizing dehydration kinetic parameters. 
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3.3 Analysis of droperidol solvent formation and their characterization 
In this section we tried to understand and rationalize the solvate formation of droperidol. 
Therefore we crystallized droperidol from solvents belonging to different solvent classes to 
investigate the possibility of forming new solvates, and we also characterized the structure and 
physiochemical properties of all droperidol solvates. We tried to rationalize solvate formation based 
on the solvate structure and solvent and droperidol properties. Besides, we characterized the 
solvent role and interactions in solvate structures and the water molecule arrangement in a partially 
filled NSH structure. 
3.3.1 Solvate screening 
A crystal form screening of droperidol was performed by selecting the most commonly used 
solvents covering different solvent classes based on classification according to statistical analysis 
of four molecular descriptors139 and hydrogen bond acceptor and donor propensity, 
polarity/dipolarity, dipole moment, and dielectric constant140. Solvents used for the screening and 
the crystal forms obtained after the crystallization are given in Table S1 in Appendix 8. It can be 
seen that besides the already known polymorphic forms I and II, hydrates NSH and DH, and the 
ethanol solvate SEt, eight new crystalline forms were obtained from methanol, acetonitrile, 
nitromethane, chloroform, dichloromethane, carbon tetrachloride, 1,4-dioxane, and toluene. All of 
the obtained crystal forms were characterized by PXRD and thermal methods and were found to 
be droperidol solvates and were labelled as SMe, SACN, SNM, SCLF, SDCM, SCTC, SDIOX and STOL 
respectively. Crystals suitable for SCXRD analyses were obtained only from methanol, acetonitrile, 
and nitromethane. Besides, all of the analyses were performed also with the poorly characterized 
solvated forms NSH, SEt and DH. 
3.3.2 X-ray diffraction 
PXRD patterns of all the obtained solvated forms are given in the Figure 3.14. It can be seen 
that the diffraction peak positions of the new solvates SMe, SACN, SNM, SDCM and SCLF were very 
similar and almost matched those of NSH and SEt, suggesting the isostructurality of all these 
solvated forms. However, PXRD patterns of STCC, SDIOX, and STOL exhibited different characteristic 
features and differed also from the PXRD patterns of all other known droperidol forms. 
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Figure 3.14. PXRD patterns of the droperidol solvates and polymorph II. 
A crystal structure determination for the newly prepared SMe, SACN, SNM, and also SEt and 
NSH was performed and the obtained crystallographic data are given in Table 3.2. The crystal 
structures of NSH and SEt were consistent with those already reported261, 265, and the newly 
prepared solvates SMe, SACN, and SNM were isostructural to NSH and SEt as already suggested by 
the PXRD patterns (a more detailed discussion is given further). In this study the NSH was 
determined to be of monohydrate stoichiometry (the previously published hemihydrate 
stoichiometry261 is explained by its nonstoichiometric behaviour264), whereas SEt, SMe, SACN, and SNM 
crystallized as hemisolvates (although monoethanol solvate was reported265, both the published265 
and our determined crystal structures corresponded to a hemiethanol solvate). 
Table 3.2. Crystallographic data for the droperidol solvates (SACN, SNM, SMe, NSH, and ISD). 
Solvate SACN SNM SMe NSH-mono NSH-hemi ISD 
Empirical formula (C22H22FN3O2)2 
·C2H3N 
(C22H22FN3O2)2 
·CH3NO2 
C22H22FN3O22 
·0.5CH4O 
C22H22FN3O2 
·H2O 
C22H22FN3O2 
·0.5H2O 
C22H22FN3O2 
Mr 399.96 409.95 395.45 397.44 388.43 379.43 
Crystal system triclinic triclinic triclinic triclinic triclinic triclinic 
Space group P1 P1 𝑃𝑃1� 𝑃𝑃1� 𝑃𝑃1� 𝑃𝑃1� 
Temperature 173 173 120 120 120 333 
a (Å) 6.0870(2) 6.06730(10) 6.0504(5) 6.3199(4) 6.2743(3) 6.2780(3) 
b (Å) 10.2177(3) 10.1884(3) 10.2207(8) 10.1525(7) 10.1560(6) 10.0865(4) 
c (Å) 16.2642(6) 16.4237(5) 16.1100(14) 15.7463(11) 15.7786(9) 16.3969(7) 
α (°) 101.2051(11) 99.8303(13) 101.397(2) 102.691(2) 102.253(2) 103.0980(10) 
β (°) 92.7447(10) 92.2880(12) 93.445(3) 91.775(2) 92.501(2) 92.8550(10) 
γ (°) 96.7569(19) 95.6243(18) 97.022(2) 100.403(2) 99.460(2) 99.4190(10) 
V (Å3) 982.78(6) 993.86(4) 965.62(14) 966.81(11) 965.95(9) 993.57(7) 
Za 2 2 2 2 2 2 
μ (mm−1) 0.094 0.099 0.096 0.098 0.095 0.089 
Dcalc (g cm−3) 1.352 1.370 1.360 1.365 1.335 1.268 
no. of parameters 533 542 350 353 353 342 
reﬂns collected 5243 5245 16568 12518 12520 11524 
reﬂns (I > 2σ) 3644 3649 5392 5357 5375 4788 
wR (all data) 0.1285 0.1346 0.1512 0.1721 0.1635 0.1558 
ﬁnal R (I > 2σ) 0.0526 0.0546 0.0534 0.0600 0.0556 0.0486 
GOF 1.012 1.023 1.011 1.073 1.030 1.020 
Packing coef. 0.705 0.704 0.717b 0.714  0.659 
a – Based on droperidol as the molecular entity. 
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b – Calculated for structure where solvent molecules were ordered. 
An overlay of the PXRD patterns obtained experimentally and simulated from crystal 
structure data confirmed the identity of the polycrystalline phases. 
3.3.3 Thermal characterization 
The DTA/TG curves of all isostructural solvates were almost the same (see Figure 3.15): 
desolvation of these solvates occurred over a wide temperature range, which started at ambient 
temperature without a characteristic sharp endothermic effect associated with the desolvation 
process, thus suggesting that all of these solvates are non-stoichiometric. When the temperature 
was increased to 115 – 130°C, melting occurred as confirmed by hot stage microscopy (HSM). 
Desolvation of these solvates occurred at different rates and at the heating rate 5°·min-1 the forms 
SEt, SACN, SNM and SCLF were not completely desolvated before melting, and thus the melting 
endotherm appeared together with a rapid loss of the rest of solvent. After the melting, 
recrystallization occurred by forming polymorph I as identified by the melting point in the DTA 
curves. The recrystallization was also observed in the HSM study. 
 
Figure 3.15. The DTA and TG curves of the droperidol isostructural solvates showing (a) 
the melting of solvate and/or ISD, (b) recrystallization, and (c) melting of the resulting polymorph 
I. 
Desolvation products of all the solvates were analysed with PXRD, the obtained diffraction 
patterns are given in Figure 3.16. By combining the PXRD and DTA/TG data it was determined 
that all of the isostructural solvates can be desolvated before melting (by heating at 100°C for a 
maximum of 2 days). 
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Figure 3.16. PXRD patterns of the desolvation products of the droperidol solvates. 
From Figure 3.16 it can be identified that desolvation of isostructural solvates produced a 
phase with only slightly different PXRD pattern: the isostructural desolvate (ISD). This was 
confirmed also by the structure determination of completely dehydrated NSH crystals (see Table 
3.2). The formation of isostructural desolvate supports the fact that isostructural solvates are non-
stoichiometric. 
Solvent stoichiometry was determined from TG curves, and the obtained results are given in 
Table 3.3. The obtained results were consistent with the solvent stoichiometry determined by 
SCXRD. The differences between the observed and calculated solvent content in isostructural 
solvates are associated with their non-stoichiometric behaviour. The stoichiometry of SDCM and 
SCLFwas determined only from TG data. Based on measurements from at least three different 
samples, SDCM was found to be a hemisolvate, whereas the stoichiometry of SCLF was unclear 
because the highest obtained solvent : droperidol ratio was only 1:3. 
Table 3.3. Physicochemical data for the droperidol isostructural solvates. 
Solvate Calculated weight 
loss, % 
Observed weight 
loss, % 
Tdesolvatationa,°C 
(peak) 
Resulting 
phase 
NSH 4.5b 2.5-4.8c 124 ISD 
SMe 4.2d 3.5-4.5 124 ISD 
SEt 6.1d 5.1-6.6 125-127 ISD 
SACN 5.4d 4.9-6.0 124-129 ISD 
SNM 8.0d 8.2-8.9 113-115 ISD 
SDCM 11.2d 5.5-11.0 123-124 ISD 
SCLF 15.7d 5.5-9.5 123-126 ISD 
a – melting peak of the solvate or resulting ISD 
b - for monosolvate stoichiometry 
c – depended on the storage conditions 
d – for hemisolvate stoichiometry 
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Desolvation of STCC and SDIOX produced the polymorph I, STOL produced a new polymorph 
IV and that of DH depended on the sample and produced either the polymorph II or a new 
polymorph III. 
Schematic representation of solvate preparation and phase transformations upon heating are 
given in Figure 3.17. 
 
Figure 3.17. Schematic representation of the droperidol solvate preparation and phase 
transformations upon their heating. 
3.3.4 Crystal structures of isostructural solvates 
NSH, SEt, and SMe crystallize in 𝑃𝑃1� space group (see Table 3.2) with one droperidol molecule 
and a water molecule or half of a disordered alcohol molecule respectively, in agreement with the 
already reported structures261, 265. However, SACN and SNM crystallize in the P1 space group with two 
droperidol molecules and a solvent molecule in the unit cell. Both droperidol molecules in these 
two solvates are inversion related, thus only the asymmetric solvent molecule breaks 
centrosymmetry of the whole crystal structure. Therefore the conformation of both droperidol 
molecules in the unit cell is the same (by taking into account the inversion symmetry). As already 
mentioned, despite the different space groups, all these droperidol solvates are isostructural and 
the solvent molecules are situated in the channels positioned along the a-axis (see Figure 3.18 and 
Appendix 8). 
 
Figure 3.18. Overlay of the crystal structures of isostructural droperidol solvates. 
In these solvates all of the acetonitrile and nitromethane molecules pointed in only one 
direction. Although the methanol and ethanol molecules are asymmetric, the disorder of these 
solvent molecules allowed description of SEt and SMe in 𝑃𝑃1� space group. The type of structural 
disorder with regard to the solvent molecules and its causes were further investigated using solid-
state NMR and theoretical calculations, and is given in Section 3.5. 
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The 2D fingerprint plots (calculated from the Hirshfeld surfaces96, 104 in CrystalExplorer 3.1103) 
of droperidol molecules from all of the solvates were almost the same, and were dominated by the 
interactions between the droperidol molecules themselves. Thus the solvent had only a minor role 
in the crystal structure, and therefore it was reasonable that isostructural solvates with quite 
different solvent molecules could form. 
3.3.5 The interactions of solvent molecules in isostructural solvates 
In order to understand the differences between the isostructural solvates, as well as the 
reasons for their stability, intermolecular interactions of solvent molecules were analysed. Solvates 
can be divided based on the presence (in NSH, SMe, and SEt) or absence (in SACN and SNM) of strong 
hydrogen bonds between the solvent and the droperidol molecule oxygen atom O1 in the 
benzimidazolone moiety. Although the disorder of solvent molecules complicated the 
characterization of this interaction in SMe and SEt, hydrogen bond parameters were characteristic 
to a strong hydrogen bond with the O1…O3 distance 2.81-2.91Å, where the longest distance was 
in SMe (see Table 3.4). 
Table 3.4. Geometrical parameters for the intermolecular interactions of solvent molecules 
in droperidol solvates SMe, SEt, SACN, SNM, and NSH 
 Interactiona X-H (Å) H···A (Å) D···A (Å) D-H···A (o) 
SMe O3-H…O1b 1.13 1.87 2.91 150 
 O3…H-C9c 0.97 2.80 3.51 130 
 C23-H…O1d 0.96 2.46 3.36 156 
SEt O3-H…O1d 0.82 2.53 2.81 102 
 O3…H-C5e 0.93 2.64 3.41 140 
 C24-H…C9f 0.95 2.99 3.85 151 
 C24-H…O1f 0.97 2.92 3.51 120 
SACN C23-H…O1Ag 0.96 2.68 3.41 133 
 C23-H…C9Bb 0.96 2.97 3.92 169 
 N4…H-C5Ac 0.93 2.80 3.70 162 
 N4…H-C5Bg 0.93 2.83 3.60 140 
SNM C23-H…O1Ah 0.96 2.44 3.31 150 
 C23-H…C9Bb 0.96 2.90 3.86 178 
 O3…H-C5Ab 0.93 2.70 3.42 135 
 O3…H-C10Ah 0.97 2.52 3.29 135 
 O3…H-C11Ah 0.97 2.66 3.51 147 
 O3…H-C4Ae 0.93 2.64 3.42 143 
 O4…H-C9Bc 0.93 2.66 3.16 115 
 O4…H-C10Bc 0.97 2.72 3.13 106 
 O4…H-C4Bg 0.93 2.67 3.28 124 
 O4…H-C5Bg 0.93 2.66 3.26 123 
NSH O3-H…O1b 0.85 1.99 2.83 171 
 O3-H…O3i 0.85 2.22 2.86 131 
 O3…H-C9c 0.95 2.73 3.38 127 
a - cutoff parameter: van der Waals radii + 0.1 Å. Symmetry codes: b x, y, z; c 1+x, y, z;  
d 1–x, 1–y, –z; e –1+x, y, z; f –1+x, –1+y, z; g 1+x, 1+y, z; h x, 1+y, z; i 2–x, –y, –z. 
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There were slightly different interactions between alkyl residues of alcohol molecules and 
droperdiol molecules: in both solvates the O3 atom was an acceptor of hydrogen bond from 
different droperidol hydrogen atoms, and the methyl group of the methanol was a hydrogen bond 
donor for a much shorter interaction than in ethanol (see Table 3.4). 
There was no strong hydrogen bond between droperidol and acetonitrile or nitromethane. 
Nevertheless, these molecules formed numerous weak hydrogen bonds and dispersion interaction 
with droperidol molecules (see Table 3.4), therefore providing sufficient interactions to allow the 
formation of a stable solvate. 
The only strong intermolecular interaction between solvent molecules was observed in NSH 
where two water molecules formed hydrogen bond by connecting two droperidol molecules via an 
O1…O3…O3…O1 linkage261 across the channel. 
Hirshfeld surface 2D fingerprint plots of the solvent molecules representing the 
intermolecular interactions are given in Figure 3.19. For this analysis crystal structures of SMe and 
SEt with ordered solvent molecules after optimization of hydrogen atom positions were used. 
From the solvent molecule 2D fingerprint plots it was possible to determined that 
interactions of both alcohol molecules were different, although both were dominated by the strong 
hydrogen bond O3-H…O1. Despite the different functional groups in acetonitrile and 
nitromethane, and the seemingly different interactions of nitrile and nitro groups (see Table 3.4), 
the interactions represented in 2D fingerprint plots, although differently shaped, were very similar. 
This suggests that the properties of SACN and SNM could be similar. Therefore, besides a strong 
hydrogen bond connecting alcohols in SMe and SEt, the stability of these solvates and that of SACN 
and SNM was provided by weak hydrogen bonds and dispersion interactions. As could be expected, 
interactions of water molecules in NSH were dominated only by strong hydrogen bonds. However, 
unusual relative arrangement of water molecules (see Figure S14 in Appendix 8) introduced 
unusually shaped broad representation of hydrogen-hydrogen interactions between both water 
molecules. 
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Figure 3.19. Hirshfeld surface 2D fingerprint plots of solvent molecules in droperidol 
isostructural solvates, where de is the distance from a point on the surface to the nearest nucleus 
outside the surface and di represents the distance from a point on the surface to the nearest nucleus 
inside the surface96, 104. 
3.3.6 Fourier-Transform Infrared spectroscopy 
ATR-FTIR spectra of the solvates are presented in Figure 3.20. Besides the few peaks 
appearing due to the presence of different solvent molecules, the spectra of these solvates were 
almost identical, confirming their isostructurality. However, noticeable differences characterizing 
the structure of solvates appeared in the carboxyl group stretching and O-H stretching regions. 
There were two distinct peaks with almost the same intensity in the carboxyl group stretching 
region for SNM, SACN, and SDCM. However, the higher frequency peak (~1692 cm-1) was observed 
as a shoulder on the lower frequency peak (~1682 cm-1) for SMe, SCLF, SEt, and NSH. At the same 
time there was sharp peak at 3468-3475 cm-1 for SEt, SMe, and SCLF, and at 3499 cm-1 for NSH 
corresponding to the O-H (in alcohols and water) and C-H (in chloroform) stretching bands, 
respectively. 
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Figure 3.20. FTIR spectra of the droperidol isostructural solvates with dashed rectangle 
highlighting the most differing spectral regions and asterisks marking the bands due to the solvent 
molecules. 
Thus, based on the similarities in IR spectra in the O-H and C-H stretching regions and in 
the C=O stretching region, it can be concluded that chloroform molecule also forms hydrogen 
bond with droperidol molecules similarly to water and alcohol molecules, whereas the solvent 
interactions in SDCM are more similar to those in SNM and SACN. 
3.3.7 Characterization of solvent content in isostructural solvates at different solvent 
activity 
The non-stoichiometric behaviour of the solvates and the presence of solvent channels 
suggested that solvent content in the structure (ε) should be dependent on the solvent activity10. 
To investigate this, NSH, SEt, SMe, SACN, and SNM were stored under atmosphere with different 
solvent activity, obtaining the sorption-desorption isotherms of the corresponding solvents. Water 
sorption-desorption isotherm of NSH is shown in Figure 3.21. The highest water content 
corresponds to monohydrate stoichiometry and lowering of the RH gradually decreased the water 
content ε by completely dehydrating the NSH and obtaining ISD at ≈0% RH. 
 
Figure 3.21. Water sorption-desorption isotherm of NSH from two sample sorption and 
desorption cycles, and localized water model describing the experimental points. 
A study of the other four solvate sorption-desorption isotherms revealed that uptake of the 
solvent also was gradual but occurred at much lower solvent activity: most of the solvent uptake 
had already had taken place when solvent activity reached 0.02 and maximum solvate stoichiometry 
(ε≈0.5) was reached at solvent activity 0.1. The resulting sorption-desorption isotherm of SMe is 
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given in Figure 3.22, but those of SEt, SACN, and SNM are in Appendix 8. The initial parts of the 
isotherms for all solvates are given in Figure 3.23. 
 
Figure 3.22. Methanol sorption-desorption isotherm of SMe. The black line corresponds to 
global isotherm model formed by combination of Langmuir isotherm (red line) and disordered 
solvent model51 (green line). 
 
Figure 3.23. Initial part of the droperidol isostructural solvate sorption-desorption 
isotherms where circles indicate experimental solvent content ε and lines represent the best 
theoretical model (Langmuir isotherm (SMe) and general localized solvent model51 with constant 
activity coefficients (NSH, SEt and SACN) or activity coefficients described by 3rd order Margules 
equation (SNM). For NSH a 10 times larger solvent activity region is shown. 
In order to compare the obtained isotherms, thermodynamic models were used to describe 
the obtained data points, thus characterizing the thermodynamics of the solvates themselves51. The 
sorption-desorption isotherm of NSH was fitted with general localized water model with constant 
activity coefficients (see Figure 3.21, parameters used for all the fittings are given in Appendix 8), 
whereas those of all organic solvates were described as a combination of a) localized solvent model 
describing solvent in the structural channels and b) disordered solvent model describing the 
adsorbed solvent51 (see Appendix 8). Localized solvent in the sorption-desorption isotherm of SMe 
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was fitted with Langmuir isotherm and that in SEt with general localized solvent model with 
constant activity coefficients. The sorption-desorption isotherms of SACN and SNM clearly did not 
correspond to Langmuir isotherm because of the hindered solvent absorption at very low solvent 
activity and thus sigmoidal shape (see Figure 3.23). The SACN isotherm was fitted with a general 
localized solvent model (usage of variable activity coefficients only slightly improved the fit), 
whereas that of SNM could be fitted only using localized solvent model with variable activity 
coefficients described by Margules equations. The differences between the isotherms are associated 
with the presence or absence of interactions between solvent molecules in two adjacent solvent 
sites positioned along the a-axis as well as the solvent molecule size differences (see Appendix 8). 
As the solvent molecules have well located crystallographic sites, the use of the Langmuir model 
or localized solvent model for describing the change of these molecules in the channels is in 
accordance with the assumptions for these models. 
3.3.8 Characterization of changes in isostructural solvate structure at various solvent 
content 
The PXRD patterns of solvates with various solvent content were recorded. By increasing 
the solvent content, continuous displacement of diffraction peaks to mostly lower 2θ values 
occurred (insertion of the solvent molecules increased the cell volume and thus the interplanar 
spacing), and continuous intensity changes of some peaks were observed. The peak positions 
changed gradually, thus confirming the continuity of structural changes, and it was possible to 
calculate the dependence of lattice parameters on the solvent content (ε) for these solvates. The 
obtained results confirmed gradual changes of the crystal structure (see Figure 3.24). The 
differences between NSH and other solvates observed from changes of the diffraction peak 
positions were reflected in the calculated lattice parameters: the direction and amplitude of the 
lattice parameter changes was almost identical for all solvates except for the NSH (see Figure 3.24). 
These differences of the lattice parameter change clearly could be associated with the 
formation of hydrogen bonds mediated by water molecules, with these bonds providing links 
between droperidol molecules situated across structural channels. Therefore the decrease of the 
cell length c and the angle α, with concurrent increase of the angle γ in NSH was due to the 
geometric effects driven by the formation of this linkage. The decrease of the cell length a for other 
solvates most probably can be associated with the presence of solvent - solvent interactions in the 
channels, but the size of the solvent molecules caused the increase of the cell lengths b and c. 
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Figure 3.24. Lattice parameter dependence on the solvent content (ε) in the isostructural 
solvates of droperidol. 
3.3.9 Water arrangement in a partially filled NSH structure 
In this study the crystal structures of NSH with three different levels of water content were 
determined: the monohydrate (120 K, obtained from synthesis), the hemihydrate (120 K, obtained 
by storing a sample at 30-40% RH), and the anhydrous form or ISD (333 K, obtained by storing a 
sample at 0% RH, or heating the sample). The intermolecular interaction geometry of droperidol 
molecules was only slightly affected by the water content. 
The hydrogen bonding parameters determined for water mediated hydrogen bond linkage 
O1…O3…O3…O1 are given in Table 3.5. In this study, both of the hydrogen atoms were located 
for the case of monohydrate stoichiometry, therefore confirming that between two water molecules 
there is a hydrogen bond with unusual geometry (see Figure S14 in Appendix 8). 
Table 3.5. Geometrical parameters for the hydrogen bond linkage provided by water 
molecules in NSH with mono- and hemi-hydrate stoichiometry. 
ε Temp., °C O1···O3, Å O3···O3, Å O1-O3-O3, ° O1···O1, Å 
1 
120 2.83 2.86 109 7.11 
173 2.85 2.83 109 7.14 
0.5 
120 2.85 2.86 108 7.13 
298261 2.85 2.76 111 7.16 
 
The geometrical parameters for the O3-H···O1 and O3-H···O3 hydrogen bonds were the 
same for both stoichiometries. Therefore the removal of water occurred by simultaneously losing 
both hydrogen bonded water molecules from some of the channel sites instead of losing water 
molecules from one of the O3 positions and thus losing hydrogen bond linkage across the channel. 
This water molecule arrangement in NSH with stoichiometry below 1 was also supported by the 
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absence of a significant increase in the equivalent isotropic displacement parameter of water oxygen 
for hemihydrate stoichiometry (thus confirming that water retains two hydrogen bonds also for 
this stoichiometry), by the energy calculations (hemihydrate structure with hydrogen bonded water 
molecules was energetically favourable by 2 - 4.5 kJ per mole of water), lattice parameter changes 
(this arrangement explained the observed lattice parameter changes), and the recorded sorption-
desorption isotherms corresponding to the presence of only equivalent water absorption sites in 
the structure. More details are given in the Appendix 8. 
We therefore conclude that the difference observed in the solvent uptake at a given solvent 
activity in the NSH sorption-desorption isotherm (see Figure 3.23) can be associated with the 
absorption of water through an insertion of two hydrogen-bonded molecules at one site, which 
theoretically is a lower probability process compared to the absorption of one solvent molecule, as 
in the rest of the solvates. 
3.3.10 Analysis of the droperidol solvate formation 
While it should not be assumed that all of the potentially existing solvates have been 
identified, the crystallization from 30 solvents selected from various solvent classes should ensure 
the discovery of most of the stable solvated forms. Interestingly, five of the newly prepared 
solvated phases were isostructural to the already known NSH and SEt. Thus, although droperidol 
solvates can be obtained with ten solvents, only five distinct solvated crystal structures were 
obtained: DH, STCC, SDIOX, STOL and the “isostructural solvate”, where the latter one formed from 
a variety of different solvents. Therefore three questions can be raised to understand the solvate 
formation of droperidol: a) what is the reason for the formation of only these five structures, b) 
why the isostructural solvates were obtained from such a wide range of solvents, and c) which 
solvents can form isostructural solvates? 
Unfortunately, the lack of information regarding the STCC, SDIOX, and STOL crystal structures 
prevents a thorough answer to the first question. It is stated that one of the driving forces for 
solvate formation can be a mismatch of the hydrogen bond donors and acceptors in a molecule305. 
Although the molecule of droperidol contains three strong hydrogen bond accepotors (HBA) and 
only one hydrogen bond donor (HBD), this HBD deficiency was compensated only in the DH 
structure. In isostructural solvates the solvent molecules did not compensate the HBD deficiency, 
and it is not theoretically possible also in the structures of STCC, SDIOX, and STOL. Therefore it can 
be concluded that the formation of droperidol solvates can be associated with the fact that 
molecules cannot pack with a sufficient efficiency and solvent molecules act as void fillers in these 
structures. This is supported by the fact that the packing index of the thermodynamically stable 
polymorph II is 0.675, which is only slightly higher than that of ISD at 333 K (0.659) where there 
are empty channels, but significantly lower than that of the isostructural solvates (0.704 – 0.717). 
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The reason for the formation of isostructural solvates is the stability of this structure. The 
calculation of both the total and lattice energy showed that the structures of II and ISD have 
almost the same energy at 0 K (the energy of ISD is even slightly favourable), and only the higher 
density of the polymorph II makes it thermodynamically stable at elevated temperature. Therefore 
this structure is not necessarily characterized by a high solvent selectivity, and the criteria for solvate 
formation most probably are a) the ability to form sufficiently efficient droperidol - solvent 
interactions, and b) the solvent molecules should fit into the channels by not significantly disturbing 
the packing of droperidol molecules. 
By evaluating the properties of solvents forming isostructural solvates, it was noticed that 
three solvates formed with aprotic polar solvents (acetonitrile, nitromethane, and 
dichloromethane), three formed with hydrogen bond donors (water, methanol, and ethanol), and 
the last one formed with chloroform that can be classified both as a hydrogen bond donor and 
aprotic polar solvent, depending on the classification scheme139. However, the classification of 
solvents according to these two groups clearly is not the main factor affecting the formation of the 
solvates (see Table S1, Appendix 8), although the formation of strong hydrogen bonds apparently 
is one of the driving forces. A better explanation of isostructural solvate formation can be achieved 
by taking into account a more detailed solvent classification based on various physical and 
physicochemical properties140. Isostructural solvates were obtained from solvents belonging to 
groups 3 (mostly alcohols), 7 (mostly halocarbons), 9 (nitriles and nitromethane), and 15 (water)140. 
Therefore only solvents from these groups were able to form energetically favourable interactions 
with the functional groups of droperidol molecules located around the structure channel. 
Nevertheless, the second important factor for the formation of isostructural solvates clearly 
is the size (and shape) of solvent molecules. Thus, only the smallest molecules from the solvent 
groups 3, 7, and 9 formed isostructural solvates, which was confirmed by the calculation of molar 
volume (see Table S14 in Appendix 8). The largest solvent molecule forming an isostructural 
solvate with droperidol is chloroform (the size of which is even higher than that of some solvents 
not able to form isostructural solvates with droperidol), explaining the solvent content in the SCLF 
phase observed by TG measurements to be below 0.5-stoichiometry. In contrast, the small size of 
water molecule and its ability to form inter-water hydrogen bonds enabled the formation of a 
monohydrate. 
3.3.11 Conclusions 
Crystallization of droperidol from 30 different solvents produced eight new solvates from 
methanol, acetonitrile, nitromethane, chloroform, dichloromethane, carbon tetrachloride, 1,4-
dioxane, and toluene, while the desolvation of droperidol solvates produced two new polymorphs 
III and IV. Droperidol solvates obtained from methanol, ethanol, acetonitrile, nitromethane, 
dichloromethane, chloroform, and water are nonstoichiometric and isostructural. The solvent 
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content in these solvates can reach up to 0.5 equivalents (with the exception of NSH, that can 
reach monohydrate stoichiometry), and desolvation of these solvates produces an isostructural 
desolvate. 
The crystal structures of five of these solvates were determined, proving that the droperidol 
molecule arrangement was isostructural despite the crystal structure description in both the 
centrosymetric 𝑃𝑃1� (NSH, SMe and SEt) and non-centrosymetric P1 (SACN and SNM) space group. 
The different space group determined for solvates with organic solvents was due to the disorder 
of methanol and ethanol molecules. The stability of isostructural solvates was mainly provided by 
the interactions between droperidol molecules themselves, while the solvent molecules were 
located in the structural channels and formed strong and/or weak hydrogen bonds with the 
droperidol molecules. Based on the IR spectra it was concluded that the chloroform molecules in 
SCLF formed hydrogen bonds with droperidol molecules. 
The solvent sorption-desorption isotherms of NSH, SMe, SEt, SACN, and SNM showed that the 
solvent molecule content in the solvate could be described with a localized solvent model and there 
was no interaction between the solvent sites in SMe. For NSH, SEt, SACN, and SNM the solvent 
interactions and the larger molecule size complicated the shape of the sorption isotherm. It was 
proved that the solvent content variation in the channels resulted in linear changes of the lattice 
parameters, therefore the transformation of the crystal structure was gradual. The lattice parameter 
changes and the solvent uptake at a given solvent activity in NSH significantly differed from those 
in the rest of the solvates. This was due to the formation of water molecule mediated hydrogen 
bond linkage across the structural channels and the simultaneous occupation of both of these 
hydrogen bonded water molecule positions. 
The analysis of the solvate formation revealed that the driving force for droperidol solvate 
formation was the inability of droperidol molecules to pack efficiently, thus the solvent molecules 
acted as a void fillers, with the exception of DH, where water molecules provided an HBD function 
matching the excess HBA functions in the molecule of droperidol. The stability of the isostructural 
solvate structure was rationalized by the very effective interactions between droperidol molecules, 
explaining the fact that no specific interaction with solvate was necessary to maintain the crystal 
structure of the isostructural solvate. Therefore isostructural solvates can be obtained with solvents 
fitting in the channels and providing sufficiently effective intermolecular interactions with 
droperidol. By analysing the solvent classification it was concluded that these solvates can be 
obtained with the smallest solvent molecules from the solvent groups 3, 7, and 9, as well as from 
water140, and the formation of strong hydrogen bonds is one of the driving forces for solvate 
formation.  
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3.4 Comparison and Rationalization of Droperidol Isostructural Solvate 
Stability 
In this section we have tried to rationalize the solvate stability with respect to the desolvation 
based on their crystal structures and to select an appropriate tool for experimental comparison of 
the solvate stability by studying droperidol isostructural solvates. Solvate stability was compared 
theoretically by calculating the intermolecular interactions in the solvate structure and 
experimentally by determining the solvate thermal stability, desolvation kinetics, and by analyzing 
in Section 3.3 given solvent sorption-desorption isotherms. Isostructural solvates of droperidol are 
useful for such study as they retain the crystal structure after the desolvation, and thus it is possible 
to avoid the effects of any other factors on the solvate stability and desolvation process. 
3.4.1 Desolvation kinetics of droperidol solvates 
Firstly, the stability of droperidol isostructural solvates was compared by determining their 
desolvation kinetic parameters. The desolvation kinetics was studied in both isothermal and 
nonisothermal modes. Various samples were analyzed in the isothermal mode (including the 
crystals of NSH, SMe, and SEt), while in the nonisothermal conditions only a well-ground sample 
was analyzed for each solvate. The Ea values were calculated by using isoconversional method only, 
to allow the identification and characterization of possible complexity of the desolvation process200 
and to identify the possible complications and errors associated with the experimental variables 
(most importantly, the sample, its mass and packing)190 which can easily affect the results, especially 
for the desolvation process of non-stoichiometric solvates. 
Desolvation activation energy. A total of 11 different NSH samples were analyzed in 
isothermal mode and the calculated activation energy values had a relatively high dispersion (see 
Table 3.6). 
Table 3.6. Summary of the NSH desolvation kinetic parameters in isothermal mode. 
Sample Crystallization conditionsa Ea, kJ·mol
-1 Ea-α dependence Kinetic model
b Temperatures used, °C 
Crystals I 50 °C/5%/100 mL 38±20 ↓ F3/2, D5 60-100 
Crystals II 50 °C/5%/100 mL 55±20 (↓) D5, D3 70-110 
Crystals III 50 °C/10%/100 mL 47±13 ↓ F1 40-90 
Crystals IV 50 °C/50%/100 mL 49±10 ↓ F3/2, D3, D5 50-100 
Small crystals I 50 °C/5%/250 mL 54±11 (↓) F2, D5 60-120 
Small crystals II 50 °C/5%/250 mL 66±7 – F3/2, F1 25-50 
Small crystals III 50 °C/10%/250 mL 60±20 – F1 35-60 
Crystals II 
ground for 10 sc 
- 68±7 – D5, F2 25-70 
Crystals II 
ground for 1 min 
- 65±10 – F3/2, F2 25-70 
Powder I 25 °C/5%/Petri 
dish 
54±12 ↓ F2, F3/2 25-50 
Powder II 25 °C/10%/Petri 
dish 
56±10 – F3/2, F1 20-60 
Summary  56±10 – modified D5 20-120 
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a – Temperature for the evaporation, volume percent of the water in the solution and volume 
of the conical flask used for the evaporation 
b – For each individual sample only commonly used kinetic models were included in the 
selection. 
However, no direct relationship between the dehydration Ea (or kinetic model) and the 
sample particle size was observed. It was confirmed that the samples with smaller particle size 
dehydrated faster at a given temperature (see Table 3.6), and it was determined that unground 
samples showed higher variation of apparent Ea with α, while the average Ea values were in the 
same range as those determined for samples without Ea variation (see Table 3.6). The average 
dehydration Ea of NSH was calculated to be 56±10 kJ·mol-1. 
The determination of the desolvation Ea was less straightforward for the organic solvates of 
droperidol. Firstly, for some of the samples complications arose due to almost identical desolvation 
rate at each temperature in the beginning of the reaction. This was observed for the samples with 
the smallest particles and could be due to the rapid escape of the solvent molecules close to the 
surface and with only minor temperature dependence, and for small particles there were many such 
solvent molecules. Secondly, a higher Ea variation from sample to sample and also higher apparent 
variation by the fraction desolvated was observed (see Table S2 in Appendix 9). This most probably 
was a result of lower reproducibility of the sample conditions and a stronger effect of different 
sample and experimental factors on the obtained results. Thirdly, the desolvation of SACN and SNM 
in the selected conditions could be analyzed only at temperatures very close to the melting point 
of these solvates, see Section 3.3. This resulted in a very high desolvation rate dependence on the 
temperature, which produced unexpectedly high calculated Ea values. This most probably was a 
result of the change of the desolvation mechanism at temperatures close to the melting point, 
therefore the calculated Ea values most probably did not actually represent the activation energy of 
the desolvation process. This assumption was supported by the relatively lower Ea values obtained 
for the SACN sample that was analyzed at slightly lower temperatures (see Table S2 in in Appendix 
9). The average desolvation Ea values for all droperidol solvates are given in Table 3.7. 
Table 3.7. Kinetic parameters for the desolvation of droperidol solvates. 
Solvate 
Isothermal mode Nonisothermal mode 
Ea, kJ∙mol-1 Model Ea, kJ∙mol-1 Model 
NSH 56±10 
Modified D5 
- - 
SMe 50±13 65 ± 10 D5 
SEt 53±15 51 ± 15 D1, D4 
SNM -a 57 ± 5 D5 
SACN -a 60 ± 15 D5 
a – desolvation mechanism changed at a temperature close to the melting point of the solvate. 
In order to bring more clarity about the desolvation kinetics of droperidol solvates with 
organic molecules, these solvates were studied also in nonisothermal mode using well ground 
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samples and a higher nitrogen flow rate. Although these results were also complicated by the 
apparent variation of Ea with the fraction desolvated and by the high uncertainty of the Ea values, 
the determined average desolvation Ea value for all four solvates was similar (50-65 kJ·mol-1) and 
almost the same as that of NSH in the isothermal mode (see Table 3.7). Therefore it was concluded 
that a) desolvation activation energy of all the droperidol solvates is almost the same and is 57±15 
kJ·mol-1, and b) in isothermal mode very high Ea calculated for desolvation of SACN and SNM was 
due to the analysis at the temperatures close to the melting point and not because of actually higher 
desolvation Ea. 
The identical desolvation Ea values did not allow to use this parameter for the comparison 
of solvate stability. 
Kinetic model. Determination of the desolvation kinetic model of droperidol solvates was 
not straightforward and none of the commonly cited171, 187, 191, 192, 303 kinetic models (see Table A5) 
derived from the rate dependence on the nuclei formation and growth, interface advance, diffusion 
and/or geometrical shape of the particles were able to convincingly and satisfactorily describe the 
desolvation kinetic curves recorded in isothermal mode. However, the shape of the desolvation 
kinetic curves was similar to those of diffusion (D5 and D3) and reaction order (F3/2, F1 and F2) 
models. The arrangement of the solvent molecules in the structural channels, the absence of 
structural changes during the desolvation (Section 3.3), and the similarity of the shape of diffusion 
and reaction order model kinetic curves suggested that the rate limiting step in the desolvation 
process for all droperidol solvates was the diffusion of the solvent molecules out of the crystals. 
However, the exact diffusion mechanism appeared to be slightly different for different solvates, 
different samples, or even different conditions used. The deviation from the classical diffusion 
mechanisms could be due to the lattice parameter shrinkage during the loss of the solvent resulting 
in the reduction of the channel cross section area, which could change the diffusion coefficient 
during the desolvation process. 
Besides, it was observed that the desolvation kinetic curves of SACN and SNM at highest used 
temperatures were significantly different from diffusion-controlled kinetic curves and could be 
fitted by the nucleation and nuclei growth models (see Table S2 in Appendix 9). This observation 
confirmed the already stated hypothesis that at temperatures close to the melting point desolvation 
mechanism of these solvates differed from that at the lower temperatures. Moreover, at 
temperatures close to the melting temperature partial melting of the sample and desolvation from 
the melt could occur, thus changing the desolvation mechanism. 
Nevertheless, the most appropriate kinetic model fitting most of the kinetic curves was the 
Zhuravlev equation D5306, 307. This kinetic model has been modified308, 309 based on the changing 
diffusion activation energy during the reaction, giving the Eq. 3.1. 
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𝑁𝑁 ∙ �(1 − 𝛼𝛼)−1 3�  − 1�2 = 𝑘𝑘𝑘𝑘𝑛𝑛   (3.1) 
This modification, however, could as well represent the changing diffusion coefficient during 
the reaction or even the effect of a hindered conversion of the largest particles appearing due to a 
broad particle size distribution. It was found that all of the kinetic curves describing the desolvation 
of droperidol solvates in isothermal mode could be fitted with this modified Zhuravlev equation 
(see Figure 3.25 and S13 in in Appendix 9). Note that an additional normalization constant N was 
introduced in this equation in order to compensate for the possible effects from either slight 
absorption of the solvent at the surface, or very slow approach to complete conversion due to the 
presence of a few very large particles. 
 
Figure 3.25. Desolvation kinetic curves of droperidol isostructural solvate samples at 
various temperatures in the isothermal mode. Theoretical curves calculated using the modified D5 
model (Eq. 3.1) are shown with black lines. 
Although the fit of the data with Eq. 3.1 could as well be empirical, the obtained description 
of desolvation of all droperidol solvates can not be a coincidence, proving that the rate limiting 
step in this desolvation process is the diffusion. This conclusion is also supported by the fact that 
the desolvation Ea of all of the solvates was the same, which can easily be true for diffusion limited 
desolvation, but is less likely to be true for other rate controlling mechanisms, because of the 
different interaction energy between the solvent and the droperidol molecules. Furthermore, also 
in the nonisothermal mode the desolvation process was best described by diffusion models, with 
the most appropriate one being D5 in particular. 
Moreover, the diffusion as the rate limiting step was also confirmed by analyzing the 
desolvation of NSH, SMe, and SEt crystals by HSM, as the desolvation before melting (up to 120 °C) 
did not introduce any apparent changes to the crystal, except for the appearance of defects due to 
the cracking of the crystals or slight distortion of the molecular layers close to the crystal surface, 
which was most probably associated with the reduction of the unit cell size. 
82 
3.4.2 Thermal stability of droperidol solvates 
Although the desolvation kinetic parameters were almost the same for all droperidol 
isostructural solvates, the solvate thermal stability was not equal. It was not possible to compare 
the desolvation onset temperature as the desolvation occurred over a wide temperature range and 
the nonstoichiometric behavior produced very broad and indistinct desolvation endotherm (see 
Figure 3.26). Therefore, the thermal stability of the droperidol solvates was evaluated from the 
experimental results characterizing the desolvation rate of the solvates in both isothermal and 
nonisothermal mode using TG curves and PXRD patterns recorded during the desolvation. The 
determination of the solvate stability in nonisothermal mode was complicated by the solvate 
melting due to the relatively slow desolvation process, during which a complete rapid desolvation 
from the melt occurred (see Figure 3.26). In this study it was possible to identify separate melting 
peaks for the solvates (a in Figure 3.26) and the melting or phase transition peak of ISD (b in 
Figure 3.26). Although in our previous experiments both of these processes were not 
distinguishable, in Table 3.3 reported melting points were consistent with those determined here. 
It was observed that SNM had the lowest melting point, while SMe had the highest melting point. 
Therefore the thermal stability of the solvates was evaluated from the desolvation curves before 
the melting point of solvate, as the melting point did not characterize the thermal stability of solvate 
with respect to the desolvation. 
 
Figure 3.26. The DTA and TG curves of the droperidol isostructural solvates showing (a) 
the melting of solvate, (b) the melting of ISD or its phase transition to I, and (c) the melting of the 
resulting polymorph I. 
Although the criteria for evaluation of the thermal stability were straightforward, the sample 
preparation appeared to be the crucial aspect to determine the thermal stability (as can be identified 
from the dehydration temperature of different NSH samples, Table 3.6). Thus, the obtained results 
were not completely unambiguous, although identical sample preparation was used to obtain all of 
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the data for this comparison. Nevertheless, the presented conclusions are based on separate 
experiments using different samples, and therefore are reliable. 
Nonisothermal (Figure 3.27) and isothermal (Figure S17 in Appendix 9) heating of ground 
droperidol isostructural solvates showed that it is possible to rationalize their thermal stability: the 
least stable was NSH, while the most stable was SNM. Although the thermal stability of SMe, SEt, 
and SACN was more similar and the established stability order slightly differed in some of the 
experiments, most of the experiments showed that from these three phases the least stable was SMe 
and the most stable was SACN. 
 
Figure 3.27. Desolvation kinetic curves of droperidol isostructural solvates in nonisothermal 
mode at the heating rate of 5°·min-1. 
The same order of thermal stability was confirmed also by monitoring the PXRD patterns 
during the isothermal solvate desolvation and by analyzing the curves recorded during the study of 
the desolvation kinetics in the nonisothermal mode. Therefore, based on the data obtained from 
all of the performed experiments, it was possible to determine the relative thermal stability of 
droperidol isostructural solvates, which increased in the following order: 
NSH<SMe<SEt<SACN<SNM. 
3.4.3 Quantitative comparison of solvate stability based on the crystal structure 
In the crystal structure of droperidol solvates, the solvent molecules and droperidol 
molecules are connected with strong and/or weak hydrogen bonds. It is clear that the stability of 
the solvates can not be associated with the presence of strong hydrogen bonds, because in the most 
stable solvates SACN and SNM the acetonitrile and nitromethane molecules form only weak hydrogen 
bonds with the droperidol molecules. Therefore, in order to rationalize the relative stability of the 
droperidol solvates, solvent-droperidol, solvent-solvent, and also droperidol-droperidol 
intermolecular interaction energy values were calculated in Gaussian 09. Before the calculation of 
the interaction energy, geometry optimization of the crystal structures was performed. To obtain 
comparable results, crystal structures of all five solvates determined at 173 K were used for the 
calculations. As it is not possible to take into account the degree of disorder, the alcohol molecules 
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in the crystal structures of SMe and SEt were oriented in one of their two possible positions for 
crystal structure optimization and calculation of the interaction energy. 
Characterization of the droperidol-droperidol intermolecular interaction energy. 
Droperidol-droperidol interaction energy in all solvates was evaluated based on droperidol 
molecule interactions with 10 closest droperidol molecules designated by the letters A – G (see 
Figure 3.28, symmetrically equivalent interactions were designated with the same letter). The 
calculated interaction energy for these droperidol molecule pairs, as well as the total droperidol-
droperidol interaction energy from these ten interactions is given in the Appendix 9. From these 
calculations it was concluded that the intermolecular interactions between droperidol molecules as 
well as their energy were almost the same in all of these solvates and did not depend on the crystal 
structure optimization method. Therefore, different solvent molecules in the channels did not 
introduce significant changes in the droperidol-droperidol molecule arrangement, although some 
minor differences of the interaction energy values occurred. 
 
Figure 3.28. The arrangement of the central droperidol molecule and ten closest droperidol 
molecules surrounding it, that was used for the evaluation of pairwise droperidol-droperidol 
interaction energy values in the droperidol isostructural solvates. 
Characterization of the intermolecular interaction energy of solvent molecules. The 
presence of various functional groups in the solvent molecules and different arrangement of these 
molecules in the crystal structure prevented a direct comparison of the intermolecular interaction 
energy for solvent-droperidol molecule pairs in different solvates. Nevertheless, the interaction 
energy was calculated between the solvent molecule and up to 8 droperidol molecules, as well as 
the closest solvent molecules. These interactions with droperidol molecules were designated by 
Greek alphabet letters α to θ and solvent-solvent interactions were designated by ι and κ (see 
Figure 3.29), and the calculated values are given in the Appendix 9. 
 
Figure 3.29. The arrangement of (a) solvent-droperidol molecule pairs and solvent-solvent 
molecule pairs in (b) organic solvates and (c) NSH, corresponding to all energetically relevant 
solvent interactions in the droperidol isostructural solvates. 
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Most of the molecule pairs were characterized by negative interaction energy and therefore 
corresponded to energetically favorable interactions, while few pairs were characterized by slightly 
positive interaction energy and corresponded to energetically unfavorable interactions, which was 
shown to be a common phenomenon and was explained by the existence of a crystal structure in 
a state where the energy minimum was reached for the whole multi-molecular system, and not 
individual molecule pairs115. 
It was observed that the calculated interaction energy for all of the molecule pairs at the 
B3LYP-D level was more negative than that calculated at the M06-2X level. This difference for 
interactions between droperidol and solvent molecules was less than 6.5 kJ·mol-1 with no direct 
correlation with the magnitude of the interaction energy (although it was noticed that B3LYP-D 
typically overestimated the magnitude of the interaction energy for pairs in which it was small). 
Therefore the total solvent interaction energy (a sum of all solvent-droperidol and solvent-solvent 
interaction energies) calculated at the M06-2X level was also less negative (see Table 3.8). The 
results obtained by using M06-2X are considered to be more accurate, as it has been shown that 
this empirical exchange-correlation functional performs better for the description of the 
noncovalent interactions, compared to the more commonly used dispersion corrected B3LYP-D 
functional310, 311. Moreover, the better accuracy of the interaction energies calculated at the M06-2X 
level also was supported by a better agreement to the interaction energy values calculated with 
PIXEL code (see Appendix 9). Unfortunately, it was not possible to use the PIXEL code for the 
calculation of the intermolecular interaction energy in droperidol organic solvates due to the 
presence of three symmetry independent molecules in the unit cell. 
The differences in crystal structure geometry obtained after different optimization methods 
were also reflected in the calculated interaction energy values. Therefore, there were only slight 
differences of interaction energy values for the individual molecule pairs (typically below 2.0 
kJ·mol-1) and for total solvent interaction energy (below 6.4 kJ·mol-1) in SACN, SNM, and SEt 
structures after all structure optimization methods (see Table 3.8). 
Table 3.8. The total solvent interaction energy (in kJ·mol-1) values calculated in Gaussian 09 
after different structure optimization methods for isostructural solvates of droperidol. 
  SNM SACN SEt SMe NSH 
B3
LY
P-
D
 
1 -104.4 -92.9 -96.5 -81.3 -71.1 
2 -101.6 -94.1 -95.6 -82.3 -75.7 
3 -103.3 -95.1 -95.7 -81.4 -77.3 
4 -97.4 -90.3 -91.1 -82.8 -72.0 
5 -98.9 -92.6 -96.2 -76.4 -69.4 
M
06
-2
X
 
1 -82.8 -72.0 -69.3 -64.6 -59.7 
2 -80.4 -74.3 -68.0 -64.6 -65.1 
3 -82.9 -76.1 -68.8 -65.6 -66.6 
4 -76.6 -71.0 -67.6 -67.6 -57.0 
5 -75.4 -70.7 -69.2 -50.5 -62.6 
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1 – PBE+TS HO in CASTEP, 2 – PBE+TS ALL in CASTEP, 3 – PBE+TS UC in 
CASTEP, 4 – PBE+G06 UC in CASTEP and 5 – B3LYP-D* UC in CRYSTAL09. 
The same applied also to the differently optimized structures of SMe, except for that 
optimized at the B3LYP-D* level. The different water molecule arrangements in NSH after 
different geometry optimization methods also showed up as differences in the water interaction 
energy values. Further discussion is given in the Appendix 9. 
From all three optimization procedures at the PBE+TS level in CASTEP, the calculated 
average total solvent interaction energy per one mole of solvent for all droperidol solvates is 
presented in Figure 3.30. From these results it follows that the total solvent interaction energy 
becomes more negative in the following order: 
NSH>SMe> (SEt, SACN) >SNM, 
where the sequence between the SEt and SACN depended on the interaction energy calculation 
level (at the B3LYP-D level the calculated total solvent intermolecular interaction energy was 
higher in SEt, whereas at the M06-2X level the calculated energy was higher in SACN), but not on 
the crystal structure optimization method (although full relaxation of the crystal structure reduced 
at the B3LYP-D level calculated energy difference between SEt and SACN). Therefore, the SNM was 
predicted to be the most stable solvate with respect to the loss of the solvent molecule, as this 
process would require disruption of energetically favored interactions, while the NSH was 
predicted to be the least stable one. 
 
Figure 3.30. The average total solvent interaction energy calculated in Gaussian 09 after 
geometry optimization at the PBE+TS level in CASTEP for all isostructural solvates of droperidol. 
It was also noticed that in SNM and SACN an important contribution to the total solvent 
interaction energy was provided by the solvent-solvent interactions, whereas they had only a minor 
contribution for the alcohol solvates (see Table 3.9). This is logical, as the acetonitrile and 
nitromethane molecules have the greatest length and do not have a specific orientation of the polar 
end (in alcohol molecules this end is hydrogen bonded to the benzimidazolone moiety of 
droperidol). Besides, the contribution from the interactions with other solvent molecules in the 
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total interaction energy increased when the interaction energy calculation level was changed from 
B3LYP-D to M06-2X, which appeared to be one of the main factors affecting the change of the 
order of the total solvent interaction energy for SACN and SEt. 
Logically, due to the presence of a strong hydrogen bond between two water molecules, 
water-water interaction energy had a relatively high contribution to the total interactions involving 
water molecules. 
Table 3.9. The average solvent-solvent interaction energy (in kJ·mol-1) and its contribution 
to the total solvent interaction energy calculated in Gaussian 09 at the M06-2X level after the 
structure optimization at the PBE+TS level in CASTEP for isostructural solvates of droperidol. 
  SNM SACN SEt SMe NSH 
B3LYP-D E (solv-solv) -8.5 -11.1 -1.8 -1.3 -15.4 
Contribution, % 16.9 23.9 3.9 3.3 20.6 
M06-2X E (solv-solv) -8.5 -10.7 -1.5 -1.2 -15.4 
Contribution, % 21.4 29.5 4.3 4.0 24.2 
 
Summary and comparison to the experimental results. The calculated total solvent 
interaction energy at the M06-2X level became more negative in the following order: 
NSH>SMe>SEt>SACN>SNM. 
Thus, the theoretically predicted order of the stability of solvates based on the total solvent 
interaction energy at the M06-2X level is opposite, compared to this sequence. This order is 
identical to that observed for the thermal stability of these solvates, which should not come as a 
surprise, as during the desolvation only solvent-droperidol and solvent-solvent interactions are 
disrupted, while the rest of the crystal structure is maintained. Therefore, the calculation of the 
total solvent interaction energy at the M06-2X level in this system can be used to rationalize and 
predict the thermal stability of solvates. 
Although the total solvent interaction energy in NSH was very similar to that of SMe, the 
thermal stability of these two solvates was quite different. This most probably could be associated 
with the small size of water molecules allowing an easier dehydration and the fact that the 
dehydration occurs by simultaneously losing the hydrogen bonded molecule pair (see Section 3.3), 
therefore the water-water interaction between the hydrogen bonded water molecules actually did 
not stabilize the NSH against the dehydration. 
Interestingly, it was noted that the order of the solvate melting points correlated with the 
calculated total droperidol-droperidol interaction energy values (see Table S17 in Appendix 9). 
Although such a small interaction energy value difference (8-9 kJ·mol-1) are unlikely to introduce 
significant melting point differences (>20°C), it would be reasonable that the solvate melting point 
would be associated with the droperidol-droperidol interactions and therefore the stability of the 
crystal lattice. 
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Although the thermal stability of the organic solvates increased in the same order as the 
boiling points of the respective solvents, this should be considered only a coincidence as the 
interactions of solvent molecules in the solvates are completely different than those in their liquid 
states. 
Although the experimental stability of the solvates can also be compared using the sorption-
desorption isotherms, which would provide an information about the thermodynamic stability, the 
solvent content in the initial part of the isotherm representing the solvent sorption at a given 
solvent vapor activity increased in the order NSH <SNM<SACN<SEt<SMe (see Section 3.3 and 
Figure S22 in Appendix 9). Therefore it appeared that the solvent content was determined by the 
steric factors of solvent molecules, and not by the intermolecular interactions. The only exception 
was the NSH, which had the lowest solvent content at any given activity, although the significant 
difference, if compared to other solvents, cannot be explained exclusively by the lower total energy 
of intermolecular interactions involving water molecules. 
3.4.4 Conclusions 
The study of the desolvation kinetics of droperidol isostructural solvates revealed that the 
desolvation activation energy of all these solvates was almost the same (57±15 kJ·mol-1) and the 
desolvation process was diffusion limited and the desolvation curves could be fitted using the 
modified Zhuravlev equation. 
The thermal stability of the solvates determined from the desolvation rate in both isothermal 
and nonisothermal mode could be successfully used as a solvate stability comparison and ranging 
tool for the droperidol solvates. The calculation of the intermolecular interaction energies in 
droperidol solvates showed that it was possible to rationalize and predict the thermal stability order 
of solvates by using a sum of the solvate-droperidol and solvate-solvate interaction energies.  
Although this solvate system can be used to understand the general trends in the 
characterization and rationalization of the solvate stability, we conclude that a) crystal structure 
does not substantially change during the desolvation, and b) droperidol-droperidol interaction 
energy in all solvates is almost the same, which makes this system a relatively simple model. 
Complications associated with a) different host-host interaction energy and b) the energy necessary 
for the crystal structure change during the desolvation will arise when a general stoichiometric 
solvate system is considered. Therefore, additional studies are necessary to obtain more general 
understanding of the solvate stability.  
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3.5 Solid-state NMR and computational investigation of solvent molecule 
arrangement and dynamics in isostructural solvates of droperidol 
Although isostructural in terms of the host droperidol structure, droperidol isostructural 
solvates are unusual in that they fall into three categories. Firstly, the NSH crystal structure is 
centrosymmetric with one droperidol and one water molecule in the asymmetric unit. The isotropic 
displacement parameter for the water oxygen at 120 K is three times higher than for other non-
hydrogen atoms, and it was not possible to locate all the water hydrogen atoms for structures 
determined at 173 K or above, see Section 3.3, suggesting that the water molecules are slightly 
disordered. Secondly, the SMe and SEt structures refine with centrosymmetry, with one droperidol 
and half a disordered alcohol molecule in the asymmetric unit. Therefore only one of the two 
droperidols in the unit cell is hydrogen bonded to the alcohol molecule, and taking into account 
disorder between two orientations related by inversion symmetry is necessary for a satisfactory 
refinement within the P  space group. Thirdly, the SACN and SNM are non-centrosymmetric, with 
two droperidol and one ordered solvent molecules in the asymmetric unit. 
In this section we use 13C, 15N and 2H solid-state NMR to determine and characterize the 
differences between these five droperidol isostructural solvates. This includes the identification and 
characterization of the molecular motion in NSH, SMe and SEt, to explain the slight disorder of 
water molecule in NSH and to distinguish between static vs. dynamic disorder in the alcohol 
solvates. Theoretical calculations are used to rationalize the differences in the molecular motion of 
the solvent molecules. 
3.5.1 Solvate characterisation using 13C CPMAS spectra 
Figure 3.31 shows the 13C CPMAS spectra of the solvates, with the peak positions given in 
Table 3.10. The resonances of the solvent molecules are readily identified (see labels), except for 
the methyl group signal of ethanol and the quaternary carbon of acetonitrile, as these overlap with 
the peaks of droperidol. Bearing in mind that the spectra were recorded under CP conditions, and 
so are not strictly quantitative, the intensity of the solvent peaks is consistently around two times 
lower than that of the droperidol CH2 peaks, consistent with a 0.5 solvate stoichiometry. CP spectra 
with short (10–50 µs) contact times were recorded to identify the carbon atoms directly attached 
to hydrogen; the peaks absent in these spectra and thus associated with quaternary carbon atoms 
are marked with arrows in Figure 3.31. 
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Figure 3.31. 50–135 ppm region of the 13C CPMAS spectra of the droperidol isostructural 
solvates together with peak assignment. Spinning sidebands are marked with asterisks, signals 
absent in short CP contact time experiments are marked with arrows, and signals in the SACN and 
SNM spectra showing evidence of splitting are circled. Full spectra are given in Figure S2 in 
Appendix 10. 
As would be expected, the NSH spectrum is consistent with one unique droperidol molecule 
in the asymmetric unit. However, the SMe and SEt spectra also do not show clear evidence of distinct 
droperidol molecules in the crystal structure, one hydrogen-bonded to the solvent, and one not. 
Only slight splitting of some peaks, circled in Figure 3.31, is observed in the spectra of SACN and 
SNM, which would be consistent with having two slightly different droperidol molecules in the 
asymmetric unit. 
To help assign the peaks, GIPAW calculations of the NMR parameters were performed for 
all solvates after geometry optimization. The results, after rescaling each set of the calculated 
shieldings against the experimental chemical shifts, are presented in Table 3.10. Different isotropic 
shielding values were calculated for the same carbon atom where inequivalent droperidol molecules 
are present in the asymmetric unit (SMe, SEt, SACN and SNM). It was observed that these differences 
were quite large (up to 6.8 ppm, with an average difference of 2–3 ppm, depending on the solvate) 
when only hydrogen atom positions were relaxed for structures solved in the P1 space group. 
Relaxing all atomic positions during the geometry optimization decreased the average difference to 
0.5 ppm. Since this is clearly in better agreement with the experimental results, only the structures 
obtained by all atom optimization were used in further calculations, and average values of the 
calculated shieldings of corresponding atoms were used when making comparisons with 
experimental data. The maximum difference of up to 2–3 ppm is observed for C9 and C10, which 
is consistent with their proximity to the solvent molecules. These results imply that solution of the 
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XRD results in P1 has “exaggerated” the asymmetry between the droperidol molecules; relaxing all 
the atomic positions results in increased local symmetry and better agreement with the experimental 
NMR data. 
As might be expected, the situation was reversed for the structures originally solved in P  
space group (SMe and SEt). With only optimization of the hydrogen atom positions, the droperidol 
environments remain essentially identical and only small maximal (1.6 to 2.2 ppm) and average (0.3 
– 0.45 ppm) differences were observed for equivalent carbon shifts in the two droperidol 
molecules. Several of these shifts, both for solvent and droperidol sites, however, deviated 
significantly from the experimentally observed values. Relaxation of all atoms resulted in almost 
identical chemical shifts to those calculated after all-atom optimization of structures solved in P1. 
The most significant differences between the 13C spectra are observed for the C4 and C9, 
marked by a dashed rectangle in Figure 3.31; these again are close to the solvent molecules. This 
observation was consistent with the GIPAW calculations, where the highest difference between 
the average chemical shifts for different solvates were predicted to be for C9 (2.7 ppm), C4 (1.8 
ppm) as well as for C8 (3.0 ppm), see Table 3.10. Overall, however, the spectra of solvates are very 
similar, showing the different solvent molecules introduce significant changes in the local chemical 
environment of the droperidol molecules. 
Taking into account the previously identified signals from quaternary carbons and solvent 
atoms, the obtained shielding values after all atom optimization were plotted versus the observed 
chemical shifts, illustrated in Figure 3.32 for SEt. As observed previously72, 252 and justified 
theoretically312, these plots had a non-unity slope. Linear regression was used to reference the mean 
experimental shift to the mean computed shielding, and to rescale the calculated shifts. These plots 
allowed the majority of the signals to be assigned, as indicated in Figure 3.31, with the exceptions 
of strongly overlapped peaks in the region 127–135 ppm, indicated by the rectangle in Figure 3.32. 
These ambiguities are not, however, significant for the purposes of this study. Further details of 
the assignment are given in Table 3.10. In each case, a smaller RMS deviation between calculated 
and experimental values was observed when all atomic positions were refined. 
 
Figure 3.32. Calculated 13C isotropic shielding (averaged over equivalent carbons) values 
versus observed chemical shifts in droperidol SEt. The dashed rectangle marks the region where the 
peak assignment is ambiguous. 
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Table 3.10. Assigned experimental peak maxima (in ppm) in 13C CPMAS spectra and 
(rescaled) average calculated 13C chemical shifts after all atom optimisation. 
 NSH SMe SEt SACN SNM  
Carbon δExp δall δExp δall diff.a δExp δall diff.a δExp δall diff.a δExp δall diff.a ∆δCalcb 
C16c 197.6 199.9 197.5 199.9 0.1 197.5 199.8 0.1 197.6 200.2 0.2 197.5 199.7 0.0 0.5 
C20c,d 167.5 171.5 167.7 171.7 0.0 167.7 171.6 0.1 167.7 171.9 0.0 167.6 171.6 0.0 0.4 
C1c 154.0 149.2 154.1 149.5 0.3 154.1 149.3 0.1 154.1 149.8 0.2 154.2 149.7 0.4 0.6 
C17/C8c,e 133.6 131.4f 133.6 131.4g 1.4 133.8 132.1g 0.6 133.7 131.4f 0.0 133.9 132.9g 0.8 0.1f 
C18 
132.2 
132.7 
132.4h 
133.0 0.2 
132.4 
132.9 0.2 
132.3 
132.8 0.0 
132.7h 
133.3 0.1 0.5 
C22 132.4 132.6 0.1 132.7 0.4 133.3 0.0 132.6 0.2 0.9 
C17/C8c,e 130.1 130.0g 130.2 131.3f 0.1 130.4 131.4f 0.0 129.8 131.3g 0.2 130.7 131.5f 0.0 3.0g 
C6c 
127.9 
127.1 
128.3 
127.1 0.4 
128.3 
127.0 0.4 
128.6 
127.2 0.5 
128.6 
127.4 0.2 0.4 
C7c 126.3 126.6 0.1 126.7 0.3 127.2 0.3 127.3 0.3 1.1 
C9 124.7 130.0 125.0 128.4 3.2 125.1 128.2 1.2 124.8 128.0 1.3 124.6h 127.3 2.1 2.7 
C4 123.7 122.9 123.1 122.0 1.3 123.0 122.1 0.9 122.1 121.0 0.2 122.9 122.3 0.3 1.8 
C3 119.8 118.1 119.4 118.0 0.3 119.3 117.9 0.3 118.9 117.4 0.1 119.0 117.5 0.0 0.6 
C19 
117.2 
117.3 
117.2 
117.6 0.5 
117.3 
117.4 0.5 
117.3 
117.6 0.0 
117.3 
117.6 0.3 0.3 
C21 116.5 116.7 0.0 116.7 0.4 116.8 0.0 116.8 0.0 0.4 
C2i 110.9 108.7 110.5 108.9 0.6 110.8 109.2 0.6 110.3 108.6 0.1 110.4 108.8 0.2 0.6 
C5i 109.4 109.0 108.9 107.5 1.3 109.2 108.3 1.1 109.0h 107.7 0.7 108.9h 107.7 0.9 1.5 
C13 59.8 60.3 60.1 60.1 0.0 60.0 60.1 1.2 60.3 60.2 0.5 60.3 60.5 1.1 0.4 
C11i 
52.4 
53.8 53.3 53.6 1.0 53.2 53.4 0.6 53.7 53.9 0.4 
52.6h 
53.2 1.2 0.7 
C10i 53.2 52.1 53.0 0.6 51.7 52.3 2.1 51.8h 51.8 1.0 52.9 2.1 1.5 
C15 35.3 36.1 35.5 36.1 0.0 35.6 36.6 0.0 35.6 36.5 0.0 35.9 37.2 0.1 1.1 
C12 28.4 28.2 28.4 28.8 0.2 28.3 28.7 0.2 28.0 28.0 0.2 28.4 29.1 0.3 1.1 
C14 21.3 21.0 21.3 21.0 0.2 21.1 21.1 0.0 21.2 20.9 0.0 21.1 21.2 0.0 0.3 
CH3 solv   50.8 52.2  21.1 19.8  4.2 6.0  63.1 62.5   
CH2/CNsolv     58.3 60.9  128.6/ 129.8j 128.3     
 
RMSDk  2.06  1.83   1.79   1.81   1.65   
a Difference in calculated chemical shift between two chemically equivalent atoms in the 
unit cell. Significant differences (greater than 0.7 ppm) are highlighted in grey (dark grey if larger 
than 2 ppm). 
b Difference between the highest and lowest calculated chemical shifts from the same atom 
in all five solvates. 
c Non-protonated carbons identified from short contact time CP spectrum. 
d Signal split by J-coupling to 19F, with 1JCF = 278–280 Hz in NSH, SMe, SEt and SACN and 
1JCF = 265 Hz in SNM.  
e High variation in CASTEP calculated chemical shifts for these two atoms in different 
solvates prevents unambiguous assignment. 
f Given value is for C17 (calculated). 
g Given value is for C8 (calculated). 
h Signal is slightly split. 
i Peak separation of C2 and C5, as well as that of C10 and C11 is too small for unambiguous 
assignment, but consistent relative position in GIPAW calculations for all solvates (with the 
exception of C2 and C5 in NSH) and the splitting of C5 and C10 peaks support this assignment. 
j Experimental peak position uncertain, but peak intensities and GIPAW calculations 
suggest that nitrile carbon corresponds to one of these peaks. 
k Root mean square difference between experimental and calculated chemical shifts. 
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The experimental spectra show only slight evidence of splitting for a few peaks in SACN and 
SNM corresponding to carbon atoms C5, C9 and C10, which are all close to the solvent molecules. 
The differences between peak maxima were at most 0.5 ppm, but these particular carbon atoms 
also show the highest splitting in the GIPAW-calculated chemical shifts, see Table 3.10. Observing 
the line splitting is complicated by the relatively broad linewidths; the widths of the peaks in the 
spectra of droperidol isostructural solvates were 0.75–1.15 ppm, whereas peak widths in the 13C 
spectra of droperidol dihydrate and form II were only 0.32–0.70 ppm under the same conditions. 
This difference in linewidths can not be explained by the presence of two slightly different 
droperidol molecules in the unit cell, as the linewidths of the organic solvates was identical to that 
of NSH, where there is a single droperidol molecule in the asymmetric unit. The “line-broadening 
factors” associated with the anisotropy of the bulk magnetic susceptibility (ABMS) for powder 
samples313 were determined using the magnetic susceptibility tensor calculated by CASTEP-NMR. 
This was found to be ~3.6 ppm for the isostructural solvates and ~1.7 ppm for both form II and 
dihydrate, suggesting that the width of the lines in the solvate spectra is associated with a large 
ABMS, making it intrinsically difficult to resolve overlapped resonances. 
3.5.2 Solvate characterisation using 15N CPMAS spectra 
 
Figure 3.33. 15N CPMAS spectra of droperidol solvates SEt, SMe and SACN, showing the 
splitting of the N2 peak in the spectrum of SACN. The lower signal-to-noise ratio of the SACN 
spectrum reflects the much longer recycle delay needed for this sample (120 s, compared to 15 and 
25 s for SEt and SMe respectively) and consequently a much reduced number of acquisitions 
compared to the alcohol solvates (440 compared to 3628 and 2308 respectively). 
As shown in Figure 3.33, 15N CPMAS spectra were recorded for the SEt, SMe and SACN 
solvates, and peaks assigned based on the GIPAW calculations. Both SEt and SMe show sharp lines 
from all three nitrogen atoms, whereas the line from N2 – the only nitrogen atom close to the 
solvent – was split (or significantly broadened) in SACN, indicating two distinct local environments. 
This confirms that the acetonitrile breaks the local symmetry of droperidol molecules, consistent 
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with the determined crystal structure. The experimental and GIPAW-calculated 15N chemical shift 
differences are almost the same, 1.0 and 0.8 ppm respectively. The alcohol molecules are strongly 
hydrogen-bonded with the droperidol O1 atom, thus affecting the strength of the intermolecular 
hydrogen bond between droperidol molecules N2-H···O1 and the calculated chemical shift 
difference for N2 is significantly higher in SMe and SEt, 1.6 and 3.2 ppm respectively. In contrast to 
SACN, only one, somewhat broader, line is observed in the 15N spectrum for the alcohol solvates 
(45–50 Hz for N2 compared to 35–40 Hz for other nitrogen resonances). This strongly suggests 
that the alcohol molecules in SMe and SEt are dynamically disordered, resulting in a single resonance. 
Although the 15N spectra were much more demanding to acquire, they are more sensitive in this 
case to the very subtle symmetry breaking involved. 
3.5.3 Characterization of solvent dynamics in droperidol isostructural solvates 
The evidence from the 13C and 15N CPMAS spectra acquired at ambient temperature, 
combined with the crystal structure determinations, suggests that the solvent molecules are 
dynamic in SMe and SEt. The crystal structure of NSH also shows evidence of disordered water 
molecules. 13C and 2H MAS spectra of SEt, SMe and NSH as a function of temperature are used 
here to try to characterize the solvent dynamics. 
Solvates with organic solvents. It can be seen in Figure 3.34 that the ethanol CH2 group 
signal (highlighted with an arrow) in the CPMAS spectrum (solid lines) of SEt broadens when the 
temperature is reduced to –15 oC and has lost most of its intensity at –40 oC. These changes are 
reversible and consistent with the presence of dynamics. Experiments with different contact times, 
confirmed that the low intensity of this peak is related to its broad nature rather than, for example, 
rapid T1ρ relaxation. The broad CH2 peak is more easily observed in the 13C direct-excitation spectra 
(dashed lines). The most likely mechanism for the broadening is interference between the 
modulation of NMR parameters by dynamics and the 1H decoupling59, 314, implying that the 
dynamics of the ethanol CH2 are on the order of 10s kHz around –40 oC. It was also noticed that 
the build-up of the ethanol CH2 group signal during cross-polarisation at 20 oC was significantly 
slower than that of CH2 carbons of droperidol (see Figure S8 in Appendix 10). This implies that 
the heteronuclear CH dipolar couplings are partially averaged by dynamics on the timescale of 10s 
of kHz or faster. 
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Figure 3.34. 13C CPMAS (solid lines) and direct-excitation (dashed lines, 20 oC and –40 oC) 
spectra of SEt at different temperatures. The signal from ethanol CH2 is marked with an arrow. 
 
The 13C T1 relaxation times measured as a function of temperature provide further insight 
into the dynamics of the ethanol molecules. These are tabulated in Table S2 in Appendix 10 and 
plotted in Figure 3.35. The relaxation times of both ethanol carbon atoms are relatively short e.g. 
1.04 s for the CH2 and 0.8 s for the CH3 at 20 oC, compared to at least 50 s for the carbon atoms 
in droperidol. The steady decrease in T1 relaxation time of the CH3 carbon with decreasing 
temperature is consistent with the approach towards a T1 minimum. Assuming Arrhenius-type 
behaviour, fitting the linear regime (i.e. excluding the data point at –40 oC) gives an activation 
barrier, Ea, of 15.1±0.6 kJ mol–1. This is a typical value for rotational diffusion of the methyl group60, 
70, 315, although it should be noted that a more extensive data set encompassing the T1 minimum 
would provide much more robust figures. The interpretation of the CH2 carbon data is less 
straightforward, but its rapid relaxation implies that there are significant local dynamics of the CH2 
over the full temperature range. While 13C relaxation rates will be dominated by dipolar relaxation 
driven by modulations of the CH heteronuclear couplings, there will also be a contribution from 
cross-relaxation to any rapidly relaxing 1H spins. Faster 1H T1 relaxation at lower temperatures 
allowed the recycle delays to be reduced from 12 s at 20 oC to 6 s at –40 oC, suggesting that the 
decrease in the 13C T1 of the CH2 in the low-temperature limit may be related to faster cross-
relaxation to 1H (associated with the methyl group re-orientation). The 13C T1 of the CH2 also 
decreases in the high temperature limit, where the methyl group dynamics is not contributing so 
effectively to T1 relaxation. This suggests that there are additional dynamic processes that become 
more effective at driving the spin-lattice relaxation in the high temperature regime (and so are likely 
to have higher activation barrier than methyl rotation). Such processes would need to be of the 
order of the 13C Larmor frequency (in this case 125 MHz) at 20 oC, which could also be consistent 
with a process that is of the order of 10s kHz at –40 oC (as observed via the spectra). 
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Figure 3.35. 13C T1 relaxation times for the ethanol carbons of SEt as a function of inverse 
temperature. The one-standard-deviation error bars on the fitting of CH2 T1 values are of the order 
of the size of symbols used. 
 
The T1 relaxation times of methyl group carbons in methanol and acetonitrile molecules are 
much longer than in the ethanol solvate, 5.1 and 17 s at 20 oC respectively (see Table S2 in Appendix 
10), and show the opposite temperature dependence (i.e. decreasing with increasing temperature). 
Bearing in mind the difficulties of interpreting relaxation data at some distance from the T1 
minimum, this suggests that the barrier for methyl group re-orientation in these solvates (and the 
acetonitrile solvate in particular) is significantly higher, and that the T1 minimum is well above 
ambient temperature. There is also no evidence for additional high-frequency motions. 
The 2H MAS spectra of the alcohol solvates prepared from d1-alcohols were very similar, 
showing resonances both from the deuterated solvent, at about 4.0 ppm, and the labile NH site of 
droperidol, at about 10.5 ppm. Figure 3.36 shows the spectra for SEt; and spectra of SMe is almost 
identical. Fitting the bandshape from both of the deuterium sites, quadrupolar coupling parameters 
were determined in pNMRsim284. The quadrupolar coupling parameters for the alcohol OD 
determined from the spectra at 20 °C were found to be the same within experimental error, χ = 
206 kHz, η = 0.17. The fitted quadrupolar coupling constants were slightly larger at –45 °C: χ = 
211 kHz for SMe and 222 kHz for SEt, with η = 0.17. The uncertainties on χ and η are estimated to 
be 2 kHz and 0.02 respectively, on the basis of duplicate measurements and different processing 
methods used to obtain flat spectral baselines. These parameters are consistent with values 
calculated by the GIPAW calculations, χ = 244–246 kHz, η = 0.15, but reduced by high frequency 
motions of increasing amplitude as the temperature is increased316. Note that flipping of the solvent 
molecules through the inversion centre will not change the quadrupolar coupling tensor orientation 
and so would not have a direct effect on the spectrum. 
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Figure 3.36. 2H MAS spectra at a spinning rate of 10 kHz for SEt at 20 and –45 oC, with the 
centreband region expanded on the right. 
In contrast to the 2H spectra, which might suggest that the solvent molecules are essentially 
static, the 2H T1 relaxation times for the alcohol OD group were short (estimated to be 0.1 – 0.3 s) 
at both measurement temperatures (–45 °C and 20 °C). Again, a simple flip of solvent molecules 
through an inversion centre cannot itself explain the fast relaxation, since the quadrupolar tensor 
is left unchanged. This implies that multiple high-frequency processes are active, resulting in fast 
relaxation rates that are not significantly temperature dependent, i.e. there is no single motional 
process creating a well-defined T1 minimum. We have previously observed small amplitude 
motions that are large enough to drive relaxation but too small to significantly average the 
quadrupolar coupling constant70. The crystal structure solution and the averaged chemical 
environments for the droperidol molecules in the unit cell indicate that the solvent molecules are 
also flipping orientations, but the 2H NMR data and the 13C relaxation times are not sensitive to 
this process. The most likely scenario is that the alcohol molecules are relatively dynamic within 
their lattice sites and also occasionally flip over to the equivalent site related by the inversion 
symmetry. 
Nonstoichiometric hydrate. Reduction of the temperature to –40 oC noticeably changed 
the 13C CPMAS spectra of NSH, Figure 3.37. The largest changes are for the signals from C9 and 
C4, both of which are close to the water molecules – C9 is even weakly hydrogen bonded with the 
water (see Section 3.3) – suggesting changes in the dynamics and/or average structure of the water 
molecules. The relatively short (largely temperature independent) 1H T1 relaxation time of about 
15 s observed in the 13C CP experiments is consistent with motion of the water molecules; 
droperidol phases without mobile solvent molecules, SACN, SNM, polymorph II and dihydrate, 
showed T1 values in excess of 2 min, which is more typical of molecular solids lacking methyl 
groups to drive relaxation. 
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Figure 3.37. 13C CPMAS spectra of NSH at 20 oC (solid line) and –40 oC (dashed line). 
Figure 3.38 shows 2H MAS spectra of NSH prepared from D2O as a function of 
temperature. Very different bandshapes and temperature dependence are observed compared to 
the alcohol solvates. The water signal in NSH has narrower bandshape with partially averaged 
quadrupolar coupling parameters: χ was 84±3 kHz, while η was more variable, in the range 0.6 to 
1.0, depending both on water content and temperature. This dependence on the water content 
presumably reflects changes in the overall dynamics with the degree of occupancy of water sites. 
While the possibility of distinct populations of static vs. dynamic water molecules can be ruled out, 
it is difficult to distinguish whether there is a distribution of similar water environments or a single 
averaged water environment with fast exchange between sites. Reducing the temperature clearly 
broadens the lines corresponding to D2O, Figure 3.38 (b), implying the water is highly dynamic at 
ambient temperature and that some aspect of the dynamics is being slowed to the 10s kHz 
frequency scale at –45 oC. The overall quadrupolar coupling constants are somewhat lower than 
those typically reported for water molecules undergoing rapid C2 flips66-68, suggesting that the 
overall dynamics is more complex. Moreover a simple C2 flip motion would produce η values of 
unity and would not explain the relatively high displacement parameters for water oxygen site 
observed in XRD. As would be expected, the 2H T1 relaxation times for the water sites are very 
short, estimated to be <0.1 s from experiments with variable recycle delays. T1 relaxation times of 
ND sites were 1–3 s, comparable to values observed for deuterium sites without high-frequency 
dynamics. The larger intensity of the ND signal in Figure 3.38 (a), probably reflects that the fact 
that the hemihydrate sample was stored for longer in the D2O atmosphere that the monohydrate 
sample. 
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Figure 3.38. 2H MAS spectra at a spinning rate of 10 kHz of NSH with (a) hemihydrate 
stoichiometry at 20 oC, and (b) monohydrate stoichiometry at different temperatures. The insets 
show the spinning sideband at about 30 kHz (marked with dashed rectangle), as the ND signal is 
clearer here than in the centreband. The spectra have the same vertical scale. 
To quantify the motional broadening seen in Figure 3.38, the linewidths of the D2O peaks 
(LW) were determined from the bandshape fitting of the spinning sideband manifold. The 
motional broadening was estimated by subtracting the width of the ND resonance (LWo = 160 
Hz), which is assumed to be unaffected by the water dynamics. The plot of linewidth due to 
motional broadening65 against inverse temperature, Figure 3.39, is linear over this temperature 
range allowing an Arrhenius-type activation barrier to be determined, Ea = 25±3 kJ mol–1. Note 
that in this fast exchange limit, the constant of proportionality between the motional broadening 
and the rate of dynamics is related in a non-trivial way to the quadrupolar parameters and motional 
mechanism. Moreover, the physical significance of the derived activation parameter is limited given 
both the non-trivial nature of the motion and the restricted temperature range covered.  
 
Figure 3.39. Estimated motional line broadening of the 2H D2O resonance of NSH as a 
function of inverse temperature. The “error bar” indicates the maximum and minimum linewidths 
observed using different methods for bandshape fitting / baseline roll suppression (see 
Section 2.13). 
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3.5.4 Theoretical analysis of the differences in solvent molecule behaviour  
In order to rationalize the observed differences in the solvent molecule dynamics between 
the different droperidol solvates, the energy difference was determined between structures where 
all the solvent molecules in a channel point in the same direction and where adjacent solvent 
molecules point in opposite directions. As a first step, the orientation of the solvent molecule in 
each hemisolvate crystal structure was approximately reversed and geometry optimization in 
CASTEP used to relax all the atomic positions. The tiny energy differences of up to 0.3 kJ cell–1 
(equivalent about 3 × 10–7 of the total cell energy) between the energies of these nominally identical 
unit cells gives an estimate of the “error bar” in this type of calculation. The unit cell dimensions 
were then doubled in the solvent channel (a-axis) direction and the orientation of one solvent 
molecule was reversed. The energy differences (per unit cell / doperidol molecule) between the 
“same direction” and “opposite direction” structures after full geometry optimization, with and 
without dispersion correction, are shown in Table 3.11. It can be seen that the cell energies are 
essentially the same for SEt, particularly when the dispersion-corrected functional is used. In 
contrast, the “same direction” structure is slightly energetically more favourable for SMe, and is 
significantly more energetically favourable for SNM and SACN. 
Table 3.11. Increase in unit cell total energy (in kJ cell–1) of droperidol solvates when adjacent 
solvent molecules are positioned in the opposite direction, with and without dispersion correction 
(+TS). 
Solvate SEt SMe SNM SACN 
PBE –1.5 2.9 9.9 26.3 
PBE+TS –0.4 3.7 12.6 26.9 
Pairwise interaction energies were also calculated to provide insight into the energetics of 
different relative solvent orientations. Interaction energies (the difference in energy between two 
separated molecules and their dimer) were calculated using Gaussian 09 between one solvent 
molecule and the two solvent and eight droperidol molecules that surround the chosen solvent 
molecule. The co-ordinates of these ten molecular pairs were extracted from the optimized “same 
direction” and “opposite direction” crystal structures, and the overall interaction energy 
approximated as the sum of these ten pairwise interaction energies. In the case of the “opposite 
direction” structure, adjacent solvent molecules can either be oriented “head-to-head” (HH) or 
“tail-to-tail” (TT), see Figure S11 in Appendix 10, along the a-axis direction. As required from the 
inversion symmetry, the total interaction energy of the solvent with its surroundings is the same, 
within the calculation accuracy, for the two solvent arrangements in "opposite direction" structure. 
As shown in Figure 3.40, the total interaction energy is essentially identical for the “same direction” 
and “opposite direction” structures in the case of SEt. In contrast, the interaction energies are much 
more favourable for the “same direction” structure for SNM and SACN. These trends are fully 
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consistent with the pattern of total unit cell energies as observed above. As shown in Figure 3.40 
and tabulated in Table S5 in Appendix 10, the most significant factor (at least 87%) contributing 
to the difference in interaction energies are the solvent-solvent interactions. The solvent-solvent 
interactions are always attractive in the “same direction” structure, whereas the interactions 
between nitromethane and acetonitrile molecules change by 13–18 kJ mol–1 from attractive to 
repulsive in the “opposite direction” structure. 
These results provide a straightforward rationalisation of the absence of solvent disorder in 
the SACN and SNM solvates – where there is a strong energetic preference for the solvent molecules 
to be consistently oriented – and the presence of solvent molecule disorder in SMe and SEt, where 
there is little energetic preference for a consistent orientation. 
 
Figure 3.40. Calculated (a) total pair-wise interaction energies of solvent molecules and (b) 
solvent-solvent interaction energies, in “same direction” and “opposite direction” droperidol 
solvate structures. 
3.5.5 Conclusions 
The 13C CPMAS solid-state NMR spectra of a set of isostructural solvates of droperidol 
(NSH, SMe, SEt, SACN and SNM) confirm that the solvent molecules have only minor effect on the 
chemical environment of the droperidol molecules. The relatively broad linewidths, which make it 
difficult to resolve the inequivalence of the droperidol molecules in the SACN and SNM solvates, can 
be explained by high anisotropy of the bulk magnetic susceptibility. The nature of the disorder was 
somewhat easier to resolve in the 15N CPMAS spectra, where dynamic disorder in the SMe and SEt 
results a single sharp set of peak for the droperidol nitrogen sites. 
Variable-temperature 13C and 2H spectra and measurements of spin-lattice relaxation times 
allow the characterization of the solvent molecule dynamics in NSH, SMe and SEt. The motion of 
the alcohol molecules in SMe and SEt contains dynamics of relatively high-frequency (on the order 
of 10s MHz to drive 2H and 13C T1 relaxation), but of limited amplitude (given the minimal 
averaging of the 2H quadrupolar parameters). The absence of well-defined T1 minima suggests that 
this is a complex motion. The dynamics also includes components on the 10s kHz frequency scale 
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(observed via the 13C spectra) and allows for occasional flipping over to the equivalent state related 
by the inversion symmetry, although the rate of this process cannot be estimated with any precision; 
the 15N spectra set a lower limit of about 40 Hz at ambient temperature (corresponding to 
collapsing a frequency difference of about 1 ppm at 40.53 MHz 15N Larmor frequency). The 
motion of the water molecules in NSH is also expected to be a composite motion, resulting in 
greater averaging of the NMR parameters than a simple C2 flip between equivalent positions, with 
an estimated C2 flip rate on the order of 10s kHz in –45 °C temperature, although an Arrhenius-
type activation barrier of Ea = 25±3 kJ mol–1 could be estimated in this case. 
The computational simulations help to rationalise these observations. There is little energy 
difference between initial and final states for inverting the orientation of the alcohol molecule in 
the SMe and SEt solvates. Although the barrier to inversion may be relatively high, this means that 
the solvent molecules appear to be disordered between the two symmetry-equivalent positions over 
the timescale of the XRD and NMR experiments. In contrast, the unfavourable energetics 
associated with adjacent acetonitrile and nitromethane molecules having opposite directions means 
that the SACN and SNM are strongly ordered on the NMR and XRD timescales. These unfavourable 
energetics are mostly associated with solvent-solvent interaction energies. 
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3.6 Structural Characterization and Rationalization of Formation, Stability, 
and Transformations of Benperidol Solvates 
A study of the solvate formation of droperidol (Section 3.3) showed that it exists as four 
polymorphs and eleven solvates. Benperidol is very similar to droperidol and also has three strong 
hydrogen bond acceptors and only one hydrogen bond donor, suggesting it could be a promiscuous 
solvate former305. In this study we tried to explore, understand, and rationalize the benperidol 
solvate formation, stability, and phase transformations. Benperidol was crystallized from solvents 
belonging to different solvent classes, the obtained solvates were characterized, and their crystal 
structures, as well as solvent and benperidol properties were used to rationalize their formation. 
The desolvation process and products were rationalized based on crystal structure and relative 
stability of non-solvated forms. Crystal structures of solvates were compared to rationalize the 
relative stability of solvates and the observed frequency of the solvate formation in the 
crystallization experiments. 
3.6.1 Crystallization 
Benperidol was crystallized from a range of solvents selected to represent different solvent 
classes based on classification according to statistical analysis of four molecular descriptors139, as 
well as hydrogen bond acceptor and donor propensity, polarity/dipolarity, dipole moment, and 
dielectric constant140. In these experiments no new benperidol polymorphs were obtained, see 
Table S1, Appendix 11. Moreover, in our experiments it was not possible to obtain polymorph III 
neither from n-heptane as described in the literature262, nor from any other solvent. From most of 
the solvents polymorph I was obtained. In accordance to previous studies262, 268, it was possible to 
crystallize polymorph II from isopropanol. However, the precipitation of the solid product from 
isopropanol usually initiated shortly after cooling the solution, and polymorph I was obtained 
instead. 
Nevertheless, besides the already reported solvates DH and SEt262, 268, nine new solvates were 
obtained in crystallization experiments from methanol, acetonitrile, ethyl acetate, nitromethane, 
1,4-dioxane, toluene/o-xylene, benzyl alcohol, carbon tetrachloride, and chloroform (labelled as 
SMe, SACN, SEtOAc, SNM, SDIOX, HH, SBenz, STCC, and SCLF, respectively). In this study, the first seven 
of these solvates, as well as the poorly explored solvated forms SEt and DH were characterized 
using PXRD patterns, DTA/TG analysis, and IR spectra, while their desolvation products were 
also identified, and the desolvation process was characterized. Preparation of solvates STCC and 
SCLF was complicated by the formation of side-products and poor reproducibility, so these solvates 
were characterized only using PXRD and DTA/TG analysis. Crystals suitable for SCXRD 
measurements were obtained for polymorph II and solvates DH, SEt, SMe, SACN, and SEtOAc. 
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Additionally, attempts were made to solve the crystal structures of the rest of the phases by using 
the recorded PXRD patterns, with success for HH, SBenz, and the polymorph III. 
3.6.2 X-ray diffraction and thermal characterization of benperidol solvates 
The PXRD patterns of all the obtained solvated forms are given in Figure 3.41. 
 
Figure 3.41. PXRD patterns of the benperidol solvates. 
It can be seen that the diffraction peak positions of solvates SMe and SEt were very similar. 
The same was found also for solvates SACN, SEtOAc, and SNM. These similarities suggest the formation 
of two sets of benperidol isostructural solvates: type 1 solvates (SMe and SEt), and type 2 solvates 
(SACN, SEtOAc, and SNM). The PXRD patterns of HH, SBenz, SDIOX, and STCC, however, exhibited 
different characteristic features, which also differed from those in PXRD patterns of all other 
known benperidol forms. The PXRD pattern of SCLF, however, was similar to that of type 2 
solvates, suggesting that this solvate probably also belongs to this type, although poor quality of 
the pattern did not allow to draw an absolute conclusion. 
The DTA/TG curves of the benperidol solvates are shown in Figure 3.42. Although this 
method allowed to confirm STCC and SCLF as solvates, the obtained curves cannot be assured to be 
characteristic for pure phases. 
The desolvation of DH and HH appeared to be a simple one step process with characteristic 
desolvation endothermic peak associated with the weight loss. The curves of other solvates, 
however, showed complex desolvation process. Type 1 and type 2 solvates usually showed two 
endothermic peaks associated with the weight loss. This suggests that the desolvation occurred in 
two stages, or other complications were encountered during the desolvation. It was shown that the 
second desolvation peak corresponded to peritectic desolvation and/or melting, see Section 3.6.5. 
Although the desolvation of SBenz most probably was also a one step process, it appeared to be 
complicated by the difficult evaporation of benzyl alcohol (Tb = 205.3 °C). 
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Desolvation products of the solvates were analyzed using PXRD and are given in Table 3.12. 
 
Figure 3.42. The DTA and TG curves of benperidol solvates. d – desolvation, dp – peritectic 
desolvation and/or melting, mI–IV – melting of polymorphs I – IV, and evapBenz – evaporation of 
benzyl alcohol. 
Table 3.12. Weight loss observed during the desolvation of benperidol solvates and the 
obtained desolvation products. 
Solvate Ratio Calculated 
weight loss, % 
Observed weight 
loss, % 
Tdesolvation,°C 
(peak) 
Resulting phase 
DH 1:2 8.6 8.8 (9.0)a 77 (V, IV)/(II, I)c 
SMe 1:1 7.8 7.9 89, 129b II/Ic SEt 1:1 10.8 11.6 87, 137b 
SACN 1:1 9.7 8.1-9.5d 86, 106b 
III/Ic SNM 1:0.5 7.4 6.9-9.0d 82, ~95b 
SEtOAc 1:0.5 10.4 8.5-9.8d 88 
HH 1:0.5 2.3 2.0–2.5 (2.1)a 89 III/Ic 
SBenz 1:1 22.1 21.8 109 I 
SDIOX 1:1.5 25.7 24.5 69 III/Ic 
STCC 1:1 16.8 16–22 66, 88 IV, V, II, I 
SCLF 1:0.5 13.5 10–17 76 III/I 
a – the water content determined by Karl Fischer titration is given in parentheses. 
b – the second value is peritectic decomposition and/or melting temperature. 
c – see discussion in Section 3.6.5. 
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d – the first number is the weight loss after the appearance of the desolvation peak in the DTA, 
and the second number is the total weight loss. 
Besides the polymorphs I and II obtained in the crystallization, desolvation of type 2 
solvates, HH, SDIOX, and SCLF produced the polymorph III described in the literature262, whereas 
the desolvation of DH produced new polymorphs IV and V. The PXRD patterns of benperidol 
polymorphs are given in Figure S2, Appendix 11, while the DTA curves are given in Figure S3, 
Appendix 11. 
Therefore, the existence of polymorph III as described in the literature262 has been 
confirmed268, although it is not clear whether it is possible to obtain it as described262, because in 
our study it was obtained only in the desolvation process. 
The stoichiometry of the solvates was calculated from the weight loss in TG curves. The 
DH phase was confirmed to be a dihydrate, whereas SEt was determined to be an ethanol 
monosolvate, in contrast to the reported ethanol disolvate stoichiometry262. With regard the 
isostructural type 2 solvates, the SACN phase was monosolvate, whereas SNM and SEtOAc appeared to 
be hemisolvates. Both TG and KF titration confirmed that HH is a hemihydrate. Repeated 
measurements suggested that SDIOX is a sesquisolvate, although this should be interpreted 
cautiously. 
Crystal structures of benperidol polymorph II, and solvates DH, SEt, SMe, SACN, and SEtOAc 
were determined from SCXRD measurements at 173 K or 100 K (SEtOAc), while those of 
polymorph III, as well as solvates HH and SBenz were determined from PXRD data collected in 
transmission mode at ambient temperature. The obtained crystallographic data are given in Table 
3.13. An overlay of the experimental data and PXRD patterns simulated from crystal structure data 
confirmed the identity of the polycrystalline phases. The correctness of the structures calculated 
from PXRD patterns was confirmed by the good agreement between experimental and calculated 
diffraction patterns (see Figure 3.43), as well as by the geometry optimization in CASTEP 
introducing only small changes in the crystal structure. Polymorphs II and III crystallized in the 
space group P  with three molecules or one molecule in the asymmetric unit, respectively. The DH 
form crystallized in the P21/n space group, SEt and SMe were isostructural and crystallized in the 
P21/c space group, SACN and SEtOAc were isostructural and crystallized in the P  space group, HH 
crystallized in the C2/c space group, and SBenz - in the Pbca space group. The asymmetric units of 
all solvated forms contained one benperidol molecule and two (DH), one (SMe, SEt, SACN, and SBenz), 
or one half (HH and SEtOAc) solvent molecules. In the HH form, the oxygen atom of water 
molecule was at a special position, and the ethyl acetate molecule in SEtOAc was disordered over two 
symmetrically related positions. The solvent stoichiometry determined from this analysis was 
consistent with that determined from TG analysis. 
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Figure 3.43. Experimental (black), calculated (red), and difference (dark blue) PXRD 
profiles from the final Rietveld refinement of various benperidol forms. 
Table 3.13. Crystallographic data for the benperidol phases II, DH, SEt, SMe, SACN, SEtOAc, 
HH, SBenz, and III. 
Solvate II DH SEt SMe SACN SEtOAc HH SBenz III 
Empirical 
formula 
C22H24FN3O2 C22H24FN3O2 
·2H2O 
C22H24FN3O2 
·C2H6O 
C22H24FN3O2 
·CH4O 
C22H24FN3O2 
·C2H3N 
C22H24FN3O2 
·0.5C4H8O2 
C22H24FN3O2 
·0.5H2O 
C22H24FN3O2 
·C7H8O 
C22H24FN3O2 
Mr 381.44 417.48 427.51 413.48 422.49 425.49 390.45 489.58 381.44 
Crystal 
system 
triclinic monoclinic monoclinic monoclinic triclinic triclinic monoclinic orthorhombic triclinic 
Space 
group 
P P21/n P21/c P21/c P P C2/c Pbca P 
a (Å) 10.8417(3) 11.0595(3) 15.0684(3) 15.1097(4) 5.56500(10) 5.4228(3) 36.7342(7) 13.7193(4) 15.61501(10) 
b (Å) 16.2903(4) 9.3896(2) 10.8602(3) 10.7200(3) 14.1256(4) 14.6014(8) 5.58581(10) 51.6467(20) 11.48189(8) 
c (Å) 17.9497(5) 20.4456(6) 15.2555(4) 15.3070(5) 15.0478(5) 14.8045(10) 23.6629(5) 7.43071(20) 5.45694(30) 
α (o) 66.7233(11) 90 90 90 109.2583(13) 109.936(3) 90 90 86.627(3) 
β (o) 87.0069(10) 91.7206(11) 117.6353(9) 119.3538(13) 90.9875(13) 90.199(2) 124.8680(8) 90 96.618(6) 
γ (o) 85.0074(16) 90 90 90 100.071(2) 100.322(3) 90 90 94.435(5) 
V (Å3) 2900.55(13) 2122.20(10) 2211.69(9) 2161.04(11) 1095.91(5) 1081.50(11) 3983.71(14) 5265.07(30) 967.71(6) 
Z/Z’ 6/3 4/1 4/1 4/1 2/1 2/1 8/1 8/1 2/1 
T, K 173(2) 173(2) 173(2) 173(2) 173(2) 100(2) 298(3) 298(3) 298(3) 
wR (all 
data) 
0.1616 0.196 0.1415 0.1997 0.1126 0.1992    
ﬁnal R (I 
> 2σ)a 
0.0765 0.048 0.0543 0.0644 0.0460 0.0751    
GOF 1.013 1.243 1.028 0.972 1.018 1.030    
Rwp       0.02897 0.03356 0.03686 
Rp       0.01721 0.02427 0.0243 
Rexp       0.00520 0.00734 0.00816 
Pacing 
coef. 
0.682 0.689 0.684 0.672 0.681 0.690 0.675 0.651 0.681 
a For the DH form I > 3σ. 
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3.6.3 Characterization of benperidol solvate crystal structures 
Analysis of the crystal structures revealed that the conformation differences appear as 
different values of the dihedral angles τ1 – τ6, although the oxobutyl side chain (τ3 – τ6) tends to be 
linear. Interestingly, molecular conformation of benperidol in polymorphs I and III, as well as that 
in all of it solvates is quite similar, but different from all three benperidol molecules in the 
polymorph II, with the most apparent difference observed for the value of τ1 (see Figure 3.44 (a) 
and Table 3.14). The molecular conformation of all three symmetrically independent molecules in 
II (designated as A, B, and C) was different, with slight variations in the conformations of A and 
C, and significant variations in the dihedral angles τ2 and τ4 for molecule B. As already mentioned, 
besides the identical conformations observed in the isostructural solvates SMe and SEt as well as in 
SACN and SEtOAc, the conformation of all solvates and polymorph III were nearly identical, with the 
exception of SBenz, which had a noticeable deviation of the dihedral angles τ2 and τ4 (see Figure 
3.44(b) and Table 3.14). It should, however, be mentioned that the geometry optimization in 
CASTEP changed the geometry of oxobutyl side chain by making it more similar to that in the rest 
of the solvates. Therefore, the overall conformation differences of benperidol were small if 
compared to other molecules with similar conformational degrees of freedom84, 91, and the observed 
structural diversity resulted from different intermolecular interaction possibilities producing 
different molecular packing. 
 
Figure 3.44. An overlay of benperidol molecules in a) polymorphs (I: green, IIA: red, IIB: 
dark grey, IIC: cyan), b) solvates (DH: dark blue, SEt: dark green, SACN: orange, SBenz: pink) and 
polymorph I (green). 
 
Table 3.14. Dihedral angles (in degrees) of benperidol in its polymorphs and solvates. 
 I267 IIA IIB IIC DH SEt SACN HH SBenz III 
τ1 –124.03 74.00 92.67 64.60 –108.82 –108.29 –113.17 –114.21 –123.07 –108.93 
τ2 –60.75 –157.37 –68.78 –156.47 –60.65 –72.75 –71.46 –72.09 –21.19 –75.32 
τ3 –172.82 175.51 –177.09 –177.98 –167.59 –176.74 –169.39 –148.24 –165.54 –162.38 
τ4 –166.14 171.94 74.07 175.18 –175.91 –179.91 –174.13 –152.45 138.78 –165.18 
τ5 –176.79 –179.31 –172.78 –173.37 179.6 –179.58 –175.07 163.25 172.75 177.45 
τ6 –177.47 155.52 161.46 –177.79 –178.83 178.82 –178.18 169.07 –149.71 170.13 
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The analysis of strong hydrogen bonding pattern showed that benperidol molecules in the 
polymorph I formed N2-H···N3 bonds creating a ring of 6 molecules characterized by 𝑅𝑅66(48) 
graph set, whereas all three molecules in II formed amide homodimers linked by N2-H···O1 bonds 
and characterized by 𝑅𝑅22(8) graph set (see Figure 3.45 and Table 3.15). 
 
Figure 3.45. Hydrogen bond patterns observed in crystal forms of benperidol. 
Table 3.15. Geometrical parameters of the strong hydrogen bonds in benperidol 
polymorphs and solvates. 
Phase Interaction Distance, Å D-H···A, ° Graph set X-H H···A D···A 
I267 N2-H…N3   2.883  𝑅𝑅66(48) 
II N2A-H…O1A 0.86 1.96 2.800(3) 165 𝑅𝑅22(8) 
 N2B-H…O1C 0.86 1.95 2.779(3) 161 𝑅𝑅22(8) 
 N2C-H…O1B 0.86 2.03 2.881(3) 171 𝑅𝑅22(8) 
III N2-H…O1 0.91 1.97 2.866(9) 167 𝑅𝑅22(8) 
SMe N2-H…O3 0.86 1.97 2.783(3) 157 
𝐶𝐶2
2(10)  O3-H…N3 0.82 2.00 2.806(3) 169 
SEt N2-H…O3 0.90 1.91 2.7872(19) 164 
𝐶𝐶2
2(10)  O3-H…N3 0.82 1.98 2.7931(19) 175 
SBenz N2-H…O3 0.86 1.99 2.841(7) 169 
𝐶𝐶2
2(10)  O3-H…N3 0.90 1.75 2.625(8) 162 
SACN N2-H…O1 0.89 1.91 2.7978(16) 177 𝑅𝑅22(8) 
SEtOAc N2-H…O1 0.86 1.93 2.776(4) 172 𝑅𝑅22(8) 
DH O4-H…O3 0.92 1.85 2.7271(19) 159  
 O4-H…O2 0.85 2.02 2.8597(19) 168 
�   𝑅𝑅44(15)  N2-H…O4 0.97 1.86 2.7629(18) 153  O3-H…O1 0.9 1.98 2.8385(17) 159 
 O3-H…N3 0.87 1.95 2.8122(18) 174 
HH N2-H…O1 0.90 1.90 2.787(8) 165 𝑅𝑅22(8) 
 O3-H…N3   3.005(15)  𝐷𝐷22 
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The observed conformation differences in benperidol polymorphs, however, could not be 
purely associated with the difference in strong hydrogen bonds, as benperidol molecules were 
arranged in amide homodimers also in the form III. Nevertheless, other intermolecular interactions 
in this form were completely different from those in both II and I. 
Although the incorporation of proton donating alcohol molecules in the crystal lattice can 
provide a possibility for the formation of additional strong hydrogen bonds, only one hydrogen 
bond acceptor N3 in both type 1 solvates and in SBenz is employed in similar hydrogen bonding 
connection with N2-H as observed in form I, with alcohol O-H group inserted between the 
benperidol molecules, and therefore creating two strong hydrogen bonds. However, infinite 
hydrogen bonded chains 𝐶𝐶22(10) are formed in these structures. The alcohol molecules in these 
solvates are positioned in structural voids which can be joined in zigzag shaped channels. However, 
the diameter of the channel in the narrowest place is smaller than that of the solvent molecules, 
and alcohol molecules are involved in the formation of the main hydrogen bonding pattern, so 
these solvates cannot be classified as channel solvates. 
In the HH and DH forms, however, the presence of the water molecules provided for the 
formation of one additional hydrogen bond in HH by employing an additional hydrogen bond 
acceptor of benperidol molecule, and an efficient hydrogen bonding in DH by employing all 
hydrogen bond acceptors of benperidol. In the HH form, benperidol molecules existed as amide 
homodimers, whereas in the DH form benperidol molecules were linked to each other by strong 
hydrogen bonds via water molecules, and directly interacted only by weak interactions. In these 
structures, the water molecules were situated in isolated structural cavities, so both of the hydrates 
were isolated site hydrates. 
The insertion of acetonitrile and ethyl acetate molecules, however, could not provide a basis 
for the emergence of additional strong hydrogen bonds. Benperidol molecules in type 2 solvates 
formed amide homodimers characterized by 𝑅𝑅22(8) graph set. The solvent molecules were located 
in structural channels and interacted with benperidol molecules only by weak hydrogen bonds and 
dispersion forces. The type 2 solvates thus were typical channel solvates. As ethyl acetate 
(81.4 cm3∙mol–1) molecules are much larger than acetonitrile (37.9 cm3∙mol–1) molecules, the size of 
the channel apparently is too small to accommodate 1 equivalent of ethyl acetate, explaining the 
different stoichiometry observed in type 2 solvates. Ethyl acetate molecules, however, did not 
occupy the two adjacent solvent sites in one channel but rather two sites from the nearby partially 
connected channels, see Figure S18, Appendix 11. Interestingly, the molecular size calculation and 
computational simulation showed that the crystal structure of SNM should be identical to that of 
SACN with monosolvate stoichiometry (see Appendix 11). This could be explained by a partial 
desolvation before the experiment, which is supported by the slow desolvation at the beginning of 
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the TG curve for type 2 solvates (particularly for SNM, see Figure 3.42), and can be explained by 
the fact that solvent molecules are located in the channel and their escape is therefore relatively 
easy. 
A more detailed comparison of the intermolecular interactions was performed through the 
analysis of weak interactions and 2D fingerprint plots of Hirshfeld surfaces, which summarized the 
information about intermolecular interactions96, 104, see Figure 3.46 and Table S4, Appendix 11. The 
program Crystal Explorer 3.1103 was used for calculations. Overall, weak hydrogen bonds were the 
most typical weak intermolecular interactions in crystal structures of benperidol forms, and mostly 
were formed by O2 (in all structures except type 1 solvates and DH), O1 (in I, type 1 solvates, II, 
SBenz, and DH), and F1 (in II, III, type 1 solvates, SBenz, and HH), while not by N3 (probably 
because of the shape and packing of the molecules). In the crystal structure of I, II, DH, and SBenz 
a noticeable role was played also by other weak interactions (mainly CH…π). In the Hirshfeld 
surface fingerprint plots, a similarity was observed between the benperidol molecules forming 
amide homodimers in II, III, type 2 solvates, and HH (except for the spike associated with the 
O3-H…N3 bond). The plot of SBenz is different from those of type 1 solvates, clearly identifying 
structural differences, whereas it is similar to that of polymorph I, suggesting structural similarity 
with it. The structural similarity between I and SBenz is also identified from the presence of similar 
weak intermolecular interactions. Due to the dominance of strong hydrogen bonding pattern 
involving water molecules in DH, its plot completely differs from that of all other phases. 
Interestingly, a common feature of the fingerprint plots of polymorphs I and II is the 
presence of a number of longer contacts (notice the points at high di and de values in Figure 3.46) 
if compared to the solvates, indicating less efficient packing. This is also supported by the presence 
of small structural voids (2.2% and 1.4% of the volume, respectively, but too small to accommodate 
residual solvent molecules) in the structure of both of these polymorphs, as determined using 
PLATON and visualized in Mercury. 
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Figure 3.46. The 2D fingerprint plots of Hirshfeld surfaces for selected molecules in 
benperidol polymorphs and solvates. 
Analysis of the molecular packing was performed in Mercury and using XPac code129, 131. It 
was determined that the only forms showing clear similarity of molecular packing (except for the 
isostructural solvates) were III with HH and type 2 solvates, in which the benperidol molecules 
were packed in a similar manner (see Figure 3.47) by forming identical 2D supramolecular 
constructs – infinite layers of molecules parallel to (110) in III, (011) in type 2 solvates, and (20 ) 
in HH, see blue and green layers in Figure 3.47. The similarity of HH and type 2 solvates, however, 
is lower, and the only identical 1D supramolecular construct (finite layers formed from amide 
homodimers as shown with red in Figure 3.47) was identified because of the presence of solvent 
molecules distorting the molecular packing. Similarly formed hydrogen bonded molecular chains 
forming similar double layers were observed also in all alcohol solvates, with small differences due 
to different molecular conformation. However, these double layers were stacked differently in SBenz, 
therefore making this structure different from those of type 1 solvates. Despite the similarity of 
intermolecular interactions and Hirshfeld surfaces when comparing I and SBenz, no obvious 
similarity in the molecular packing of these two forms could be identified. All other benperidol 
forms did not show identifiable packing similarities, see Figure 3.47 and Figure S19, Appendix 11. 
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Interestingly, it was noticed that benperidol molecule layers could be identified in all solvated 
forms, whereas molecular packing of the two stable polymorphs I and II was more complex. 
 
Figure 3.47. Molecular packing in benperidol polymorphs and solvates. Benzimidazolone 
moiety is in blue, and fluorophenyl moiety is in green color. Green, blue and red layers represent 
identical supramolecular constructs identified in the crystal structures. Hydrogen atoms have been 
omitted for clarity. 
3.6.4 Fourier-Transform Infrared Spectroscopy 
The FTIR spectra confirmed the already identified isostructurality within type 1, as well as 
type 2 solvates. Individual solvates, however, could be identified by the presence of particular bands 
from different solvent molecules, see Figure 3.48. Also, the already identified similarity of 
molecular packing in the polymorph III, hydrate HH, and less explicitly in type 2 solvates, as well 
similarity between the polymorph I and SBenz identified by intermolecular interaction analysis was 
reflected as similarity of their IR spectra. No clear similarities, however, were observed between 
DH and polymorph V (see Figure S5, Appendix 11), suggesting that there is no direct structural 
relation between these forms, although this can also be explained by the significant changes 
introduced in benperidol molecular environment by removal of the water molecules. Interestingly, 
the IR spectra of polymorphs IV and V are slightly similar, suggesting that structural 
rearrangements during the transition from V to IV could be quite limited in magnitude. 
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Figure 3.48. FTIR spectra of the benperidol solvates and polymorphs I and III. Asterisks 
mark the most characteristic bands from the solvent molecules in isostructural solvates. 
The most easily noticeable difference in the IR spectra was the position of the carbonyl group 
stretching bands, as two peaks (at ~1708 and ~1684 cm–1) appearing for the polymorph I and SBenz, 
whereas two indistinguishable or slightly split peaks (at ~1696 – 1683 cm–1) appeared for other 
polymorphs and solvates. By using computational methods it was shown that the position of amide 
carbonyl stretching band was significantly affected by the hydrogen bonding, with the N2-H…N3 
and N2-H…O3 hydrogen bonds in I and SBenz observed at ~1710 cm–1, while the N2-H…O1 and 
N2-H…O3 hydrogen bonds in other benperidol phases were observed at ~1695 cm–1 vibrational 
frequency. 
3.6.5 Characterization and rationalization of benperidol solvate desolvation 
Dihydrate. The TG analysis and PXRD patterns showed that the dehydration of DH 
occurred in one stage. However, the dehydration products of DH depended on the sample and its 
preparation. Dehydration of fine DH powder at 30°C over P2O5 resulted in the formation of 
polymorph V. At elevated temperature (above 40°C), the polymorph V transformed to polymorph 
IV. However, when DH crystals were dehydrated, polymorph II or a mixture of II and I was 
obtained. This could be explained by slower water escape from the crystal, which could lead to 
recrystallization of the product in thermodynamically preferred polymorphs II and I (see 
Appendix 11) These polymorphs also typically appeared when powdered DH obtained by grinding 
its crystals was dehydrated, and could be explained by the nucleation of polymorphs II and I during 
grinding. The fact that water molecules had a crucial role in the stabilization of the crystal structure 
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implies that the dehydration most probably involved complete structural collapse, followed by 
recrystallization to a completely different crystal structure, which explains the possibility of forming 
different dehydration products. 
Type 1 solvates. The PXRD measurements and crystal structure analysis indicated that the 
presence of two endothermic peaks in the desolvation process of SMe and SEt (Figure 3.42) cannot 
be associated with the formation of a desolvation intermediate. Besides, a change of the sample 
particle size affected the contribution from each peak. Therefore, the appearance of two peaks 
apparently resulted from different desolvation rates associated with the molecules located at 
different distances from the surface of the crystals. The first peak was associated with the 
desolvation of solvate close to the surface, for which the escape of solvent molecules was relatively 
easy. The amount of solvate desolvated in this way depended on the particle size. The further 
desolvation, however, slowed down because of the hindered escape of solvent molecules through 
the product phase. Nevertheless, the desolvation slowly continued at increased temperature. The 
second desolvation peak appeared when a fast and complete desolvation occurred by reaching the 
peritectic decomposition/melting point of the solvate at 129°C for SMe, and at 137°C for SEt. 
Therefore the desolvation profile depended both on the particle size and on the heating rate (see 
Figure 3.49). 
 
Figure 3.49. The effect of particle size (on the left, solid lines – large crystals, dashed – small 
crystals, dotted – well ground powder) and the heating rate (on the right, solid lines – 20°·min-1, 
dashed – 2°·min-1, dotted – 0.2°·min-1) on the desolvation of SEt. 
The desolvation product in most cases was the structurally different polymorph II. 
Nevertheless, when desolvation was performed with solvates prepared by suspending technique, 
or with large solvate crystals, a mixture of polymorphs II and I was obtained in both desolvation 
stages, although it was noticed that slow desolvation at low temperature facilitated the formation 
of polymorph II, while fast desolvation at high temperature facilitated the formation of I. The 
formation of polymorph I can be explained by the presence of small nuclei of I in the solvates 
obtained by suspending technique, as well as the recrystallization from retained or condensed 
solvent in large crystals, as I is the thermodynamically stable polymorph at temperatures required 
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for the desolvation process. This was supported by the observation that seeding of SMe with 5% of 
I led to the formation of pure I after desolvation. Moreover, the crystallization of polymorph I 
from ethanol solution, as well as the occurrence of peritectic decomposition and/or melting was 
confirmed by a hot-stage microscopy experiment. 
Type 2 solvates. Similarly to the type 1 solvates, thermal analysis of SACN with various particle 
sizes showed that the second desolvation peak (at 106°C in Figure 3.42) corresponded to the 
peritectic melting and/or decomposition of this solvate. The desolvation process of these solvates 
usually produced a mixture of polymorphs III and I, with smaller particle size and lower 
temperatures facilitating the formation of III. The desolvation of these solvates was easy and 
occurred even by grinding at ambient conditions in a mortar, producing III with low crystallinity. 
This relatively easy desolvation can be explained by the presence of solvent channels and the 
absence of strong benperidol-solvent interactions facilitating the solvent removal process. The 
appearance of polymorph I as a desolvation product most probably occurred in the presence of 
nuclei of this thermodynamically stable polymorph or in a recrystallization process from 
acetonitrile solution in the case when large crystals were desolvated. 
Other solvates. Dehydration of HH over P2O5 at 30°C produced pure III, while dehydration 
at elevated temperature produced besides III also the polymorph I. Desolvation of SBenz both at 
elevated temperature and at ambient temperature produced only the polymorph I. Desolvation of 
SDIOX produced the polymorph III or HH, depending on the conditions. 
Structural characterization of benperidol solvate desolvation. A summary of the most 
characteristic phase transitions occurring during the desolvation of solvates is given in Figure 3.50. 
 
Figure 3.50. A schematic representation of benperidol solvate preparation and the phase 
transformations occurring during their desolvation. 
By analyzing these phase transitions in association with the crystal structure data and phase 
stability of polymorphs, it was concluded that two driving forces determined the obtained 
desolvation product: a) structural similarity between the solvate and the obtained polymorph, and 
b) thermodynamic stability of the resulting polymorph. The only solvate clearly producing only one 
desolvation product was SBenz, which formed only the thermodynamically stable polymorph I. 
Besides, strong similarity of intermolecular interactions was observed in both of these phases. 
Although type 2 solvates and HH showed clear structural similarity with polymorph III, which 
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usually was their main desolvation product, hardly ever it appeared without polymorph I as minor 
component. The formation of polymorph I was enhanced in situations facilitating the formation 
of thermodynamically stable polymorph: at high temperatures and in the case of large solvate 
crystals, when recrystallization from trapped solvent was possible. Similar effects facilitating the 
formation of I were observed also in the desolvation of type 1 solvates, and in that case further 
supported by the observation that seeding with I produced I as the only desolvation product. For 
type 1 solvates, however, no structural similarities with the main desolvation product II could be 
observed. 
Similar observations as for type 2 solvates were made also for the desolvation of DH, 
although in that case the main desolvation product was the unstable polymorph V, and the 
thermodynamically stable byproducts were polymorphs II and I. In this case, however, structural 
similarity between DH and V could not be determined. 
3.6.6 Rationalization of solvate stability and frequency of solvate formation in 
crystallization 
The solvate stability was compared using the lattice energies and pairwise intermolecular 
interaction energies. The results obtained for structures where atom positions were relaxed in 
CASTEP are given in Table 3.16. As shown previously, the results from semi-empirical PIXEL 
code had similar accuracy to those from DFT-D methods98, while results from empirical AA-CLP 
are less accurate and are given only to compare the lattice energy of solvates with more than two 
molecules in the asymmetric unit. Total pairwise interaction energy values were less conclusive than 
the lattice energies, especially those calculated for benperidol-benperidol interactions, as they did 
not take into account the energetically relevant long-range interactions. However, they allowed an 
approximate evaluation of the contribution from benperidol and solvent molecule interactions in 
the lattice energies and gave a fast insight into the relative stability of solvates with similar 
structures. 
Table 3.16. The lattice energy and total pairwise interaction energy (in kJ∙mol–1) for 
benperidol solvates. 
Solvate 
Lattice energy Total pairwise interaction energy 
PIXEL AA-CLP benperidola solventb 
DH – –99.3 –227.1 –86.1 / –79.4c 
HH –84.3 –65.6 –269.7 –44.7 
SBenz –130.7 –109.5 –167.8 –151.9 
ty
pe
 1
 SMe –119.9 –107.4 –245.7 –92.9 
SEt –124.3 –121.9 –223.0 –104.9 
ty
pe
 2
 SACN –110.7 –116.0 –295.6 –53.5 
SEtOAc – –137.6 –301.1 / –301.8c –60.9 
SNM –108.2 –119.7 –273.5 –75.8 
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a – the sum of all pairwise benperidol-benperidol interaction energies with cutoff distance equal to 
the sum of vdW radii + 0.3 Å. 
b – the sum of all pairwise solvent-benperidol and solvent-solvent interaction energies with cutoff 
distance equal to the sum of vdW radii + 1.6 Å. 
d – for each water molecule (in DH) or benperidol molecule (in SEtOAc) in the asymmetric unit. 
The higher lattice energy of SEt compared to that of SMe apparently explains the higher 
stability of this solvate, as observed by its higher peritectic desolvation and/or melting point (see 
Table 3.12) and higher desolvation Ea, see Appendix 11. 
Logically, by comparing the interaction energies in type 1 solvates with those in SBenz, it is 
observed that an increase in the size of the solvent molecule increase the contribution of the total 
pairwise solvent interaction energy to the lattice energy, while the contribution from the total 
pairwise benperidol interaction energy decrease due to the larger separation of these molecules. 
Although the thermal stability of type 2 solvates is very similar, crystallization from 
acetonitrile always resulted in the formation of SACN, whereas crystallization from ethyl acetate 
mainly produced pure polymorph I. Moreover, SNM was obtained only once. Besides, SACN was 
obtained also in slurry experiments, whereas preparation of the other two solvates using this 
approach was not possible. The lattice energy of SACN was slightly more negative than that of SNM, 
and the pairwise interaction energies between benperidol molecules in the crystal structure of SNM 
were less efficient (due to the larger size of nitromethane molecule). This theoretically can lead to 
hindered formation of SNM, as the formation of its crystals is energetically less favored, compared 
to the formation of SACN crystals. Due to the different stoichiometry, reliable comparison with 
SEtOAc was possible only using pairwise interaction energies, which showed that the ethyl acetate 
molecule in this structure did not form as efficient interactions as acetonitrile or nitromethane 
molecules, explaining the complications with its crystallization. Nevertheless, it should not be 
forgotten that the crystallization product can also be associated with the molecular interactions in 
the liquid state, and it is theoretically possible that ethyl acetate and nitromethane somehow 
facilitate the crystallization of polymorph I. 
The easier desolvation of type 2 solvates, compared to the type 1 solvates, is explained by 
the presence of solvent channels and weaker interaction energies experienced by the solvent 
molecules89. 
Although all the strong hydrogen bonds in DH structure are formed with or between water 
molecules, interactions between benperidol molecules in the form of weak hydrogen bonds and 
dispersion forces contributed more to the lattice energy. Nevertheless, the overall interactions in 
DH were energetically more favored than those in HH, which apparently explain the fact that this 
is the most stable of benperidol hydrates. Therefore, the facile crystallization of DH can be 
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explained by a more efficient hydrogen bond network, while the formation of HH was possible 
only under the conditions with a very low water activity and in the presence of specific solvent 
molecules, probably providing for the formation of favorable benperidol molecule associates. 
3.6.7 The analysis of benperidol solvate formation 
Crystallization of benperidol from a range of 31 solvents selected from various solvent 
classes resulted in the formation of 11 solvates. Nevertheless, SEtOAc and SNM were obtained only 
in some crystallization experiments from the respective solvents, hemihydrate crystallized only 
from xylene and toluene containing traces of water, and repeated preparation of SCLF and STCC was 
complicated. These observations suggest that discovery of additional benperidol solvates with the 
studied solvents is theoretically possible. Nevertheless, the obtained amount of solvates and the 
knowledge of benperidol and solvent properties, as well as the elucidation of solvate crystal 
structure allowed to rationalize the formation of benperidol solvates. 
Generally it was concluded that solvates formed with solvent molecules representing 
different solvent classes: hydrogen bond donors (type 1 solvates, HH, and DH), aprotic polar 
solvents (type 2 solvates, SCLF), aromatic apolar or lightly polar solvents (SBenz; although benzyl 
alcohol is a hydrogen bond donor, its ability to form dispersion interactions appeared to be even 
more important for the formation of this solvate), and aprotic polar electron pair donor (SDIOX). 
Even though the crystal structures of some of the solvates are not known, it was possible to 
conclude that the solvent molecules in all solvates employed features (strong or weak hydrogen 
bonds, dispersion interactions) characteristic of the corresponding solvent class. More detailed 
classification of solvents did not provide additional clarification for the solvate formation of 
benperidol, as type 1 solvates formed from solvents belonging to group 3, type 2 solvates from 
solvents from groups 2 and 9, and other solvates were obtained from solvents belonging to groups 
1, 7, 10, 11, and 15140 (see Table S1, Appendix 11). 
As already mentioned, although the solvates were obtained with four different hydrogen 
bond donors, only in both hydrates the additional hydrogen bond acceptor sites of benperidol 
molecule were employed. Therefore, the formation of hydrates was directly explained by the 
advantages of a more efficient hydrogen bonding network. The formation of alcohol solvates, 
however, was not driven purely by this feature, although the presence of strong benperidol-solvent 
hydrogen bonds definitely provided stability for these structures. The solvent molecules in other 
solvates could not participate in strong hydrogen bonds, but provided new, weak interactions and 
allowed energetically favourable packing of benperidol molecules with the solvent molecules. 
Interestingly, although there were some voids in the crystal structures of both polymorphs I and 
II, which were not observed in any of the solvate structures, the packing index of solvates was 
generally the same as that in the polymorphs, see Table 3.13. Nevertheless, the presence of voids 
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and complex structural patterns in the crystals of stable benperidol polymorphs (six-molecule rings 
in I, see Figure 3.45, and Z’= 3 for II) suggested that energetically efficient packing is complicated 
for phases consisting of benperidol molecules only. The presence of certain functional groups in 
the benperidol molecule, however, provides possibilities for efficient interactions with solvent 
molecules containing different functional groups. These appear to be the two main reasons for the 
formation of such a wide range of benperidol solvates with various solvent molecules. 
The appearance of two isostructural solvate groups suggests that in the case of some 
particular solvent properties, solvent molecules are incorporated in identical crystal structures. The 
comparison of these structures shows that both the specific interactions provided by solvent, as 
well as the size of the solvent molecules are important factors. Therefore, small hydrogen bond 
donating alcohol molecules form type 1 solvates, whereas aprotic polar donors and acceptors of 
weak hydrogen bonds with appropriate molecular size and shape form type 2 solvates. 
3.6.8 Conclusions 
Crystallization of benperidol from various solvents produced nine new solvates containing 
methanol, acetonitrile, ethyl acetate, nitromethane, 1,4-dioxane, water, benzyl alcohol, carbon 
tetrachloride, and chloroform, while the desolvation of benperidol solvates produced two new 
polymorphs IV and V. It was determined that benperidol forms two sets of isostructural solvates: 
type 1 (with methanol and ethanol) and type 2 (with acetonitrile, nitromethane, and ethyl acetate). 
Infrequent formation of some of the solvates, however, showed that the existence of a certain 
solvate cannot guarantee its facile formation and discovery, even if there are isostructural solvates 
forming easily. 
It was determined that the main reason for the formation of various benperidol crystal 
structures was the diverse possibilities of molecular packing, resulting in different intermolecular 
interactions, whereas the molecular conformation of benperidol was typically very similar. A 
comparison of the crystal structures of benperidol phases showed that the only structures showing 
clear similarities of molecular packing were the polymorph III, hemihydrate HH, and type 2 
solvates, while similarities of intermolecular interactions were observed also for SBenz and 
polymorph I. 
Desolvation studies of benperidol solvates showed that the stability of solvates can be 
associated with the intermolecular interactions in the crystal structure, while the structures of 
desolvation products were determined through an interplay of structural similarity and 
thermodynamic stability of the resulting polymorphs, and each of these factors could become 
dominant due to sample preparation procedures or experimental conditions. 
The inability of benperidol molecules to pack efficiently without solvent was found to be the 
main reason for solvate formation, whereas the presence of specific functional groups in benperidol 
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molecule enabled the formation of a wide range of stable solvate structures containing various 
solvent molecules. This is similar to the properties for droperidol solvates, although less structural 
variation was observed in the case of droperidol solvates, Section 3.3. Nevertheless, theoretical 
prediction of benperidol solvates would be quite complicated as it would be difficult to predict the 
energetically favorable packing for each particular solvate. The formation of both benperidol 
hydrates, however, was driven by the compensation for hydrogen bond donor deficiency in 
benperidol molecules. 
By using both sets of isostructural solvates it was proved that both the possible interactions 
and the size of the solvent molecules were important factors in solvate formation. The solvate 
structures of benperidol, however, were more interaction-specific, if compared to those of 
droperidol, which formed only one set of isostructural solvates with at least 7 very different 
solvents, Section 3.3. In the formation of type 2 solvates, both the size and shape of the solvent 
molecules appeared to be relevant, as two nearby partially connected channels could be occupied 
by smaller molecules in each of the channel (as in SACN and SNM), or by larger molecules occupying 
both of the channels (SEtOAc). 
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CONCLUSIONS 
1. The dehydration of mildronate DH is a single step process leading directly to the anhydrous 
form AP. This is explained by similar mildronate molecule packing in both of these 
structures. The dehydration occurs as escape of the water molecules through structural 
channels, molecular conformation changes and molecular translation of mildronate 
molecules. 
2. The dehydration of mildronate DH can be described with 1D phase boundary reaction with 
Ea is 75±3kJ·mol-1. Based on the crystal structure it can be suggested that for small particles 
the phase boundary advancement during the dehydration occurred along the a-axis. 
3. Comparable dehydration kinetic parameters of mildronate dihydrate was obtained in both 
isothermal and nonisothermal mode. However, both the interpretation of obtained results 
and experimental procedures were more complicated when experiments were performed in 
nonisothermal mode. 
4. Different sample and environmental factors, particularly particle size, sample weight, 
nitrogen flow rate and sample history affected not only the dehydration rate, but also the 
dehydration Ea and kinetic model. Study of the effect of these factors revealed that the 
dimensionality of the phase boundary advance can increase to 2D for large particles, and 
change of some of the factors showed that also a) the diffusion of water outside the crystal 
and b) diffusion of water from the inside of the powder could limit this dehydration process. 
5. The driving the driving force for droperidol solvate formation was the inability of droperidol 
molecules to pack efficiently; thus the solvent molecules acted as a void fillers, with the 
exception of droperidol DH, where water molecules provided a hydrogen bond donor 
function matching the excess hydrogen bond acceptor functions in the molecule of 
droperidol. 
6. The stability of droperidol isostructural solvate structure was rationalized by the very 
effective interactions between droperidol molecules, explaining the fact that no specific 
interaction with solvate was necessary to maintain the crystal structure of the isostructural 
solvate. Therefore, droperidol isostructural solvates can be obtained with solvents fitting in 
the channels and providing sufficiently effective intermolecular interactions with droperidol. 
7. The study of the desolvation kinetics of droperidol isostructural solvates revealed that the 
desolvation Ea of all of these solvates was almost the same (57±15 kJ·mol−1) and the 
desolvation process was diffusion limited, and the desolvation curves could be fitted using 
the modified Zhuravlev equation. 
8. The thermal stability of the solvates determined from the desolvation rate in both isothermal 
and nonisothermal modes could be successfully used as a solvate stability comparison and 
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ranging tool for the droperidol solvates. The calculation of the intermolecular interaction 
energies in droperidol solvates showed that it was possible to rationalize and predict the 
thermal stability order of solvates by using a sum of the solvate−droperidol and 
solvate−solvate interaction energies. 
9. Using solid-state NMR spectroscopy it was determined that solvent molecules in droperidol 
isostructural solvates NSH, SMe and SEt are dynamic, whereas in SACN and SNM are static and 
ordered. The alcohol molecules are relatively dynamic within their lattice sites and also 
occasionally flip over to the equivalent site related by the inversion symmetry. Also water 
molecules experience complex motion consisting of C2 flips and some other type of motion, 
with total estimated Ea = 25±3 kJ mol–1. 
10. Differences in the presence of solvent molecule dynamics in droperidol isostructural solvates 
with organic solvents was rationalized using total energy and intermolecular interaction 
energy: for SEt and SMe there was little energy difference between structures where all solvent 
molecules pointed in one direction and adjacent solvent molecules pointed in opposite 
directions, whereas for SACN and SNM the first structures were highly favourable. 
11. The formation of wide range of solvates for benperidol was mainly due to the inability of the 
benperidol molecules to pack efficiently without solvent, while incorporation of solvent 
molecules allowed energetically efficient molecule packing. Solvate formation was observed 
with solvents providing specific intermolecular interactions and having appropriate size and 
shape. Also for benperidol excess of benperidol hydrogen bond acceptor functions was 
compensated only in the hydrates. 
12. The stability of benperidol solvates was determined by the intermolecular interactions in the 
crystal structure, while the desolvation products was determined in an interplay of structural 
similarity and thermodynamic stability of the resulting polymorph, and each of both factors 
could be made dominant by sample preparation and experimental conditions. 
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Appendix 1. 
Table A1. Thermodynamic models for non-stoichiometric hydrates and the the corresponding water sorption-desorption isotherms. 
Model Characterization of the model Basic equations Equations for sorption the sorption-desorption isotherms 
A Substitution solid solution of a (n+p)-hydrate in a 
n-hydrate. 
This model can describe only crystalline solids 
where water molecules are considered to be in 
fixed ordered locations in the crystal lattice. 
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ε – amount of water sorbed (in 
moles) per mole of substance, n and 
p – amount of water, y1 and y2 – 
activity coefficients of n and (n+p)-
hydrates, PW – equilibrium water 
partial pressure, KA – equilibrium 
constant at temperature T. 
a) Henry’s law: 
if p = 1 and PW is close to 0, 
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c) Activity coefficients models: 
Activity coefficients are evaluated by the Margules method. 
Mathematical expressions for the case when n=0 and Margules’ 
equations of second order are used: 
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For the case when n=0 and Margules’ equations of third order 
are used: 
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B Crystallographic vacant location. 
Also this model can describe only crystalline solids 
where water molecules are considered to be in 
fixed ordered locations in the crystal lattice. An 
additional assumption is that the water molecules 
are associated into clusters of q molecules on well-
defined crystallographic sites in the skeleton of the 
n-hydrate. 
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 where Aij – constants reflecting the interaction between n and (n 
+ p)-hydrates. 
C Non-stoichiometric hydrates with disordered 
water distribution. 
In this model a partition equilibrium of water 
between the vapor phase and the solid solution is 
assumed. The solid can either be crystalline or 
amorphous. Molecules can be associated in 
clusters of q molecules. As no position or 
interaction with a site is assumed, this model 
describes disordered water molecules. Depending 
on the energy difference between the low energy 
and the high-energy positions ΔE, the relative 
concentration of molecules in the high and the 
low energy state will vary as exp(−(ΔE/kT). 
Therefore, if the difference in energy is small 
compared to the thermal agitation, the molecules 
can easily move to the upper band and the system 
is disordered; elsewhere the molecules are mainly 
trapped in sharp energy minima and the system is 
ordered. Note that ΔE should be equal to the 
activation energy for diffusion. 
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When Margules’ equations of second order are used: 
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Appendix 2. Classification of solvents. 
Table A2. Solvent classification using  the k-nearest neighbour classification method139. 
ID Solvent A B C ID Solvent A B C ID Solvent A B C 
1 acetic acid 4 4 4 52 diethylene glycol 4 4 4 103 nitrobenzene 1 1 1 
2 acetic anhydride 1 1 1 53 dietyl ether 3 3/5 3 104 nitroethane 1 1 1 
3 acetone 1 1 1 54 di-isopropyl ether 5 5 3 105 nitromethane 1 1 1 
4 acetonitrile 1 1 1 55 1,2-dimethoxyethane 3 1/3 3 106 n-octane 5 5 5 
5 acetophenone 2 2 2 56 N,N-dimethylacetamide 1 1 1 107 1-octanol 4 4 4 
6 acetylacetone 2 1 1 57 N,N-dimethylaniline 1 1 1 108 n-pentane 5 5 5 
7 2-aminoethanol 4 4 4 58 3,3-dimethyl-2-butanone 1 1 1 109 1-pentanol 4 4 4 
8 aniline 1 1 1 59 N,N-dimethylformamide 1 1 1 110 2-pentanol 4 4 4 
9 anisole 2 2 2 60 2,4-dimethylpyridine 1 1 1 111 3-pentanol 4 4 4 
10 benzaldehyde 2 2 2 61 2,6-dimethylpyridine 1 1 1 112 2-pentanone 1 1 1 
11 benzene 2 2 2 62 dimethylsulfoxide 1 1 1 113 3-pentanone 1 1 1 
12 benzonitrile 1 1 1 63 2,6-dimethyl-4-heptanone 1 1 1 114 pentyl acetate 1 1 1 
13 benzyl alcohol 2 2 2 64 2,4-dimethyl-3-pentanone 1 1 1 115 phenetole 2 2 2 
14 bromobenzene 2 2 2 65 1,4-dioxane 1 1 3 116 phenol 2 2 2 
15 1-bromobutane 3 3 3 66 diphenyl ether 2 2 2 117 3-picoline 1 1 1 
16 bromoethane 3 1/3 3 67 di-n-propyl ether 5 5 3 118 4-picoline 1 1 1 
17 1-butanol 4 4 4 68 DMEU 1 1 1 119 piperidine 4 4 4 
18 2-butanol 4 4 4 69 DMPU 1 1 1 120 1-propanol 4 4 4 
19 2-butanone 1 1 1 70 ethanol 4 4 4 121 2-propanol 4 4 4 
20 n-butyl acetate 1 1 1 71 ethyl acetate 1 1 1 122 n-propylamine 4 4 4 
21 n-butylamine 4 4 4 72 ethyl benzoate 2 2 2 123 propyl formate 1 1 1 
22 butyronitrile 1 1 1 73 ethyl formate 1 1 1 124 propylene carbonate 1 1 1 
23 carbon disulfide 2 2/5 5 74 ethyl propionate 1 1 1 125 propionitrile 1 1 1 
24 carbon tetrachloride 5 4 4 75 ethylenediamine 4 4 4 126 pyridine 1 1 1 
25 chlorobenzene 2 2 2 76 ethylene glycol 4 4 4 127 pyrrolidine 4 4 4 
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26 1-chlorobutane 3 3 3 77 fluorobenzene 2 2 2 128 quinoline 1 1 1 
27 chloroform 4 4/1/3 3 78 formamide 4 4 4 129 styrene 2 2 2 
28 1-chloropropane 3 3/1 3 79 furfuryl alcohol 1 2/4 2 130 sulfolane 1 1 1 
29 2-chloropropane 3 3/1 3 80 glycerol 4 4 4 131 tert.-butyl alcohol 4 4 4 
30 m-cresol 2 2 2 81 n-heptane 5 5 5 132 tert.-butyl methyl ether 3 5/3 3 
31 cyclohexane 5 5 5 82 HMPTA 1 1 1 133 TEGDME 1 1/3 3 
32 cyclohexanol 4 4 4 83 n-hexane 5 5 5 134 1,1,2,2-tetrachloroethane 1 3 1 
33 cyclohexanone 1 1 1 84 1-hexanol 4 4 4 135 tetrachloroethylene 5 4/2 5 
34 cyclohexene 2 5/2 5 85 iodobenzene 2 2 2 136 tetraethylene glycol 4 4 4 
35 cyclopentane 5 5 5 86 iodoethane 3 1/3 3 137 tetrahydrofuran 3 3 3 
36 cyclopentanone 1 1 1 87 isobutyl alcohol 4 4 4 138 1,1,3,3-tetramethyl urea 1 1 1 
37 cis-decaline 5 5 5 88 iso-octane 5 5 5 139 toluene 2 2 2 
38 n-decane 5 5 5 89 mesitylene 2 2 2 140 tributylamine 3 3 3 
39 DEGDEE 3 3/1 3 90 methanol 4 4 4 141 1,1,1-trichloroethane 1 1 1 
40 DEGDME 1 1/3 3 91 methyl acetate 1 1 1 142 trichloroethylene 1 1 1 
41 dibenzyl ether 2 2 2 92 methyl benzoate 2 2 2 143 triethylamine 3 3 3 
42 di-n-butyl ether 5 5/3 3 93 2-methyl-2-butanol 4 4 4 144 triethylene glycol 4 4 4 
43 m-dichlorobenzene 2 2 2 94 3-methyl-1-butanol 4 4 4 145 trifluoroacetic acid 4 4 4 
44 o-dichlorobenzene 2 2 2 95 3-methyl-2-butanone 1 1 1 146 2,2,2-trifluoroethanol 4 4 4 
45 1,2-dichloroethane 1 1 1 96 methyl formate 1 1 1 147 trimethylene glycol 4 4 4 
46 1,1-dichloroethane 1 1 1 97 4-methyl-2-pentanone 1 1 1 148 2,4,6-trimethylpyridine 1 1 1 
47 1,1-dichloroethylene 1 1 1 98 2-methoxyethanol 4 4 4 149 m-xylene 2 2 2 
48 Z-1,2-dichloroethylene 1 1 1 99 N-methylacetamide 1 1 1 150 o-xylene 2 2 2 
49 dichloromethane 1 1 1 100 N-methylformamide 1 1 1 151 p-xylene 2 2 2 
50 diethylamine 4 4 4 101 N-methyl-pyrrolidin-2-one 1 1 1 152 water 4 4 4 
51 diethyl carbonate 1 1 1 102 morpholine 1 4/1 4      
A: KNN classification; B: CP-ANN-1 classification; C: CP-ANN-2 classification (see original publication139). 1: Class 1, aprotic polar (AP); 2: Class 2, aromatic apolar or 
lightly polar (AALP); 3: Class 3, electron pair donors (EPD); 4: Class 4, hydrogen bond donors (HBD); 5: Class 5, aliphatic aprotic apolar (AAA). 
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Table A3. Solvent classification based on the cluster analysis of following solvent property 
parameters: hydrogen bond acceptor propensity, hydrogen bond donor propensity, 
polarity/dipolarity, dipole moment, and dielectric constant140. 
Group 1 n-Dodecane (0.0), n-decane (0.1), Cyclohexane (0.1), n-octane (0.1), n-hexane (0.2), n-heptane 
(0.2), cis-decalin (0.2), n-pentane (0.2), carbon tetrachloride (0.3), tetrachloroethene (0.3) 
Group 2 Ethyl acetate (0.2), diethyl sulfide (0.4), propyl ethanoate (0.6), methyl benzoate (0.8), methyl 
ethanoate (0.8), butyl ethanoate (1.1), tetrahydrofuran (1.4), methyl tertiary-butyl ether (1.6), 
diethyl ether (1.9), ethyl formate (2.3), diisopropyl ether (2.8), methyl methanoate (2.8), 
dibutylether (3.1), dimethyl disulfide (3.5) 
Group 3 2-methyl-1-propanol (0.3), 2-butanol (0.5), 1-butanol (0.9), 2-methoxyethanol (1.1), 1-pentanol 
(1.3), 2-propanol (2.8), 2-methyl-2-propanol (4.0), 1-propanol (4.1), 1-octanol (6.6), ethanol 
(8.4), morpholine (9.0), butylamine (11.9), methanol (16.2) 
Group 4 m-Xylene (0.1), p-xylene (0.1), benzene (0.1), mesitylene (0.2), carbon disulfide (0.3), toluene 
(0.3) 
Group 5 2-hexanone (0.0), cyclopentanone (0.8), 2-pentanone (1.1), pyridine (1.2), 4-methyl-2-
pentanone (1.2), cyclohexanone (1.5), 4-methylpyridine (2.2), 2-heptanone (2.5), 3-pentanone 
(2.7), acetophenone (3.4), butanone (4.1), 2,4-dimethylpyridine (4.7), acetone (6.4), 2,6-
dimethylpyridine (7.0) 
Group 6 N,N-dimethylacetamide (0.8), N,N-dimethylformamide (1.3), N-methyl-2-pyrrolidone (6.3), 
dimethylsulfoxide (8.3) 
Group 7 1-iodobutane (0.4), chlorobenzene (0.6), fluorobenzene (0.8), 1,1,1-trichloroethane (0.9), 
dibromomethane (1.0), diiodomethane (1.0), 1,2-dibromoethane (1.4), chloroform (1.6), 
iodobenzene (1.7), anisole (2.0), bromoform (2.1), ethyl phenyl ether (2.1), dichloromethane 
(2.7), trichloroethene (2.9), 1,1-dichloroethane (3.8), o-dichlorobenzene (3.9), 1,2-
dichloroethane (3.9) 
Group 8 Acetic acid (0.1), propanoic acid (2.8), pentanoic acid (3.5), m-cresol (6.2) 
Group 9 Propanenitrile (1.0), benzonitrile (4.7), acetonitrile (5.4), butanenitrile (6.0), nitromethane (6.3) 
Group 10 Benzyl alcohol (2.8), aniline (2.8) 
Group 11 Triethylamine (0.4), 1,4-dioxane (0.4) 
Group 12 Formic acid (4.9), ethylene glycol (4.9) 
Group 13 Diethylamine 
Group 14 Glycerol 
Group 15 Water 
The Euclidean distance of each solvent to the centre of the corresponding group is provided in 
the parentheses. 
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Appendix 3. Classification of the dehydration process with respect to the crystal structure 
changes. 
 
 
Figure A1. “Rouen 96 model” for classification of hydrates according to the dehydration 
process162. 
   
(C1) Existence of channels or planes exclusively occupied by water molecules or 
possibility of cooperave structural deformaon leading to these channels or planes 
(C2) Decreasing value of R – Rao (energy for liberaon of 
water) / (energy of the crystal)
Cooperave release of water molecules through speciﬁc 
direcons of the mother planes or its deformaon 
(C3) Increasing size (s) of domains with maintained 
cohesion between molecules
(C4) Increasing quality of the long range order (LRO) 
Cooperave rearrangement 
with persistence of contacts No reorganisaon 
Destrucve dehydraon 
departure of water molecules 
generates amorphous 
material 
No reorganisaon Nucleaon and 
growth 
I – Destr. -Disorg. 
(I-D.D.) 
I – Destr. –Cryst. 
(I-D.C.) 
I – Coop. -Cryst. 
(I-C.C.) 
I – Coop. -
Disorg. (I-C.D.) 
II – Coop. -Reorg. 
(II-C.R.) 
II – Topotacc 
(II-T.) 
 
 
 
Class I  
(No structural filiation between parent and daughter phases) 
 
 
 
Class II 
(Structural filiation between parent and daughter phases) 
Disorganised material Crystallised material Crystallised parcles 
NO 
YES 
R ≈ 1 
R « 1 
s < s* 
s > s* 
Insuﬃcient 
Suﬃcient 
Criteria for 
pathway of 
H2O release 
Process  of release 
of water molecules 
Criteria for 
evoluon of the 
new anhydrous 
material 
Reorganisaon process 
Table A4. Water evaluation types (WET) with the corresponding representation of phase 
boundary163. 
WET Criteria Characterization of structure and 
phase boundary 
Phase 
boundary 
Reaction rate 
controls 
WET1 Crystal structure 
maintained (no 
geometric rate 
controls) 
Crystal spacing unchanged by 
dehydration.  
1A – diffusion, 
1B – desorption 
from a surface. 
WET2 Diffusion across an 
adherent barrier layer 
Topotactic reaction. Lattice spacing 
reduced on dehydration without 
cracking. 
 
Diffusion and 
(possible) 
geometric factor. 
WET3 Interface advance. 
Nucleation and 
growth, or contracting 
envelope 
a) Topotactic reaction. Crystal 
spacings changed sufficiently to 
cause cracking within the reaction 
zone. 
 
Interface reaction 
and geometric 
control. 
b) Product recrystallization. 
Reaction may or may not be 
topotactic. 
 
c) Amorphous product that 
subsequently recrystallizes.  
d) Amorphous product that does 
not recrystallize.  
WET4 Homogeneous 
reactions in crystals 
a) Release of water is blocked by the 
product layer until the internal 
pressure leads to explosive 
disintegration. 
 a) explosive 
disintegration. 
b) Change of the water vapour 
pressure leads to systematic change 
in the lattice parameters. 
b) progressive 
structural change. 
c) Changes occur at sites randomly 
distributed in the crystal, without 
regard to their position. 
c) homogeneous 
intracrystalline 
chemical change. 
WET5 Melting and formation 
of imprevious outer 
layer 
a) During dehydration of large 
crystals fast release of water from 
the crystal surface occur. 
b) Dehydration of powder initially 
produces amorphous phase which 
melts before recrystallization. 
 Untypical kinetic 
characteristics. 
WET6 Comprehensive 
melting 
Melting may be accompanied by 
reactions other than the 
dehydrations. 
 
Chemical reaction 
and/or diffusion. 
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Appendix 4. Kinetic models and kinetic parameter determination methods commonly used in the 
analysis of solid state kinetics. 
Table A5. Solid-state integral rate expressions g(α) for the most often used solid-state kinetic 
models90, 171, 187, 190-192. 
Model g(α)  Model g(α) 
Nucleation models   Diffusion models  
Power law (P2) 2
1
α  
 1-D diffusion (D1) 2
2α  
Power law (P3) 31α  
 2-D diffusion (D2) )1ln()1( ααα −−+  
Power law (P4) 4
1
α  
 3-D diffusion – Jander 
(D3)  ( )
2
3
1
11 


 −− α  
Avrami-Erofeyev (A3/2) ( )[ ] 3
2
1ln α−−  
 Ginstling-Brounshtein 
(D4) ( ) 


 −−−
3
2
13
21 αα  
Avrami-Erofeyev (A2) ( )[ ] 2
1
1ln α−−  
 Zhuravlev (D5) ( )[ ]23/1 11 −− −α  
Avrami-Erofeyev (A3) ( )[ ] 3
1
1ln α−−  
 Reaction-order models  
Avrami-Erofeyev (A4) ( )[ ] 4
1
1ln α−−  
 First-order (F1)  ( )α−− 1ln  
Prout-Tompkins (B1) 



−α
α
1
ln  
 
1.5-order (F3/2) 
( ) 







−
− −
1
1
12
2
1
α
 
Geometrical contraction models 
 
Second-order (F2) ( ) 11
1
−
−α
 
Contracting disk (R1) α   Third-order (F3) ( )( )115.0 2 −− −α  
Contracting area (R2) ( ) 


 −−
2
1
11 α  
   
Contracting volume (R3) ( ) 


 −−
3
1
11 α  
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Table A6. Mathematical expressions used in the most common isoconversional methods. 
Method Equation Procedure 
Friedman (FR)208 
( )
α
α
α
α
α
α
RT
EfA
dt
d a−⋅=




 )(lnln  
Ea is calculated from desolvation curves 
recorded at different heating rates using the 
slope of the line in coordinates 





dt
dαln  – 
T−1 for α values with step size 0.02. 
Average linear 
integral method 
(ALIM)209 
)(
ln)(lnln ,
tRT
E
Agt a ααα −+∆−=∆−  
Ea is calculated from desolvation curves 
recorded at different heating rates using the 
slope of the line in coordinates t∆− ln  – 
T-1 for α values with step size 0.02. 
Advanced 
isoconversional 
method (AIC)210, 
211 
( ) dtetTEJ
t
t
tRT
E
ia
a
∫
∆−
−
=
α
αα
α
αα
)(
,
)(,  
( )
( ) min)(,
)(,
=








∑∑
≠
n
i
n
ji ja
ia
tTEJ
tTEJ
αα
αα  
Desolvation curves are recorded at 
different heating rates. Parameter Φ(Ea) is 
then calculated and minimized with MS 
Excel Solver, obtaining Ea for α values with 
step size 0.1 
Table A7. Mathematical expressions used for determination of the kinetic models. 
Method Procedure 
Model fitting method This method is used only for isothermal data. Two approaches have been used. 
Firstly, experimental points for a particular desolvation curve is plotted in 
coordinates 𝑔𝑔(𝛼𝛼) − 𝑘𝑘𝑡𝑡𝑡𝑡𝑡𝑡 and model with the best linear fit is selected. 
Secondly, experimental points for a particular desolvation curve and theoretical 
lines modelled from selected kinetic models are plotted in the coordinates 
𝛼𝛼 –  𝑘𝑘𝑡𝑡𝑡𝑡𝑡𝑡. The sum of squared differences between the experimental and 
theoretically calculated α values is minimized with MS Excel Solver. The best 
model is identified by the smallest sum of least squares. 
Average linear integral 
method (ALIM)209 
Experimental data points are linearized as in ALIM method, Table 6: 
− lnΔ𝑘𝑘 = − lnΔ𝑔𝑔(𝛼𝛼) + ln𝐴𝐴𝑑𝑑 − 𝐸𝐸𝑎𝑎,𝑑𝑑𝑅𝑅𝑇𝑇( 𝑘𝑘)  
The intercept Iα of this line is calculated and for each kinetic model following 
linear relationship is constructed by using previously determined Ea values: lnΔ𝑔𝑔(𝛼𝛼) + 𝐼𝐼𝑑𝑑 = 𝑏𝑏𝐸𝐸𝑎𝑎,𝑑𝑑 + 𝑐𝑐 
Model with the best linear fit is selected. 
Reconstruction of the 
integral or differential 
reaction model72, 157, 186 
Kinetic model 𝑔𝑔(𝛼𝛼) or 𝑘𝑘(𝛼𝛼) is reconstructed from experimentally determined 
Ea and A values, using Equations 1.3, 1.4 and 1.5. For reconstruction of integral 
kinetic model 𝑔𝑔(𝛼𝛼) numerical integration is used. Frequency factor A is 
calculated using isokinetic relationship: ln𝐴𝐴 = 𝑏𝑏𝐸𝐸𝑎𝑎 + 𝑐𝑐 
Where b and c are determined from the ALIM method described above. 
Theoretical model best fitting with the constructed curve is selected. 
Reduced time plots188 This method is used for isothermal data. This approach uses the fact that for the 
correct kinetic model a curve constructed from the experimental ratio 
𝑘𝑘(𝛼𝛼)/𝑘𝑘(0.5) should match with the curve constructed from the ratio 
𝑔𝑔(𝛼𝛼)/𝑔𝑔(0.5): 
𝑔𝑔(𝛼𝛼)
𝑔𝑔(0.5) = 𝑘𝑘(𝛼𝛼)𝑘𝑘(0.5) 
Theoretical model with curve best fitting to the constructed curve is selected. 
“Master plots”215 This method is used for non-isothermal data. For a particular desolvation curve 
parameter 𝑍𝑍(𝛼𝛼) is calculated and plotted: 
𝑍𝑍(𝛼𝛼) = 𝑑𝑑𝛼𝛼/𝑑𝑑𝑘𝑘
𝛽𝛽
ℎ(𝑥𝑥)𝑇𝑇 
where β is the heating rate and ℎ(𝑥𝑥) is the temperature integral. 
Curves for theoretical models are constructed using equation: 
𝑍𝑍(𝛼𝛼) = 𝑘𝑘(𝛼𝛼)𝑘𝑘(𝛼𝛼) 
Theoretical model with curve best fitting to the constructed curve is selected. 
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 Appendix 5. 
Table A8. Characterization of inorganic compounds and solvents used. 
Compound Purity Manufacturer 
Solvents 
acetone >99.5% Penta 
acetonitrile >99.9% Fluka 
benzyl alcohol >99% Alfa Aesa 
1-butanol >99.5% Penta 
butanone >99.5% Sigma-Aldrich 
butyl acetate >99% Alfa Aesa 
tert-butyl methyl ether >99.9% Alfa Aesa 
carbon tetrachloride >99.8% Merck 
chloroform >99% Alfa Aesa 
Cyclohexane >99% Alfa Aesa 
cyclohexanol >99% Alfa Aesa 
cyclohexanone >99% Alfa Aesa 
1,1-dichloroethane >98% Реахим 
dichloromethane 99.7% Alfa Aesa 
dimethylsulfoxide >99%, USP Penta 
1,4-dioxane >99.9% Sigma-Aldrich 
ethanol 99.97% LABSCAN 
ethyl acetate >99.5% Penta 
glycerine >98%, Ph. Eur. Penta 
isobuthanol >99% Alfa Aesa 
isopropyl acetate >99% Alfa Aesa 
Methanol >99.8% Fluka 
N,N-dimethylformamide >98% Penta 
n-heptane >98% Реахим 
n-hexane >98% Реахим 
nitromethane >98% Merck 
3-pentanone >99% Merck 
1-propanol >99.5% Penta 
2-propanol >99.5% Alfa Aesa 
tetrahydrofuran >99.5% Hempur 
toluene >98% Реахим 
o-xylene >98% Реахим 
ethanol-d1 99.5 atom % D Sigma-Aldrich 
methanol-d1 99.5 atom % D Sigma-Aldrich 
D2O 99.9 atom % D Sigma-Aldrich 
water Deionised in the laboratory using Crystal 5, conductivity <0.2 μS 
Inorganic compounds 
CH3CO2K >99% Реахим 
K2SO4 >99% Реахим 
KCl 100% НПО ЭКРОС 
KI >99% Реахим 
LiBr  >99% Sigma-Aldrich 
LiCl >98% Penta 
MgCl2 >99% Реахим 
N2 (compressed gas) >99.99%, technical AGA 
NaBr >98%, Ph. Eur. Penta 
NaCl >99% Реахим 
P2O5 >98% Реахим 
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Appendix 6. Supplementary Information for publication “Dehydration of mildronate 
dihydrate: a study of structural transformations and kinetics” 
 
Analysis of the particle size distribution 
A Mastersizer 2000 (Malvern) laser diffraction instrument was used for particle size analysis. Integration 
time was 3000 ms. The measurement range was set to 0.020 – 2000 μm, and 59 counting channels were 
used. For sample dispersion nitrogen with 1.0 bar pressure was used. All measurements were carried out 
three times and the average value was used. 
 
Figure S1. Particle size distribution of different fractions of mildronate dihydrate sample 
Moisture Sorption-Desorption isotherm 
Mildronate AP was used for acquiring a sorption isotherm. AP was prepared by heating DH at 100 °C 
temperature. Approximately 0.8 g of sample was weighed in each of ten containers. These containers were 
placed in humidity chambers where the relative humidity was provided with saturated salt solutions and 
phosphorus pentoxide. The salts used for this experiment and the corresponding relative humidity values 
were LiBr (6%), LiCl (11%), CH3CO2K (23%), MgCl2 (32%), NaBr (56%), KI (68%), NaCl (75%), KCl 
(84%), K2SO4 (97%) and also P2O5 (~0%)1. Humidity chambers were thermostated at 25±1 °C 
temperature and containers were weighed on analytical balance (d=0.1 mg) until no notable change of 
mass was observed (except for containers where sample deliquesced). At the end of the experiment, the 
phase composition of each sample was determined with PXRD. For desorption isotherm, approximately 
0.8 g of mildronate DH sample stored at 22.5% relative humidity was weighed into containers and 
inserted in the previously described humidity chambers up to relative the humidity of 32%. The same 
analytical procedure as described for sorption isotherm was used. Inorganic compounds for relative 
humidity control were purchased from commercial sources and used without further purification. 
From sorption-desorption isotherm of mildronate at 25 °C temperature it was observed that DH was 
stable in the relative humidity interval from 6 to 50% (See Figure S2). Dehydration of DH was observed 
only at 0% relative humidity and AP was obtained as the product. By using AP as a starting material, it 
was observed that a small amount of DH formed at 6% relative humidity (~10% of the AP transformed 
into the DH over 2 months), while fast transition to DH occurred at a higher humidity. By PXRD it was 
determined that samples contained either AP or DH. This confirmed2 that MH was not 
thermodynamically stable at any of the examined conditions. However, continuous monitoring of the 
phase transition was not done. Thus, it was not possible to exclude the MH as a possible transition state 
in the transformation from DH to AP or vice versa. 
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Figure S2. Sorption – desorption isotherm of mildronate (water content is given after storing for 2 
months) 
Study of the mildronate DH dehydration 
 
Figure S3. PXRD patterns of mildronate dihydrate (DH), monohydrate (MH) and anhydrous phase 
(AP) 
Dehydration of DH samples with different particle sizes (the particle size distribution for various 
fractions is given in Figure S1) was performed during DTA/TG experiments at a heating rate of 1 °∙min-1 
in open pans under nitrogen flow. One endothermic peak appeared with dehydration starting temperature 
below 50 °C and the peak thermal effect around 60-65 °C (See Figure S4 (b)). For both of these 
characteristic dehydration temperatures, a significant impact of particle size was observed – dehydration of 
smaller particles was faster than that of bigger particles at the same heating rate. When analysis of the 
same samples was performed at a higher hating rate, the dehydration thermal effect was split in two parts 
(See Figure 3). The second endothermic effect was observed as a relatively sharp peak at 86-88 °C. The 
temperature of this second maximum was not affected by the heating rate or the particle size, and it 
contributed more at higher heating rates and larger particle sizes. Changing the atmosphere from nitrogen 
flow to static air increased the dehydration starting temperature and the maximum temperature, while also 
increasing the contribution from this second maximum. It was also observed that for large particle sizes 
(above 350 µm) after appearance of this second maximum the dehydration rate dropped dramatically, and 
breaches appeared in the TG line (See Figure S5). 
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Figure S4. a) DSC curves of ildronate DH at heating rate 5 o·min-1 and b) DTA/TG curves of 
mildronate DH at heating rate 1 °·min-1 for fractions 1) <40 µm, 2) 40-67 µm, 3) 67-150 µm and 4) 150-
350 µm. 
 
Figure S5. DTA/TG curves of mildronate DH at a heating rate of 4 o·min-1 for fraction >350 µm 
The effect of the atmosphere on the dehydration starting temperature and the temperature of peak 
dehydration rate could be easily explained by the fact that dehydration process was affected by the 
moisture content in the atmosphere. By providing a dry nitrogen flow, water was effectively removed 
from the sample, thus enhancing the dehydration rate. The effect of heating rate could be associated with 
the total heating time, thus a higher conversion degree for given temperature was obtained with slower 
heating rates. The observation that smaller particles dehydrated faster can be associated with the larger 
surface to mass ratio and it is known that dehydration reactions typically start on the surface where the 
dehydration is enhanced3. 
It was determined that the only factor affecting the dehydration peak position and shape in the DSC 
experiments was the heating rate. When the heating rate was 1 °⋅min-1, dehydration starting temperature 
decreased to the same value as was observed in the VT-PXRD experiment, although a sharp peak at 87 °C 
was still observed (See Figure S6). 
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Figure S6. DSC curve of mildronate DH sample for fraction of 67-150 µm (with heating rate 1o·min-1) 
In order to get more insight into the processes occurring during the dehydration of DH and to explain 
observations from thermal analysis, dehydration of 67-150 µm and 350-700 µm DH fractions was 
analysed with hot stage polarized light microscopy. When particles from the 67-150 µm fraction were 
heated at the rate of 8 °·min-1, sample darkening was observed at 70 °C temperature and no further 
changes were observed until the temperature of 140 °C was reached (see Figure S7). When particles from 
the 350-700 µm fraction were analysed, the sample darkened at 72 °C. When the temperature reached 
almost 90 °C, emanation of liquid water was observed from most of the crystals, and this process 
continued upon further heating of the sample. Bubbling of evolved water was observed above 100 °C, and 
the bubbling intensified upon further increasing of the temperature. In some of the experiments within 
the temperature interval of 115 – 130 °C some of the crystals from the 350-700 µm fraction even 
exploded. 
 
Figure S7. Polarized light photomicrographs of the dehydration process of mildronate DH (70-150 µm 
and 350-700 µm fractions). 
 
Figure S8. Polarized light photomicrographs of the dehydration process of mildronate DH single 
crystal at 60 – 85 ºC and the cross section of the crystal after the heating. 
Thus, above the peritectic temperature mildronate water solution formed by abruptly slowing down 
the dehydration process, as observed in DTA/TG scans. Crystal explosion most probably happened 
due to the fact that the newly formed AP surrounded the crystal, which temporarily blocked the 
release of water. After the peritectic temperature was reached, liquid water was released in the interior 
of the particle. Water was not able to escape the particle, and increasing the temperature led to a 
pressure increase, followed by disruption of the particle. This observation agrees with the appearance 
of branches in DTA/TG curves for larger particle sizes. 
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Parameters for calculations in CRYSTAL09 
The level of accuracy in evaluating the Coulomb and exchange series was controlled by ﬁve thresholds4, 
for which values 10-8, 10-7, 10-7, 10-7 and 10-24 were used as suggested in the literature5, in order to avoid 
numerical instabilities in computing the exact exchange contributions. For numerical integration of the 
density (75, 974)p, an extra-large grid was adopted4. The irreducible Brillouin zone was sampled using 170 
k-points (the shrinking factor4 of the reciprocal space net was set to 8). Levshift function with level shift 
of 1 hartree without locking was used in order to reach the convergence in energy. Full crystal structure 
optimization was done with analytical gradients for the unit cell. For optimization procedure, the space 
group symmetry of the original crystal structures was retained. Convergence criteria for geometry 
optimization were as follows: maximum energy gradient/component = 0.00045, RMS energy 
gradient/component = 0.0003, maximum displacement/component = 0.0018, RMS 
displacement/component = 0.0012, threshold for energy change = 0.1·10-6, all in a.u. 
Crystal structure correction 
The crystal structures of AP and MH had previously been determined from PXRD data, thus only 
positions of non-hydrogen atoms were reported6. Moreover, the reported bond distances of carboxyl 
group oxygen atoms were not optimized but left as in non-conjugated systems6. The structural 
information for AP and MH was taken from the literature6 and improvements in the following order 
were applied: 1) hydrogen atoms were added, 2) molecular cluster consisting of a central molecule 
surrounded by 12 closest neighbour molecules was prepared. Positions of central molecule’s carboxyl 
group oxygen atoms O1 and O2, hydrogen atom bounded to nitrogen H1, hydrogen atoms of water 
molecules H15, H16 (in MH and DH), H17 and H18 (in DH), to central molecule’s N-H intermolecular 
hydrogen bonded oxygen (O1’ in AP and O2’ in MH), the hydrogen bound to central molecule’s carboxyl 
group (H1’’) and hydrogen atoms of water molecule H15’’ and H16’’ (in MH) (See Fig. S2) were 
optimized at the B3LYP/6-31G level in Gaussian097. It should be remarked that the dihedral angle τ1 was 
altered after this operation. 3) Positions of all hydrogen atoms of the central molecule were optimized at 
the B3LYP/6-31G level in Gaussian097. For further calculations, the corrected structure of AP and MH 
was used. Corrected DH structure was used only for extraction of mildronate molecules to calculate the 
intramolecular energy. 
 
Figure S9. Labeling scheme for atoms in crystal structures of DH, MH and AP used for atom position 
optimization in Gaussian09 
The values of bond distances, angles, and dihedral angles, which were changed during the crystal 
structure correction in Gaussian09 in all three structures, are given in Table 1S. All atom positions in 
fractional coordinates after optimization are given in Table 2S. By comparing the obtained data with the 
results from crystal structure optimization in CRYSTAL09, it can be seen that there were only minor 
differences, meaning that the procedure performed in Gaussian09 was reliable and the corrected crystal 
structures were suitable for further use. 
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Table S1. Original and final values of mildronate molecule bond lengths, angles and torsion angles affected by crystal structure correction in Gaussian09 at the 
B3LYP/6-31G level and after full structure optimization in CRYSTAL09 at the B3LYP-D*/6-31G(d,p) level 
Parameter AP MH DH Original6 Optimizeda Optimizedb Original6 Optimizeda Original8 Optimizeda Optimizedb 
d(O1-C1) 1.21 1.275 1.270 1.21 1.279 1.257 1.276 1.258 
d(O2-C1) 1.36 1.255 1.258 1.36 1.307 1.267 1.307 1.275 
d(N1-H14) - 1.013 1.035 - 1.010 0.919 1.045 1.032 
Angle(O1-C1-O2) 1.20 124.7 125.65 120.0 123.1 123.7 123.1 123.3 
Angle(O1-C1-C2) 1.20 119.9 115.64 120.0 118.2 118.5 120.4 119.2 
Angle(C3-N1-H1) - 111.1 109.21 - 111.6 108.9 109.4 108.1 
Torsion(O1-C1-C2-C3) 175.1 -156.2 -179.6 45.3 47.8 51.4 49.0 52.8 
Torsion(C2-C3-N1-H1) - 55.3 63.14 - 48.0 57.0 52.2 52.3 
a – optimization of central molecule in molecule cluster in Gaussian09 at the B3LYP/6-31G level  
b – full crystal structure optimization in CRYSTAL09 at the B3LYP-D*/6-31G(d,p) level 
 
Table S2. Fractional coordinates of all atoms after crystal structure correction in Gaussian09 and full structure optimization in CRYSTAL09 
Code Gaussian09 CRYSTAL09 
Form AP MH DH AP DH 
O1 0.7805 1.1208 0.8543 0.7081 0.2152 0.6783 0.4451 0.1202 0.6766 0.7576 1.1022 0.8876 0.4562 0.1272 -0.3267 
C1 0.7252 1.0653 0.7254 0.6518 0.3032 0.5596 0.3205 0.0811 0.5923 0.7214 1.0680 0.7349 0.3237 0.0845 -0.4084 
O2 0.6117 1.0986 0.6356 0.7478 0.4510 0.3868 0.2144 0.1498 0.5172 0.6201 1.1154 0.6394 0.2020 0.1509 -0.4803 
C2 0.7986 0.9477 0.6916 0.4686 0.2253 0.6141 0.3011 -0.0520 0.5702 0.8133 0.9603 0.6635 0.3096 -0.0537 -0.4255 
H2 0.9200 0.9523 0.7236 0.4548 0.1026 0.5797 0.1738 -0.0681 0.5010 0.9374 0.9831 0.6658 0.1827 -0.0753 -0.4975 
H3 0.7494 0.8823 0.7738 0.4306 0.3223 0.5180 0.4360 -0.0805 0.5480 0.7984 0.8867 0.7561 0.4503 -0.0830 -0.4432 
C3 0.7743 0.9158 0.5035 0.3549 0.1695 0.8540 0.2797 -0.1270 0.6653 0.7693 0.9207 0.4791 0.2899 -0.1273 -0.3265 
H5 0.8168 0.9878 0.4295 0.2309 0.0770 0.9000 0.3941 -0.1022 0.7380 0.8002 0.9910 0.3867 0.4067 -0.0990 -0.2525 
H4 0.6530 0.9068 0.4739 0.4104 0.0935 0.9434 0.2993 -0.2203 0.6478 0.6433 0.9068 0.4698 0.3131 -0.2236 -0.3419 
N1 0.8651 0.8103 0.4644 0.3399 0.3331 0.8985 0.0795 -0.1003 0.6808 0.8630 0.8146 0.4376 0.0863 -0.1014 -0.3129 
H1 0.8388 0.7432 0.5433 0.3113 0.4208 0.7920 -0.0293 -0.1124 0.6081 0.8331 0.7471 0.5238 -0.0216 -0.1165 -0.3871 
N2 0.8415 0.7676 0.2946 0.2170 0.2947 1.1123 0.0215 -0.1773 0.7602 0.8322 0.7605 0.2657 0.0246 -0.1808 -0.2347 
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C5 0.9502 0.6713 0.2645 0.0460 0.1992 1.1544 0.1400 -0.1432 0.8706 0.9457 0.6584 0.2550 0.1439 -0.1466 -0.1198 
C4 0.8684 0.8616 0.1701 0.2160 0.4676 1.1370 -0.1965 -0.1520 0.7471 0.6667 0.7160 0.2461 -0.1986 -0.1541 -0.2519 
C6 0.6832 0.7231 0.2708 0.2602 0.1838 1.2696 0.0452 -0.3075 0.7430 0.8691 0.8458 0.1191 0.0501 -0.3156 -0.2522 
H9 1.0646 0.7067 0.2763 -0.0478 0.2010 1.3020 0.2934 -0.1736 0.8836 1.0619 0.6969 0.2640 0.1360 -0.0483 -0.1106 
H10 0.9316 0.6364 0.1383 0.0331 0.0581 1.1748 0.0739 -0.1856 0.9288 0.9301 0.6136 0.1301 0.3024 -0.1751 -0.1054 
H11 0.9341 0.6047 0.3599 0.0242 0.2693 1.0214 0.1364 -0.0477 0.8788 0.9219 0.5999 0.3659 0.0758 -0.1936 -0.0634 
H12 0.6699 0.6893 0.1430 0.1719 0.1744 1.4277 -0.2774 -0.1797 0.6664 0.5836 0.7885 0.2655 -0.2158 -0.0573 -0.2382 
H13 0.5999 0.7918 0.2871 0.2533 0.0493 1.2670 -0.2150 -0.0575 0.7565 0.6471 0.6477 0.3450 -0.2789 -0.1784 -0.3360 
H14 0.6650 0.6551 0.3631 0.3890 0.2553 1.2306 -0.2475 -0.2034 0.8062 0.6555 0.6807 0.1140 -0.2555 -0.2097 -0.1962 
H6 0.8658 0.8220 0.0454 0.1202 0.4406 1.2975 -0.0330 -0.3291 0.6602 0.9870 0.8802 0.1356 0.2126 -0.3374 -0.2272 
H7 0.9812 0.8979 0.1929 0.3404 0.5367 1.1131 -0.0231 -0.3549 0.7977 0.7832 0.9171 0.1166 -0.0218 -0.3371 -0.3381 
H8 0.7794 0.9267 0.1756 0.1862 0.5515 1.0191 0.2036 -0.3291 0.7620 0.8638 0.7941 -0.0014 -0.0268 -0.3658 -0.2016 
O3    0.9950 0.7438 0.3183 0.5994 0.0778 0.8884    -0.3996 0.0736 -0.1124 
H15    1.1007 0.7378 0.3308 0.5402 0.0876 0.8098    -0.4575 0.0837 -0.1920 
H16    0.9141 0.6252 0.3580 0.4964 0.1029 0.9270    0.4896 0.0980 -0.0806 
O4       0.3112 0.1251 0.9945    0.3017 0.1222 -0.0181 
H17       0.2773 0.2048 1.0179    0.2762 0.2031 0.0095 
H18       0.3248 0.0573 1.0463    0.3276 0.0612 0.0413 
a – optimization of central molecule in molecule cluster in Gaussian09 at the B3LYP/6-31G level, lattice parameters unchanged 
b – full crystal structure optimization in CRYSTAL09 at the B3LYP-D*/6-31G(d,p) level, lattice parameters given in Table 1 
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Analysis of the molecule conformation and hydrogen bonding 
It is already stated that conformation of mildronate molecule is almost the same for the DH 
and MH (see Table S3). Torsion angles O1-C1-C2-C3 (τ1) and C1-C2-C3-N1 (τ2) in AP are 
significantly different than those in DH and MH. Hydrogen bond geometry of DH, MH and 
AP is presented in Table S4. Geometry of hydrogen bonds in MH and AP structures was 
determined after structure correction at the B3LYP level. Analysis of hydrogen bonding motifs in 
crystal structure showed that inversion related mildronate moieties in crystal structures of DH 
and MH form N1-H1…O2 hydrogen bonded dimers with graph set 𝑅𝑅22(12) (See Figure S10 (a)). 
Additionally, mildronate carboxyl groups and water molecules in MH form O-H···O hydrogen 
bonds with second order graph set 𝑅𝑅44(12) (See Fig. S11). In crystal structure of DH four water 
molecules form hydrogen bonded 𝑅𝑅44(8) motifs (See Fig. S11). Water molecules are connected to 
mildronate molecules by infinite 𝐶𝐶33(8) and 𝐶𝐶34(12) chains (See Fig. S11). In AP crystal structure 
mildronate molecules form N1-H1…O1 hydrogen bonded chains designated by C(6) graph set 
(See Figure S10 (b)). 
Table S3. Torsion angle values of the mildronate molecule in all three crystal structures 
Angle O1-C1-C2-C3, τ1, o C1-C2-C3-N1, τ2, o C2-C3-N1-N2, τ3, o C3-N1-N2-C4, τ4, o 
DH8 51.4 69.4 172.1 -169.2 
MH6 45.3 74.6 171.5 179.2 
AP6 175.1 171.6 175.5 54.0 
APcorra -156.2  171.6 175.5 54.0 
a – optimization of central molecule in molecule cluster in Gaussian09 at the B3LYP/6-31G level 
 
Table S4. The geometric parameters and graph set assignments of hydrogen bonds in 
mildronate crystalline phases 
Hydrogen bond Symmetry D-H, Å H···A, Å D-A, Å 
∠DHA, 
o 
Graph set 
notation 
DH 
N1—H1···O2 -x, -y, 1-z 0.919 2.004 2.920 175.5 𝑅𝑅22(12) 
O4—H18··· O3 1-x,-y,2-z 0.988 1.775 2.728 161.1 
� 𝑅𝑅4
4(8) O3—H16··· O4 x,y,z 1.171 1.594 2.760 173.5 
O4—H17··· O2 x,1/2-y,1/2+z 0.777 0.955 2.714 165.4 
 O3—H15··· O1 x,y,z 0.786 1.941 2.719 170.3 
MH 
N1—H1··· O2 1-x,1-y,1-z 1.040 1.742 2.779 1774.4 𝑅𝑅22(12) 
O3—H16··· O2 x,y,z 0.991 1.782 2.748 164.1 
� 𝑅𝑅4
4(12) O3—H15··· O1 2-x,1-y,1-z 1.002 1.675 2.657 165.6 
AP 
N1—H1··· O1 1,5-x,1/2+y,1.5-z 1,013 1,925 2.894 159.0 𝐶𝐶(6) 
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Figure S10. Hydrogen bonding motif connecting mildronate molecules (a) in DH and MH 
and (b) in AP 
 
Figure S11. Hydrogen bonding motif formed by water molecules in DH (a), and by water and 
mildronate molecules in MH (b) and DH (c and d) 
 
Figure S12. Molecular packing and hydrogen bonding network in the crystalline forms of 
mildronate (hydrogen atoms have been omitted for clarity). 
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Analysis of the potential energy surface (PES) scans 
In order to examine the potential energy surface (PES) of observed conformations with 
respect to other available conformations all four torsion angles were scanned at the MP2/6-
31G(d,p) level with step size of 10° while conformation for the rest of the molecule was 
maintained as observed whether in DH or AP structure. For this analysis mildronate molecule 
was extracted from nonoptimized DH structure with atom coordinates as in the literature and 
from AP structure corrected at the B3LYP/6-31G level. PES scans with marked torsion angles as 
observed in experimental structures are presented in Figure S13. It can be seen that the form of 
PES scans with respect to the same torsion angle slightly depends on the conformation of the 
rest of the molecule although the positions of minimums and maximums are generally at the 
same angles. 
Minimums in the PES scan with respect to torsion angle τ1 (Figure S13) can be associated with 
C3-H…O1 (in experimental DH structure) and C3-H…O2 (in experimental AP structure) 
interaction while maximums are associated with intramolecular interactions N1…O1 and 
N1…O2. In the scan with respect to torsion angle τ2 global minimum is observed when 
intramolecular hydrogen bonding N1- H…O1 (in DH) and N1-H…O2 (in AP) is present, 
maximum at τ2 = 0 is related to eclipsed conformation where N1…O1(8) interaction is observed 
but local minimums are due to C3-H…O1 (in DH) and C3-H…O2 (in AP) intramolecular 
interaction. Energy difference between global minimum and global maximum is higher in AP 
structure due to shorter distances in observed interactions. Experimental structures correspond 
to different local energy minimums. Energy maximums in τ3 scan is associated with close C1-
H…H-C4 and C1-H…H-C6 interaction in AP and with methyl group close interaction with 
carboxyl group and with close C1-H…H-C5 and C1-H…H-C6 interaction in DH. Although it 
seems that from τ3 = 100 to -100 o there is a plateau with the same energy, closer look reveals 
that AP is located in global energy minimum while DH in local minimum. Energy scan of τ4 
corresponds to conformational energy diagram for rotation around single bond with observed 
crystal structures situated in global energy minimums. 
 
Figure S13. PES scans of mildronate molecule with respect to one torsion angle (the rest of 
the molecule was fixed at conformation observed in DH or AP structure) 
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By analysing the PES graphs with respect to one dihedral angle, it was calculated that the 
energy barrier necessary for conformation changes during the transition from DH to AP was 15 
kJ⋅mol-1 for changing τ1, 10-25 kJ⋅mol-1 for changing τ2, and 30-40 kJ⋅mol-1 for changing τ4. From 
these results it can be seen that the activation energy necessary for conformation changes was 
slightly lower than typical energy barriers in phase transitions. 
To more realistically evaluate the activation energy necessary for transformation of molecular 
conformation, PES graphs with respect to two dihedral angles were created as well. In this 
transition from DH to AP, where the dihedral angles τ3 and τ4 did not change, a pathway where 
simultaneous changes dihedral angles τ1 - τ2 could be important. 
PES with respect to two adjacent torsion angle change of all three adjacent torsion angle 
combinations were performed at the B3LYP/6-31G level with step size 15° for each dihedral 
angle and it was observed that PES for torsion angles τ1-τ2 and τ2-τ3 are basically the same for 
DH and AP conformations while PES scan for torsion angle τ3-τ4 changes is different for both 
structures. All three PES scans for DH structure and τ3-τ4 scan for AP is showed in Figure S14 
but the rest two scans for AP structure are shown in Figure S15. Energy minimums observed in 
PES scan with respect to τ1-τ2 1 and 1` and minimum 2 in scan with respect to τ2-τ3 corresponds 
to intramolecular hydrogen bond N1-H…O1(O2), but minimum 3 corresponds to weak 
intramolecular hydrogen bond C5-H…O1 in DH and C3-H…O2 in AP. Energy maximum in 
PES scan with respect to τ1-τ2 corresponds to N1…O1 and N1…O2 interaction. In scan with 
respect to τ1-τ2 DH and AP structures are located in local energy minimums and changes from 
one conformation to second one is associated with energy barrier 20 kJ⋅mol-1. In PES scan with 
respect to τ3-τ4 conformation as in AP structure corresponds to global minimum without specific 
interaction. However, in DH global minimum 4 corresponds to C5-H…O1 interaction. Energy 
maximums in PES scans with respect to τ2-τ3 and τ3-τ4 correspond to unrealistic overlapping of 
atoms or unrealistically short intramolecular distances explaining huge energy difference 
comparing with observed conformations. 
 
Figure S14. PES scans of mildronate molecule with respect to two adjacent torsion angles while 
the rest of the molecule was fixed at conformation observed in DH structure (except bottom 
right where the rest of the molecule had conformation as in AP structure) 
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Figure S15. PES scans of mildronate molecule where two adjacent torsion angles were 
changed while the rest of the molecule was fixed at conformation observed in AP structure 
Optimization of the molecule conformation of mildronate in DH and AP 
structures 
Torsion angle optimization of of mildronate molecule surrounded by 12 closest molecules was 
performed in Gaussian09 at the B3LYP/6-31G level for both DH and AP structures. This 
procedure was repeated several times by updating the conformation of surrounding molecules 
with the goal to prove that observed conformation is the most stable in the experimental crystal 
structures. Full crystal structure optimization of both DH and AP was performed in 
CRYSTAL09. Results are shown in Table S5. 
Table S5. Optimized torsion angles of mildronate molecules in DH and AP structures 
Angle τ1, o τ2, o τ3, o τ4, o 
DH 
Original8 51.4 69.4 172.1 -169.2 
HF/STO3G 3rd iteration 58.7 71.5 172.5 -170.6 
HF/6-31G 1st iteration 55.0 66.0 176.4 -165.5 
HF/6-31G 2nd iteration 53.9 67.7 175.2 -165.0 
B3LYP-D* CRYSTAL09 52.8 68.9 169.3 -169.0 
AP 
Original6,a 175.1 171.6 175.5 54.0 
HF/STO3G 3rd iteration -158.9 -177.7 177.1 55.4 
HF/6-31G 1st iteration -158.4 176.6 172.0 51.7 
HF/6-31G 2nd iteration -162.3 173.3 175.0 53.9 
B3LYP-D* CRYSTAL09 -179.6 -177.4 177.9 61.6 
a – Torsion angle values from the literature6 were used while all other parameters were used from crystal structure 
corrected in Gaussian09 at the B3LYP level. 
Torsion angles in Gaussain09 calculations have been changed by less than 5 o with one 
exception of τ1 of AP structure which has been changed by more than 20 o while after 
calculations in CRYSTAL09 changes up to 10o for AP structure were observed. It should be 
remembered that similar torsion angle τ1 value for AP structure was obtained also when full 
oxygen and hydrogen atom position optimization in the molecule cluster was performed during 
structure correction in Gaussian09. Such a big change can be explained by previous optimization 
of oxygen atom bond distance and angle in such a way changing molecular environment. 
Differences between results from both calculation methods are associated with more accurate 
periodic boundary approach in CRYSTAL09 and different calculation levels used. Also it can be 
seen that after full optimization in CRYSTAL09 only minor changes in conformation of 
mildronate molecules in DH structure are introduced thus confirming that the AP crystal 
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structure probably is less accurate due to the determination from the PXRD data. Thus it can be 
seen that molecule conformation observed in crystal structures correspond to energy minimum 
in crystalline environment. 
Interaction energy of hydrogen bonded molecule pairs 
To compare the intermolecular energy of the AP and DHWW structures, at first the hydrogen 
bonding energy of mildronate molecules in the crystal structure was calculated. The interaction 
energy between hydrogen bonded molecules is shown in Table S6. However, it should be noted 
that in DHWW two hydrogen bonds formed between two molecules while in AP each molecule 
formed two hydrogen bonds, each with a different molecule. Thus, the interaction energy given 
in Table S6 corresponded to two hydrogen-bonds in the DHWW structure, but only one 
hydrogen bond in the AP structure, so the energy value obtained for DHWW was related to one 
hydrogen bond. It can be seen that the total interaction energy of two molecules was more 
favourable in the DHWW structure. By analysing the contribution from different types of 
interactions, it was concluded that the Coulomb energy dominated in both of these dimers, 
which was already expected for a molecule with highly polar groups, especially because 
mildronate molecule is a zwitterion. It can also be evaluated that all four energy types contributed 
similarly to the total energy of dimers from both structures and the main differences in the total 
energy resulted from more negative Coulomb energy in DHWW structure and small differences 
of other energy types. 
Table S6. Interaction energy of hydrogen bonded molecule pairs in AP, DHWW and 
MHWW crystal structures. 
Phase Symmetry 
operation dr, Åa 
Ecol, 
kJ·mol-1 
Epol, 
kJ·mol-1 
Edisp, 
kJ·mol-1 
Erep, 
kJ·mol-1 
Etot, 
kJ·mol-1 
AP 1,5-x, -1/2+y, 
1,5-z 
7.09 -111.0 -42.7 -18.2 49.5 -122.4 
DHWW -x, -y, 1-z 4.96 -238.4 -80.0 -36.6 89.5 -265.5 
Per 1 hydrogen bond: -119.2 -40.0 -18.3 44.75 -132.75 
MHWW 1-x, 1-y, 1-z 4.91 -273.3 -98.0 -40.1 143.8 -267.7 
Per 1 hydrogen bond: -136.7 -49.0 -20.1 71.9 -133.9 
a - dr is distance between mass centers of the molecules, Å 
Additionally, interaction energy of mildronate molecule dimer in MH structure was calculated 
and given in Table S6. By comparing the interaction energy of mildronate dimers in DH and 
MH structures, it can be seen that the total interaction energy is the same, although components 
slightly differed – Coulomb and polarization energy terms were more negative for MH and the 
repulsion energy term was more positive. This result could be associated with the fact that 
molecules in hydrogen bonded pairs in the MH structure were situated closer to each other. 
Energy of optimized and non-optimized crystal structures 
The obtained lattice energy for both structures is given in Table S7. As expected for non-
optimized crystal structures, by both calculation methods it was determined that the lattice energy 
of AP was lower than that of DHWW by 33.0 kJ·mol-1 (from PIXEL) and 20.4 kJ·mol-1 (from 
CRYSTAL09), due to the large empty channels in the DHWW structure. By comparing the 
contribution from lattice energy components calculated with PIXEL, it can be seen that the 
Coulomb, polarization and dispersion energy was more negative in AP structure, while repulsion 
energy was lower in the DHWW structure. This could be explained by the fact that molecules in 
AP were packed more compactly than in non-optimized DHWW structure. 
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Table S7. Crystal lattice energy and its components calculated with PIXEL and lattice energy 
corrected for basis set superposition error, calculated with CRYSTAL09 for the original (SP) and 
optimized (OP) AP and DHWW structures. 
 ECoul, kJ⋅mol-1 EPol, kJ⋅mol-1 EDisp, kJ⋅mol-1 ERep, kJ⋅mol-1 ETot, kJ⋅mol-1 
AP 
PIXELSP -278.9 -79.8 -110.5 160.7 -308.4 
CRYSTAL09SP     -330.4 
CRYSTAL09OP     -334.9 
DHWW 
PIXELSP -222.1 -58.4 -73.5 78.6 -275.4 
CRYSTAL09SP     -309.5 
CRYSTAL09OP     -320.9 
In order to allow for possible reorganization in the DHWW structure after the water loss, 
crystal structure optimization was carried out with the ab initio code CRYSTAL09. Moreover, 
optimization was performed also for AP, to ensure that both structures are compared at the same 
conditions, because optimization (temperature-less relaxation) of the structure determined at 
room temperature led to cell shrinkage9). 
After the optimization reduction in the cell volume for both structures was observed. 
Although the cell volume reduction was larger after optimization of the DHWW structure, 
crystallographic density of the AP was higher, which can be explained by the relatively large 
empty channels still present in the optimized DHWW structure. 
By comparing the lattice energy of optimized crystal structures with that for non-optimized 
crystal structures (see Table S7), a decrease of the lattice energy was observed for both crystal 
structures. As may be predicted, reduction of the DHWW lattice energy was bigger than that for 
AP, although lattice energy of optimized AP structure was still energetically favourable. 
The total crystal structure energy and lattice parameters obtained by structure optimization are 
given in Table S8, and fractional atom coordinates are given in Table S2. The addition of zero-
point vibration and thermal correction to the calculated total energy did not alter the energy 
difference significantly. After this correction the AP was still energetically more favourable by 9.7 
kJ·mol-1. 
Table S8. The total energy and lattice parameters obtained after the crystal structure 
optimization in CRYSTAL09 for the structures of AP and DHWW. 
 AP DHWW 
Energy, Hartree -496.7405 -496.7363 
E(AP)-E(DHWW), 
kJ·mol-1 -11.0 - 
a, Å 8.5616 6.7874 
b, Å 11.2490 11.1558 
c, Å 7.6354 11.7025 
β, ° 89.26 111.63 
d, g·cm-1 1.320 1.178 
V 735.307 823.687 
ΔV, % -5.2 -15.8 
The total energy of DHWW was very similar to that of AP, so this theoretical structure could 
not be considered as completely unrealistic and it may represent a transition structure during the 
dehydration process. 
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Appendix 7. Supplementary Information for publication “Effect of experimental and sample 
factors on dehydration kinetics of mildronate dihydrate: mechanism of dehydration and 
determination of kinetic parameters” 
 
Physicochemical evaluation of mildronate dihydrate 
When crystallized from water or water containing solutions, mildronate crystallizes as a dihydrate DH. 
Thermogravimetrically determined water content is 19.7-20.0% (theoretical water content: 19.7 %). It is 
already reported1 that DH is stable and at ambient temperature dehydration occurs only when the relative 
humidity (RH) was almost 0%. However, DH is highly hygroscopic: humidity induced changes appeared 
already at 56% RH and sample deliquesced when RH was 68% or higher. Therefore sample should be 
stored at 11 – 32% RH. 
 
Figure S1. Sorption – desorption isotherm of mildronate (water content is given after storing for 2 
months)1 
Dehydration process and dehydration profiles of mildronate dihydrate 
A study of the DH dehydration process is already published1. It was shown that the dehydration of DH 
in an open atmosphere can result in two processes: dehydration process initiating at 40 – 60 oC 
(depending on the sample and experimental conditions) and the melting/peritectic decomposition process 
occurring at 86-88 oC (if the dehydration was not already finished). Therefore, depending on the particle 
size, atmosphere and heating rate two situations were possible: a) dehydration finished before reaching the 
melting/peritectic decomposition temperature and only the thermal effect of the dehydration showed up 
(see Fig. S2 a), or b) dehydration did not finish before reaching the melting/peritectic decomposition 
temperature and thermal effect of both dehydration and melting/peritectic decomposition showed up (as 
for highest heating rates in Fig. S2 b). Phase composition analysis showed that in the first case the only 
phases present in the sample during the dehydration process was DH and anhydrous phase AP (see 
Fig. S2 c), whereas in the second case this was true only up to the reaching of the melting/peritectic 
decomposition temperature (see Fig. S2 d). In the second case above the 86-88 oC temperature (after 
appearance of the second endotherm) sample contained a mixture of all three known mildronate phases: 
DH, AP and a small amount of monohydrate MH (see Fig. S2 e, MH is marked with red asterisks). 
Formation of MH occurred due to the crystallization of mildronate from solution or solid phase 
transition from the AP in the presence of liquid water1. 
1 - Bērziņš A, Actiņš A. 2014. Dehydration of mildronate dihydrate: a study of structural transformations and 
kinetics. CrystEngComm, DOI: 10.1039/C3CE42077A. 
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Figure S2. Dehydration DTA (in green) and TG (in blue) curves of mildronate DH fractions a) <40 
µm and b) 67-150 µm in non-isothermal mode (with corresponding heating rates in oC·min-1), and 
fractions f) 40-67 µm and g) 350-700 µm in isothermal mode (temperature increases from right to left with 
5 oC step, minimum and maximum temperature is given in oC). c) – e) shows PXRD pattern of the sample 
during the non-isothermal dehydration process and PXRD patterns of pure DH, AP and MH. 
The dehydration profiles in the isothermal experiments are shown in Fig. S2 f and g. 
Sample preparation 
Totally 4 samples differing in the preparation method and storage conditions were used. Sample A was 
prepared in mortar by adding a small amount of water to mildronate, so that a paste formed, which was 
allowed to dry in the ambient conditions. The obtained sample was then fractionated by pushing through 
sieves with mesh size 350, 150, 67 and 40 μm, thus obtaining 5 fractions. Part of the fraction with particle 
size above 150 μm was gently ground and fractionated in the same manner, yielding the sample A2. Both 
samples A and A2 were stored above saturated magnesium chloride solution at ambient temperature 
(relative humidity 34%). Sample B was prepared by slowly crystallizing mildronate from water at 30 ºC. 
The obtained crystals were fractionated by pushing through sieves with mesh size 1300, 700, 350, 150, 67 
and 40 μm, yielding 7 fractions (the obtained particle size distribution for different fractions of sample B is 
given in Figure S1). Part of the fractions 150-350 μm and 350-700 μm was slightly ground and 
fractionated by pushing through sieves with mesh size 350, 150, 67 and 40 μm, and 5 fractions of sample 
C were thus obtained. Samples B and C were stored above saturated solution of potassium acetate in 
ambient temperature (relative humidity 22.5%). All four samples were used for determination of the 
dehydration kinetic parameters. 
All of the non-isothermal experiments were carried out using sample A (study of the particle size, 
sample weight, N2 flow rate and mechanical compression effect) and sample A2 (study of the particle size 
effect). Sample A was also used to study the particle size effect in isothermal mode. Sample B was used to 
study the particle size, sample weight, N2 flow rate, relative humidity, previous dehydration-rehydration 
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and mechanical compression effect in isothermal mode. Sample C was used only to study the particle size 
effect in isothermal mode. 
Analysis of particle size distribution 
Particle size distribution of all sample B fractions is given in Figure S1. It can be seen that in every 
fraction there were particles with smaller and bigger sizes than corresponding mesh sizes used for their 
preparation. Presence of the bigger particles most probably was due to the fact that either particles were 
not perfectly round and smallest of their dimensions was less than the mesh size or that during the particle 
size determination particles formed aggregates and size of this aggregates was determined. The presence 
of the smaller particles suggested that longer sieving time was necessary for better separation of fractions 
or that during fractionation there was an attraction between the particles and the size of formed aggregate 
was bigger than the corresponding mesh size used. However, for sample indication in the text fractions 
are named after the mesh sizes used for their preparation. 
 
Figure S3. Particle size distribution for different fractions of sample B. 
Effect of the particle size, sample preparation and storage conditions 
Particle size, sample preparation and storage condition effect on the Ea for fractions up to 150-350 µm 
can be evaluated from Figure S2, where the average Ea values in conversion degree interval from 0.2 to 0.7 
are shown. As it is shown in the section 3.1., Ea values calculated from non-isothermal experiments were 
lower than those calculated from isothermal experiments. It is obvious that the particle size had no effect 
on the dehydration Ea value for fractions with particle size below 350 μm. Besides this, also sample 
preparation and storage had no effect on the Ea. 
 
Figure S4. Particle size, sample preparation and storage effect on the average dehydration activation 
energy. 
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Figure S5. Dehydration kinetic curves of mildronate DH various fractions a) in isothermal mode and 
b) in non-isothermal mode (where fractions are marked as follows: 1 = <40 µm, 2 = 40-67 µm, 3 = 67-
150 µm, and 4 = 150-350 µm). For better clarity time in a) was set to 0 at α = 0.02 for each fraction due to 
the small differences in the actual initiation times. 
<40 µm fraction dehydrated slower than the 40-67 µm fraction in isothermal experiments, and its 
dehydration starting temperature was higher than that of fractions with bigger particle sizes in non-
isothermal experiments (see Fig. S3). The reason for the slower dehydration rate of the <40 µm 
fraction, as observed in isothermal mode for the same temperature, could be the agglomeration of 
small particles, thus slowing down the dehydration process on the common surfaces and complicating 
the escape of water vapor. In the non-isothermal mode the dehydration rate of the <40 µm fraction was 
the fastest, but only because its dehydration starting temperature was the highest of all analyzed 
fractions. The higher dehydration starting temperature probably was observed due to the low 
occurrence of crystal defects on the surface of very small particles limiting the number of dehydration 
reaction initiation centers, or the dehydration was delayed by the slow escape of water vapor from the 
aggregates formed52, 53. However, once the dehydration was successfully initiated, the temperature was 
already higher than that for the other fractions, thus explaining the higher dehydration rate. 
Table S1. Temperature intervals used for the dehydration kinetic analysis of the different fractions of 
mildronate DH. 
Fraction 
Temperature interval αmelt  
Isothermal mode Non-isothermal mode 
<40 μm 35-67 45-90 0.97 
40-67 μm 35-67 40-85 0.98 
67-150 μm 35-67 40-1101 0.80 
150-350 μm 35-67 45-(130)1,2 0.55 
350-700 μm 36-69 45-(130)2  
700-1300 μm 46-78 -  
1 – Melting/peritectic decomposition point was reached and endothermic peak corresponding to 
melting/peritectic decomposition appeared in the DTA curve. 
2 – Complete transformation was not reached for the highest heating rates due to the fact that after the 
melting/peritectic decomposition point dehydration rate slowed down. 
αmelt – conversion degree at which the melting/peritectic decomposition point was reached for the 
highest heating rate in non-isothermal mode. 
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Table S2. Conversion degree at which melting/peritectic decomposition point in non-isothermal 
experiments was reached for each DH fraction at each heating rate. 
Heating rate, o·min-1 0.5 1 2 3 4 5 
<40 μm - - - - - 0.97 
40-67 μm - - - - - 0.98 
67-150 μm - - - 0.99 0.91 0.80 
150-350 μm - - 0.96 0.83 0.68 0.55 
350-700 μm - - 0.86 0.70 0.61 0.49 
 
 
Figure S6. (a) Slope and (b) intercept of the straight line characterizing the dependence of the 
reciprocal dehydration rate constant on the sample weight for the <40μm fraction at various temperatures 
and for the 40-67μm, 67-150μm, 150-350μm, and 350-700μm fractions at 55 °C temperature. 
 
Figure S7. Nitrogen flow rate effect on the dehydration rate constant of the mildronate DH fraction 
<40 µm at 55 ºC temperature. 
 
Figure S8. Effect of the water vapor pressure on the dehydration rate constant of the mildronate DH 
fraction <40 µm at 70 ºC temperature. 
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Effect of the previous dehydration-rehydration 
Dehydration Ea obtained for fresh samples and previously dehydrated and rehydrated samples are 
shown in Figure S6. 
 
Figure S9. Dehydration activation energy of the different fractions of the DH original sample and 
sample which was previously dehydrated and rehydrated. 
Effect of the mechanical compression 
By analyzing the effect of mechanical compression on the dehydration rate, Ea and kinetic model, two 
different approaches have been used: a) tablets obtained after the compression were disassembled with 
mortar and pestle, and the obtained powder was analyzed; b) tablets were analyzed directly. 
By comparing the dehydration rate of compressed and original DH samples in isothermal experiments 
it was concluded that the dehydration rate of compressed powder samples were comparable to 
uncompressed samples and no characteristic trend was observed. However, dehydration rate of tablets 
was slower than that of uncompressed powdered samples, but no dependence on the applied mechanical 
pressure was observed. In non-isothermal experiments it was observed that the dehydration of 
compressed samples started at lower temperature, but the dehydration rate was slower, so complete 
dehydration of the uncompressed samples was achieved faster. However, also in this case no relationship 
between the applied pressure and the dehydration starting temperature or the rate was found. 
Dehydration Ea values of both mechanically compressed and the original DH samples in both 
experimental modes are shown in Figure S7. It can be seen that there was no obvious relationship 
between Ea and neither pressure applied or the sample form (powder or tablet). The small differences of 
the dehydration Ea value for powder samples could be a random error or due to the changes in particle 
size after breaking the tablet. Although fraction <40 µm compressed with 370 and 740 MPa and 
dehydrated as a tablet in isothermal mode showed lower dehydration Ea than the same sample dehydrated 
as a powder, and lower Ea values were obtained also for samples dehydrated as a tablets in non-isothermal 
mode, this did not represent an Ea decrease due to the compression, because in non-isothermal mode 
obtained Ea values generally were lower than those obtained under isothermal mode (as discussed in 
section 3.1.), and the standard deviation of Ea for samples analysed as a tablets was higher, suggesting that 
the decrease of the Ea obtained for fraction <40 µm in isothermal mode may be coincidental. 
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Figure S10. Mechanical compression effect on the average dehydration activation energy of the 
mildronate DH in isothermal mode and in non-isothermal mode. 
Besides the dehydration Ea, also the kinetic model was determined for all the analysed samples (See 
Table S3). For powder samples the same kinetic model R1 as for uncompressed samples was determined. 
However, for the tablet samples determination of the kinetic model was not straightforward. For many of 
these samples R2 was determined as the most appropriate model, although for some of the samples R1 or 
Avrami-Erofeev models showed a better fit. It was already stated that dehydration of the particles larger 
than 350 μm was best described with kinetic model R2. During the mechanical compression, the smaller 
particles were compressed tightly so it may be possible that the same effect on the dehydration rate 
control as for larger size particles was achieved. This theory was partly supported by the measurement of 
the particle size distribution of the compressed samples after the disassembling the tablets (see Figure S8). 
It can be seen that after compression the average particle diameter grew noticeably for fraction <40 µm, 
while a small decrease of the average particle size and widening of the particle size distribution was 
observed for the fraction 67-150 µm. This can be associated with the formation of particle associates for 
smaller fractions and reduction of particle size for bigger particles. However, as mentioned, particle size 
analysis was carried out after disassembling the tablet while the dehydration kinetic model R2 was 
obtained when dehydration was carried out for compressed tablet where particles were in close contact to 
each other. 
 
Figure S11. Particle size distribution for fractions <40 µm and 67-150 µm before and after the 
compression with 370 MPa pressure. 
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Table S3. The most appropriate dehydration kinetic model for different DH samples determined by 
studying the effect of mechanical compression 
Method Sample Fraction 130 MPa 370 MPa 740 MPa 
Is
ot
he
rm
al 
Powder 
<40 µm R1 R1 R1 
67-150 µm R1 R1 R1 
Tablet <40 µm R2, A3/2 R2, A3/2 R2, A3/2 
N
on
-
iso
th
er
m
al 
Tablet 
<40 µm R1, R2 R2 R2 
40-67 µm R2, A3/2 R2 R2, R1 
67-150 µm R2, R1 R2 R1, R2 
 
171 
Appendix 8. Supplementary Information for publication “On the formation of droperidol 
solvates: characterization of structure and properties” 
 
PREPARATION AND CHARACTERIZATION OF DROPERIDOL SOLVATES 
 
Table S1. Crystal forms obtained after the crystallization of droperidol from different solvents 
Solvent Classification1 Group2 Temperature, oC Phase 
Cyclohexane AAA 1 70a II 
n-hexane AAA 1 60a II 
carbon tetrachloride HBD 1 70 STCC 
Ethyl acetate AP 2 70 II 
Butyl acetate AP 2 90 II 
tetrahydrofuran EPD 2 60 II/I 
methyl tertiary-butyl ether EPD / AAA 2 50a II 
iso-propyl acetate AP 2 90 II 
1-butanol HBD 3 90 II 
2-propanol HBD 3 70 II 
1-propanol HBD 3 90 II 
ethanol HBD 3 70 SEt 
methanol HBD 3 60 SMe 
toluene AALP 4 90 STOL 
o-xylene AALP 4 90 II 
cyclohexanone AP 5 130 II 
3-pentanone AP 5 90 II 
butanone AP 5 70 II 
acetone AP 5 50 II 
N,N-dimethylformamide AP 6 130 no crystallization 
dimethylsulfoxide AP 6 130 no crystallization 
chloroform EPD / HBD / 
AP 
7 50 SCLF 
dichloromethane AP 7 40 SDCM 
1,1-dichloroethane AP 7 70 II 
acetonitrile AP 9 80 SACN 
nitromethane AP 9 80 SNM 
Benzyl alcohol AALP 10 130 no crystallization 
1,4-dioxane AP / EPD 11 90 SDIOX 
Water HBD 15 - NSH / DH 
cyclohexanol HBD - 130 II 
Bold – droperidol solvate was obtained, Blue bold – new droperidol solvate was obtained, Gold 
shading – isostructural droperidol solvates, a – solution was partially evaporated at 50 oC temperature 
Classifications: AP = aprotic polar, AALP = aromatic apolar or lightly polar, EPD = electron pair 
donors, HBD = hydrogen bond donors, AAA = aliphatic aprotic apolar. 
Groups are based on cluster analysis of following solvent parameters: hydrogen bond acceptor 
propensity, hydrogen bond donor propensity, polarity/dipolarity, dipole moment, and dielectric 
constant, and contain various solvents with similar properties (except for: group 13 = diethylamine, 
group 14 = glycerol, and group 15 = water). 
 
Powdered DH was obtained when droperidol solution in acetone or DMF was poured into a 
large amount of cold water, by stirring the obtained suspension. DH crystals were obtained when a 
similar volume of cold water was slowly added to cold droperidol solution in acetone and the 
resulting solution was slowly evaporated at 50°C temperature. However, when a small amount of 
water (5-10%) was added to droperidol solution in acetone and the resulting solution was slowly 
evaporated at 50°C temperature, NSH crystals were obtained. 
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Figure S1. Overlay of the experimental and from crystal structure data simulated PXRD patterns 
for droperidol solvates a) NSH, b) SEt, c) SMe, d) SACN, e) SNM and f) ISD. 
 
In Fig. S1 observed differences in peak positions was due to the different temperature used for 
the crystal structure determination and experimental PXRD measurements, whereas the intensity 
differences between calculated and experimental PXRD patterns suggested the presence of 
preferred orientation. 
The PXRD patterns of isostructural solvates showed obvious intensity differences for some of 
the first diffraction peaks. Miller indices corresponding to these peaks were 001, 002, and 011 (see 
Figure S2). These crystallographic planes are positioned along the solvent channels and thus changes 
in the diffraction peak intensity are associated with the presence of different solvent molecules and 
their different arrangement in the solvate structure. 
 
Figure S2. Overlay of the initial part of the droperidol isostructural solvate (NSH is black, SMe is 
blue, SEt is red, SACN is green, SNM is purple, SDCM is brown, and SCLF is orange) PXRD patterns. 
For three of the peaks corresponding Miller indexes are indicated. 
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Fig. S3. DTA and TG curves of the droperidol solvates SCLF, STCC, SDIOX, STOL, and DH. 
Although desolvation of isostructural solvates produced an identical desolvated phase, the 
observed melting points of partially desolvates solvates presented in Figure 3 were different: for 
most of the isostructural solvates it was 123-129°C (see Table 2), whereas that of SNM was lower by 
10°C. Although SNM had the highest solvent content in the structure upon reaching the melting, a 
relationship between the solvent amount and the melting point was not observed neither for SNM, 
no for any other of the isostructual solvates. Therefore the melting point most probably depended 
on the properties of solvent in the solvate structure. 
Desolvation of STCC, SDIOX, STOL, and DH (see Fig. S3) occurred over a smaller temperature 
interval with a characteristic desolvation endotherm in the DTA curve typical of stoichiometric 
solvates, with the peak maximum at 60 – 75°C (see Table S2). From the TG curves STCC and SDIOX 
were determined to be monosolvates, whereas STOL was a hemisolvate. 
 
Table S2. Physicochemical data for some of the droperidol solvates. 
Solvate Calculated weight loss, 
% 
Observed weight 
loss, % 
Tdesolvatation,°C (peak) Resulting phase 
STCC 28.8a 28.0 69 I 
SDIOX 19.5a 22.5 61 I 
STOL 10.4b 9.6 74 IV 
DH 8.7c 8.5 67 II / III 
a - for monosolvate stoichiometry 
b – for hemisolvate stoichiometry 
c – for dihydrate stoichiometry 
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For HSM, a Laborlux 12 PolS (Leitz) polarized light microscope equipped with a heating stage 
and a Newtronic heating control module was used. The heating rate was 5°·min-1. Images were 
acquired with Leica Application Suite software from a DFC450 (Leica) digital microscope camera. 
 
Figure S4. HSM photomicrographs of the droperidol NSH upon the heating. 
 
Fig. S5. DTA curves of the droperidol polymorphs. 
Table S3. Crystallographic data of droperidol solvates SMe, SEt and NSH determined at 173 K 
a – Based on droperidol as the molecular entity. 
b – Calculated for structure where solvent molecules were ordered. 
Solvate SMe NSH SEt 
Empirical formula (C22H22FN3O2)2·CH4O C22H22FN3O2·H2O (C22H22FN3O2)2·C2H6O 
Mr 395.45 397.44 402.47 
Crystal system triclinic triclinic triclinic 
Space group P1� P1� 𝑃𝑃1� 
Temperature 173 173 173 
a (Å) 6.0671(2) 6.2936(2) 6.08400(10) 
b (Å) 10.2183(4) 10.1673(4) 10.2978(3) 
c (Å) 16.2078(8) 15.9173(4) 16.1737(5) 
α (o) 101.3130(10) 102.6133(18) 100.9299(10) 
β (o) 93.208(2) 91.8553(19) 92.6382(10) 
γ (o) 96.996(2) 99.9459(16) 95.9415(15) 
V (Å3) 974.65(7) 976.41(6) 987.35(4) 
Za 2 2 2 
μ (mm−1) 0.095 0.097 0.096 
Dcalc (g cm−3) 1.347 1.348 1.354 
no. of parameters 275 262 274 
reﬂns collected 4401 3828 5220 
reﬂns (I > 2σ) 2618 3106 3784 
wR (all data) 0.1955 0.1333 0.1402 
ﬁnal R (I > 2σ) 0.0661 0.0472 0.0518 
GOF 1.043 1.002 1.036 
Packing coef.   0.708b 
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CRYSTAL STRUCTURE ANALYSIS OF DROPERIDOL ISOSTRUCTURAL SOLVATES 
 
 
Fig. S6. Overlay of both droperidol molecules in the unit cell in SACN and SNM structures (one of 
the molecules is inverted). 
 
Fig. S7. Crystal structure of the droperidol solvate SACN representing the solvent molecule 
arrangement in isostructural solvate channels. 
 
Fig. S8 Overlay of the droperidol molecules from the crystal structures of isostructural solvates 
NSH, SEt, SMe, SACN, and SNM. 
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Fig. S9. Packing diagrams of droperidol isostructural solvates. Solvent molecules are showed in 
Spacefill style. 
 
Table S4. Torsion angles (o) characterizing the droperdiol molecule conformation in isostructural 
solvates 
Torsion angle NSH SMe SEt SACN SNM A B A B 
O2-C16-C15-C14 11.4 11.6 10.2 -12.7 9.4 -10.9 11.0 
C16-C15-C14-C13 178.0 -179.2 179.9 179.5 179.4 179.6 179.6 
C15-C14-C13-N3 -176.3 -175.7 -175.6 176.5 -175.5 174.3 -174.0 
C14-C13-N3-C11 -170.3 -169.8 -170.9 171.4 -171.0 172.6 -170.2 
C14-C13-N3-C10 67.3 68.9 67.4 -65.7 67.4 -65.7 67.2 
C1-N1-C8-C9 124.1 122.6 123.1 -124.0 122.5 -122.4 121.7 
C1-N1-C8-C12 -59.1 -60.3 -59.3 60.8 -58.5 61.6 -61.4 
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Fig. S10. Intermolecular interactions of droperidol molecules in isostructural solvates. 
 
 
Fig. S11. Hirshfeld surface 2D fingerprint plots of droperidol molecules in isostructural solvates. 
Symmetrically different molecules in SACN, SNM, SMe and SEt are designated with 1 and 2. 
 
It was noted that alcohol molecule ordering in crystal structures of SMe and SEt is a good 
representation provided that the energy of both orientations is the same and solvent molecule 
reorientation does not affect the adjacent unit cells. This is explored and confirmed in our next 
study. 
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Fig. S12. Hirshfeld surface 2D fingerprint plots of droperidol molecules in DH and polymorph II. 
 
Table S5. Geometrical parameters of strong hydrogen bonds in SMe, SEt and NSH crystal 
structures after all atom geometry optimization in CASTEP (unit cell parameters were fixed to the 
experimental values) 
Solvate Interaction X-H (Å) H···A (Å) D···A (Å) D-H···A (o) 
SMe O3-H…O1 0.99 1.88 2.83 163 
SEt O3-H…O1 0.98 1.81 2.78 166 
NSH O3-H
…O1 0.99 1.79 2.76 167 
O3-H…O3 0.98 2.27 2.91 121 
 
By comparing the position of solvent oxygen atom in these three crystal structures (both in the 
experimental data and after geometry optimization), it was determined that its orientation with 
respect to droperidol molecules was the same in NSH and SMe, whereas it was different in SEt (see 
Fig S13), probably due to the steric effects of the rest of the ethanol molecule. These differences led 
to the formation of different interactions between alkyl residues of alcohol molecules and droperdiol 
molecules. 
 
Fig S13. Overlay of the crystal structures of NSH, SMe and SEt showing solvent molecule 
orientation. Ethanol molecule in channel on the left has blue colour and methanol has green colour. 
Oxygen atom in all three solvents in this channel is showed as enlarged balls. Hydrogen atom 
positions are not optimized. 
 
Fig. S14. Geometrical representation of water molecule provided hydrogen bond linkage across 
the structure channel in NSH.  
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FOURIER-TRANSFORM INFRARED SPECTROSCOPY 
  
IR spectra of NSH, DH, STCC, SDIOX and STOL and polymorphs (see Fig. S15 and S16) showed 
characteristic features and thus can be used to confirm the identity of these phases. It was noticed 
that spectra of STOL and polymorph IV was very similar (see Fig. S17) thus suggesting that local 
local environment of droperidol molecules in these two phases is similar, as the crystal structure 
similarity of the solvate and its desolvation product is a very common phenonenon3-7. 
 
Table S6. FTIR bands characterizing the isostructurale solvates of droperidol 
NSH SMe SEt SACN SNM SCLF SDCM 
3662    3663 3678 3678 
3554 3557 3557  3555 3559 3561 
3499    3500  3503 
  3475 3468     3468   
3105 3105 3131 3125 3129 3129 3129 
3062 3063 3063 3064 3066 3063 3060 
3031 3032 3033 3032 3032 3032 3032 
2966 2967 2966 2966 2966 2966 2965 
2898 2896 2896 2896 2896 2897 2897 
2813 2814 2814 2812 2816 2814 2814 
2769 2770 2770 2769 2770 2770 2769 
      1693 1692   1691 
1682 1682 1683 1682 1682 1684 1681 
1623 1623 1622 1622 1623 1623 1622 
1595 1594 1594 1594 1595 1595 1594 
    1564   
1505 1506 1505 1506 1506 1506 1506 
1481 1481 1482 1482 1483 1482 1481 
1470 1470 1470 1470 1471 1471 1471 
1443 1442 1443 1443 1442 1443 1442 
1404 1405 1406 1404 1402 1406 1405 
1395 1395 1395 1394 1395 1395 1394 
1380 1379 1380 1380 1380 1380 1380 
1359 1359 1359 1359 1360 1359 1359 
1338 1338 1338 1337 1339 1338 1338 
1313 1313 1312 1312 1312 1313 1313 
1292 1292 1292 1291 1291 1292 1291 
1271 1271 1272 1272 1272 1272 1271 
1231 1231 1231 1231 1231 1231 1231 
1205 1203 1203 1203 1203 1203 1203 
1194 1194 1193 1194 1195 1194 1194 
1162 1162 1162 1162 1163 1162 1162 
1127 1126 1125 1125 1125 1126 1126 
1103 1102 1101 1102 1102 1102 1102 
1075 1074 1082 1075 1074 1078 1074 
1066 1066 1066 1067 1066 1066 1066 
1048 1048 1049 1048 1048 1049 1048 
 1032      
1023 1024 1023 1024 1023 1024 1023 
998 998 998 998 998 998 998 
986 986 986 986 986 986 986 
966 967 967 968 967 967 967 
919 917 919 917 917 918 917 
889 888 887 888 888 888 887 
877 876 876 876 876 876 876 
845 845 845 845 845 845 845 
835 833 833 834 834 834 834 
809 809 809 809 810 809 809 
772 773 772 772 772 772 772 
750 750 750 750 750 750 751 
735 735 735 733 735 734 733 
706 706 706 705 706 706 705 
677 678 678 678 678 678 678 
    656   
In green the most differing spectral regions are highlighted and in red bands due to the solvent 
molecules are marked. 
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Fig. S15. FTIR spectra of droperidol solvates NSH, DH, STCC, SDIOX and STOL. 
 
Fig. S16. FTIR spectra of droperidol polymorphs I, II, III and IV as well as solvates NSH and 
DH. 
 
Fig. S17. FTIR spectra region 1500 – 1750 cm-1 for a) droperidol isostructural solvates, b) 
droperidol solvates NSH, DH, STCC, SDIOX and STOL and c) droperidol polymorphs I, II, III and 
IV as well as solvates NSH and DH. 
 
Fig. S18. FTIR spectra of droperidol solvate STOL and polymorph IV. 
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SOLVENT SORPTION-DESORPTION ISOTHERMS OF DROPERIDOL SOLVATES 
 
For determination of organic solvent content in non-stoichiometric solvates in atmosphere with 
very low solvent vapour pressure, desiccators with glycerol (for methanol and ethanol) and glycerol 
and dimethylformamide (for acetonitrile and nitromethane) were prepared and a small amount of 
corresponding solvents were added by portions. 
For determination of the water content in NSH approximately 0.35 g of the NSH sample was 
weighted in two containers which initially were placed in 0% and 32% RH. After the stabilization 
of the sample mass, the samples were moved to the desiccators with adjacent relative humidity. In 
this way full sorption-desorption cycle was recorded for both samples. 
For determination of the organic solvent content in non-stoichiometric solvates, firstly 
corresponding solvate was desolvated on the P2O5 at ambient temperature. Then approximately 
0.25 – 0.35 g of corresponding desolvated solvate was weighted in two sample containers which 
initially were placed in desiccators with 0 and 20% mole fraction of the corresponding solvent. After 
the stabilization of the sample mass the samples were moved to desiccators with adjacent solvent 
mole fraction. In this way full sorption-desorption cycle was recorded for both samples. For studies 
of the solvent sorption in atmosphere with very low solvent vapour pressure, approximately 0.25 – 
0.35 g of corresponding desolvated solvate was weighted in container, which were placed in the 
desiccator prepared as described above. After the stabilization of the sample mass, portion of the 
corresponding solvent was added to the desiccator corresponding to addition of 0.05 – 0.2% solvent 
mole fraction. 
It can be seen that the sorption-desorption isotherm does not exhibit a hysteresis. Besides, it was 
not found that the amount of solvent absorbed or desorbed would be dependent on the sorption-
desorption cycle number. 
Although the data points for solvates with organic solvent were obtained in two stages, they 
formed common sorption-desorption isotherm (the reversibility and hysteresis was not checked for 
solvent activity below 0.02). Reliability of the obtained data can be evaluated from isotherm of SACN 
where data obtained from four experiments with four different samples formed one isotherm 
without noticeable deviations, as clearly illustrated in Fig. S22. 
When SACN and SNM were stored in the desiccators with corresponding solvent activity above 0.5 
for more than 5 days, samples got wet because of the solvent vapor adsorption and condensation 
on the sample. Therefore, the solvent amount in the sample was dependent on the storage time. 
It was observed that at a high solvent activity all organic solvates sorbed more solvent than the 
corresponding solvent content determined from SCXRD and TG analysis. Although it is 
theoretically possible that additional solvent molecules were randomly placed in the structural 
channels, the additional solvent was in fact adsorbed on the powder surface. This was supported by 
the results from PXRD where no diffraction pattern changes were observed for these over-
stoichiometric solvent content changes. 
 
Localized solvent in solvent sorption-desorption isotherms of droperidol solvates NSH, SMe, SEt, 
SACN and SNM were fitted with a) Langmuir isotherm, b) general localized solvent model with 
constant activity coefficients and c) general localized solvent model with variable activity coefficients 
described with c1) 2nd order Margules equation and c2) 3rd order Margules equation. Usage of the 
variable activity coefficients allowed the analysis of the isotherm only in limited solvent content ε 
range because of the computational specifics. For Langmuir isotherm and general localized solvent 
model with constant activity coefficients also solvent adsorption was described mathematically using 
disordered solvent model. It is noted that the disordered solvent model originally was provided for 
characterization of the solvent molecules absorbed in the solid phase8. However, equations 
corresponding to that also are able to describe the solvent adsorbed on the sample surface. 
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For fitting used mathematical equations8 and parameters characterizing the theoretical isotherm 
for each of the four used general models are given in a) Eq. 1 and Table S7, b) Eq. 2 and Table S8, 
c1) Eq. 3 and Table S9, and c2) Eq. 4 and 5 and Table S10, respectively. Fitting was performed by 
using the least-squares method to optimize the compatibility between theoretical and experimental 
data using the Excel add-in Solve by optimizing the parameters in the theoretical mathematical 
models. 
For NSH all points were included in the calculation of Root-mean-square deviation RMSD, but 
for SMe data up to PW = 5%, for SEt up to PW = 2%, for SACN up to PW = 2% and for SNM up to PW 
= 5% were used. 
𝜀𝜀 = 𝑝𝑝 𝑎𝑎𝑃𝑃𝑤𝑤1 + 𝑎𝑎𝑃𝑃𝑤𝑤 + 𝑄𝑄 𝑃𝑃𝑤𝑤𝛾𝛾2 + 𝑃𝑃𝑤𝑤                (1) 
Table S7. Parameters characterizing the Langmuir isotherm fitting the experimental droperidol 
solvate sorption-desorption isotherms. 
 Localized water Disordered water RMSD  p a Q γ2 
NSH 1.49 1.93 - - 0.040 
SMe 0.449 398 0.0096 1.07 0.021 
SEt 0.511 340 0.013 1.13 0.043 
SACN 0.58 220 - - 0.068 
SNM 0.69 47 - - 0.068 
 
𝜀𝜀 = 𝛾𝛾1𝛾𝛾2  𝑝𝑝𝑃𝑃𝑤𝑤𝑞𝑞
𝐾𝐾(𝐼𝐼𝐼𝐼) + 𝛾𝛾1𝛾𝛾2 𝑃𝑃𝑤𝑤𝑞𝑞 + 𝑄𝑄 𝑃𝑃𝑤𝑤𝛾𝛾2 + 𝑃𝑃𝑤𝑤                (2) 
Table S8. Parameters characterizing the general localized solvent model with constant activity 
coefficients fitting the experimental droperidol solvate sorption-desorption isotherms. 
 Localized water Disordered water RMSD  γ1/γ2 p K(II) q Q γ2 
NSH 345 1.05 42.4 1.58 - - 0.020 
SMe 34.8 0.447 0.0727 1.03 0.012 1.08 0.021 
SEt 344 0.459 0.00206 2.01 185 1570 0.0017 
SACN 1930 0.483 3.16·10-5 3.20 274 1230 0.0029 
SNM 1920 0.513 3.19·10-5 4.12 345 874 0.0090 
 
𝑃𝑃𝑤𝑤 = 𝐾𝐾(𝐼𝐼𝐼𝐼) 𝜀𝜀𝑝𝑝 − 𝜀𝜀 �exp�𝐴𝐴12𝑅𝑅𝑅𝑅 �1 − 2 𝜀𝜀𝑝𝑝���1𝑞𝑞                (3) 
Table S9. Parameters characterizing the general localized solvent model with variable activity 
coefficients described using 2nd order Margules’ equation fitting the experimental droperidol solvate 
sorption-desorption isotherms. 
 p q K(II) A12/RT RMSD 
NSH 1.09 1.20 55.2 0.39  
SMe 0.421 1.00 0.239 0.683 0.0075 
SEt 0.447 1.00 0.240 1.62 0.0092 
SACN 0.505 1.00 0.391 1.55 0.0038 
SNM 0.526 1.00 1.18 1.76 0.0079 
𝑃𝑃𝑤𝑤 = 𝐾𝐾(𝐼𝐼𝐼𝐼) 𝜀𝜀𝑝𝑝 − 𝜀𝜀 �exp �ln 𝛾𝛾1𝛾𝛾2��1𝑞𝑞                (4) 
 ln 𝛾𝛾1
𝛾𝛾2
= � 1
𝑅𝑅𝑅𝑅
��
𝜀𝜀
𝑝𝑝
�
2
𝐴𝐴12 + 2 �𝜀𝜀𝑝𝑝�2 (𝐴𝐴21 − 𝐴𝐴12) �𝑝𝑝 − 𝜀𝜀𝑝𝑝 ��
− ��
𝑝𝑝 − 𝜀𝜀
𝑝𝑝
�
2
𝐴𝐴21 + 2 �𝑝𝑝 − 𝜀𝜀𝑝𝑝 �2 (𝐴𝐴12 − 𝐴𝐴21) �𝜀𝜀𝑝𝑝���     (5) 
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Table S10. Parameters characterizing the general localized solvent model with variable activity 
coefficients described using 3rd order Margules’ equation fitting the experimental droperidol solvate 
sorption-desorption isotherms. 
 p q K(II) A12/RT A21/RT RMSD 
NSH 1.19 1.00 35.8 0.230 0.875  
SMe 0.420 1.00 0.203 0.720 0 0.0045 
SEt 0.446 1.00 0.212 1.66 0.746 0.0027 
SACN 0.509 1.00 0.402 1.41 1.80 0.0016 
SNM 0.520 1.00 1.19 2.12 1.37 0.0015 
 
 
Fig. S19. Water sorption-desorption isotherm of NSH described using Langmuir isotherm (on 
the left) and localized solvent model with variable activity coefficients (on the right). 
 
When the experimental NSH sorption-desorption data were fitted with Langmuir isotherm, 
reasonable fit was obtained (RMSD was 2 times higher than that for general localized water model). 
However, it was clear that this model only roughly described the characteristic water content 
dependence on the relative humidity. 
 
Fig. S20. Solvent sorption-desorption isotherm of SMe and SEt described using Langmuir isotherm 
(on the left) and localized solvent model with constant activity coefficients (on the right). 
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Fig. S21. Initial part of the solvent sorption-desorption isotherm of SMe and SEt described using 
Langmuir isotherm (on the left) and localized solvent model with constant (in the middle) and 
variable (on the right) activity coefficients. 
 
Fig. S22. Solvent sorption-desorption isotherm of SACN from two sample (1 and 2) solvent 
sorption and desorption measurements and two sample (3 and 4) solvent sorption measurements. 
 
Fig. S23. Solvent sorption-desorption isotherm of SACN and SNM described using Langmuir 
isotherm. 
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Fig. S24. Initial part of the solvent sorption-desorption isotherm of SACN and SNM described using 
Langmuir isotherm (on the left) and localized solvent model with constant (in the middle) and 
variable (on the right) activity coefficients. Although almost ideal fit for the sorption-desorption 
isotherm of SNM was obtained using 3rd order Margules equation, the meaning of this is open to 
discussion because of the experimental complications which arose during recording the sorption-
desorption isotherm of SNM (see the further discussion). 
Apparently the small size of methanol molecules caused the lack of interactions between solvent 
molecules in two adjacent solvent sites positioned along a-axis and therefore their sorption in SMe 
was described with a Langmuir isotherm. However, this was not true for the rest of the four solvates. 
Although the solvent uptake in the channels at a given solvent activity completely differed between 
NSH and the other solvates, all of these solvates showed lower solvent uptake for very low solvent 
activity values, probably because of the interaction between solvent molecules situated at two 
adjacent solvent sites. Nevertheless, based on the isotherms, this interaction was relatively weak in 
NSH and SEt. The hindered solvent uptake period was the longest for SNM, and variable activity 
coefficients had to be used to describe its isotherm. Therefore the larger size of nitromethane most 
probably prevented this solvent molecule from entering into the channels at very low solvent 
content in the atmosphere and only the reaching of some critical amount allowed more sudden 
structural changes by allowing easier insertion of additional solvent molecules. This can be also 
partially true for ethanol and acetonitrile molecules. 
It was noticed that maximum solvent content in the channels (described by the localized solvent 
model) did not reach 0.5 stoichiometry as determined from the SCXRD data for SMe. This could be 
explained by either actually lower solvent content in the structure or by the fact that all of the solvent 
did not left the solvate and solvent content actually did not reach zero in this isotherm. However, 
sorption-desorption isotherm of SNM showed higher solvent content because of the effective 
solvent adsorption process on the solvate particles even at relatively low solvent content in the 
atmosphere, as suggested by the obtained fitting results (see Fig. S24). 
 
DROPERIDOL ISOSTRUCTURAL SOLVATE STRUCTURE WITH DIFFERENT SOLVENT 
CONTENT 
Gradual changes of the PXRD patterns were observed when all of the solvates were stored in 
desiccators with different corresponding solvent activity in the atmosphere (see Fig. S25 – S29) and 
also when fully solvated SACN and SNM were desolvated above the P2O5 (see Fig. S30 and S31). 
The most noticeable peak intensity differences in the PXRD patterns of droperidol solvates with 
different solvent content (see Fig. S25 – S31) was associated to the peaks corresponding to Miller 
indices 001, 002 and 011 (see Fig. S2). It was already noted that these peaks are associated with the 
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planes along the solvent channels in the structure, thus, the change of the solvent molecule amount 
in the channels introduced the intensity changes. Moreover, the intensity of the peak 001 decreased 
by increasing the solvent content until the peak completely disappears at solvent content around ε 
= 0.5. However, when solvent content was increased even more, intensity of this peak again 
increased. This was most obvious for NSH where 001 peak was absent for water stoichiometry 0.5-
0.6. Changes of the other peak intensity (for example, 102�, 021, and 11�0) was observed as well. 
However, these changes were not as apparent as those occurring with the first peaks and were not 
identified for all of the solvates. 
It was noticed that the peak shift observed for the NSH was different from that occurring with 
the rest of the solvates, suggesting that different crystal structure changes occurred when water 
molecules entered the crystal structure, compared to the insertion of other solvent molecules. 
The PXRD patterns of SACN obviously showed that the amount of solvent correlated with the 
diffraction peak shifts and therefore also with the changes in crystal structure: smaller changes in 
the solvent content at the initial phase of the sorption-desorption isotherm were consistent with 
smaller changes in the diffraction peak positions. 
In the case of SNM, after the initial changes of the lattice parameters there was no further gradual 
peak position shift, but peaks at the positions characteristic of a fully solvated SNM phase appeared 
instead (see Fig. S29). Thus, it can be concluded that two phases were actually present during the 
sorption: a phase with nitromethane content around 0.15 equivalents, and a phase with 
nitromethane content of 0.5 equivalents. This suggests that two data points in the presented 
sorption-desorption isotherm within the solvent content interval of 0.15 – 0.4 equivalents (see 
Figure 11) did not actually correspond to the thermodynamic solvent content in the solvate, but 
rather to the kinetic solvent content in the phase mixture. Moreover, after fitting a sorption-
desorption isotherm, the obtained constants reflecting the solvent - droperidol interaction according 
to the activity coefficient model also suggested that phase separation was possible for this particular 
case8. 
It should be noted that such gradual structural changes were observed only when the solvent 
content changes in the solvate occurred slowly. However, when the solvates were desolvated at 
elevated temperature, the changes of solvent content were too fast for gradual structural changes to 
take place, and a two phase mixture was observed during the desolvation process. 
 
Fig. S25. PXRD patterns of NSH with different water content in the structure (given in brackets) 
obtained by storing the sample in different RH. 
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Fig. S26. PXRD patterns of SMe with different methanol content in the structure (given in 
brackets) obtained by storing the sample in the atmosphere with different methanol activity. 
 
Fig. S27. PXRD patterns of SEt with different ethanol content in the structure (given in brackets) 
obtained by storing the sample in the atmosphere with different ethanol activity. 
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Fig. S28. PXRD patterns of SACN with different acetonitrile content in the structure (given in 
brackets) obtained by storing the sample in the atmosphere with different acetonitrile activity. 
 
Fig. S29. PXRD patterns of SNM with different nitromethane content in the structure (given in 
brackets) obtained by storing the sample in the atmosphere with different nitromethane activity. 
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Fig. S30. PXRD patterns of SACN with different acetonitrile content in the structure (given in 
brackets) obtained by storing fully solvated sample at 50 oC temperature above the P2O5 for different 
amount of time. 
 
Fig. S31. PXRD patterns of SNM with different nitromethane content in the structure (given in 
brackets) obtained by storing fully solvated sample at 50 oC temperature above the P2O5 for different 
amount of time. 
 
An increase of the solvent content increased the NSH cell length a and the angle γ, while the 
same parameters decreased for other solvates. The cell length c at the same time exhibited the 
opposite trend (see Table S11). Moreover, the directions of changes in the lattice parameters c and 
α were reversed when the water content increased above 0.5 equivalents, although the cell volume 
and calculated density still increased gradually (see Fig. S32). 
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Fig. S32. Calculated density of NSH with different water content in the structure. 
 
Table S11. Direction of the lattice parameter change by increasing the solvent content in the 
structure of droperidol isostructural solvates. 
Parameter NSH 
(up to 0.5 stoichiometry) 
NSH 
(above 0.5 stoichiometry) 
SMe SEt SACN SNM 
a ↑ ↑ ↓ ↓ ↓ ↓ 
b ↑ ↑ ↑ ↑ ↑ ↑ 
c ↓ ↑ ↑ ↑ ↑ ↑ 
α ↓ ↑ ↓ ↓ ↓ ↓ 
β ↓ ↓ - ↓ ↓ ↓ 
γ ↑ ↑ ↓ ↓ ↓ ↓ 
 
 
WATER ARRANGEMENT IN A PARTIALLY FILLED NSH STRUCTURE 
 
It was determined that the removal of water from NSH structure occurred by simultaneously 
losing both hydrogen bonded water molecules from some of the channel sites. 
Firstly, this arrangement of water molecules explained the observed lattice parameter changes for 
NSH with different water content. If the first water molecules entering the channel would not link 
the droperidol molecules across the channel, a different lattice parameter change should be 
observed. Formation of the O1···O1 hydrogen bond linkage clearly explains the decrease of lattice 
parameters c, α, and β, and the insertion of water molecules above 0.5 stoichiometry increases the 
interaction of non-bonded water molecules positioned along the a-direction, most probably 
affecting the further lattice parameter changes for c and α. Moreover, the simulation of lattice 
parameter changes for NSH structure with different water content also confirmed that this water 
molecule arrangement should result in an observed lattice parameter behaviour with changes in the 
effects of water content on c and α at ε ≈ 0.5 (see Fig. S33). 
Lattice parameter calculation in CASTEP was performed by creating a supercell from NSH unit 
cell repeated 2 times (for ε = 0.5) or 5 times (for ε = 0.2, 0.4, 0.6 and 0.8) in the a-direction and 
removing the water molecules to obtain the necessary water content. Then full geometry 
optimization of the obtained structures were performed. Lattice parameter a was calculated by 
dividing the obtained length of the supercell a edge 2 or 5 times respectively. Lattice parameters for 
ε = 1 and ε = 0 were calculated by performing identical geometry optimization of NSH structure 
with none or both of the water molecules removed. 
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Fig. S33. Experimental (coloured as in Figure 12) and in CASTEP calculated (black filled circles) 
lattice parameter changes for NSH with different water content. 
 
Secondly, the hemihydrate structure double-sized in the a-direction with two hydrogen bonded 
water molecules was slightly energetically favourable compared to that where the water molecules 
were positioned so that this hydrogen bond was lost (by 2 - 4.5 kJ per mole of water depending on 
the arrangement of water molecules in the second case, see Fig. S34). 
 
Fig. S34. Geometry and relative energy for three possible water arrangements in 2 times extended 
(in a-direction) NSH unit cell with hemihydrate stoichiometry. 
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Thirdly, the geometrical parameters for the O3-H···O1 and O3-H···O3 hydrogen bonds were 
the same for both stoichiometries. Slightly increased distances in ISD are associated with the 
expansion of the unit cell due to the increased temperature during the measurements, see Table 1). 
Interestingly, the equivalent isotropic displacement parameters in the hemihydrate structure had 
increased for all of the atoms, thus suggesting that the structure is more ordered when the solvent 
molecules fully occupy the channels. The displacement parameters of ISD measured at 333K were 
significantly higher than those in the structures with water both at 120K and even in 298K9, thus 
suggesting that a complete loss of solvent makes the structure even more disordered, as already 
noted for channel hydrates10. It should be noted that the hydrogen positions for hemihydrate 
stoichiometry could not be located in the difference Fourier map and were placed in the calculated 
positions. 
It was also observed that there were almost no changes in geometry parameters for other 
droperidol interactions, as presented in Table S12. 
 
Table S12. Geometrical parameters for droperidol-droperidol intermolecular interactions in 
experimental NSH structures with different water content 
Stoichiometry Interaction X-H (Å) H···A (Å) D···A (Å) D-H···A (o) 
1 
N2-H…O1 0.97 1.82 2.79 175 
C19-H…N3 0.97 2.56 3.49 159 
C22-H…O2 0.99 2.49 3.29 138 
C21-H…F1 1.01 2.54 3.50 158 
0.5 
N2-H…O1 0.92 1.87 2.79 175 
C19-H…N3 0.96 2.57 3.48 157 
C22-H…O2 0.98 2.51 3.28 136 
C21-H…F1 1.01 2.54 3.50 158 
0 (ISD) 
N2-H…O1 0.95 1.87 2.81 173 
C19-H…N3 0.99 2.58 3.53 161 
C22-H…O2 0.99 2.56 3.35 136 
C21-H…F1 0.99 2.56 3.49 158 
 
Fourthly, the water sorption-desorption isotherm was represented with a smooth line 
corresponding to a localized water model, which is possible only if all of the solvent sites are 
equivalent. Therefore both of the hydrogen-bonded water molecule positions should be regarded 
as one absorption site. 
 
EVALUATION OF THE DROPERIDOL ISOSTRUCTURAL SOLVATE FORMATION 
 
Lattice and total energy of polymorph II and ISD were compared after the geometry optimization 
in CASTEP. Geometry optimization was performed by optimizing all atom positions (ALL) or all 
atom positions and the lattice parameters (FULL). Total energy was calculated in CASTEP, but 
lattice energy was calculated in PIXEL. It was observed that both lattice and total energy of ISD 
was slightly lower than that of polymorph II. However, the instability of the ISD at ambient and 
elevated temperature can be due to its lower density which could result the reduction of the ISD 
relative thermodynamic stability by increasing the temperature up to ambient temperature and 
above. 
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Table S13. Comparison of total energy, lattice energy and density of ISD and polymorph II 
  ALL FULL 
EISD – EII, 
kcal·mol-1 
Etotal -0.45 -0.33 
Elattice -0.59 -0.53 
d, g·cm-3 II 1.31 1.36 ISD 1.27 1.32 
 
Table S14. Solvent molecule molar volume calculated with Gaussian09 
Solvent Molar volume, cm3·mol-1 
Water 12.842 
Methanol 25.69 
Acetonitrile 37.9 
Ethanol 42.012 
Nitromethane 48.07 
Propionitrile 48.791 
Dichloromethane 49.603 
Propanol-2 60.177 
1,2-dichloroethane 64.753 
Propanol-1 67.384 
Chloroform 69.072 
1,1-dichloroethane 73.598 
Tetrachlorocarbon 96.705 
Shading – solvates from which the isostructural droperidol solvates formed. 
 
It can be seen that molar volume of chloroform exceeds that of the next biggest solvent molecules 
forming isostructural solvates by 20 cm3·mol-1 and that of propanol-2, propanol-1, and 1,2-
dichloroethane does not form the isostructural solvates. This could be explained by the ability of 
chloroform to form multiple hydrogen bonds with multiple droperidol molecules and probably also 
by the round shape of this molecule. In the same time both alcohol molecules and probably also the 
1,2-dichloroethane can not form so efficient intermolecular interactions (except for the hydrogen 
bond with OH in alcohols and Cl in 1,2-dichloroethane), and also the shape of the alcohol molecules 
impede the solvate formation. Almost linear shape of the propionitrile prevents formation of its 
solvate as even smaller linear acetonitrile molecule completely occupies the space in the channels 
along the a-direction. 
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Appendix 9. Supplementary Information for publication “Comparison and Rationalization of 
Droperidol Isostructural Solvate Stability: an Experimental and Computational Study” 
 
CHARACTERIZATION OF SOLVATES 
Table S1. Crystallographic data of the droperidol solvates NSH, SMe, SEt, SACN, and SNM 1 
Solvate SACN SNM SMe NSH SEt 
Empirical 
formula 
(C22H22FN3O2)2 
·C2H3N 
(C22H22FN3O2)2 
·CH3NO2 
C22H22FN3O22 
·0.5CH4O 
C22H22FN3O2 
·H2O 
(C22H22FN3O2)2 
·C2H6O 
Mr 399.96 409.95 395.45 397.44 402.47 
Crystal system triclinic triclinic triclinic triclinic triclinic 
Space group P1 P1 P P P 
Temperature 173 173 173 173 173 
a (Å) 6.0870(2) 6.06730(10) 6.0671(2) 6.2936(2) 6.08400(10) 
b (Å) 10.2177(3) 10.1884(3) 10.2183(4) 10.1673(4) 10.2978(3) 
c (Å) 16.2642(6) 16.4237(5) 16.2078(8) 15.9173(4) 16.1737(5) 
α (°) 101.2051(11) 99.8303(13) 101.3130(10) 102.6133(18) 100.9299(10) 
β (°) 92.7447(10) 92.2880(12) 93.208(2) 91.8553(19) 92.6382(10) 
γ (°) 96.7569(19) 95.6243(18) 96.996(2) 99.9459(16) 95.9415(15) 
V (Å3) 982.78(6) 993.86(4) 974.65(7) 976.41(6) 987.35(4) 
Za 2 2 2 2 2 
a – Based on droperidol as the molecular entity. 
 
Fig. S1. Crystal structure of the droperidol solvate SACN representing the solvent molecule arrangement 
in isostructural solvate channels. 
 
Fig. S2. PXRD patterns of the droperidol isostructural solvates. 
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DESOLVATION ACTIVATION ENERGY 
 
Fig. S3. The dehydration kinetic curves of various NSH samples in isothermal mode at 60°C. 
 
Fig. S4. Dehydration kinetic curves of different NSH samples at different temperatures in isothermal mode. 
 
Fig. S5. Dehydration activation energy at different α values for different NSH samples in isothermal mode. 
Table S2. Summary of droperidol organic solvate desolvation kinetic parameters in isothermal mode. 
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Solvate Sample Ea, kJ·mol-1 
Ea-α 
dependence 
Kinetic 
modela 
Temperatures 
used, °C 
SMe 
Powder I 50±13 – D5 50-100 
Powder II 52±7 – D5 40-110 
Suspension 46±12 ↓ F, D 45-90 
Small crystals 21±10 – A3/2, R2 40-100 
SEt 
Powder 61±14 ↓ D, F3/2 50-110 
Small crystals 45±10 – A3/2, R3 40-110 
SACN 
Powder I 100±20b – D5 90-115 
Powder II 490±130b – D5, D3 A2c 113-125 
SNM 
Powder I 400±50b – D, F 90-120 
Powder II 380±60b ↑ D5, A3/2c 100-115 
Suspension 190±60b – 
D5, D3, 
A3/2c 
90-110 
a – For each individual sample only commonly used kinetic models were included in the selection (see 
Table S4). 
b – Only apparent Ea value, which does not characterize the actual desolvation process. 
c – At highest used temperatures. 
 
 
Fig. S6. Desolvation activation energy at different α values for droperidol solvate samples in isothermal 
mode. 
Decrease (or growth) of the desolvation Ea values by increasing the fraction desolvated is only apparent 
and is a result from the wide particle size distribution or slight change of the desolvation mechanism during 
the reaction which thus affects the desolvation curves and therefore results in the changes of the calculated 
Ea values. 
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Fig. S7. Desolvation kinetic curves of crystalline SMe and SEt samples at different temperatures in 
isothermal mode. 
 
Fig. S8. Desolvation activation energy at different α values for crystalline SMe and SEt samples in 
isothermal mode. 
 
Although one of the reasons for slower desolvation in isothermal experiments (which led to usage of 
such a high temperatures) might be lower nitrogen flow than that used in nonisothermal mode, most 
probably the main reason for the differences was associated with the sample preparation and storage. 
 
Fig. S9. Desolvation kinetic curves of droperidol solvate samples at different heating rates in 
nonisothermal mode. 
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Fig. S10. Desolvation activation energy at different α values for droperidol solvate samples in 
nonisothermal mode. 
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DESOLVATION KINETIC MODEL 
Table S3. Solid-state integral expressions g(α) for the most often used different reaction models2-7 
Model g(α)  Model g(α) 
Nucleation models   Diffusion models  
Power law (P2) 2
1
  
 
1-D diffusion (D1) 
2
2  
Power law (P3) 3
1
  
 2-D diffusion (D2) )1ln()1(    
Power law (P4) 4
1
  
 3-D diffusion – Jander 
(D3)  
 
2
3
1
11




   
Avrami-Erofeyev (A3/2)   
3
2
1ln   
 Ginstling-Brounshtein 
(D4) 
 





3
2
1
3
21   
Avrami-Erofeyev (A2)   
2
1
1ln   
 
Zhuravlev (D5)   23/1 11    
Avrami-Erofeyev (A3)   
3
1
1ln   
 
Reaction-order models  
Avrami-Erofeyev (A4)   
4
1
1ln   
 
First-order (F1)    1ln  
Prout-Tompkins (B1) 







1
ln  
 
1.5-order (F3/2) 
  










1
1
1
2
2
1

 
Geometrical contraction models 
 
Second-order (F2) 
 
1
1
1


 
Contracting disk (R1)    Third-order (F3)   115.0 2    
Contracting area (R2)   




2
1
11   
   
Contracting volume (R3)   




3
1
11   
   
 
Table S4. Correlation coefficients R2 of fitting nonisothermal dehydration data of droperidol solvates 
with diffusion models (other models generally showed smaller R2 values) according to the average linear 
integral method8. 
 D1 D2 D3 D4 D5 
SMe 0.987 0.991 0.995 0.992 0.998 
SEt 0.9999 0.9998 0.9996 0.9997 0.9987 
SNM 0.993 0.994 0.995 0.994 0.996 
SACN 0.996 0.997 0.997 0.997 0.998 
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Fig. S11. Fit of the dehydration kinetic curves of different NSH samples with different kinetic models in 
isothermal mode: a) dehydration of Crystals I at 90 °C fitted with D5 model, b) dehydration of Crystals III at 
80 °C fitted with F1 model, c) dehydration of Small crystals II at 35 °C fitted with F3/2 model, and d) 
dehydration of Powder I at 30 °C fitted with F2 model. 
 
Fig. S12. Fit of the desolvation kinetic curves of droperidol solvate samples with different kinetic models 
in isothermal mode: a) desolvation of SMe Powder I at 55 °C fitted with D5 model, and b) desolvation of SEt 
Small crystals at 80 °C fitted with A3/2 model. 
Interestingly, crystals of SMe and SEt had different shape of the desolvation curves (see Fig. S7) which 
reflected also in the different dehydration kinetic model (A3/2 or R2) determined for these samples (see 
Table S3). Moreover, particularly these two samples had lower Ea values (20-45 kJ·mol-1, see Fig. S8) than 
the other samples of these solvates. Different kinetic model determined for crystalline SMe and SEt samples 
suggested that the desolvation process of these samples could be limited by different mechanism than the 
diffusion. However, dehydration mechanism of NSH crystals did not differ from that of the powdered 
NSH samples. 
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Fig. S13. Dehydration kinetic curves of different NSH samples at different temperatures in isothermal 
mode. Theoretical curves calculated using the modified D5 model (Eq. 1) are shown with black lines. 
Possible explanation for the observed differences in the exact diffusion mechanism between the solvates 
can be the presence of different interactions between the solvent and the droperidol molecules, which could 
also explain the fact that the desolvation curves of organic solvates were more similar if compared with 
those of the NSH. The differences arising between the different samples could result from the different 
particle size distribution of the samples and/or different solvent content in the channels. Besides, also very 
differing particle size could introduce the changes in the diffusion mechanism (as observed for different 
NSH samples), because the channel length and the crystal shape can be very different. Although apparent 
deviations from the classical diffusion mechanisms could result from a wide particle size distribution, this 
would not result as different kinetic curves as observed for NSH. 
For the kinetic curves best described with original D5 model, constant n in Eq. 1 was close to 1, whereas 
for curves best described by reaction order models F, n increased up to 3. 
 
Table S5. Parameters for the modified D5 kinetic model (Eq. 1) providing the fit with different NSH 
sample dehydration kinetic curves 
Crystals 
II 
T, °C 70 79 89 99 109  
k, min-1 0.00188 0.00161 0.00341 0.00511 0.00786  
n 1.12 1.15 1.11 1.24 1.17  
N 0.979 1.012 0.991 0.976 0.998  
Small 
crystals I 
T, °C 61 79 98 106 114  
k, min-1 0.000923 0.00430 0.0118 0.0182 0.0192  
n 1.52 1.40 1.52 1.54 1.76  
N 0.959 0.948 0.948 0.939 0.986  
Powder 
I 
T, °C 25 31 40 50   
k, min-1 0.00123 0.00224 0.00742 0.0160   
n 1.62 1.54 1.56 1.77   
N 1.016 1.003 0.975 0.957   
Powder 
II 
T, °C 22 28 32 36 40 58 
k, min-1 0.000840 0.00164 0.00323 0.00501 0.0102 0.109 
n 2.29 2.31 2.22 2.43 2.52 2.90 
N 0.989 0.967 0.957 0.978 0.969 0.998 
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Table S6. Parameters for the modified D5 kinetic model (Eq. 1) providing the fit with different droperidol 
solvate sample desolvation kinetic curves 
SMe powder 
II 
T, °C 41 52 61 70 79 88 104 
k, min-1 0.000962 0.00185 0.00408 0.00502 0.00755 0.0132 0.0331 
n 1.01 1.07 1.10 1.18 1.17 1.29 1.54 
N 1.137 1.125 1.026 1.062 1.054 0.989 0.957 
SEt powder 
T, °C 52 62 66 71 80 99 106 
k, min-1 0.000753 0.00131 0.00204 0.00255 0.00611 0.0157 0.0244 
n 1.00 0.96 0.97 1.06 1.13 1.05 1.23 
N 1.120 1.172 1.135 1.093 1.042 1.021 0.973 
SACN 
powder 
T, °C 89 94 109 114    
k, min-1 0.00372 0.00658 0.0154 0.0157    
n 1.08 1.09 1.17 1.66    
N 1.166 1.076 1.030 1.058    
SNM 
suspension 
T, °C 89 98 103 108    
k, min-1 0.000702 0.00142 0.00125 0.00123    
n 1.07 1.09 1.19 2.09    
N 1.126 1.250 1.378 1.118    
 
 
Figure S14. Hot stage photomoicrographs revealing the changes during the dehydration process 
of NSH and its transformation to polymorph I. 
 
Figure S15. Hot stage photomoicrographs revealing the changes during the desolvation process 
of SMe and its transformation to polymorph I. 
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Figure S16. Hot stage photomoicrographs revealing the changes during the desolvation process 
of SEt and its transformation to polymorph I. 
When the melting point solvate was reached, either fast transition or melt with a rapid desolvation and 
following recrystallization occurred by producing polymorph I, as already reported1. 
In the HSM study it was observed that the desolvation of SMe and SEt, crystals are not controlled by the 
nucleation and nuclei growth or the phase boundary advance, as determined from the analysis of the 
desolvation kinetic curves. As for now, we do not have any explanation for this observation, but the most 
reasonable possibility is that the kinetic curves are strongly distorted due to a cause associated with the 
sample, but not yet identified. 
 
THERMAL STABILITY OF THE SOLVATES 
In the nonisothermal mode solvate which had reached higher fraction desolvated at a certain temperature 
using the same heating rate was considered to be less stable, whereas in isothermal mode solvate which 
desolvated faster at a given temperature was indicated to be less stable. When solvate stability was 
compared using PXRD patterns, time necessary for complete desolvation was identified by the match 
of the sample PXRD patterns to that of the ISD. These times are given in Table S8. 
 
Figure S17. Desolvation kinetic curves of ground droperdiol isostructural solvate samples in isothermal 
mode at 60°C and 90°C temperature. 
 
Slightly different order of stability was determined from the nonisothermal measurements recorded 
during the desolvation kinetic study (see Table S8). In these experiments SNM desolvated at lower 
temperature than SACN, SEt and SMe. However, results from all of the other measurements performed with 
different SNM samples confirmed that the stability of the SNM is higher than that of all the other solvates. 
Incompatibility of this results most probably is associated with the differences in sample preparation or 
possible changes of the sample during the storage processes as this particular kinetic study was performed 
with only one sample. 
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Table S7. Characterization of droperidol solvate thermal stability from nonisothermal kinetic TG curves 
and PXRD patterns recorded during the isothermal desolvation 
 NSH SMe SEt SACN SNM 
 Tα=0.5a in nonisothermal kinetic curves, °C 
1 o·min-1 32 63 68 71 55 
2 o·min-1 34 72 82 86 63 
 Time for complete desolvation as determined 
from the PXRD measurements 
80°C <0.5 h 1 h - - - 
100°C - - 4 h 5 h 48 h 
a – Temperature at which fraction desolvated (α)=0.5 was reached. 
COMPARISON OF CRYSTAL STRUCTURES AFTER THE GEOMETRY OPTIMIZATION 
Crystal structures obtained after the geometry optimization with different methods was compared based 
on: a) lattice parameters after full unit cell (UC) optimization, b) solvent arrangement in the channels and c) 
all intermolecular interaction geometry. 
As already pointed out, it is essential to use the dispersion correction if full unit cell optimization is 
perfumed9, because proper description of dispersion interactions is crucial for correct description of the 
intermolecular interactions10-12. Optimization of droperidol solvate crystal structures with pure PBE 
functional in CASTEP increased the unit cell volume by more than 20%, which was already reported for 
other organic crystal structures9. It can be seen that the cell volume was closest to the experimental one 
when PBE+TS (-3%) method was used (as already reported for other organic crystal structures9), while the 
optimization with B3LYP-D* (-6%) and PBE+G06 (-7.5%) resulted in slightly larger volume reduction (see 
Table S9). 
Table S8. Comparison of the unit cell parameter changes of droperidol solvates and ISD introduced by 
different optimization methods 
 a, Å b, Å c, Å α, ° β, ° γ, ° V, Å3 
ACN 6.09 10.22 16.26 101.2 92.7 96.8 982.8 
B3LYP -2.0 -1.0 -2.6 -0.7 2.0 -0.5 -5.4 
PBE+TS -0.7 -0.9 -2.0 -1.4 0.4 0.0 -3.0 
PBE+G06 -1.4 -1.0 -4.8 -1.3 1.8 0.8 -7.1 
NM 6.07 10.19 16.42 99.8 92.3 95.6 993.9 
B3LYP -1.9 -1.1 -2.9 -1.0 2.4 -0.4 -5.7 
PBE+TS -0.5 -0.7 -2.3 -1.3 0.0 -0.2 -3.1 
PBE+G06 -1.4 -0.9 -4.8 -1.8 1.1 0.5 -6.7 
ET 6.08 10.30 16.17 100.9 92.6 95.9 987.3 
B3LYP -1.9 -1.1 -2.9 -1.0 1.2 -0.2 -5.6 
PBE+TS -0.5 -0.6 -2.5 -1.1 0.2 0.1 -3.3 
PBE+G06 -1.2 -1.1 -5.6 -1.8 1.7 1.0 -7.6 
ME 6.07 10.22 16.21 101.3 93.2 97.0 974.7 
B3LYP -2.5 -0.5 -3.1 -0.5 2.4 -0.5 -6.0 
PBE+TS -0.8 -0.5 -1.7 -0.7 0.6 0.0 -2.9 
PBE+G06 -1.4 -0.8 -4.9 -1.2 1.6 0.5 -6.9 
NSH 298 K 6.28 10.15 16.19 102.6 91.9 99.3 991.6 
B3LYP -3.8 0.7 -3.5 0.1 5.3 -2.1 -6.9 
PBE+TS 0.2 -0.6 -4.3 -1.6 0.0 0.1 -4.1 
PBE+G06 -3.5 -0.1 -7.2 -4.3 0.6 -2.3 -8.7 
NSH 173 K 6.29 10.17 15.92 102.6 91.9 99.9 976.4 
PBE+TS 0.5 -0.2 -2.9 -0.8 0.5 -0.2 -2.3 
ISDa 6.27 10.13 16.23 102.7 92.6 99.2 989.0 
B3LYP -2.2 0.3 -4.7 0.1 2.7 0.0 -6.9 
PBE+TS 0.0 -0.1 -4.0 -1.2 0.6 -0.1 -3.6 
PBE+G06 -1.1 -0.8 -6.7 -2.3 2.1 0.0 -7.9 
a - from PXRD data at ambient temperature 
 
By comparing the individual lattice parameter changes after the optimization, it can be seen that all of the 
optimization schemes performed similarly by reducing a, b, c and α while not changing or slightly increasing 
angles β and γ. The changes introduced to the lattice parameters were almost the same for all solvates except 
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for the NSH which showed different behaviour of the unit cell parameter changes. Similar changes of the 
lattice parameters and volume was observed also for the isostructural desolvate ISD, for which calculated 
values were compared with lattice parameters determined from PXRD data at ambient temperature. 
Evaluation of the changes introduced by HO and ALL structure optimization procedures was possible 
by comparing the geometry of intramolecular interactions and the solvent molecule arrangement in the 
crystal structure. Such a comparison is given in the Table S10 where only selected intermolecular interactions 
of the solvent molecules are given. 
Table S9. Geometrical parameters of the selected solvent-droperidol intramolecular interactions (by using 
solvent-droperidol interaction labelling as given in Figure 6) in the droperidol solvate crystal structures after 
different geometry optimization procedures. 
Solvate Interaction Parameter 
B3LYP-
D* 
PBE+G06 
PBE+TS 
UC 
PBE+TS 
ALL 
PBE+TS 
HO 
SACN N4H-C5A D A, Å 3.565 3.6 3.603 3.642 3.704 
 γ D-H···A, ° 161.2 162.6 162.4 161.9 161.3 
 C24-HH-C4A D A, Å 3.039 2.915 3.082 3.09 3.094 
 α D-H···A, ° 126.3 122.9 127.6 128.4 128.2 
 C24-Hπ D A, Å 3.817 3.799 3.841 3.914 3.91 
 ε D-H···A, ° 158.9 167.1 165.6 168.3 169.5 
SNM O3H-C4A D A, Å 3.195 3.325 3.362 3.395 3.44 
 α D-H···A, ° 143.1 138.7 140.9 141.6 142.3 
 O4H-C5B D A, Å 3.147 3.184 3.202 3.258 3.269 
 η D-H···A, ° 126 120.6 122.8 121.65 121.5 
 C23-HO1A D A, Å 3.307 3.371 3.309 3.335 3.32 
 δ D-H···A, ° 155.3 156.3 156.7 145.9 143.9 
SEt C24-Hπ D A, Å 3.72 3.731 3.737 3.808 3.83 
 δ D-H···A, ° 161.5 151.9 151.6 151.9 147.7 
 O3-HO1 D A, Å 2.77 2.748 2.759 2.776 2.823 
 ε D-H···A, ° 167.9 165.1 165.7 165.8 167.6 
 O3H-C5 D A, Å 3.292 3.332 3.446 3.464 3.454 
 γ D-H···A, ° 133.4 139.9 129.1 127.9 129.7 
SMe O3-HO1 D A, Å 3.552 2.791 2.798 2.834 2.955 
 ε D-H···A, ° 161.3 165.9 164.5 162.5 159.5 
 C23-HO1 D A, Å 3.332 3.42 3.387 3.411 3.248 
 δ D-H···A, ° 134 158.4 152.6 150.7 149.9 
 C23-HH3 D A, Å 2.854 2.919 2.971 2.979 2.97 
 α D-H···A, ° 118.2 130 133.5 134.8 129 
NSH O3-HO1 D A, Å   2.754 2.763 2.85 
 ε D-H···A, °   166.4 166.5 167.2 
 O3H-C9 D A, Å 3.143 3.23 3.217 3.274 3.446 
 ζ D-H···A, ° 168.4 121.2 128.9 128.6 126 
 O3HO3 D A, Å 2.944 3.029 2.897 2.904 2.757 
  D-H···A, ° 104.4 112.4 121 121.3 119.6 
 
By comparing the solvent molecule arrangement and geometrical parameters of intermolecular 
interactions it was concluded that there were almost no differences for crystal structures of SACN, SNM and 
SEt. However, in SMe similar location of the methanol methyl group, but completely different direction of 
the O-H bond was observed after the optimization with B3LYP-D* if compared with other optimization 
techniques (see Figure S18). This difference was a result of the bad initial position of the O-H hydrogen 
atom (not forming the hydrogen bond with benzimidazolone moiety). In NSH water molecules did not 
form any hydrogen bonds with droperidol molecules after geometry optimization with B3LYP-D* and 
PBE+G06, whereas after the structure optimization with PBE+TS water arrangement corresponded to that 
observed in the experimental NSH structure determined at 120 K1 and there was a hydrogen bonding 
between the water molecule and the benzimidazolone moiety of droperidol molecule (See Figure S19). 
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Figure S18. Overlay of SMe crystal structure after UC geometry optimization procedure at the PBE+TS 
level in CASTEP (in dark blue, methanol OH group coloured by elements) and B3LYP-D level in 
CRYSTAL09 (in cyan, methanol OH group coloured dark green). 
 
Figure S19. Overlay of NSH crystal structure after geometry optimization at the PBE+TS (UC in dark 
blue, ALL – red, HO – orange) and PBE+G06 (UC in green) level in CASTEP and B3LYP-D* level in 
CRYSTAL09 (UC in cyan). 
 
It was noticed that interatomic distances after ALL and HO optimization procedures generally were larger 
than those after UC optimization procedures because of the more compact molecule arrangement after the 
reduction of unit cell volume after the UC optimization. 
By comparing the geometry of droperidol-droperidol intermolecular interactions it was concluded that 
there were no significant differences between the structures after different optimization procedures, and 
also between different solvates and even the ISD. 
 
DROPEIDOL-DROPERIDOL INTERMOLECULAR INTERACTION ENERGY 
Droperidol-droperidol intermolecular interaction energy in all solvates was compared for all of the 
optimized crystal structures to explore the possible differences introduced by the presence of different 
solvent molecules and to explore the effect of different structure optimization methods on the obtained 
results. In this analysis droperidol molecule pairs where droperidol-droperidol interactions with interatomic 
distance shorter than sum of atom Van der Waals radii were included. It was not checked whether 
interactions with other molecules were not relevant for the total interaction energy because the objective of 
this analysis was only to compare the differences between different solvents and results after different 
geometry optimization procedures and analysis of selected interactions was enough to reach this goal. 
Intermolecular interactions present in the selected droperidol molecule pairs A – G are given in the Table 
S11. 
Table S10. Intermolecular interactions present in the droperidol molecule pairs A - G selected for the 
calculation of intermolecular interaction energy 
Molecule pair Interaction Graph set 
A N2-H···O1 𝑅2
2(8) 
B C13-H···O2, π ···π  
C C21-H···N3, C2-H···π  
D π ···π  
E C18-H···O2 𝑅2
2(10) 
F C11-H···F1  
G C19-H···F1 𝑅2
2(8) 
208 
It should be pointed out that after the geometry optimization in organic solvates basically there were two 
symmetrically independent droperidol molecules in the unit cell and interaction energies were evaluated only 
for one of these molecules. However, the droperidol molecules themselves are related by the inversion 
centre. Nevertheless, slight variations due to the presence of the solvate molecule most probably were 
introduced and thus could affect the calculated droperidol interaction energy. 
Intermolecular interaction energy of droperidol molecule pairs were calculated at the B3LYP-D* level 
from a) all five solvate and ISD structures after UC optimization in CASTEP (PBE+G06) and 
CRYSTAL09 (B3LYP-D*), b) SACN, SEt, NSH and ISD structures after all three optimization procedures 
in CASTEP (PBE+TS), and c) SNM and SMe structures after ALL and UC optimization procedures in 
CASTEP (PBE+TS). Droperidol molecule pair interaction energy for all five solvate structures after UC 
optimisation in CASTEP (PBE+G06 and PBE+TS) was also calculated at the M06-2X level, while for 
NSH and ISD structures these calculations were also performed using semi-empirical PIXEL13 
methodology (code provided in the CLP software suite). Empirical parameters were used as provided in the 
literature13. Hydrogen atom positions were kept as optimized with CASTEP or CRYSTAL09. Molecular 
electron density calculations were performed in Gaussian 0914 at the MP2/6-31G(d,p) level using standard 
grid parameters. Condensation level 4 was used. 
From all of the calculations it was concluded that the intermolecular interactions between droperidol 
molecules as well as their energy were almost the same for all solvates and did not depend on the crystal 
structure optimization method. By comparing the results from different crystal structure optimization 
procedures it was determined that the most sensitive interaction was for the hydrogen bonded droperidol 
molecule dimer (A) where interaction energy varied by up to 1 kcal·mol-1 for all structures and up to 0.8 
kcal·mol-1 for UC optimized structures (with the exception of NSH, which showed higher structure 
differences depending on the optimization method as discussed later, and thus interaction energy varied up 
to 1.5 kcal·mol-1). By comparing the interaction energy of an individual molecule pairs from all of the 
structures, differences up to 1.7 kcal·mol-1 was observed. However, also in this case extreme values were 
obtained for NSH and ISD crystal structures and thus can be related with an important differences in the 
arrangement of the solvent molecules in the channels. Calculated interaction energies between the 
droperidol dimers in each solvate after all performed geometry optimization procedures are given in Table 
S12 to S17. 
Table S11. Interaction energy of droperidol-droperidol molecule pairs (in kcal·mol-1) in SACN structure 
after different geometry optimization procedures 
Molecule 
pair 
B3LYP-D M06-2X 
TS, ALL TS, HO TS, UC G06, UC B3LYP-D*, UC TS, UC G06, UC 
A -21.84 -21.39 -21.73 -21.67 -21.11 -19.61 -19.55 
B -11.95 -11.62 -12.07 -12.1 -12.55 -7.65 -7.82 
C -11.8 -11.81 -12.04 -11.8 -11.87 -10.09 -10.33 
D -10.51 -10.54 -10.53 -10.69 -10.97 -8.91 -9.8 
E -6.06 -5.94 -6.02 -6.2 -5.98 -4.47 -4.72 
F -3.09 -3.06 -3.27 -3.22 -3.34 -1.33 -1.24 
G -2.7 -2.67 -2.74 -2.68 -2.63 -1.63 -1.63 
Total -94.79 -93.52 -95.78 -95.47 -96.21 -72.75 -74.48 
 
Table S12. Interaction energy of droperidol-droperidol molecule pairs (in kcal·mol-1) in SNM structure 
after different geometry optimization procedures 
Molecule 
pair 
B3LYP-D M06-2X 
G06, UC B3LYP-D*, UC TS, ALL TS, UC TS, UC G06, UC 
A -21.5 -20.81 -21.8 -21.85 -19.77 -19.44 
B -11.5 -11.85 -11.53 -11.48 -7.04 -7.27 
C -11.76 -11.98 -11.7 -11.92 -9.78 -10.11 
D -10.64 -10.92 -10.37 -10.5 -9.04 -9.76 
E -6.07 -5.95 -5.99 -6.03 -4.47 -4.58 
F -3.38 -3.38 -3.17 -3.32 -1.41 -1.37 
G -2.71 -2.68 -2.71 -2.74 -1.62 -1.64 
Total -94.2 -94.78 -93.67 -94.56 -71.36 -72.92 
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Table S13. Interaction energy of droperidol-droperidol molecule pairs (in kcal·mol-1) in SEt structure after 
different geometry optimization procedures 
Molecule 
pair 
B3LYP-D M06-2X 
TS, ALL TS, HO TS, UC G06, UC B3LYP-D*, UC TS, UC G06, UC 
A -22.02 -21.44 -22.06 -21.82 -21.37 -19.94 -19.73 
B -11.58 -11.63 -11.67 -11.73 -11.94 -7.28 -7.55 
C -11.74 -11.74 -11.94 -11.58 -11.73 -10.17 -10.28 
D -10.38 -10.58 -10.71 -10.84 -11.04 -9.33 -10.09 
E -5.98 -5.83 -6.01 -6.01 -5.93 -4.46 -4.54 
F -3.11 -3.1 -3.25 -3.31 -3.33 -1.31 -1.28 
G -2.69 -2.66 -2.69 -2.6 -2.67 -1.61 -1.6 
Total -93.93 -93.45 -95.18 -94.51 -95.01 -72.86 -74.18 
 
Table S14. Interaction energy of droperidol-droperidol molecule pairs (in kcal·mol-1) in SMe structure after 
different geometry optimization procedures 
Molecule 
pair 
B3LYP-D M06-2X 
G06, UC B3LYP-D*, UC TS, ALL TS, UC TS, UC G06, UC 
A -22.04 -21.12 -22.09 -22.22 -20.13 -19.95 
B -11.98 -12.73 -12.17 -12.4 -8.02 -7.84 
C -11.58 -11.49 -11.65 -11.66 -9.71 -10.14 
D -10.63 -10.79 -10.27 -10.56 -9.04 -9.78 
E -6.18 -5.98 -6.09 -6.12 -4.57 -4.71 
F -3.27 -3.33 -3.14 -3.29 -1.34 -1.29 
G -2.71 -2.69 -2.73 -2.74 -1.62 -1.63 
Total -95.23 -95.68 -95.1 -96.34 -73.5 -74.62 
 
Table S15. Interaction energy of droperidol-droperidol molecule pairs (in kcal·mol-1) in NSH structure 
after different geometry optimization procedures 
Molecule 
pair 
B3LYP-D M06-2X PIXEL  
TS, ALL TS, HO TS, UC TS, ALL TS, HO TS, UC TS, ALL TS, UC 
A -22.29 -21.4 -22.4 -20.2 -19.28 -20.33 -16.11 -16.85 
B -11.48 -11.42 -11.37 -6.83 -6.68 -6.77 -8.94 -8.89 
C -11.86 -11.88 -11.99 -9.6 -9.48 -9.98 -9.89 -9.56 
D -10.66 -10.84 -11.25 -8.48 -8.68 -9.47 -7.58 -7.74 
E -6.14 -6.02 -6.18 -4.65 -4.51 -4.72 -5.23 -5.35 
F -2.92 -2.25 -3.02 -1.26 -0.5 -1.3 -1.82 -1.86 
G -2.67 -2.59 -2.62 -1.6 -1.56 -1.59 -2.20 -2.10 
Total -94.28 -91.95 -95.22 -70.31 -67.35 -72.21 -72.42 -72.68 
 
Table S16. Interaction energy of droperidol-droperidol molecule pairs (in kcal·mol-1) in ISD structure 
after different geometry optimization procedures 
Molecule 
pair 
B3LYP-D PIXEL 
TS, ALL TS, HO TS, UC G06, UC B3LYP-D*, UC TS, ALL TS, UC 
A -21.62 -22 -21.59 -21.26 -20.77 -16.20 -17.57 
B -11.61 -11.5 -11.69 -11.83 -12.48 -9.25 -9.20 
C -11.84 -11.66 -12 -11.8 -11.84 -9.75 -9.49 
D -10.41 -10.42 -11.15 -11.2 -11.2 -7.34 -7.29 
E -6.12 -5.91 -6.25 -6.19 -6.13 -5.04 -5.16 
F -2.9 -2.84 -3.07 -3.16 -3.14 -2.08 -2.27 
G -2.73 -2.62 -2.66 -2.67 -2.68 -2.22 -2.17 
Total -93.59 -92.96 -95.17 -94.89 -95.71 -72.97 -74.12 
 
The total droperidol interaction energy (a sum from all ten dimers, see Table S18) calculated ta the 
B3LYP-D level varied up to 2.8 kcal·mol-1 for different optimization methods (but only 0.8 kcal·mol-1 for 
UC optimization procedures) within the same solvate (with the exception of NSH where changes up to 3.5 
kcal·mol-1 for all and 3.0 kcal·mol-1 for UC optimization procedures were obtained). By comparing the total 
interaction energies from all solvates (excluding the NSH) with every optimization procedure, maximal 
differences were 3.3 kcal·mol-1 for all and only 2.0 kcal·mol-1 for UC optimization procedures. 
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Although similar conclusions were drawn also for interaction energy calculated at the M06-2X level, 
differences between different structures were higher: for UC optimized structures individual droperidol pair 
interaction energy varied by up to 1.4 kcal·mol-1 and the total interaction energy varied by 3.3 kcal·mol-1. 
 
Table S17. Total droperidol-droperidol interaction energies (in kcal·mol-1) calculated as a sum from the 
interaction energy of ten droperidol molecule pairs in the droperidol solvates after all used geometry 
optimization procedures 
Solvate 
B3LYP M06-2X 
TS, ALL TS, HO TS, UC G06, UC B3LYP-D*, UC TS, UC G06, UC 
SACN -94.79 -93.52 -95.78 -95.47 -96.21 -72.75 -74.48 
SEt -93.93 -93.45 -95.18 -94.51 -95.01 -72.86 -74.18 
SMe -95.1  -96.34 -95.23 -95.68 -73.5 -74.62 
SNM -93.67  -94.56 -94.2 -94.78 -71.36 -72.92 
NSH -94.28 -91.95 -95.22   -72.21  
ISD -93.59 -92.96 -95.17 -94.89 -95.71   
 
As already mentioned, droperidol interaction energies of NSH were calculated at the M06-2X level, while 
those of NSH and ISD were also calculated with semi-empirical PIXEL code. Interaction energy calculated 
at the M06-2X level was by 1 to 4.7 kcal·mol-1 lower than that calculated at the B3LYP-D level. The 
difference could not be associated with the magnitude of the interaction energy and the biggest difference 
was observed for droperidol molecule pair B. Resulting total droperidol interaction energy was 23-25 
kcal·mol-1 lower than that calculated at the B3LYP-D level. In PIXEL calculated interaction energy was 0.5 
to 6.2 kcal·mol-1 lower than that calculated at the B3LYP-D level with the biggest difference observed for 
hydrogen bonded droperidol molecule pair A. Although the difference between energy calculated at the 
M06-2X level and in PIXEL varied from -4 to +2 kcal·mol-1, total droperidol interaction energy between 
these two methods differed only 0.5 to 2 kcal·mol-1. 
 
SOLVENT INTERMOLECULAR INTERACTION ENERGY 
It was determined that for all of the solvates it was enough to include the solvent interactions with 
droperidol molecules for which the shortest interatomic distance was below Van der Waals radii + 0.6 Å 
(for most of the solvents smaller distances were enough to obtain the same solvent-droperidol interactions, 
whereas this value hat to be used for NSH because of the smaller size of water molecules if compared to 
the other solvent molecules) and the interactions with the closest solvent molecules. It was also confirmed 
that no other droperidol molecule had an intramolecular interaction with the solvent molecule even if the 
cutoff value for interatomic distance was increased to Van der Waals radii + 1.5 Å, and it was proved that 
if the solvent molecule in a particular solvate formed intramolecular interaction with distance longer than 
Van der Waals radii + 0.6 Å, interaction between these molecules was energetically irrelevant and did not 
change the total solvent interaction energy. 
It was confirmed that the geometry of strong hydrogen bond O3-HO1 in NSH, SMe and SEt with ε 
droperidol molecule was almost identical and was not disturbed by different geometry optimization 
procedures (with the exception of NSH structure after geometry optimization at the PBE+G06 level in 
CASTEP and B3LYP-D* level in CRYSTAL09). 
Solvent molecule interaction energy for all crystal structures was calculated at both B3LYP-D and M06-
2X levels. Obtained results are presented in Table S19 to S23. 
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Table S18. Interaction energy of solvent-droperidol and solvent-solvent molecule pairs (in kcal·mol-1) in SACN structure after different geometry optimization procedures 
Molecule 
pair 
B3LYP-D M06-2X 
TS, ALL TS, HO TS, UC B3LYP-D*, UC G06, UC TS, ALL TS, HO TS, UC B3LYP-D*, UC G06, UC 
α -0.72 -0.75 -0.75 -0.74 -0.54 -0.03 -0.05 -0.07 -0.11 0.02 
β -0.97 -0.96 -1 -0.99 -0.96 -0.1 -0.09 -0.07 -0.03 0.07 
γ -2.52 -2.44 -2.54 -2.41 -2.61 -2.08 -2 -2.11 -1.96 -2.18 
δ -6.53 -6.4 -6.61 -6.18 -6.31 -5.79 -5.57 -6.06 -5.64 -5.85 
ε -2.4 -2.39 -2.5 -2.81 -2.25 -1.54 -1.5 -1.68 -2 -1.52 
ζ -1.34 -1.39 -1.24 -1.13 -1.09 -0.83 -0.84 -0.73 -0.62 -0.63 
η -2.78 -2.78 -2.8 -2.71 -2.81 -2.34 -2.28 -2.34 -2.22 -2.41 
θ 0.4   0.34 0.41 0.93   0.97 0.88 
ι -2.62 -2.55 -2.65 -2.75 -2.71 -2.52 -2.44 -2.56 -2.64 -2.68 
 
Table S19. Interaction energy of solvent-droperidol and solvent-solvent molecule pairs (in kcal·mol-1) in SNM structure after different geometry optimization procedures 
Molecule 
pair 
B3LYP-D M06-2X 
TS, ALL TS, HO TS, UC B3LYP-D*, UC G06, UC TS, ALL TS, HO TS, UC B3LYP-D*, UC G06, UC 
α -1.03 -1.14 -0.89 -0.53 -0.58 -0.27 -0.39 -0.16 0.16 0.07 
β -1.03 -0.99 -1.06 -1.09 -1.01 -0.09 -0.06 -0.02 0.01 0.12 
γ -2.39 -2.72 -2.49 -2.33 -2.54 -1.91 -2.3 -2.01 -1.82 -2.06 
δ -8 -8.76 -8.28 -8.52 -7.65 -7.16 -7.99 -7.62 -7.83 -7.01 
ε -3.66 -3.34 -3.64 -3.7 -3.75 -2.63 -2.26 -2.66 -2.79 -2.92 
ζ -1.91 -1.77 -1.9 -1.33 -1.8 -1.32 -1.06 -1.29 -0.63 -1.27 
η -2.42 -2.36 -2.38 -2.35 -2.34 -2.02 -1.88 -2.02 -2 -1.97 
θ 0.61   0.59 0.62 1.14   1.11 1.07 
ι -1.92 -1.94 -2.02 -2.19 -2.12 -1.91 -1.93 -2.02 -2.12 -2.17 
 
Table S20. Interaction energy of solvent-droperidol and solvent-solvent molecule pairs (in kcal·mol-1) in SEt structure after different geometry optimization procedures 
Molecule 
pair 
B3LYP-D M06-2X 
TS, ALL TS, HO TS, UC B3LYP-D*, UC 
G06, 
UC 
TS, ALL TS, HO TS, UC B3LYP-D*, UC G06, UC 
α -2.31 -2.4 -2.35 -2.34 -2.38 -1.76 -1.81 -1.8 -1.81 -1.91 
β -1.26 -1.26 -1.24 -1.06 -1.14 -0.46 -0.48 -0.43 -0.29 -0.37 
γ -1.18 -0.78 -1.17 -1.24 -1.06 -0.41 0.04 -0.41 -0.39 -0.28 
δ -5.28 -4.68 -5.39 -5.66 -5.32 -4.47 -3.87 -4.73 -4.99 -4.96 
ε -8.4 -9.48 -8.25 -8.33 -7.95 -7.2 -8.38 -7.08 -7.19 -7.06 
ζ -1.63 -1.63 -1.68 -1.61 -1.33 -0.51 -0.53 -0.54 -0.42 -0.2 
η -1.38 -1.48 -1.35 -1.31 -1.16 -0.76 -0.87 -0.77 -0.75 -0.69 
θ -0.53 -0.61 -0.52 -0.53 -0.51 0.02 -0.09 0.05 0.03 0.06 
ι -0.44 -0.37 -0.46 -0.46 -0.46 -0.35 -0.29 -0.37 -0.37 -0.37 
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Table S21. Interaction energy of solvent-droperidol and solvent-solvent molecule pairs (in kcal·mol-1) in SMe structure after different geometry optimization procedures 
Molecule 
pair 
B3LYP-D M06-2X 
TS, ALL TS, HO TS, UC B3LYP-D*, UC 
G06, 
UC 
TS, ALL TS, HO TS, UC B3LYP-D*, UC G06, UC 
α -1.46 -1.56 -1.5 -1.62 -0.28 -0.87 -0.98 -0.93 0.01 -1.43 
β -1 -1.09 -1.05 -0.83 -1.57 -0.34 -0.38 -0.35 -0.31 -1.12 
γ -0.41   -1.15 -1.08 -0.12   -0.34 -0.29 
δ -3.27 -3.17 -3.37 -5.74 -3.13 -2.29 -2.28 -2.41 -4.68 -2.16 
ε -9.23 -9.27 -9.23 -1.15 -9.08 -8.4 -8.4 -8.45 -0.34 -8.55 
ζ -1.83 -1.69 -1.79 -5.74 -1.65 -1.25 -1.12 -1.19 -4.68 -1.05 
η -1.95 -1.88 -1.94 -1.62 -2 -1.65 -1.57 -1.65 -1.15 -1.7 
θ -0.23  0.16 -0.17 -0.25    0.15 0.23 
ι -0.35 -0.38 -0.37 -0.12 -0.38 -0.32 -0.35 -0.35 -0.37 -0.04 
 
Table S22. Interaction energy of solvent-droperidol and solvent-solvent molecule pairs (in kcal·mol-1) in NSH structure after different geometry optimization procedures 
Molecule 
pair 
B3LYP-D M06-2X 
TS, ALL TS, HO TS, UC B3LYP-D*, UC 
G06, 
UC 
TS, ALL TS, HO TS, UC B3LYP-D*, UC G06, UC 
α -0.42 -0.65 -0.35 -0.27 0.28 0.04 -0.19 0.1 0.07 -0.2 
β -1.42 -1.49 -1.72 1.27 -1.83 -0.86 -0.83 -1.08 0.38 -1.48 
γ -0.83 -0.75 -0.82 -2.26 -2.39 -0.3 -0.08 -0.27 -1.97 -2.16 
δ 0.1   0.29 0.2 0.22   0.29 0.37 
ε -7.98 -7.47 -8.15 -3.86 -3.1 -7.51 -6.93 -7.7 -3.23 -2.4 
ζ -1.91 -1.51 -2.04 -0.49 0.08 -1.62 -1.1 -1.79 -0.14 0.5 
η -1.68 -1.7 -1.62 -1.43 -0.1 -1.54 -1.56 -1.48 -0.92 1.47 
θ 0.11   -1.29 -2.23 0.18   -1.15 -2.1 
κ -3.85 -3.43 -3.77 -4.16 -4.18 -3.77 -3.57 -3.69 -4.12 -3.99 
ι 0.05 0.67 0.07 -4.39 -3.94 0.1 0.74 0.11 -4.17 -3.64 
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For NSH water molecule interaction energy calculation was also performed with PIXEL. In contrast to 
the droperidol-droperidol interactions, the total water interaction energy calculated with PIXEL was almost 
identical to that calculated at the B3LYP-D in Gaussian 09, although the energy calculated for particular 
molecule pairs differed by up to 1 kcal·mol-1. 
 
Exclusion of the solvent-solvent intermolecular interaction energy from the total solvent intermolecular 
interaction energy significantly reduced its value for SACN and SNM, by changing the order of the solvates 
sorted with respect to this parameter and making the differences between the total solvent interaction energy 
smaller if compared with the case where all of the solvent interactions were taken into account (see Fig. 
S20). 
 
Fig. S20. Average total solvent interaction energy excluding solvent-solvent interaction energy calculated 
in Gaussian 09 after the structure optimization at the PBE+TS level in CASTEP for all droperidol solvates. 
 
By adding together the energy for all the interactions present in the unit cell (from two droperidol 
molecules and from one solvent molecule in organic solvates and two water molecules in NSH, by taking 
into account correction for the double summation of droperidol-droperidol and water-water interactions), 
it was observed that the interaction efficiency calculated at the B3LYP-D level changed in the same order 
as observed when only the total solvent interaction energy was calculated at the M06-2X level (see Fig. S21). 
The only exception was the more negative energy of the SACN if compared with that of SNM, because of the 
more efficient droperidol-droperidol molecule interactions in SACN. This was also observed when the 
interaction energy was calculated at the M06-2X level. This most probably is due to the fact that 
nitromethane is the largest of all the analyzed solvent molecules, and particularly its size perpendicular to 
the channel direction is larger than that for other solvent molecules. However, for SMe at the M06-2X level 
calculated total droperidol-droperidol and solvent interaction energy was more negative than that in SEt and 
even in SNM by thus changing the order of the solvates sorted by this parameter. This could probably be 
because small size of the methanol molecules allowed more efficient packing and thus the interaction 
between the droperidol molecules. This effect was not observed in the NSH structure, which could be 
explained by the formation of monohydrate, while the methanol formed hemimethanolate. 
However, the presence of two water molecules in the unit cell of NSH resulted the total droperidol-
droperidol and solvent interaction energy of this solvate to be the most negative one (see Fig. S21). 
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Fig. S21. Total droperidol-droperidol and solvent interaction energy in the unit cell calculated in Gaussian 
09 after the structure optimization at the PBE+TS level with UC optimization procedure in CASTEP for 
all droperidol solvates. 
 
EFFECT OF THE REORIENTATION OF THE ALCOHOL MOLECULES 
In order to confirm the validity of the ordered solvent model for alcohol solvates, the effect of the 
reorientation of the alcohol molecule to the opposite direction than that of the adjacent molecules on the 
interaction energy was evaluated.  
The unit cell of these solvates was doubled in the solvent channel (a-axis) direction and one of the solvent 
molecules was flipped to the opposite direction by obtaining the “opposite direction” structure. Geometry 
optimization of this structure was performed in CASTEP (PBE+TS, ALL). Solvent-droperidol and solvent-
solvent interaction energies were calculated for both different alcohol molecules in the “opposite direction” unit 
cell. Comparison of the total solvent interaction energy in “same direction” structure to that in “opposite direction” 
structure revealed that this value was the same for SEt, and was only slightly less effective for SMe. By 
analyzing the interaction energies for individual molecule pairs it was found that the variable most affecting 
the total solvent interaction energy in SMe was the interactions between two adjacent alcohol molecules (see 
Table S24). 
These results and the observation that the alcohol-alcohol interaction energy in SMe and SEt had only 
minor contribution in the total solvent interaction energy justified that it was reasonable to approximate the 
disordered SMe and SEt structures with the ordered ones. 
Table S23. From individual molecule pairs calculated total solvent interaction energy and solvent-solvent 
interaction energy in “same direction” and “opposite direction” droperidol alcohol solvate structures (in kJ·mol-1) 
 “same direction” “opposite direction” 
 Total Solvent paira Total1 Total2b Solvent pair1a Solvent pair2a,b 
SEt -68.0 -1.2 -69.0 -69.0 -2.3 -1.0 
SMe -64.6 -1.5 -58.2 -58.5 0.0 3.1 
a – interaction energy between two adjacent alcohol molecules. 
b – there are two different alcohol molecules in the “opposite direction” structure. 
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SOLVENT SORPTION ISOTHERMS OF DROPERIDOL ISOSTRUCTURAL SOLVATES 
 
 
Fig. S22. Initial part of the droperidol isostructural solvate sorption-desorption isotherms1. 
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Appendix 10. Supplementary Information for publication “Solid-state NMR and 
computational investigation of solvent molecule arrangement and dynamics in 
isostructural solvates of droperidol” 
 
 
Fig. S1. Molecular packing in the droperidol isostructural solvates showing the carbon atoms in 
proximity to the solvent molecules. 
 
Figure S2. Full 13C CPMAS spectra of the droperidol isostructural solvates, together with peak 
assignment. Spinning sidebands are marked with asterisks, signals that disappear in short CP 
contact time experiments are marked with arrows. The dashed rectangle marked region is 
enlarged in Figure 2. 
 
Fig. S3. 13C CPMAS spectra for SEt using different contact times at –40 oC. 
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Fig. S4. 13C CPMAS spectra for droperidol solvates using 50 µs contact time. 
Table S1. Rescaled average calculated 13C chemical shifts (in ppm) after optimisation of only 
hydrogen atoms, plus the difference between the same carbon atom in two molecules in the unit 
cell. 
 NSH SMe SEt SACN SNM 
Assig δHO δHO dif. δHO dif. δHO dif. δHO dif. 
C16 200.2 199.1 5.8 200.8 0.3 200.3 3.2 200.6 0.2 
C20 170.6 170.6 5.9 171.4 2.1 171.5 3.5 170.3 4.2 
C1 149.9 150.9 0.3 147.4 1.4 148.4 1.4 147.7 0.9 
C17/C8 137.4 135.5 6.0 134.1 3.8 134.4 3.7 134.6 4.7 
C18 133.1 132.1 4.4 133.5 0.4 134.7 0.7 134.7 1.3 
C22 132.7 131.0 5.8 132.8 1.9 134.6 1.2 134.1 1.5 
C17/C8 131.7 131.1 4.4 132.5 0.2 132.1 0.7 132.7 2.7 
C6 128.4 127.5 1.1 128.0 0.0 127.6 1.1 129.8 3.7 
C7 127.5 125.9 3.6 126.2 3.0 126.8 3.5 126.3 3.9 
C9 122.3 128.6 1.5 127.6 4.1 127.1 5.2 125.8 6.5 
C4 121.7 124.5 4.5 120.9 3.2 123.0 2.1 121.7 2.8 
C3 117.9 116.2 5.3 117.7 2.4 117.4 2.0 115.7 5.1 
C19 115.8 117.5 0.2 119.2 2.6 117.0 3.3 117.6 0.2 
C21 115.8 115.6 6.6 115.5 4.4 116.9 1.8 117.5 1.9 
C2 109.4 109.8 0.4 109.2 2.2 109.2 1.8 108.0 0.2 
C5 105.6 105.9 3.6 107.4 2.4 107.8 3.7 106.9 5.5 
C13 62.6 61.1 1.7 60.5 1.8 61.4 0.6 61.1 0.9 
C11 54.5 53.4 1.5 53.5 1.8 54.7 0.2 54.5 0.4 
C10 54.2 53.2 1.1 51.9 4.4 52.4 0.9 54.3 0.4 
C15 35.1 35.4 0.9 37.7 0.8 36.1 1.7 37.0 1.2 
C12 27.8 27.8 1.0 29.1 0.5 28.6 0.1 29.2 1.1 
C14 21.1 20.5 0.2 20.7 2.3 20.8 0.9 21.3 0.7 
CH3 solv  53.8  22.3  4.1  59.3  CH2/CNsolv    56.5  120.6    
RMSD 2.16 1.87  2.18  2.54  2.27  
 
Droperiodol dihydrate, DH, was prepared by dissolving droperidol in acetone at 50 oC, 
cooling the solution to ~10 °C, slowly adding similar volume of water and then slowly partially 
evaporating the resulting solution at 5 oC. Droperidol polymorph II was obtained by 
recrystallizing the sample from acetone at 50 oC [1]. 13C CP/MAS spectra of II and DH were 
recorded with the same conditions as described in the main text, using a 120 s recycle delay. 
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Fig. S5. 13C CPMAS spectra of droperidol dihydrate DH. 
 
Fig. S6. 13C CPMAS spectra of droperidol polymorph II. 
 
 
Fig. S7. Plot of the experimental 15N chemical shifts versus the calculated shieldings in SEt and 
SACN after optimization of all atoms. 
 
Fig. S8. Overlay of SEt 13C CPMAS spectra at 20 oC using 50 µs (blue) and 1000  µs (red) 
contact time (intensities are scaled to match the peaks from droperidol CH2 groups).  
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Table S2. 13C spin-lattice relaxation times determined for solvent molecule carbon atoms in 
droperidol solvates from 13C direct-excitation experiments. 
T / oC SEt SMe SACN 
 
T1(CH2) / sa T1(CH3) / sa,b T1(CH3) / sc T1(CH3) / sc 
20 1.04 0.8 5.2 17 
10 1.05 0.6 
  0 1.23 0.5 7.0 
 –10 1.55 0.35 
  –20 1.44 0.3 
  –30 1.37 0.2 
  –40 0.94 0.2 7.6 32 
a – determined from saturation recovery experiments. 
b –values can be considered only as estimates due to NOE effects (see below), and were 
calculated by fitting only the initial intensity rise. 
c – estimates from simple experiments using different delay times. 
 
Figure S9 shows that the peak intensity of ethanol CH3 group carbon in saturation recovery 
experiments reached a maximum as a function of the recovery time, τ, and then decreased to an 
intensity similar to that observed for the ethanol CH2 group. The same pattern was observed 
when the recycle delay was increased in 13C direct-excitation experiments. This phenomenon can 
be explained by the magnetization transfer from 1H atoms by transient Nuclear Overhauser 
effects; at short recycle delays the 1H nuclei have insufficient time to reach the thermal 
equilibrium before applying the next pulse after the applied decoupling [2]. This effect slightly 
differed when the temperature was changed, which no doubt reflects the temperature 
dependence of 13C and 1H relaxation times (in turn largely dependent on methyl group re-
orientation). 
 
Figure S9. Intensity of ethanol 13C signals as a function of recovery time in 13C saturation 
recovery experiments at 20 and –40 °C. 
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Fig. S10. 2H MAS spectra at a spinning rate of 10 kHz of SMe at 20 and –45 oC. 
 
Table S3. Fitted quadrupolar coupling parameters for 2H MAS spectra of droperidol solvates at 
different temperatures. 
Solvate Temperature 
N-D site Solvent site 
χ / 
kHz η 
χ / 
kHz η 
SEt 20 °C 166
a 0.22a 207 0.20 
–45 °C 153b 0.26b 222 0.15 
SMe 20 °C 162 0.23 206 0.14 –45 °C 160 0.23 213 0.15 
NSH 32% RH 20 °C 165 0.21 83 0.62 –45 °C 162 0.26 86 0.8c 
NSH 100% RH 
20 °C 172 0.20 81 0.87 
–10 °C 165 0.26 87 0.88 
–30 °C 169 0.19 87 1.0c 
–45 °C 161b 0.33b 89 1.0c 
a –typical estimated uncertainty from repeat bandshape fittings using different methods / 
baseline roll suppression (see Experimental) is 2 kHz for χ and 0.02 for η. The statistical 
uncertainties returned by fitting, which assume a perfect model, are much lower, typically 
<0.1 kHz and <0.002, and unrealistically small. 
b –fit was unsatisfactory (most likely due to exchange effects) and so parameters obtained 
should be interpreted cautiously. 
c – very low intensity of the peaks from the water sites prevented accurate determination of η. 
 
Table S4. 2H spin-lattice relaxation times T1 determined for solvent hydroxyl and droperidol 
amide hydrogen atoms. 
Solvate Temperature N-D site Solvent site 
NSH 32% RH 20 °C 1.33 <0.1 -45 °C 2.51 <0.1 
SEt 20 °C 1.60 0.11 -45 °C 1.93 0.27 
SMe 
20 °C 0.63 0.11 
-45 °C 1.71 0.15 
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Fig. S11. Solvent orientations in the channels in (a) “same direction” and (b) “opposite 
direction” SACN crystal structures, showing one type of solvent-solvent interaction (“head-to-tail” 
(HT) with black arrows) in “same direction” structure, and two types of solvent-solvent 
interactions (HH with blue arrow and TT with brown arrow) in “opposite direction” structure. 
 
Table S5. Total pair-wise interaction energies of solvent molecules and solvent-solvent 
interaction energies (in kJ mol–1) in “same direction” and “opposite direction” droperidol solvate 
structures. 
 “same direction” “opposite direction” 
Solvent-solvent 
contributionb 
 
Total 
Solvent-
solvent HT 
Totala 
Solvent-
solvent HH 
Solvent-
solvent TT 
SEt –68.0 –1.2 –69.0 –2.3 –1.0 – 
SMe –64.6 –1.5 –58.4 0.0 3.1 96 
SNM –80.4 –8.1 –51.6 4.7 4.4 87 
SACN –74.3 –10.2 –38.5 7.7 2.9 88 
a - Total interaction energies for the “opposite direction” structures are averages over both of 
the solvent orientations. The largest differences between total interaction energies for both 
orientations were 0.8 kJ mol–1 for SNM and 0.3 kJ mol–1 for SMe. 
b - Percentage contribution of the change of solvent-solvent interaction to the change of the 
total pairwise interaction energies. 
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Appendix 11. Supplementary Information for publication “Structural characterization and 
rationalization of formation, stability, and transformations of benperidol solvates” 
 
PREPARATION AND CHARACTERIZATION OF BENPERIDOL SOLVATES AND POLYMORPHS 
Table S1. Crystal forms obtained after the crystallization of  droperidol from different solvents. 
Solvent Classification1 Group2 Temperature, oC Obtained phase 
n-hexane AAA 1 60a I 
n-heptane AAA 1 70a I 
carbon tetrachloride HBD 1 70 (STCC)b 
Ethyl acetate AP 2 70 I/SEtOAcc 
butyl acetate AP 2 80 I 
tetrahydrofuran EPD 2 60 I 
tert-butyl methyl ether EPD/AAA 2 50a I 
isopropyl acetate AP 2 80 I 
1-butanol HBD 3 80 I 
2-propanol HBD 3 70 I/II 
1-propanol HBD 3 80 I 
isobuthanol HBD 3 80 I 
ethanol HBD 3 70 SEt 
methanol HBD 3 60 SMe 
toluene AALP 4 80 I/HHd 
o-xylene AALP 4 80 I/HHd 
cyclohexanone AP 5 120 I 
butanone AP 5 70 I 
3-pentanone AP 5 80 I 
acetone AP 5 50 I 
N,N-dimethylformamide AP 6 120 I 
dimethylsulfoxide AP 6 120 no crystallization 
chloroform EPD/HBD/AP 7 50 (SCLF)b 
dichloromethane AP 7 40 I 
1,1-dichloroethane AP 7 70 I 
acetonitrile AP 9 80 SACN/I 
nitromethane AP 9 80 I/SNMe 
benzyl alcohol AALP 10 100f SBenz 
1,4-dioxane AP/EPD 11 80 SDIOX 
water HBD 15 -g DH 
cyclohexanol HBD - 120 I 
a - solution was partially evaporated at 50 °C temperature 
b – Obtained products typically contained impurities and/or PXRD patterns differed significantly. 
c – Mainly polymorph I was obtained, but slow crystallization at low temperatures produced SEtOAc. 
d – Hemihydrate (HH) formed only when solvents contained traces of  water. 
e – SNM was obtained only once and all repeated crystallizations produced only polymorph I. 
f – Crystallization was very slow and occurred either at 20° or at -5°C. 
g – Solvent exchange method was used either at ambient temperature or at 50 °C. 
Classifications: AP = aprotic polar, AALP = aromatic apolar or lightly polar, EPD = electron pair donors, 
HBD = hydrogen bond donors, AAA = aliphatic aprotic apolar. 
Groups are based on cluster analysis of  following solvent parameters: hydrogen bond acceptor 
propensity, hydrogen bond donor propensity, polarity/dipolarity, dipole moment, and dielectric constant, 
and contain various solvents with similar properties (except for: group 13 = diethylamine, group 14 = 
glycerol, and group 15 = water). 
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Figure S1. The DTA and TG curves of  the benperidol solvates. d – desolvation,, m – melting of  
polymorphs. 
 
Figure S2. PXRD patterns of  the benperidol polymorphs. 
 
Figure S3. The DTA curves of  the benperidol polymorphs. m – melting of  polymorphs, pt – phase 
transition. 
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Figure S4. FTIR spectra of  the benperidol solvates and polymorphs I and III. Asterisks marks the most 
characteristic bands from the solvent molecules in isostructural solvates. 
 
Figure S5. FTIR spectra of  the benperidol DH and polymorphs IV and V. The peaks showing most 
characteristic differences between IV and V are designated with asterisks.  
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EVALUATION OF THE THERMODYNAMIC STABILITY OF BENPERIDOL POLYMORPHS 
From the melting points of  I (171 °C) and II (161 °C) and from slurry bridging experiment in isopropanol 
of  the mixture of  polymorphs I and II at 50 °C it was determined that thermodynamically stable polymorph 
at elevated temperatures is polymorph I. Interestingly, slurry bridging experiments of  the same mixture in 
acetone at ambient temperature showed the transformation of  polymorph I to polymorph II, while no 
phase change occurred in isopropanol. This could show that II is thermodynamically stable at ambient and 
lower temperatures. This, however, was not supported by computational calculations, as total energy 
calculated in CATSEP of  I is by 2.5 kJ·mol-1 lower than that of  II. This was calculated after relaxation of  
all atom positions for crystal structures determined at 173 K. 
The melting points of  polymorphs III (146 °C) and IV (149 °C) indicates that both of  these phases have 
lower thermodynamic stability than I and II in high temperatures, while the same stability relationship at 
lower temperatures was confirmed by the observed conversation of  III and IV to polymorph I in slurry 
bridging experiment in 2-propanol and tetrahydrofuran at 50 °C. 
The exothermic peak corresponding of  phase transition from V to IV at 127 °C proves monotropic 
relation between these polymorphs with V being thermodynamically less stable in all temperatures. 
 
DETERMINATION OF CRYSTAL STRUCTURES OF BENPERIDOL SOLVATES AND POLYMORPHS 
Table S2. Crystallographic data for the benperidol phases II, DH, SEt, SMe, SACN, SEtOAc, HH, SBenz and III. 
Solvate II DH SEt SMe SACN SEtOAc HH SBenz III 
Empirical 
formula 
C22H24FN3O2 C22H24FN3O2 
·2H2O 
C22H24FN3O2 
·C2H6O 
C22H24FN3O2 
·CH4O 
C22H24FN3O2 
·C2H3N 
C22H24FN3O2 
·0.5C4H8O2 
C22H24FN3O2 
·0.5H2O 
C22H24FN3O2 
·C7H8O 
C22H24FN3O2 
Mr 381.44 417.48 427.51 413.48 422.49 425.49 390.45 489.58 381.44 
Crystal 
system 
triclinic monoclinic monoclinic monoclinic triclinic triclinic monoclinic orthorombic triclinic 
Space 
group 
P P21/n P21/c P21/c P P C2/c Pbca P 
a (Å) 10.8417(3) 11.0595(3) 15.0684(3) 15.1097(4) 5.56500(10) 5.4228(3) 36.7342(7) 13.7193(4) 15.61501(10) 
b (Å) 16.2903(4) 9.3896(2) 10.8602(3) 10.7200(3) 14.1256(4) 14.6014(8) 5.58581(10) 51.6467(20) 11.48189(8) 
c (Å) 17.9497(5) 20.4456(6) 15.2555(4) 15.3070(5) 15.0478(5) 14.8045(10) 23.6629(5) 7.43071(20) 5.45694(30) 
α (o) 66.7233(11) 90 90 90 109.2583(13) 109.936(3) 90 90 86.627(3) 
β (o) 87.0069(10) 91.7206(11) 117.6353(9) 119.3538(13) 90.9875(13) 90.199(2) 124.8680(8) 90 96.618(6) 
γ (o) 85.0074(16) 90 90 90 100.071(2) 100.322(3) 90 90 94.435(5) 
V (Å3) 2900.55(13) 2122.20(10) 2211.69(9) 2161.04(11) 1095.91(5) 1081.50(11) 3983.71(14) 5265.07(30) 967.71(6) 
Z/Z’ 6/3 4/1 4/1 4/1 2/1 2/1 8/1 8/1 2/1 
T, K 173(2) 173(2) 173(2) 173(2) 173(2) 100(2) 298(3) 298(3) 298(3) 
μ (mm−1) 0.092 0.096 0.091 0.091 0.089 0.090    
Dcalc (g 
cm−3) 
1.310 1.307 1.284 1.271 1.280 1.264    
no. of 
parameters 
757 271 286 273 285 276    
reﬂns 
collected 
13138 5709 5900 5753 4973 3659 6407 6603 6407 
reﬂns (I > 
2σ)a 
6787 3734 4081 3503 3730 2532    
wR (all 
data) 
0.1616 0.196 0.1415 0.1997 0.1126 0.1992    
ﬁnal R (I 
> 2σ)a 
0.0765 0.048 0.0543 0.0644 0.0460 0.0751    
GOF 1.013 1.243 1.028 0.972 1.018 1.030    
Δρmax 
(e·Å-3) 
0.244 0.59 0.293 0.265 0.212 0.603    
Δρmin (e·Å-
3) 
-0.285 -0.63 -0.251 -0.287 -0.189 -0.543    
Rwp       0.02897 0.03356 0.03686 
Rp       0.01721 0.02427 0.0243 
Rexp       0.00520 0.00734 0.00816 
final R (all 
data) 
      0.1203 0.0787 0.0660 
GOF       5.57 4.57 4.52 
Pacing 
coef. 
0.682 0.689 0.684 0.672 0.681 0.690 0.675 0.651 0.681 
a – For DH I > 3σ  
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Figure S6. Experimental (black), calculated (red), and difference (dark-blue) PXRD profiles from the final 
Le Bail refinement of  different benperidol forms. 
 
Figure S7. Molecular structure of  benzyl alcohol with the numbering of  non-hydrogen atoms and 
labelling of  flexible torsion angles. 
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Figure S8. Overlay of  the experimental and from crystal structure data simulated PXRD patterns for 
benperidol solvates and polymorphs. Observed differences in peak positions were due to the different 
temperature used for the crystal structure determination and experimental PXRD measurements, whereas 
the intensity differences between calculated and experimental PXRD patterns suggested the presence of  
preferred orientation. 
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Figure S9. Overlay of  crystal structures after final Rietveld refinement and geometry optimization in 
CASTEP. 
 
ANALYSIS OF CRYSTAL STRUCTURES OF BENPERIDOL SOLVATES AND POLYMORPHS 
 
Figure S10. Overlay of  the benperidol molecules in polymorph II. IIA: red, IIB: dark grey, IIC: cyan. 
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Figure S11. Overlay of  the benperidol molecules in type 1 solvates. SEt – dark green, SMe – light blue 
 
Figure S12. Overlay of  the benperidol molecules in type 2 solvates, HH and polymorph III. III – red, 
SEtOAc –green, HH – blue, and SACN – orange. 
Table S3. Torsion angles (in degrees) of  benperidol in its solvates SMe and SEtOAc. 
 SMe SEtOAc 
τ1 -107.02 -114.25 
τ2 -72.92 -71.26 
τ3 -176.56 -169.89 
τ4 178.26 -170.85 
τ5 -179.87 -176.10 
τ6 178.40 -177.23 
 
 
Figure S13. 2D fingerprint plots of  Hirshfeld surface for benperidol molecules in polymorphs II and III. 
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Figure S14. 2D fingerprint plots of  Hirshfeld surface for benperidol solvate SMe. 
Slight differences in small spikes corresponding to CHF interaction was observed for SMe and SEt due 
to different hydrogen bond geometry. Besides, closer molecule packing in SMe was identified from smaller 
di and de distances for central spike corresponding to HH contacts. This is due to smaller size of  the 
methanol molecule and this increase of  benperidol molecule separation possibly explains the reason for not 
observing isostructural solvates with bigger alcohol molecules. 
 
 
Figure S15. 2D fingerprint plots of  Hirshfeld surface for benperidol solvate SEtOAc. 
Most noticeable differences observed in plots of  benperidol molecules in SACN and SEtOAc is associated 
with differences in interactions with the solvent molecules. 
 
 
Figure S16. 2D fingerprint plots of  Hirshfeld surface for water molecules in both benperidol hydrates. 
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Table S4. Geometrical parameters for all intermolecular interactions (with D···A distance lower than vdW 
radii – 0.1Å) in benperidol polymorphs and solvates. 
Phase Interaction 
Distance, Å 
D-H···A (o) Graph set 
X-H H···A D···A 
I N2-HN3   2.883  𝑅6
6(48) 
 C21-HO2   3.140  C(6) 
 C21-HO1   3.235  𝑅6
6(84) 
 C15-HO1   3.454  𝑅6
6(66) 
II N2A-HO1A 0.86 1.96 2.800(3) 165 𝑅2
2(8) 
 N2B-HO1C 0.86 1.95 2.779(3) 161 𝑅2
2(8) 
 N2C-HO1B 0.86 2.03 2.881(3) 171 𝑅2
2(8) 
 O2AH-C2B 0.93 2.48 3.389(4) 165  
 C18A-HO2B 0.93 2.50 3.217(4) 134  
 C13A-HO1C 0.97 2.50 3.348(4) 146  
 C2A-HO2C 0.93 2.42 3.347(4) 178  
 C22A-HO1B 0.93 2.62 3.499(4) 158  
 C10A-HF1C 0.97 2.53 3.409(4) 151  
 C21A-HF1A 0.93 2.53 3.265(4) 136  
 O2BH-C15C 0.97 2.52 3.469(4) 165  
 O1BH-C9C 0.97 2.61 5.514(4) 155  
SMe N2-HO3 0.86 1.97 2.783(3) 157 𝐶2
2(10) 
 O3-HN3 0.82 2.00 2.806(3) 169  
 C11-HO1 0.97 2.51 3.420(3) 156  
 C19-HO1 0.93 2.48 3.191(3) 133 C(15) 
 C4-HF1 0.93 2.48 3.332(3) 152 C(19) 
 C15-HF1 0.97 2.51 3.420(3) 156 C(8) 
SEt N2-HO3 0.90(2) 1.91(2) 2.7872(19) 163.9(18) 𝐶2
2(10) 
 O3-HN3 0.82 1.98 2.7931(19) 175  
 C11-HO1 0.97 2.56 3.444(2) 152  
 C19-HO1 0.93 2.53 3.249(2) 134 C(15) 
 C21-HO1 0.93 2.62 3.498(2) 158 C(15) 
 C15-HF1 0.97 2.45 3.365(2) 158 C(8) 
SACN N2-HO1 0.89(2) 1.906(19) 2.7978(16) 177.1(14) 𝑅2
2(8) 
 C18-HO2 0.93 2.45 3.246(2) 143 𝑅2
2(10) 
 C21-HN4 0.93 2.60 3.511(2) 165 𝐷 
SEtOAc N2-HO1 0.86(4) 1.93(4) 2.776(4) 172(4) 𝑅2
2(8) 
 C18-HO2 0.93 2.50 3.238(5) 137  
 C15-HO2 0.97 2.61 3.511(5) 155  
 F1H-C23 1.08 2.16 3.232(4) 172  
 F1 H-C25 1.08 2.33 3.065(5) 124  
 O3 H-C5 0.93 2.61 3.352(5) 137  
 O3 H-C21 0.93 2.52 3.411(5) 162  
DH O4-HO3 0.92 1.85 2.7271(19) 159  
 O4-HO2 0.85 2.02 2.8597(19) 168  
 N2-HO4 0.97 1.86 2.7629(18) 153  
 O3-HO1 0.9 1.98 2.8385(17) 159  
 O3-HN3 0.87 1.95 2.8122(18) 174  
 C3-HO2 0.96 2.60 3.382(2) 139  
 C12-HO1 0.96 2.54 3.434(2) 156  
 C15-HO1 0.96 2.48 3.384(2) 157  
III N2-HO1 0.91 1.97 2.866(9) 167 𝑅2
2(8) 
 C5-HF1 0.93 2.50 3.113(10) 124  
SBenz N2-HO3 0.86 1.99 2.841(7) 169 𝐶2
2(10) 
 O3-HN3 0.90 1.75 2.625(8) 162  
 C15-HO1 0.96 2.57 3.470(7) 155  
 C21-HO2 0.93 2.27 3.190(6) 171  
 C19-HF1 0.93 2.43 3.173(6) 136  
HH N2-HO1 0.90 1.90 2.787(8) 165 𝑅2
2(8) 
 O3-HN3   3.005(15)  𝐷2
2 
 C11-HO3 0.96 2.60 3.23(2) 124  
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Figure S17. Packing of  benperidol molecules in polymorphs I and II showing structural voids. 
 
Figure S18. Arrangement of  solvent molecules in the channels of  type 2 solvates. 
 
Figure S19. Molecular packing in benperidol polymorphs and solvates. 
Besides the identified packing similarities, some additional minor similarities of  packing between 
individual molecule moieties associated with the presence of  a particular identical intermolecular 
interactions was found using XPac code3. Most similar feature was identified in the crystal structures of  
type 1 and type 2 solvates, which contains identical 0D supramolecular construct: a benperidol molecule 
dimer. Identical 0D supramolecular construct (benperidol molecule dimer) was found also in polymorph II 
and in the structures of  type 2 solvates, HH, III as well as in DH. However, packing of  these dimers in 
crystal structures is completely different. 
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Using crystal structures of  SACN and SEtOAc crystal structure of  isostructural SNM was modelled. Firstly 
lattice parameters were determined from ambient temperature PXRD pattern using LP-Search indexing 
algorithm implemented in TOPAS v4.2. After that crystal structure of  SACN was modified by setting the 
determined lattice parameters and replacing the acetonitrile molecule with the nitromethane molecule 
(extracted from crystal structure of  droperidol nitromethane solvate). Then the obtained structure was used 
as input for geometry optimization (by relaxing all atom positions) in CASTEP. It was determined that SNM 
should exist in a form of  monosolvate as the size of  nitromethane (48.1 cm3∙mol-1) is only slightly larger 
than that of  acetonitrile (37.9 cm3∙mol-1) and it is able to position in one channel. 
 
COMPUTATIONAL SIMULATION OF INFRARED SPECTRA 
Interestingly, based on the presence of  a single carbonyl stretching band at 1685 cm–1 in the IR spectra, 
it has been stated that benperidol in II and SEt has ionized and exists in the zwitterionic form, whereas the 
presence of  two carbonyl stretching bands at 1685 cm–1 and 1710 cm–1 in I benperidol has been associated 
with its existence in a neutral state. However, crystal structure data rejects this statement (see Table S5). Also 
it was stated that polymorph III actually is a mixture of  I and II4, despite unique PXRD peak positions 
have been given elsewhere5. 
Table S5. Lengths of  the selected bonds as well as the location of  hydrogen atom H5 in crystal structures 
of  benperidol solvates and polymorphs. 
Phase C1-O1 N2-C1 Hydrogen attached to: 
I 1.211 1.369 
N2 
IIa 1.238-1.247 1.363-1.374 
SEtOH 1.233 1.366 
SACN 1.237 1.358 
DH 1.235 1.365 
a – maximum and minimum value for three molecules in the asymmetric unit. 
 
Table S6. Experimental and calculated IR frequencies and their intensities for both carbonyl groups in 
different benperidol solvates and polymorphs. 
Band Experimental, cm-1 Calculated*, cm-1 
Polymorph I 
C=Oamide 1707 (100%) 1728 (100%) 
C=Oketone 1685 (98%) 1706 (25%) 
SBenz 
C=Oamide 1709 (100%) 1721 (100%) 
C=Oketone 1682 (100%) 1702 (40%) 
Polymorph II 
C=Oamide 1696 (90%) 1708 (100%) 
C=Oketone 1683 (100%) 1701 (30%) 
Type I solvates 
C=Oamide 1689 (100%) 1706 (100%) 
C=Oketone 1692 (30%) 
Type II solvates 
C=Oamide 1695 (98%) 1708 (100%) 
C=Oketone 1683 (100%) 1700 (30%) 
HH 
C=Oamide 1696 (96%) 1704 (100%) 
C=Oketone 1683 (100%) 1699 (20%) 
Calculated at pm6 level and rescaled by multiplying with scale factor 0.953. 
STUDY OF DEHYDRATION PROCESS AND KINETICS OF BENPERIDOL SOLVATES 
For studying the desolvation kinetics, TG analysis in open aluminium pans was performed with 
Exstar6000 TG/DTA6300 (SII Nanotechnology). Desolvation kinetics were studied in the isothermal mode 
at the temperature range from 30 to 110°C with a step of  5 °C. The heater unit was preset to the required 
temperature before the insertion of  the sample. For each sample, desolvation was performed at four to eight 
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different temperatures selected according to the desolvation rate, which depended on the analysed solvate 
and the particle size. The sample weight was 5.0±0.5 mg and the nitrogen flow rate was 100±10 mL∙min-1. 
The desolvation activation energy and kinetic model were determined using a model-free approach6. The 
data sets of  fraction desolvated (α) – time were obtained with Δα = 0.02 for each temperature. Ea was 
calculated from the Arrhenius equation with isoconversional methods7-9: Friedman (FR)10 and average linear 
integral method (ALIM)11. The Ea was calculated from the slope of  the line in the corresponding 
coordinates for α values with step size 0.0210, 11, and identical Ea values were obtained. The confidence 
intervals for the calculated Ea values were evaluated from the slope error of  the line used for calculation of  
Ea with the FR method. Kinetic model determination was performed with ALIM11 and also with the reaction 
progress reconstruction in the coordinates g(α) – α12, 13 and f(α) – α9, 12, 13. Besides, kinetic model 
determination was performed with reduced time plots14. The most often used solid state kinetic models 
were included in the analysis7-9, 15-17. 
Dihydrate. Dehydration kinetics of  DH powder was studied in isothermal mode. It was determined that 
the dehydration Ea = 120±20 kJ·mol-1, and the dehydration is limited by the phase boundary movement, 
with the most suitable kinetic model being R2 in particular. Hot-stage microscopy (HSM) analysis of  the 
dehydration of  a single crystal, however, showed the nucleation and nuclei growth, which could explain the 
formation of  polymorphs II and I in the dehydration process of  a crystal. 
 
S20. Dehydration kinetic curves of  DH at different temperatures in isothermal mode. 
 
Type 1 solvates. A study of  the desolvation kinetics of  grinded type 1 solvate samples in isothermal mode 
was performed and it was determined that the desolvation Ea is 100±20 kJ·mol-1 for SMe and 120±20 kJ·mol-
1 for SEt. Nevertheless, the desolvation curves was complicated by fast desolvation up to desolvation degree 
α = 0.5 and then relatively slow desolvation at higher α values due to already described difference in the 
desolvation rates for solvate with different distance from the surface of  the particles. The desolvation curves 
resembled those of  diffusion models (D5 in particular), meaning that the rate limiting step is a diffusion, 
which agrees with the observation that the escape of  the solvent across the product layers is difficult and 
able to significantly slow down the desolvation process. 
 
Figure S21. Desolvation kinetic curves of  type 1 solvates at different temperatures in isothermal mode. 
235 
Type 2 solvates. Desolvation Ea for both SACN and SEtOAc was determined to be 150±30 kJ·mol-1 and 
desolvation appeared to be limited by the phase boundary movement. HSM analysis revealed that 
desolvation of  SACN crystal occurred by the appetence of  dark spots oriented along the crystal longest 
dimension, which, based on the morphology prediction in Mercury, is along a−axis in the direction of  the 
solvent channels. Both of  these observations support the assumption that the desolvation occurs by the 
solvent escape via the channels. 
 
Figure S22. Desolvation kinetic curves of  SACN at different temperatures in isothermal mode. 
 
Benzyl alcohol solvate. It was determined that the desolvation Ea = 100±10 kJ·mol-1, and the desolvation 
is limited by the phase boundary movement, with the most suitable kinetic model being R3 in particular. 
 
Figure S23. Desolvation kinetic curves of  SBenz at different temperatures in isothermal mode. 
 
Dioxane solvate. The desolvation of  SDIOX at elevated temperature produced mainly polymorph III, 
although typically also impurities of  I were observed. Desolvation analysis with VT-PXRD showed that 
poorly crystalline III was the initial desolvation product with the following transformation to more 
crystalline III. More complex desolvation occurred at ambient conditions, see Figures S24. In the first step 
the intensity of  peaks characteristic to SDIOX decreased, followed by the appearance of  new peaks, position 
for part of  which corresponded to that of  polymorph III. Further reduction of  the intensity for peaks not 
corresponding to the polymorph III occurred, and after 22 days only peaks corresponding to HH was 
present. Parallel to PXRD analysis thermal analysis was carried out (see Figures S25) and showed the 
reduction of  the solvent content by increasing the time. This confirms the presence of  two phases after the 
desolvation and suggests that the disappearing phase probably is a lower stoichiometry dioxane solvate 
(designated as SDIOX2 in Figure 11), while phase present after 22 days is pure HH. 
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Figure S24. PXRD patterns recorded during storage of  SDIOX in ambient conditions. 
 
Figure S25. DTA/TG patterns recorded during storage of  SDIOX in ambient conditions. 
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The dehydration of mildronate dihydrate (3-(1,1,1-trimethylhydrazin-1-ium-2-yl)propionate dihydrate) was
investigated by powder X-ray diffraction, thermal analysis, hot-stage microscopy, water sorption–desorption
studies and dehydration kinetic studies. It was determined that mildronate dihydrate dehydrated in a single
step, directly transforming into the anhydrous form. In order to understand the reasons for a one step
dehydration mechanism, crystal structures of dihydrate, monohydrate and anhydrous forms were compared,
proving the similarity of the dihydrate and anhydrous forms. In order to understand the reasons for molecule
reorganization during dehydration, the energy of the anhydrous form was compared with that of a theoretical
dihydrate structure without water molecules. It was proven that the experimentally observed anhydrous
phase AP was thermodynamically more stable. By analyzing the effect of the particle size and sample weight
on the dehydration kinetic parameters it was determined that besides the main rate limiting step, phase
boundary advancement, contribution from the water diffusion outside the crystal and the water diffusion
outside the powdered sample also appeared to affect the dehydration kinetics and contribution from
these processes could be changed by changing the aforementioned factors.Introduction
It has been shown that many active pharmaceutical ingredi-
ents (APIs) can exist in hydrated forms.1 Changes in the
hydration state of API can occur during crystallization, drying,
wet granulation, milling, freeze drying, tableting, or even
during storage and transportation.1,2 Such changes result in
modification of API physicochemical properties, such as solu-
bility, dissolution rate and bioavailability,2 so it is important
to identify possible phase transitions and to determine the
conditions in these transitions before undertaking routine
manufacturing. One of the main factors affecting hydrate sta-
bility is the role played by water molecules in the crystal struc-
ture, and it has been pointed out3 that besides investigating
the conditions for hydrate stability and phase transitions it is
also important to understand and explain these phenomena
from a structural point of view, thus enabling the prediction
of hydrate stability and changes using crystal structures as the
only starting information.
The most common techniques for studying dehydration or
desolvation are powder X-ray diffraction (PXRD),4–6 differential
scanning calorimetry (DSC),6–9 thermogravimetry (TG),10,11hot-stage microscopy (HSM),4,12–14 differential thermal analysis
(DTA),9 infrared and Raman spectroscopy15–17 and nuclear
magnetic resonance spectroscopy.16,18 By using these methods
it is possible to explore the dehydration behaviour of a hydrate.
However, these techniques alone are insufficient for under-
standing the reasons for changes if structural analysis of the
crystals is not performed. Thus, the crystal structures of
hydrate and dehydration products should be compared. That
includes comparison of structures19 by using packing
analysis,20–22 investigation of molecular conformation23 and
intermolecular interactions.24–26
An additional tool to better understand dehydration
mechanisms is the determination of dehydration kinetic
parameters: kinetic model and activation energy (Ea).
5,27
Although it is known that there are a lot of factors affecting
the dehydration kinetics and there are cases where these
effects can be very important,28 it is generally accepted that
the crystal structure is usually the dominant factor.16,29,30
Therefore, by knowing the crystal structure of a hydrate and
its dehydration kinetic parameters, it is possible to under-
stand the mechanism of the dehydration process.4,5,14,27,29–31
Mildronate (3-(1,1,1-trimethylhydrazin-1-ium-2-yl)propionate;
Fig. 1) is a γ-butyrobetaine analogue, an inhibitor of
γ-butyrobetaine hydroxylase, and used as an anti-ischemic
drug.32,33 It is known to exist in the form of dihydrate,34 mono-
hydrate or anhydrous phase.35 The crystal structures of all of
these phases are known. Dihydrate DH belongs to the P21/c
space group,34,36 the monohydrate MH crystallizes in the P1¯
space group,37 and both hydrates contain water molecules inoyal Society of Chemistry 2014
Fig. 1 Molecular structure of mildronate showing the atom
numbering scheme and dihedral angle designations used in this work.
CrystEngComm Paperstructural channels. The anhydrous phase AP belongs to the
P21/n space group with empty channels present in the
structure.37 Mildronate is hygroscopic and deliquesces if kept
in high humidity. When heated in dry air, mildronate DH
transforms into AP, whereas at high temperature and relatively
high humidity it transforms into MH.35 However, the dehydra-
tion mechanism of the DH, the only stable mildronate form in
ambient conditions, has not yet been examined. Understanding
the mechanism of such dehydration is important for the
systematic study of the dehydration processes of pharma-
ceutical materials.38
The aims of this study were: a) to determine the dehydra-
tion mechanism of mildronate DH; b) to establish the
reasons for the observed one step dehydration process of
mildronate DH directly to the AP, c) to understand the
observed dehydration product formation by calculating the
conformation and crystal structure energy, and d) to calculate
the dehydration kinetic parameters and relate them to the
dehydration mechanism and the crystal structure of DH.
Experimental section
Sample preparation and storage
Mildronate was provided by JSC Grindeks, Riga, Latvia, and
was confirmed as pure DH by PXRD. A sample was prepared
by slowly crystallizing mildronate from water at 30 °C. The
obtained product was then fractionated according to the
particle size by pushing through sieves with mesh sizes of
1300, 700, 350, 150, 67 and 40 μm, thus obtaining 6 fractions
(the obtained particle size distribution for different fractions
is given in Fig. S1†). The sample was stored above the saturated
solution of potassium acetate (relative humidity of 22.5%).
Powder X-ray diffraction
PXRD patterns were measured on a D8 Advance (Bruker)
diffractometer using copper radiation (CuKα) at a wavelength
of 1.54180 Å. The tube voltage and current were set to 40 kV
and 40 mA, respectively. The divergence and antiscattering
slits were set at 1.0 mm, and the receiving slit was set at
0.6 mm. The diffraction patterns were recorded with a scintil-
lation detector using a scanning speed of 0.5 s/0.02° from 3°
to 30° in the 2θ scale. When necessary, to prevent the atmo-
spheric humidity effect, samples were covered with a 10 μm
polyethylene film.
For variable temperature PXRD (VT-PXRD), a D8 Advance
(Bruker) diffractometer equipped with a MRI heating stage, a
Sol-X energy dispersive detector, automatically adjustableThis journal is © The Royal Society of Chemistry 2014slits (1.0, 1.0 and 0.1 mm) and Soller collimators were used.
The diffraction patterns were recorded using a scanning speed
of 4 s/0.02° from 10° to 25° in the 2θ scale. A stepwise temper-
ature increase of 1 °C per diffraction pattern was used from
30 to 60 °C, and then 5 °C per diffraction pattern was used up to
80 °C.Thermal analysis
DSC patterns were recorded with a DSC 823e apparatus
(Mettler Toledo), and 5–10 mg of each sample was used for
analysis. Samples were heated in sealed aluminium pans at a
heating rate of 1 °C min−1 or 5 °C min−1 from 30 °C to
120 °C in static air atmosphere. Some of the samples were
pinholed with a hole diameter 0.5 mm.
DTA/TG analysis was performed with an Exstar6000 TG/DTA6300
(SII) apparatus. Open aluminum pans were used. Sample
heating from 30 to 120 °C was performed at heating rates of
0.5, 1, 2, 3, 4 and 5° min−1. A sample mass of 7.0 ± 0.5 mg and
nitrogen flow with a rate of 80 ± 10 mL min−1 were used.
Dehydration kinetics was analyzed isothermally in a
temperature range of 25 to 80 °C with a step of 5 °C using an
Exstar6000 TG/DTA6300 (SII) apparatus. The heater unit was
preset to the required temperature allowing fast stabilization
of the necessary temperature at the start of the experiment.
For each sample, dehydration was performed at eight different
temperatures selected according to the dehydration rate. The
sample mass was 7.0 ± 0.5 mg, and the nitrogen flow rate was
80 ± 10 mL min−1. The effect of the sample mass was deter-
mined at additional data points, where the sample mass was
2, 4, 6, 8, 10 mg.
For HSM, a Laborlux 12 PolS (Leitz) polarized light micro-
scope equipped with a heating stage and a Newtronic heating
control module was used. The heating rate was 5° min−1.
Images were collected with Leica Application Suite software
from a DFC450 (Leica) digital microscope camera.Energy calculation and geometry optimization
Single molecule and molecular cluster energy calculation and
geometry optimization were performed in Gaussian09.39
Energy calculation and geometry optimization of crystal struc-
tures were performed in CRYSTAL0940 at the B3LYP-D*41,42
level using a 6-31G(d,p) basis set.43,44 DFT-D dispersion correc-
tion was performed with a Grimme dispersion correction
model45 modified as described in the literature.42,46,47 Detailed
parameters used for calculations in CRYSTAL09 are given in
the ESI.† For calculations crystal structures of DH (determined
from SCXRD data36) and AP (determined from PXRD data,37
corrected in Gaussian09 at the B3LYP/6-31G level. See ESI†)
were used. All of the obtained energies were corrected for the
basis set superposition error by the counterpoise method.48
Infrared frequency calculation49,50 was performed for structures
after the full geometry optimization in order to calculate the
zero-point vibration correction and thermal correction on the
total energy.CrystEngComm, 2014, 16, 3926–3934 | 3927
Fig. 2 VT-PXRD patterns of mildronate DH dehydration.
Fig. 3 DTA/TG curves of mildronate DH fraction 67–150 μm at various
heating rates.
CrystEngCommPaperHydrogen bonded dimer and lattice energy calculation in
CLP suite
Lattice energy calculations were performed with semi-
empirical PIXEL51 methodology (code provided in the CLP
software suite). Empirical parameters were used as provided
in the literature.51,52 The atom positions for the purposes of
this calculation were obtained by standard procedure using
RETCIF and RETCOR modules. Hydrogen atom positions
were renormalized. Molecular electron density calculations
were performed in Gaussian0939 at the MP2/6-31G(d,p) level
using standard grid parameters. Condensation at level 4 and
a calculation cutoff value of 35 Å were used.
Calculation of kinetic parameters
Data sets of conversion degree (α)-time were obtained with
Δα = 0.02 at each temperature. Ea was calculated using model
fitting methods: the kinetic model was determined from
linearization of experimental points in coordinates g(α)-time,
and the model with the best linear fit was selected from the
list of the most often used solid-state kinetic models.4,27,53,54
The dehydration rate constants were subsequently determined
by plotting experimental data points in the coordinates α-time
and fitting theoretical lines modelled from selected kinetic
models to the experimental points. The sum of the squared
differences between practical and theoretically calculated α
values was minimized with MS Excel Solver. If more than one
model was selected for this procedure, then the best model
was identified by the smallest sum of the least squares. The
Ea values were then determined from the Arrhenius plot.
Results and discussion
Characterization of mildronate dihydrate dehydration
It was determined that at a 25 °C temperature DH was stable
in the relative humidity interval from 6 to 50%, but
dehydrated to AP at humidity below 6%. Thus it was con-
firmed that MH was not thermodynamically stable at any of
the examined conditions (see ESI†). It was observed that the
dehydration of DH at various temperatures gave AP as the
only product, implying that the dehydration of DH was a one
step process. In order to confirm this dehydration mecha-
nism, we analyzed the dehydration of DH with VT-PXRD
under air atmosphere. The temperature in the range where
dehydration was observed in other experiments was raised
with a 1 °C step size per diffraction pattern, until complete
dehydration was observed. Diffraction patterns for those
temperatures where phase transition was observed are given
in Fig. 2. It can be seen that at p(H2O) = 1.1 kPa, with relative
humidity of 40% at 22 °C, dehydration started at the 57 °C
temperature, which was identified by appearance of the AP
peaks (marked with blue triangles). Formation of MH was
not observed in this experiment, nor in other similar experi-
ments. The characteristic diffraction peak position for MH
would be at 12.0° and 16.6° in the 2Θ scale (as illustrated in
Fig. S3†).3928 | CrystEngComm, 2014, 16, 3926–3934Dehydration of DH samples was analyzed with DSC in
closed or pinholed sample holders and with DTA/TG in open
pans under nitrogen flow. In DTA analysis one or two
overlapping endothermic peaks appeared with dehydration
starting at 45–55 °C. The second endothermic effect was
always observed as a relatively narrow peak at 86–88 °C and
above this temperature the weight loss rate noticeably
decreased. The temperature of the first peak was affected by
the heating rate and the particle size, whereas these parameters
did not affect the temperature of the second peak (see Fig. 3
and S4†). When DH samples were analyzed with DSC, dehy-
dration was observed as a narrow signal with peak tempera-
tures of 88–90 °C, regardless of the hole in the container
(see Fig. S4†). From various experiments (9 scans for particle
size fractions from <40 μm up to 350–700 μm) the enthalpy
of the observed process was calculated as 31.8 ± 0.9 kJ mol−1.
From the obtained data it can be concluded that the
observed endothermic process in the DSC scans under static
air atmosphere was melting/peritectic decomposition of
the DH. This explains the observed enthalpy value (31.8 ±
0.9 kJ mol−1), which was too low even for the evaporation of
two water molecules (the vaporization enthalpy of water at
the corresponding temperature is 41.6 kJ mol−155). This was
obvious for closed pans, and the explanation for pinholed
pans was that the size of the hole was too small for evapora-
tion of the evolved water during the analysis. However, whenThis journal is © The Royal Society of Chemistry 2014
CrystEngComm PaperDH was heated in a DTA/TG instrument on open pans, nucle-
ation of AP started at lower temperatures and water was lost
much more effectively. Thus the dehydration of the DH was
finished before reaching the melting temperature in cases
when the heating rate was slow enough and/or particles were
small enough. By using the DTA data it was calculated that
the dehydration enthalpy of the DH was 120 ± 10 kJ mol−1,
corresponding to the sum of the crystal hydrate decomposi-
tion and water vaporization enthalpies (DTA was calibrated
with substances having known melting and dehydration
enthalpy values).
If complete dehydration was not reached until the melting
temperature in the DTA scans, then a melting/peritectic
decomposition process was also observed. This was supported
by the HSM study of two samples with different particle sizes
(see ESI†) and by the decrease of the weight loss rate.
Phase composition of the samples obtained after and
during DTA/TG analysis was determined with PXRD. It was
found that for samples where dehydration was observed as a
one step process (complete dehydration was reached below
86–88 °C), the only phase which formed during and after the
dehydration was AP. The results of PXRD and thermal analy-
sis thus indicated that AP formed as the only product in a
one-step dehydration process. However, when dehydration
was slower (and also the melting/peritectic decomposition
signal appeared in DTA) during and after the second endo-
thermic dehydration peak (at temperatures above 90 °C), MH
was sometimes also detected as one of the phases. Neverthe-
less, after exceeding the melting temperature, formation of
MH occurred due to the crystallization of mildronate from
the solution or solid phase transition from the AP in the
presence of liquid water. This observation agreed with the
previously reported fact that MH was stable only at an
elevated temperature.35
The relationship between crystal structures and the observed
dehydration mechanism
The dehydration of DH resulted in the formation of AP
instead of MH. This observation could be related to the simi-
larity of the crystal structures of DH and AP. To explore this
theory, we analyzed the structures of three crystalline phases
formed by mildronate.This journal is © The Royal Society of Chemistry 2014
Fig. 4 Molecular packing in the crystalline forms of mildronate (hydrogen aMildronate molecules in the structures of DH and MH
adopted the same conformation and were characterized by
the same hydrogen bonding motif different from that in the
AP structure (see ESI†). Thus, from this analysis, the crystal
structures of DH and MH appeared to be similar.37
However, analysis of molecular packing in the crystal
structures of DH, AP and MH showed that the structures of
DH and AP were similar and consisted of four mildronate
molecules notated A, B, C and D (each generated by one of
four symmetry operations corresponding to the P21/c or P21/n
space group). In DH these molecules were grouped around
the hydrogen bonded graph set ring R44(8) formed by water
molecules (see Fig. S12†). Each of the four molecules, A, B, C
and D, formed a hydrogen bonded molecule pair with the
molecules A′, B′, C′ and D′, respectively. Similarly arranged
four pairs of molecules, A–A′, B–B′, C–C′ and D–D′, could be
identified in the crystal structure of AP as well (see Fig. 4).
However, in the structure between these molecules there was
an empty channel, and molecule pairs were packed more
tightly. Besides this, there were significant changes in molec-
ular conformation (τ1 and τ2, see ESI†) and hydrogen bonds
between the molecule pairs A and A′, B and B′ etc. were
lost, but new hydrogen bonds formed between molecules
A and D, and between B and C, thus forming C(6) chains
(see Fig. S12†). Therefore, inversion-related antiparallel mole-
cule pairs occurred in the crystal structures of DH and AP.
Two such antiparallel pairs (A–A′ and C–C′) were situated
perpendicularly to two other (B–B′ and C–C′).
In the crystal structure of MH, inversion-related antiparallel
molecule pairs E–F were packed parallel to other such pairs,
resulting in layers of mildronate molecules (see Fig. 4). These
layers were interconnected by hydrogen bonds mediated by
water molecules (see Fig. S12†). Although hydrogen bonded
antiparallel molecule pairs with the same molecular conforma-
tion were present in both hydrates, these pairs in theMH struc-
ture were packed in a different way. Therefore, the molecular
conformation can be associated with hydrogen bonding motif
and/or the presence of the hydrogen bonds with water mole-
cules but not with the molecular packing.
Thus, it was shown that the transformation from DH to
AP was associated with only minor changes in packing of the
mildronate molecules. At the same time, the transformationCrystEngComm, 2014, 16, 3926–3934 | 3929
toms have been omitted for clarity).
CrystEngCommPaperfrom the DH structure to MH was connected with important
reorganization of mildronate molecular packing, which could
occur only during destructive dehydration followed by crystal-
lization of a new phase. Thus it can be seen that transition
from DH to AP should be an easy one-step process, and not
connected with formation of MH as an intermediate step.
However, dehydration did not occur as a single crystal to sin-
gle crystal transition. It can be concluded that structure reor-
ganization was important enough to introduce cracking and
thus AP was produced as a polycrystalline powder.
Based on the structural analyses, we provide a mechanism
of water elimination and structure reorganization explaining
the observed dehydration of DH to AP. Due to the presence
of large channels containing all of the water molecules, it
was likely that the first step in the dehydration process repre-
sented escape of water by emptying of the channels (see 1 in
Fig. 5). After this step, conformation change (2) and molecu-
lar translation (3) occurred, forming AP as the final product.
Although separated in the Fig. 5 for clarity, most probably
both of these processes happened simultaneously and were
associated with disappearance of the hydrogen bonded mole-
cule pairs and formation of new hydrogen bonds observed in
the AP structure.
Thus, based on the dehydration process classification
according to structural changes during the dehydration,
dehydration of the DH could be classified as a) a water evolu-
tion type WET3 with direct formation of the AP crystalline
phase after the dehydration3 and b) cooperative release of
water followed by the cooperative rearrangement, thus
belonging to the class II-Coop.-Reorg.,56 according to the two
systems described in the literature.Analysis of the observed structural changes during the
dehydration of mildronate DH
Despite the presented rationalization why the dehydration of
DH resulted directly in AP, the observations did not explain
why conformation of mildronate changed and why complete
rearrangement in the hydrogen bonding network between
mildronate molecules was observed during the dehydration.
Firstly, conformation energy analysis was performed in order
to explain the presence of the observed conformations in AP3930 | CrystEngComm, 2014, 16, 3926–3934
Fig. 5 Schematic representation of structural reorganizations during the trand DH structures and to evaluate the energy barriers associ-
ated with conformation changes. Secondly, the energy of the
AP structure was compared with the energy of the theoreti-
cally proposed DH structure without water molecules (DHWW)
where molecular conformations and hydrogen bonding
patterns were retained as in the DH structure. This structure
would be obtained if the water molecules left the channels
without introducing major changes to the rest of the structure,
as it is observed for typical channel hydrates.57,58
Analysis of molecular conformation in AP and DH.
Intramolecular energy calculation of mildronate molecules
extracted from AP and DH structures showed that the energy
of both molecular conformations was almost the same. From
PES scans (see ESI†) it was determined that the
conformations observed in both DH and AP structures did
not correspond to the global energy minimum, defined as
the molecular conformation with an intramolecular hydrogen
bond N–H⋯O. Both in the DH and AP structures mildronate
molecules had weak intramolecular hydrogen bonds
C3–H⋯O2(O1). However, if the intramolecular hydrogen
bond N–H⋯O formed, it would prevent the formation of
strong intermolecular hydrogen bonds that dramatically
affect the lattice energy. So it may be concluded that the
molecular conformations observed in crystal structures
correspond to local energy minima, which allow efficient
intermolecular interactions.
Reliability of this conclusion and the obtained PES scans
was supported by the crystal structures of various salts and
co-crystals of mildronate.36 In these crystal structures the τ1
values clustered around 39° (4 hits) and 179° (9 hits) with
one exception, and τ2 clustered around 70° (4 hits) and 178°
(9 hits) with one exception. For the dihedral angle τ3 there
were 11 values in the interval 180 ± 10° and three values lying
in the interval 180 ± 20°, while the dihedral angle τ4 in all the
cases matched the PES scan minima. In most of the cases
weak intramolecular hydrogen bond C3–H⋯O was observed
also in these crystal structures.
From the PES analysis it was determined that the energy
necessary for molecular conformation changes in transition
from DH to AP was 10–25 kJ mol−1 (see ESI†).
The comparison of intermolecular interaction energy and
total energy for AP and DHWW. It was calculated that theThis journal is © The Royal Society of Chemistry 2014
ansition from DH to AP.
CrystEngComm Paperinteraction energy of two hydrogen-bonded molecules was
more favourable in the DHWW structure (see ESI†). However,
after optimization of the crystal structure, AP was found to be
energetically favourable by 11.0 kJ mol−1 and the lattice
energy of the AP structure was energetically favourable by
14 kJ mol−1 (see ESI†) thus proving that the role of strong
hydrogen bonds does not always determine the stability of
the crystal structure, as emphasized recently.59,60
Therefore, the observed molecular reorganization and for-
mation of AP during the dehydration of DH is explained by
the fact that the AP structure is energetically more favourable
because of more favourable intermolecular interactions.Kinetic parameters and mechanism of dehydration
Kinetic parameters of dehydration
Particle size. Dehydration of DH was studied for samples
with different particle sizes. Particle size distribution for
different DH fractions is given in Fig. S1.† PXRD was used to
determine that in all of the cases AP was obtained as the only
dehydration product. The dehydration Ea value for each
fraction was calculated from isothermal experiments and are
shown in Fig. 6.
From Fig. 6 it can be seen that the Ea of the samples with
a particle size of up to 350 μm was 75 ± 3 kJ mol−1, but for
particles larger than 350 μm there was a significant decrease
of the Ea caused by increasing the particle size. Most probably
this decrease of the Ea for larger particles was due to diffusion
control. When considering water vapor escape through a thick
product layer, the rate becomes diffusion limited for some
critical particle size, and this effect grows upon further
increase in the particle size.
It was determined that the most appropriate kinetic model
for dehydration of fractions with a particle size below 150 μm
was the one-dimensional phase boundary model R1, but for
the particle size above 350 μm it was the two-dimensional
phase boundary model R2. Kinetic models R1 and R2 both
describe phase boundary controlled reactions with different
dimensionality. This result fits with the observations from
hot stage microscopy where the dehydration process initiated
on the single crystal surface and then reaction boundaryThis journal is © The Royal Society of Chemistry 2014
Fig. 6 Dehydration activation energy for different fractions of DH.progressed inwards to the crystal interior (as shown in
Fig. S8†). It has been mentioned in the literature3 that the
typical thickness of the reaction interface is 10–150 μm, so
for smaller particles the only rate limiting step can be the for-
mation and advancement of this interface towards the crystal
interior from only one energetically more favourable direc-
tion. However, the formation of the phase boundary for big-
ger particles (applicable in this case where the average
particle diameter was above 350 μm) was complete when
there was still a lot of DH present. Thus the rate limiting step
could also involve reaction interface advancement from other
crystal faces, which could be described by a two dimensional
phase boundary mechanism.
Sample weight. Dehydration of DH <40 μm fraction was
studied for samples with different weight. It was determined
that the dehydration rate decreased when the sample weight
was increased. The reason for the decrease of the rate
constant by increasing the sample weight can be due to the
slower vapor diffusion through the sample layer, which limits
the total dehydration rate. Dehydration Ea dependence on the
sample weight was calculated as well and the obtained
results are shown in Fig. 7. It is apparent that the Ea
decreased by increasing the sample weight. Such an effect
can be the result of increased contribution from the bulk
diffusion effect upon increasing the sample weight as the Ea
of the diffusion step typically is smaller than that of the
phase boundary reaction and more contribution from the
diffusion would be observed by increasing the sample weight.
Dehydration mechanism. There are large channels
containing water molecules along the a-axis34,36 in the DH
structure. Thus, we suggested that during the dehydration
of mildronate DH, water molecules escaped through these
channels. It has been postulated that if the dehydration envi-
ronment is controlled by nitrogen flow with relative humidity
close to zero, then the water molecule diffusion to the crystal
surface should not control the dehydration rate,31 as it
appeared for mildronate DH where dehydration kinetics were
described by models R1 and R2. Thus it can be concluded
that the rate limiting step should be hydrogen bond dissocia-
tion and/or molecular conformation change and reorganization.
From the PES analysis it was determined that the energyCrystEngComm, 2014, 16, 3926–3934 | 3931
Fig. 7 Dehydration activation energy dependence on sample weight
for the <40 μm fraction.
Fig. 8 Schematic representation of the dehydration process and the
rate limiting steps.
CrystEngCommPapernecessary for molecular conformation changes was at least
three times lower than the dehydration Ea (see ESI†). Thus it
can be predicted that the rate limiting step most probably is
the disruption of the hydrogen bonding network, or separation
of mildronate molecules paired through hydrogen bonds in the
crystal structure of DH.34
However, it was also found that besides phase boundary
advancement other factors limited the rate of dehydration: a)
the diffusion rate of water outside the crystal and b) diffusion
of water from the inside of the powder. By changing the
particle size and sample weight the influence of these rate
limiting steps could be modified. However, based on the
results from kinetic model determination, phase boundary
advancement was the main rate limiting step.
Based on the crystal structure it can be suggested that for
small particles the phase boundary advancement during the
dehydration of DH occurred along the a-axis and complete
dehydration was reached by phase boundary advancement
only in this direction. The dehydration rate could thus be
described with a one-dimensional phase boundary reaction
model. However, for particles with a size larger than 350 μm,
dehydration most probably occurred also in the second ener-
getically favourable direction. This can be described by the
movement of the reaction interface also perpendicular to the
channels where water molecules are situated in the DH
crystal structure. As a result the dehydration could be
described by a two-dimensional phase boundary reaction
model. It is possible that evolving of water in the direction
perpendicular to the water channels is hindered, thus contri-
bution from the diffusion increased in this case, and the
dehydration Ea decreased as observed for samples where R2
was determined as the most appropriate kinetic model.
Schematic representation of the dehydration process and the
rate limiting steps are given in Fig. 8.
Conclusions
The mechanism of mildronate dihydrate (DH) dehydration
was analyzed according to various experimental methods,
and it was determined that dehydration of the DH is a single-
step process leading directly to the anhydrous form (AP). By
analyzing the crystal structures of the DH, MH and AP it was3932 | CrystEngComm, 2014, 16, 3926–3934determined that, in addition to the similar molecular confor-
mation and hydrogen bonding patterns in DH and MH,
molecular packing in the DH and AP structures was also sim-
ilar, thus explaining the one-step dehydration of the DH
directly to AP.
The dehydration of the mildronate DH was linked to the
escape of water molecules through structural channels, as
molecular conformation changes and molecular translation.
Thus, dehydration of the DH could be classified as a) WET3
with direct formation of the AP crystalline phase after the
dehydration3 and b) class II-Coop.-Reorg.56
The dehydration Ea of DH was 75 ± 3 kJ mol
−1 for particles
with a diameter below 350 μm but it decreased for larger
particles due to the increasing effect of water diffusion out of
the particle. The kinetic model best describing the dehydra-
tion of particles smaller than 150 μm was R1, while for parti-
cles larger than 350 μm it was the R2 model. This change
was associated with the altered dimensionality of the phase
boundary movement towards the center of the crystal.
By analyzing the sample weight effect on the dehydration,
a decrease of the reaction rate and the dehydration Ea were
observed by increasing the sample weight. This decrease was
associated with increasing contribution from the water diffu-
sion out of the powdered sample.
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ABSTRACT: The dehydration kinetics of mildronate dihydrate [3-(1,1,1-trimethylhydrazin-1-ium-2-yl)propionate dihydrate] was analyzed
in isothermal and nonisothermal modes. The particle size, sample preparation and storage, sample weight, nitrogen flow rate, relative
humidity, and sample history were varied in order to evaluate the effect of these factors and to more accurately interpret the data
obtained from such analysis. It was determined that comparable kinetic parameters can be obtained in both isothermal and nonisothermal
mode. However, dehydration activation energy values obtained in nonisothermal mode showed variation with conversion degree because
of different rate-limiting step energy at higher temperature. Moreover, carrying out experiments in this mode required consideration of
additional experimental complications. Our study of the different sample and experimental factor effect revealed information about changes
of the dehydration rate-limiting step energy, variable contribution from different rate limiting steps, as well as clarified the dehydration
mechanism. Procedures for convenient and fast determination of dehydration kinetic parameters were offered. C© 2014 Wiley Periodicals,
Inc. and the American Pharmacists Association J Pharm Sci 103:1747–1755, 2014
Keywords: dehydration; kinetics; thermal analysis; particle size; mathematical model; kinetic model; isoconversional methods
INTRODUCTION
It is known that many organic compounds can exist in hy-
drated forms1,2 and a variety of active pharmaceutical ingre-
dients (APIs) are produced as hydrates.2 The determination
of the hydrate stability is thus important both form indus-
trial and scientific point of view. Typically hydrate stability
is evaluated by characterizing the dehydration conditions and
observed phase changes. The most common techniques for
studying dehydration are powder X-ray diffraction (PXRD),3–7
thermal analysis,3,5,6,8–14 spectroscopic methods,8,12,15–17 and
particle morphology and particle size characterization of the
original and dehydrated products.18–20 By using these meth-
ods, it is possible to determine the dehydration conditions and
understand the behavior of hydrate upon dehydration. An addi-
tional tool for the better understanding of dehydration mecha-
nisms is the determination of dehydration kinetic parameters:
kinetic model and activation energy (Ea).4,21
Although it is generally accepted that the crystal struc-
ture in most cases determines the dehydration kinetics,17,22,23
several other factors may contribute significantly.24 Determi-
nation of the dehydration reaction kinetic parameters has
been thoroughly explored, and a lot of studies can be found
in the literature for organic compound hydrates, especially
for API, for example,3,11,15 because of the practical interest in
these compounds.2 However, determination of the API hydrate
dehydration kinetic parameters under various experimental
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modes and under different conditions has not been sufficiently
studied.
As already mentioned, it has been observed that the dehy-
dration kinetic parameters can be strongly affected by vari-
ous sample and experimental factors.25–27 Differences of the
sample particle size,28–32 crystal habit,33 sample history,25 and
crystal defect distribution24 can result in different dehydration
rates, Ea variation, and even change the kinetic model. Besides
these factors, all the mentioned kinetic parameters can be af-
fected by the relative humidity,31,32,34–36 inert gas flow rate,31,34
and sample weight.28,37 Thus, for the better understanding
of the dehydration process and calculated kinetic parame-
ters, the effects of sample and experimental factors should be
evaluated.
Mildronate [3-(1,1,1-trimethylhydrazin-1-ium-2-yl)propiona
te; Fig. 1] is a (-butyrobetaine analogue, inhibitor of (-
butyrobetaine hydroxylase, and used as an anti-ischemic
drug.38,39 It is known to exist in a form of dihydrate DH,40,41
monohydrate MH, and anhydrous phase AP.42 Water molecules
in the DH and MH are situated in structural channels,40,41,43
whereas in the structure of the AP, empty channels are
present.43 Dehydration of the DH is a single-step process re-
sulting directly in the formation of AP.44 The effects of some
sample and experimental factors on the dehydration kinetic
parameters have already been reported. However, only limited
number of factors were studied for one sample in isothermal
mode.44
In this study, (1) the possibilities of determining the dehy-
dration kinetic parameters of mildronate hydrate DH (the form
used as API) by both isothermal and nonisothermal methods
were explored, (2) the effect of various sample and experimen-
tal factors on the dehydration activation energy and kinetic
model were studied in depth, (3) variations of kinetic parame-
ters were used for understanding the dehydration mechanism,
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Figure 1. Molecular structure of mildronate.
and (4) optimal conditions for determining the dehydration ki-
netic parameters were selected.
Although the effects of various sample and experimental fac-
tors on the dehydration process of API hydrates have been in-
vestigated in a number of papers,14,18,28–30,45,46 in this study the
effect of multiple factors on a single system was examined, so
the magnitude and direction of each effect could be analyzed
and explained. Investigation of the sample and experimental
factors in both isothermal and nonisothermal modes allowed
us to compare the influence of each factor on the results ob-
tained in both modes. Moreover, evaluation of various factors
allowed the identification of the most appropriate sample and
experimental factors for performing reliable determination of
the dehydration kinetic parameters.
EXPERIMENTAL
Sample Preparation and Storage
Mildronate DH was provided by JSC Grindeks (Riga, Latvia).
The sample was confirmed as pure DH by PXRD. Four samples
differing by the preparation procedure and/or storage condi-
tions were used in this study. Samples were prepared by slowly
crystallizingmildronate fromwater at 30◦C or by drying a paste
obtained by adding a small amount of water to mildronate
in mortar. The obtained samples were fractionated by push-
ing through sieves with mesh size 1300, 700, 350, 150, 67,
and 40 :m, yielding a maximum of seven fractions (the ob-
tained particle size distribution for different fractions is given
in Fig. S3). Part of the 150–350 and 350–700 :m fractions
was slightly ground and then fractionated by pushing through
sieves with mesh size 350, 150, 67, and 40 :m, and five frac-
tions were thus obtained. Samples were stored at ambient tem-
perature above saturated solutions of potassium acetate (rela-
tive humidity 22.5%) or magnesium chloride [relative humidity
34%, see Supporting Information (SI)]. All of the samples were
used for determination of the dehydration kinetic parameters.
Inorganic salts for humidity control were purchased from com-
mercial suppliers and used as received. More details of sample
preparation procedures are given in the SI.
For studying the effect of mechanical compression on the de-
hydration kinetics of DH, approximately 30 mg of sample was
inserted in a die with 13 mm diameter, and then compressed
at 130, 370, and 740 MPa for 1 min. Manual hydraulic press
was used for compression of the samples. Right after the com-
pression, the obtained tablet was either gently ground to obtain
powder or divided into smaller pieces suitable for analysis with
thermogravimetric (TG). Dehydration analyses were started
immediately afterwards.
For studying the effect of prior history of dehydra-
tion/rehydration, the initial DH samplewas dehydrated at 50◦C
temperature under N2 flow. Then, the dehydrated sample was
stored at the ambient temperature in 22.5% relative humidity.
Powder X-Ray Diffraction
Powder X-ray diffraction patterns were measured on a D8 Ad-
vance (Bruker AXS GmbH, Karlsruhe, Germany) diffractome-
ter using copper radiation (CuK") at a wavelength of 1.54180 A˚.
The tube voltage and current were set to 40 kV and 40 mA. The
divergence slit was set at 0.6 mm, and the antiscattering slit
was set at 8.0 mm. The diffraction pattern was recorded us-
ing a 0.2 s/0.02◦ scanning speed from 3◦ to 30◦ in 22scale and a
LynxEye position sensitive detector. To prevent the atmosphere
humidity effect, samples were covered with a 10 :m polyethy-
lene film.
Particle Size Analysis
A Mastersizer 2000 (Malvern Instruments Ltd., Malvern, UK)
laser diffraction instrument was used for particle size analysis.
Integration time was 3000 ms. The measurement range was
set to 0.020–2000 :m, and 59 counting channels were used.
For sample dispersion, nitrogenwith 1.0 bar pressure was used.
All measurements were carried out three times and the average
particle size distribution was calculated.
Thermal Analysis
For studying the dehydration kinetics of mildronate DH, TG
analysis was performed with Exstar6000 TG/DTA6300 (SII
Nanotechnology Inc., Chiba, Japan). The samples were heated
in nonisothermal mode from 30◦C to 120◦C temperature with
heating rates of 0.5, 1, 2, 3, 4, and 5◦C/min. Open aluminum
pans were used. The sample weight was 7.0 ± 0.5 mg, and ni-
trogen flow rate was 80 ± 10 mL/min. The effects of sample
size and nitrogen flow rate were determined at additional data
points, where the sample weight was 3 or 15 mg and nitrogen
flow rate was 30 or 300 mL/min.
Dehydration was also analyzed isothermally at the temper-
ature range from 25◦C to 80◦C with a step of 5◦C. The heater
unit was preset to the required temperature before the inser-
tion of the sample. For each sample, dehydrationwas performed
at eight different temperatures selected according to the dehy-
dration rate. The sample weight was 7.0± 0.5 mg, and nitrogen
flow rate was 80± 10mL/min. The effects of sample weight and
nitrogen flow rate were determined at additional data points,
where the sample weight was 2, 4, 6, 8, and 10mg, and nitrogen
flow rate was 0, 45, 200, and 300 mL/min.
For studying dehydration at controlledwater vapor pressure,
a system previously described in the literature45 was used for
providing specific water vapor activity. Dry and moist nitrogen
gas was mixed in a gas controller unit (SII) at selected flow
rates. The combined flow rate was 300 mL/min. The relative
humidity wasmeasuredwith a TFH620 (Ebro) humiditymeter,
which was previously calibrated using saturated solutions of
NaCl and MgCl2.
Methods for Kinetic Parameter Determination
For isothermal experiments, both model-free and model-based
methods were used, but for nonisothermal experiments only
model-free kinetic analysis was performed.47 For isothermal
experiments, data sets of "–time were obtained with "
= 0.02 at each temperature. Temperature stability during the
reaction was evaluated and further analysis was performed in
the conversion degree region where temperature change was
smaller than 0.3◦ for all used temperatures. For nonisother-
mal experiments, data sets of "–temperature and time were
Be¯rzin¸sˇ and Actin¸sˇ, JOURNAL OF PHARMACEUTICAL SCIENCES 103:1747–1755, 2014 DOI 10.1002/jps.23972
RESEARCH ARTICLE – Pharmaceutics, Drug Delivery and Pharmaceutical Technology 1749
obtained with " = 0.02 for each heating rate. By using re-
sults from both experimental modes, Ea was calculated with
isoconversional methods: Friedman (FR),48 average linear in-
tegral method (ALIM),49 and advanced isoconversional method
(AIC).50,51 For the first two methods, Ea was calculated from
the slope of the line in corresponding coordinates for " val-
ues with step size 0.02,48,49 but for AIC method, the parameter
(Ea) was minimized with MS Excel Solver, obtaining Ea for "
values with step size 0.1.50,51 Confidence intervals for the cal-
culated Ea values were evaluated from the slope error of the
line used for calculation of Ea with the FR method. Kinetic
model determination was performed with ALIM49 and reaction
progress was reconstructed in the coordinates g(")–"30,52 and
f(")–".21,30,52 Besides, kinetic model determination for isother-
mal experiments was performed with reduced time plots,35 but
for nonisothermal experiments, frommaster plots using the pa-
rameter Z(").53 Most often used solid-state kinetic models were
included in the analysis.3,21,54,55
For isothermal experiments, model-fitting methods were
used as well. The kinetic model was determined from lineariza-
tion of the experimental points in coordinates g(")–time, and
model with the best linear fit was selected from the list of the
most often used solid-state kinetic models.3,21,54,55 The dehydra-
tion rate constants were subsequently determined by plotting
experimental data points in the coordinates "–time and fit-
ting theoretical lines modeled from selected kinetic models to
the experimental points. The sum of squared differences be-
tween experimental and theoretically calculated " values was
minimized with MS Excel Solver. If more than one model was
selected for this procedure, then the best model was identified
by the smallest sum of least squares. The Ea values were then
determined from the Arrhenius plot.
RESULTS AND DISCUSSION
As mentioned in the Experimental section, Ea and the kinetic
model were determined by more than one method. Matching
Ea values were obtained with all the calculation methods for
each sample in each particular experiment. For representation
of the model-free method results, Ea values calculated with
FR’s method were used in this paper. In each of the cases, a
certain kinetic model was determined as the most appropriate
according to all methods, unless stated otherwise.
Powder X-ray diffraction was used to determine that AP was
obtained as a dehydration product. However, in samples where
the dehydration continued after the melting/peritectic decom-
position point, MHwas also detected, even though its formation
was not associated with direct dehydration of the DH44 (see SI).
It was determined that sample preparation procedure and
storage conditions had no effect on the examined kinetic pa-
rameters. For example, the similarity of the dehydration Ea for
fractions up to 150–350 :m of all the samples can be evalu-
ated from Figure S4. Thus, the sample designations given in
the SI were not used in the text. The sample particle size is re-
ported in this article according to the mesh sizes used for their
preparation.
Particle Size Effects Evaluated from Dehydration in Isothermal
and Nonisothermal Modes
To evaluate the possibility of determining the dehydration ki-
netics of DH under isothermal and nonisothermal modes, as
well as for the evaluation of the particle size effects, Ea and
kinetic models from dehydration experiments of different DH
particle size fractions in both modes were calculated and com-
pared. Particle size distribution for different DH fractions is
given in Figure S3. The particle size effects on the dehydration
rate for different fractions in isothermal mode at 45◦C tempera-
ture and in nonisothermal mode at the heating rate of 1◦C/min
are shown in Figure S5. It can be seen that by increasing the
particle size, the dehydration process slowed, and the dehy-
dration rate constant correspondingly decreased in isothermal
mode, whereas the dehydration starting and finishing temper-
atures increased in the nonisothermal mode. This is because of
the fact that for smaller particles there was more surface area
accessible to dehydration than that for larger particles. Never-
theless, it was observed that the dehydration rate expressed as
fraction converted per 1◦ was similar for all sample fractions in
the nonisothermal mode (See Fig. S5b). However, more detailed
study identified that the fraction of less than 40 :m showed an
exception from these trends (see SI).
It has already been reported that dehydration Ea of the DH
samples with particle size up to 350 :m is almost the same, but
for particles larger than 350 :m there is a significant decrease
of the Ea by increasing the particle size, explained by diffusion
control.44 In this study, the dehydration Ea was calculated with
isoconversional methods from both isothermal and nonisother-
mal experiments. The obtained dehydration Ea as a function of
conversion degree " for samples with various particle sizes is
shown in Figure 2.
From the isothermal experiments shown in Figure 2a, it was
confirmed thatEa of the samples with particle size up to 350 :m
was the same, whereas it decreased by further increasing the
particle size. From the nonisothermal experiments shown in
Figure 2b, it was possible to identify differences in the final
part of the Ea–" plots for fractions with particle size up to
350 :m.
In Figure 3, the dehydration Ea–" plots calculated from
isothermal and nonisothermal experiments for the 40–67 :m
fraction are shown. It can be seen that the Ea values calculated
from both modes were the same at the start of the reaction,
within the limits of experimental error, and a small decrease in
the values was observed by increasing the conversion degree.
This decrease was explained by the fact that the higher dehy-
dration Ea at the start of the reaction was caused by nucleation
of the product phase3 or by the reversibility of the dehydration
reaction.52
After this initial decrease, Ea values calculated from isother-
mal experiments in the " interval from 0.2 to 0.8 were
almost constant. However, the Ea values obtained from non-
isothermal experiment were constant only for a small " in-
terval and after that started to decrease slowly by increasing
". This decrease became faster when the conversion degree
approached 1.
Similar results were obtained also when other fractions were
compared, although there typically was some divergence of the
Ea values at the beginning of the dehydration reaction. Compar-
ison of the obtained Ea values in isothermal and nonisothermal
experiments for the fractions from less than 40 :m up to 150–
350 :m is given in Figure 4. In this diagram, the bottom and
the top of the presented column corresponds to the lowest and
highest dehydration Ea values in " interval from 0.2 to 0.7. The
color change point corresponds to the average Ea value in this
interval.
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Figure 2. Dehydration activation energy–conversion degree plot for various DH fractions obtained (a) from isothermal experiments and
(b) from nonisothermal experiments.
Figure 3. An activation energy–conversion degree plot for dehydra-
tion of the 40–67 :m fraction calculated from isothermal and non-
isothermal experiments.
Figure 4 clearly illustrates that in all cases, the average,min-
imum, and maximum values of dehydration Ea were higher for
isothermal experiments. Also, for nonisothermal experiments,
the Ea value changed more within the conversion degree in-
terval from 0.2 to 0.7, because Ea decreased at higher conver-
sion degree, as presented in Figures 2b and 3. Moreover, in
nonisothermal experiments, the range of Ea values in this "
interval became wider by increasing the particle size. These
results can easily be connected with Figure 2, where the Ea
values are constant for fractions up to 150–350 :m in isother-
mal experiments and decrease in nonisothermal experiments.
Furthermore, this decrease was faster for larger particles.
The temperature range at which the dehydration reaction
was examined in both experimental modes for each DH frac-
tion is given in Table S1. It is evident that higher temperatures
were used in nonisothermal experiments. Moreover, the Ea val-
ues for nonisothermal experiments at high conversion degrees
were calculated from data measured at higher temperatures,
explaining the differences in Ea values presented in Figure 3.
Figure 4. Minimum, maximum, and the average value of the dehy-
dration activation energy calculated from nonisothermal and isother-
mal experiments for the less than 40, 40–67, 67–150, and 150–350 :m
fractions.
Thus, the decrease of Ea by increasing " suggested that at
higher temperatures the energy of the rate-limiting step was
different, or contribution from a different rate-limiting step be-
came apparent. The more pronounced decrease of the Ea for
larger particles in nonisothermal experiments could easily be
associated with slower dehydration, which led to higher de-
hydration temperature. Moreover, in order to reach complete
dehydration at every experimentally used heating rate for the
fractions with 67–150 and 150–350 :m particle size, samples
were heated above the melting/peritectic decomposition point
at 88◦C–92◦C.44 The conversion degree at which this point was
reached for the fastest heating rate is given in Table S1. It is
clear that data obtained above melting point cannot be used for
calculation of the dehydration Ea. Thus, Ea obtained above this
conversion degree could not be considered purely as dehydra-
tion Ea, because some of the data used for its calculation was
not actually from the dehydration process. For the 150–350 :m
fraction, this " value was as low as 0.55, thus explaining the
significantly lower minimum Ea value in Figure 4.
Thus, also for nonisothermal experiments, Ea was not de-
pendent on the particle size for fractions with particle size
up to 350 :m. Unfortunately, it was not possible to reliably
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Table 1. The Most Appropriate Dehydration Kinetic Model for Different DH Fractions, Determined by Studying the Effect of Various Sample
and Experimental Factors
Study
Less Than 40 to
67–150 :m 150–350 :m 350–700 :m
700–1300 :m,
More Than 1300 :m
Isothermal modea R1 R1/R2 R2 R2
Nonisothermal modea R1 R2 R2 -
Sample weight R1 R1 R2 -
Atmosphere R1 - - -
Dehydration/rehydration R1 - - -
Mechanical compressionb R1 - - -
aStudy of the particle size effect.
bResults from dehydration of the powdered sample under isothermal mode.
calculate theEa of the samples with particle size above 350 :m,
because the evolution of water above the melting point caused
problems inmost of the experiments. Thus,Ea decrease for frac-
tions with particle size above 350 :m was not demonstrated in
nonisothermal experiments.
As can be seen from Figure 2a, small decrease of the Ea by
increasing the " was observed in isothermal experiments for
the 350–700 and 700–1300 :m fractions. This cannot be ex-
plained by the higher temperature, because dehydration of the
350–700 :m fraction was examined at the same conditions as
the fractions with smaller particle size. As already mentioned,
decrease of the average Ea for these two fractions was associ-
ated with the increased diffusion of water out of the particles.44
Thus, it was possible that the diffusion effect slightly increased
during the dehydration, and in this way Ea decreased by in-
creasing ", as shown in Figure 2a. Therefore, the decrease of
the Ea resulting from increased contribution of water diffusion
was because of the fact that water molecules had to travel a
longer distance to leave the particle, or because of the possi-
ble phase boundary advance in directions perpendicular to the
water channels,44 which was observed for larger particles, es-
pecially at the end of the reaction when all of the hydrate was
surrounded by a thick AP layer.
The most appropriate kinetic models for the dehydration
process were determined for all of the samples with various
particle sizes under both isothermal and nonisothermal condi-
tions, as well as for samples where the influence of other factors
was examined. The obtained results are presented in Table 1. It
is visible that the dehydration of fractions with particle size be-
low 150 :m was best described by the one-dimensional phase
boundary model R1, whereas that of fractions with particle
size above 350 :m was best described by the two-dimensional
phase boundary model R2. This was consistent with our pre-
vious work.44 The other examined experimental and sample
factors did not change the dehydration kinetic model. However,
for all of the analyzed samples, there were deviations from the
most appropriate kinetic model at the beginning and the end
of the dehydration process. Deviations at the beginning can
be associated with stabilization of the temperature or heating
rate, whereas at the end, there may have been actual devia-
tions from the chosen model associated with either (1) a certain
degree of diffusion control or (2) the fact that the escape of
the last water molecules can occur in other directions rather
than those associated with the main movement of the phase
boundary.30 The reason for different kinetic models determined
for different particle size fractions is associated with change
of the dimensionality of the phase boundary movement.44
Although it can be seen that the same dehydration kinetic
model for all of the analyzed samples was found both from
isothermal and nonisothermal experiments, determination of
the kinetic model from isothermal experiments was more
straightforward and it was possible to make a selection more
convincingly.
Effect of the Sample Weight
It was already reported that the dehydration rate of the DH
decreased for larger samples, because of the slower vapor diffu-
sion through the sample layer.44 By carrying out more detailed
investigation, it was observed that the reciprocal dehydration
rate constant determined with model fitting methods was lin-
early dependent on the sample weight (see Fig. 5, the slopes
and intercept points of these lines are given in Fig. S6). It can
be seen that the slope was decreasing if the temperature was
raised, showing that the sample weight had a more pronounced
effect on the dehydration rate constant at lower temperatures.
This probably was because of slower water diffusion from the
sample volume at lower temperatures. However, it was con-
cluded that the particle size did not have an effect on the slope,
although the slopes determined for 40–67 and 350–700 :m
fractions were different than that for the rest of the fractions.
For the 40–67 :m fraction, this could be because of random
errors, but for the 350–700 :m fraction, this was because of the
different kinetic model used, producing different rate constant
values and thus changing the slope (see Table 1). Increase of the
intercept (thus decrease of the dehydration rate) by increasing
the particle size was because of the slower dehydration rate of
the larger particles, as discussed previously.
It also has been reported that the dehydrationEa determined
under isothermal conditions decreased by increasing the sam-
ple weight because of the increasing contribution from the bulk
diffusion effect.44 In this work, the effect of the sample weight
on the dehydration Ea was measured in both isothermal and
nonisothermal conditions, and the obtained Ea dependence on
" for samples of various weight is shown in Figure 6.
Decrease of the dehydration Ea by increasing the sample
weight was observed in both experimental modes. By changing
the sample weight from 2 to 15 mg, dehydration Ea changed
from 84 to 64 kJ/mol. These Ea values were in accordance with
our previous study44 and showed that larger samples gave even
smaller dehydration Ea. From the obtained results, it was eval-
uated that sample weights of 2, 3, and 4 mg were not appro-
priate for accurate study of the dehydration kinetics because of
the elevated random error in calculated Ea values. However, by
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Figure 5. Sample weight effect on the reciprocal dehydration rate constant of mildronate DH: (a) different fractions at 55◦C temperature and
(b) less than 40 :m fraction at different temperatures.
Figure 6. Dehydration activation energy dependence on (a) sample weight for the less than 40 :m fraction in isothermal experiments and
(b) sample weight (empty markers) and nitrogen flow rate (filled markers) for the less than 40 :m fraction in nonisothermal experiments.
using excessively large samples, unacceptable diffusion effects
would appear, so samples of moderate weight are preferable.
Thus, both experimental modes could easily be used for the
evaluation of the sample weight effect on the dehydration rate
and Ea, although results obtained under nonisothermal mode
were complicated by the sample weight unrelated Ea changes,
the reason for which is already discussed.
Effect of the Atmosphere
Experiments with dehydration of DH less than 40 :m frac-
tion were carried out under nitrogen gas flow at various flow
rates. It was determined that by increasing the N2 flow rate in-
creased the dehydration reaction rate as shown for isothermal
experiments in Figure S7. This is because the rate of reversible
dehydration was enhanced noticeably when the evolved vapor
was promptly removed from the sample. The same effect was
found in nonisothermal mode as well. However, changes of the
nitrogen flow had less effect on the dehydration rate, compared
with changes in other factors (like particle size, sample weight,
and water vapor content in the atmosphere). From the results
obtained under nonisothermal conditions, dehydration Ea was
calculated and the obtained results are shown in Figure 6b.
Although the increase of the nitrogen flow resulted in faster
dehydration, it did not noticeably reduce the contribution from
the step associated with the water diffusion out of the sample
that would result in a lower Ea value. On the contrary, the de-
hydration Ea decreased when the N2 flow rate was increased.
Themagnitude of theEa changes was similar to that introduced
by the sample weight variation. These results suggested that
the increased N2 flow provided for a more efficient removal of
water from the bulk of DH particles, most probably resulting in
an increase of the contribution from the water vapor diffusion
from the DH particles. Thus, the observed total dehydration
Ea decreased because the Ea of water vapor diffusion from the
particles was lower than that of the phase boundary advance.
Figure 6b indicates that with 300 mL/min N2 flow the calcu-
lated dehydrationEa values did not show initial decrease at low
" values as observed in all the other cases. This initial decrease
was therefore most probably associated with the reversibility
of the dehydration reaction, and faster nitrogen flow precluded
this effect.
The effect of variable water vapor pressure on the dehydra-
tion of DH was evaluated as well. It was observed that the
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Figure 7. The dependence of the dehydration activation energy on
the relative humidity for the less than 40 :m fraction.
dehydration rate decreased with increasing water vapor pres-
sure at a given temperature, and the rate constant dependence
on water vapor pressure could be approximated with straight
line (see Fig. S8). This observation can be associated with the
reversibility of the dehydration reaction. The observation of a
linear dehydration rate decrease suggested that the presence
of water in the vapor phase did not change the dehydration
mechanism. By using dehydration curves recorded at different
temperatures for a particular relative humidity, the dehydra-
tion Ea dependence on the relative humidity was calculated,
and the results are shown in Figure 7. It is visible that the
dehydration Ea did not depend on the relative humidity. This
confirms that the presence of water did not change the dehy-
dration mechanism and did not introduce any changes in the
dehydration rate-limiting step energy at the reaction interface.
However, the three highest relative humidity levels used had
a high uncertainty, which could be related to slow dehydration
where other factors could play a major role in the determina-
tion of the dehydration rate and the fact that the AP and DH
phase boundary has a slight temperature dependence.42
Effect of the Sample History
The considered aspects of sample history were (1) previous de-
hydration/rehydration of the sample and (2) mechanical com-
pression. It was observed that repeated dehydration of previ-
ously dehydrated/rehydrated samples occurred faster and the
dehydration Ea was lower (See Fig. S9). This effect could re-
sult from the cracking of the crystals and formation of channels
throughwhichwater escape was facilitated during the repeated
dehydration as well as because of the formation of internal
defects allowing for an easier phase boundary advance. Also,
it was possible that previous dehydration/rehydration reduced
the particle size, allowing faster dehydration in the second de-
hydration cycle.46 However, reduction of the particle size alone
would not explain the decrease of the dehydration Ea.
It was observed that the mechanical compression (in terms
of enhanced crystal defects and stress) had no effect on the
dehydration Ea and the kinetic model. However, these defects
promoted the initiation of the dehydration process, which was
clearly observed as lower dehydration starting temperatures in
nonisothermal experiments. When dehydration of compressed
tablets was performed, water evolution from samples was more
difficult compared with powdered samples; thus, the dehydra-
tion rate was reduced, as observed both in isothermal and
nonisothermal experiments. Extended discussion about the ob-
tained results for mechanically compressed samples can be
found in the SI.
CONCLUSIONS
It was possible to obtain comparable Ea values and the same
kinetic model for the dehydration of mildronate DH in both
isothermal and nonisothermal mode. However, both the ob-
tained results and experimental procedures were more com-
plicated when experiments were performed in nonisothermal
mode. First, there was a decrease of dehydration Ea at high
conversion degree values, either because of different contri-
butions from various rate-limiting steps at different temper-
atures, or because of altered Ea of rate-limiting step at high
temperatures. Second, dehydration process should be complete
before reaching the melting/peritectic decomposition point for
every employed heating rate. Thus, in nonisothermal mode, it
was possible to analyze only sufficiently small particles; there-
fore, the possibility to study the particle size effect was limited.
Moreover, obtained results were complicated by the Ea changes
not directly caused by the change of the particle size. For fast
identification of the possible complications and for setting up
the dehydration kinetic study, results obtained from thermal
analysis should be used to get insight about the appropriate
temperature interval for the study.
Particle size influenced both the dehydration rate and Ea.
This factor should therefore be controlled and sample with nar-
row particle size distribution would be preferred for the dehy-
dration kinetic study. Although in isothermal mode it was pos-
sible to study the dehydration of all prepared fractions, small
variation in dehydrationEa was observed for particles with size
above 350 :m, because of the changing diffusion contribution,
and less than 40 :m fraction showed deviation from typical
dehydration behavior.
Study of the experimental factor effects revealed that very
low-sample weight resulted in elevated random error for de-
hydration Ea, whereas very high-sample weight increased the
diffusion contribution. Increase in the nitrogen flow decreased
the dehydration Ea, suggesting that the contribution from wa-
ter diffusion out of the particles was possibly increased by this
change. Relative humidity did not affect the dehydration Ea,
thus the presence of water at the reaction interface did not
change the energy of the dehydration rate-limiting step.
Although sample preparation and storage did not show an
effect on the examined dehydration parameters, sample history
did. Thus, in order to perform a kinetic study, the sample should
be handled carefully prior to dehydration experiments, in order
not to induce any physical changes.
As the dehydration Ea is affected by the diffusion of the wa-
ter out of the particle and the kinetic model is affected by the
phase boundary advance in other directions than those along
the water channels,44 the particle morphology can be an impor-
tant factor affecting these kinetic parameters. In this study, we
used samples with particles lacking a characteristic morphol-
ogy, which had crystallized as a particle aggregate. However, it
is possible that other crystallization procedures can produce
particles with different characteristic morphologies showing
different dehydration kinetics.
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For the determination of diffusion-independent kinetic pa-
rameters characterizing the main DH dehydration mechanism,
an isothermal experimental mode should be selected, withmod-
erate particle size (narrow range within 40–150 :m) and sam-
ple weight (6–8 mg), and nitrogen flow providing effective re-
moval of the evolved water (∼100 mL/min) should be used.
Sample preparation and handling should be performed care-
fully. Such conditions would preclude the detection of the sam-
ple property and experimental factor effects, thus limiting the
study of the dehydration mechanism. However, parameters ob-
tained through such approach would be characteristic of the
DH dehydration. Nevertheless, if one wants to study the dehy-
drationmechanism, effects of various sample and experimental
factors should be investigated.
Of course, the study of dehydration mechanisms through
the influence of various sample and experimental factors on
the kinetic parameters is not limited to mildronate DH. Thus,
a similar study could easily reveal essential information about
the dehydration mechanism of other organic and inorganic hy-
drates, as well as provide conditions for determining the main
dehydrationmechanism characterizing dehydration kinetic pa-
rameters.
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Agris Ber̅ziņs,̌*,†,‡ Edgards Skarbulis,† Toms Rekis,† and Andris Actiņs ̌†
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ABSTRACT: A solvate screening and characterization of the
obtained solvates was performed to rationalize and understand
the solvate formation of active pharamaceutical ingredient
droperidol. The solvate screening revealed that droperidol can
form 11 diﬀerent solvates. The analysis of the crystal structures
and molecular properties revealed that droperidol solvate
formation is mainly driven by the inability of droperidol
molecules to pack eﬃciently. The obtained droperidol solvates
were characterized by X-ray diﬀraction and thermal analysis. It
was found that droperidol forms seven nonstoichiometric
isostructural solvates, and the crystal structures were
determined for ﬁve of these solvates. To better understand the structure of these ﬁve solvates, their solvent sorption−
desorption isotherms were recorded, and lattice parameter dependence on the solvent content was determined. This revealed a
diﬀerent behavior of the nonstoichiometic hydrate, which was explained by the simultaneous insertion of two hydrogen-bonded
water molecules. Isostructural solvates were formed with suﬃciently small solvent molecules providing eﬀective intermolecular
interactions, and solvate formation was rationalized based on already presented solvent classiﬁcation. The lack of solvent
speciﬁcity in isostructural solvates was explained by the very eﬀective interactions between droperidol molecules. Desolvation of
stoichiometric droperidol solvates produced one of the four droperidol polymorphs, whereas that of nonstoichiometic solvates
produced an isostructural desolvate.
■ INTRODUCTION
The investigation of solid phase diversity of pharmaceutical
molecules has clearly shown the formation of diﬀerent phases,
including polymorphs and solvates.1,2 The fact that diﬀerent
polymorphs and solvates have diﬀerent stability,3 mechanical
properties,4−6 and bioavailability (because of diﬀerent sol-
ubility7) makes solid form screening an essential step during
drug development, in order to prevent unexpected solid form
appearance after the approval of a drug.8,9 Moreover, the ability
of a compound to form numerous polymorphs3 and, as
reported, more than 100 solvates2 makes it necessary to include
various research techniques in the screening process and to
carefully choose the commercial form and its storage
conditions.
Solvates typically appear during the active pharmaceutical
ingredient (API) puriﬁcation stage or the API processing
stages, such as mixing and blending, wet granulation,
lyophilization, spray drying, etc., when APIs are exposed to
solvents or solvent vapors.10−13 Moreover, solvates tend to
crystallize more easily than solvent-free polymorphs because of
the more eﬃcient packing together with solvent molecules.14
However, the stability of the solvates under an atmosphere
without the corresponding solvent vapor is typically limited.
During the desolvation, unstable polymorphs can form, which
can make formation of the solvate either undesirable or
advantageous, as polymorphs inaccessible by crystallization can
be obtained in such cases.15−18
Therefore, the understanding of the reasons for solvate
formation is important in order to enable prediction of their
formation and even stability. Currently, it would be the most
reasonable to make solvate predictions based on the solvent
and host properties, as computational structure predictions
have been successful only for polymorphs19−23 and relatively
simple hydrate systems.20,24−26
Although structural features leading to the solvate formation
have not been completely identiﬁed, there are two main
scenarios in which solvent molecules tend to incorporate into
the crystal lattice by forming solvates:1 (a) potential
intermolecular interactions between the molecules of the
compound are not well satisﬁed and the incorporation of
solvent molecules provides a strong intermolecular interaction,
or (b) solvent inclusion in the crystal decreases the void space.
In the ﬁrst scenario, the solvate selectivity is typically based on
their functionality, whereas it does not have to be so for the
second scenario. However, most solvates include contributions
from both of these driving forces, which can be viewed as
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lowering the crystal free energy primarily through electrostatic
and van der Waals interactions, respectively. In more speciﬁc
cases the solvent molecules can act as bridges between polar
and apolar structure regions and/or serve the role of ligands
completing the coordination around a metal ion.12 It has also
been concluded that solvate ability to involve multipoint
recognition through hydrogen bonds strongly facilitates its
stability.27
More challenging is understanding the reason for the
formation of isostructural solvates, where the same host
structure can incorporate diﬀerent solvent molecules. There
are cases where the formation of isostructural solvates can
occur only from solvents with some speciﬁc interaction28,29 or
molecular shape,30 although it is common that such solvates
form with very diﬀerent solvent molecules located in structural
channels.18,31,32 It has been found that in some cases even
empty host structures can be thermodynamically stable if
compared to polymorphs,33 although more typically they are
unstable.34 In many cases, however, host structure collapses
immediately after the removal of the guest despite the weak
nature of the host−guest interactions.35,36
To understand the solvate formation, it is necessary to study
and understand both the structural features of the solvates as
well as their stability and phase transitions occurring at diﬀerent
conditions.17,18,37−39
Droperidol, 1-{1-[4-(4-ﬂuorophenyl)-4-oxobutyl]-1,2,3,6-tet-
rahydro-4-pyridyl}-1,3-dihydro-2H-benzimidazol-2-one (Figure
1) is a neuroleptic pharmaceutical. It is reported to exist in two
polymorphic forms I and II (also labeled as z)40,41 and three
solvated forms: dihydrate DH,41,42 nonstoichiometric hydrate
NSH (also labeled as x),40,41,43 and ethanol solvate SEt.
44 The
crystal structures of the DH, SEt, NSH, and the polymorph II
have been reported, and it was determined that the NSH and
SEt are isostructural.
43 Although NSH is reported as hemi-
hydrate,40 it is nonstoichiometric and the water content in its
structure can change freely from 0 to 1.43 In the polymorph II
and in isostructural solvates, droperidol forms hydrogen
bonded amide homodimers. Additional structural stability in
II is provided by two weak hydrogen bonds formed by a
carbonyl group, whereas the isostructural solvate structures are
stabilized by three weak hydrogen bonds formed by a carbonyl
group, a tertiary nitrogen and ﬂuorine, as well as by the
hydrogen bond between the amide carbonyl group and the
solvent molecules. However, in DH the structure is stabilized
by a strong hydrogen bond network mediated by water
molecules employing all the strong hydrogen bond donor and
acceptor sites of droperidol.
In this work we tried to understand and rationalize the
solvate formation of droperidol. Therefore, we crystallized
droperidol from solvents belonging to diﬀerent solvent classes
to investigate the possibility of forming new solvates, and we
also characterized the structure and physiochemical properties
of all droperidol solvates. We tried to rationalize solvate
formation based on the solvate structure and solvent and
droperidol properties. Besides, we characterized the solvent role
and interactions in solvate structures and the water molecule
arrangement in a partially ﬁlled NSH structure.
■ EXPERIMENTAL SECTION
Materials. Droperidol (purity >99%) was obtained from JSC
Grindeks (Riga, Latvia). The sample consisted of polymorph II.
Inorganic compounds and organic solvents of analytical grade were
purchased from commercial sources and used without further
puriﬁcation.
Preparation of the Crystal Forms. The most popular solvents
chosen from diﬀerent solvent classes45,46 (grouped according to
physical and physicochemical properties) were selected for the
crystallization of droperidol. Saturated or concentrated solutions of
droperidol in all of the solvents were prepared at 40−130 °C
depending on the boiling point of the solvent (see Table S1,
Supporting Information). The obtained solutions were then cooled
down to −5 °C. In the cases when no crystallization was observed, the
solutions were slowly evaporated at 40 or 50 °C, while preventing a
complete evaporation. The obtained products were collected by
ﬁltration, air-dried, and characterized. Depending on the procedure,
both of the previously known hydrates were obtained from
crystallization in the presence of water (see Supporting Information).
Single Crystal X-ray Diﬀraction (SCXRD). The single-crystal X-
ray diﬀraction data for droperidol solvates were collected either at 173
K on a Bruker-Nonius Kappa CCD diﬀractometer or at 120 K, or 333
K on a Bruker SMART CCD 6000 diﬀractometer, both using Mo Kα
radiation (graphite monochromator, λ = 0.71073 Å) and Oxford
Cryostream (Oxford Cryosystems) open-ﬂow nitrogen cryostat for
sample temperature control. The structure was solved by direct
method and reﬁned by full-matrix least-squares on F2 for all data using
SHELXTL47 and OLEX248 software or SHELX-97 suite.47 All
nondisordered non-hydrogen atoms were reﬁned anisotropically. For
disordered alcohol molecules ﬁxed SOF = 0.5 was used.
The packing coeﬃcients for crystal structures were calculated by
PLATON.49 Mercury 3.3 software50 was used for crystal structure
analysis and simulation of powder X-ray diﬀraction patterns based on
crystal structure data.
Powder X-ray Diﬀraction (PXRD). PXRD patterns were
measured at ambient temperature on a D8 Advance (Bruker)
diﬀractometer using copper radiation (Cu Kα) at the wavelength of
1.54180 Å, equipped with a LynxEye position sensitive detector. The
tube voltage and current were set to 40 kV and 40 mA. The divergence
slit was set at 0.6 mm, and the antiscattering slit was set at 8.0 mm.
The diﬀraction patterns were recorded using a 0.2 s/0.02° scanning
speed (for phase identiﬁcation) or 0.5 s/0.02° (for lattice parameter
determination) from 3° to 35° in 2θ scale. To prevent the atmospheric
humidity eﬀect and decomposition of the solvates, when necessary the
samples were covered during the analysis with a 10 μm polyethylene
ﬁlm.
Diﬀerential Thermal Analysis/Thermogravimetry (DTA/TG).
DTA/TG analysis was performed with Exstar6000 TG/DTA6300
(SII). Open aluminum pans were used. Heating of samples from 30 to
200 °C was performed at a 5°·min−1 heating rate. Samples of 5−10 mg
mass were used, and the nitrogen ﬂow rate was 100 ± 10 mL·min−1.
Gravimetric Determination of Solvent Content. Solvent
content was determined for nonstoichiometric solvates stored in
desiccators with controlled solvent activity in the vapor phase. To
provide a variety of relative humidity (RH) values for determination of
water content in NSH, saturated salt solutions and P2O5 were used.
The salts used for this experiment and the corresponding RH values
were LiBr (6%), LiCl (11%), CH3CO2K (23%), MgCl2 (32%), NaBr
(56%), KI (68%), NaCl (75%), KCl (84%), K2SO4 (97%), and also
P2O5 (∼0%).51 To provide a variety of ethanol, methanol, acetonitrile,
and nitromethane vapor activity, solutions with diﬀerent compositions
of the corresponding solvents and glycerol for methanol and ethanol,
and glycerol and dimethylformamide for acetonitrile and nitromethane
were prepared. The solvent activity in the vapor phase was estimated
Figure 1. Molecular structure of droperidol.
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by Raoult’s Law. All desiccators were thermostated at 30 ± 0.5 °C
temperature, and the sample containers were weighed on analytical
balance (d = 0.1 mg). Further experimental details are given in
Supporting Information.
Determination of Lattice Parameters of Solvates with
Diﬀerent Solvent Content. The PXRD patterns were determined
for solvates with diﬀerent solvent content. Samples identical to those
used for gravimetric solvent content determination were used. Both
samples were stored together, and thus the solvent content was
assumed to be identical. The lattice parameters of the fully solvated
nonstoichiometric solvates was determined at ambient temperature
with LP-Search algorithm in TOPAS 4.252 using lattice parameters
determined at 173 K in SCXRD measurements as the initial guess. The
lattice parameters of the nonstoichiometric solvates with diﬀerent
solvent content were determined by performing the Pawley reﬁnement
in TOPAS 4.2 by relaxing the lattice parameters and the crystallite size
parameter.
Fourier Transform (FTIR) Infrared Spectroscopy. The ATR-
FTIR spectra were collected for neat solids on a PerkinElmer Frontier
FTIR spectrometer equipped with a Universal ATR Sampling
Accessory with a diamond window. The spectra were recorded from
650 to 4000 cm−1 at a 2 cm−1 spectral resolution with 16 scans.
Theoretical Calculations. The geometry optimization and energy
calculation for crystal structures were performed using CASTEP53 with
the PBE54 functional using on-the-ﬂy generated ultrasoft pseudopo-
tentials and a cutoﬀ energy of 600 eV. In CASTEP calculations,
disorder could not be taken into account, and therefore the structures
of SMe and SEt with one of the possible solvent orientations were used,
thus creating a structure in the P1 space group with two symmetrically
individual droperidol molecules. When lattice paramters were relaxed,
Tkatchenko−Scheﬄer dispersion correction scheme55 was used.
The molar volumes of selected solvent molecules were calculated in
Gaussian0956 after the geometry optimization at the B3LYP/6-
311G(d,p) level using Grimme’s dispersion correction.57
Lattice energy calculations were performed with the semiempirical
PIXEL58 methodology. Hydrogen atom positions were optimized by
CASTEP.
Figure 2. PXRD patterns of the droperidol solvates and polymorph II.
Table 1. Crystallographic Data for the Droperidol Solvates (SACN, SNM, SMe, NSH, ISD, and SEt)
solvate SACN SNM SMe NSH-mono NSH-hemi ISD
empirical formula (C22H22FN3O2)2·
C2H3N
(C22H22FN3O2)2·
CH3NO2
C22H22FN3O22·
0.5CH4O
C22H22FN3O2·
H2O
C22H22FN3O2·
0.5H2O
C22H22FN3O2
Mr 399.96 409.95 395.45 397.44 388.43 379.43
crystal system triclinic triclinic triclinic triclinic triclinic triclinic
space group P1 P1 P1̅ P1̅ P1̅ P1̅
temperature 173 173 120 120 120 333
a (Å) 6.0870(2) 6.06730(10) 6.0504(5) 6.3199(4) 6.2743(3) 6.2780(3)
b (Å) 10.2177(3) 10.1884(3) 10.2207(8) 10.1525(7) 10.1560(6) 10.0865(4)
c (Å) 16.2642(6) 16.4237(5) 16.1100(14) 15.7463(11) 15.7786(9) 16.3969(7)
α (deg) 101.2051(11) 99.8303(13) 101.397(2) 102.691(2) 102.253(2) 103.0980(10)
β (deg) 92.7447(10) 92.2880(12) 93.445(3) 91.775(2) 92.501(2) 92.8550(10)
γ (deg) 96.7569(19) 95.6243(18) 97.022(2) 100.403(2) 99.460(2) 99.4190(10)
V (Å3) 982.78(6) 993.86(4) 965.62(14) 966.81(11) 965.95(9) 993.57(7)
Za 2 2 2 2 2 2
μ (mm−1) 0.094 0.099 0.096 0.098 0.095 0.089
Dcalc (g cm
−3) 1.352 1.370 1.360 1.365 1.335 1.268
no. of parameters 533 542 350 353 353 342
reﬂns collected 5243 5245 16 568 12 518 12 520 11 524
reﬂns (I > 2σ) 3644 3649 5392 5357 5375 4788
wR (all data) 0.1285 0.1346 0.1512 0.1721 0.1635 0.1558
ﬁnal R (I > 2σ) 0.0526 0.0546 0.0534 0.0600 0.0556 0.0486
GOF 1.012 1.023 1.011 1.073 1.030 1.020
packing coeﬀ 0.705 0.704 0.717b 0.714 0.659
aOn the basis of droperidol as the molecular entity. bCalculated for structure where solvent molecules were ordered.
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■ RESULTS AND DISCUSSION
Solvate Screening. A crystal form screening of droperidol
was performed by selecting the most commonly used solvents
covering diﬀerent solvent classes based on classiﬁcation
according to statistical analysis of four molecular descriptors45
and hydrogen bond acceptor and donor propensity, polarity/
dipolarity, dipole moment, and dielectric constant.46 Solvents
used for the screening and the crystal forms obtained after the
crystallization are given in Table S1, Supporting Information. It
can be seen that besides the already known polymorphic forms
I and II, hydrates NSH and DH, and the ethanol solvate SEt,
eight new crystalline forms were obtained from methanol,
acetonitrile, nitromethane, chloroform, dichloromethane, car-
bon tetrachloride, 1,4-dioxane, and toluene. All of the obtained
crystal forms were characterized by PXRD and thermal
methods and were found to be droperidol solvates and were
labeled as SMe, SACN, SNM, SCLF, SDCM, SCTC, SDIOX, and STOL
respectively. Crystals suitable for SCXRD analyses were
obtained only from methanol, acetonitrile, and nitromethane.
Besides, all of the analyses were performed also with the poorly
characterized solvated forms NSH, SEt, and DH.
X-ray Diﬀraction. PXRD patterns of all the obtained
solvated forms are given in Figure 2. It can be seen that the
diﬀraction peak positions of the new solvates SMe, SACN, SNM,
SDCM, and SCLF were very similar and almost matched those of
NSH and SEt, suggesting the isostructurality of all these
solvated forms. However, PXRD patterns of STCC, SDIOX, and
STOL exhibited diﬀerent characteristic features and diﬀered also
from the PXRD patterns of all other known droperidol forms.
A crystal structure determination for the newly prepared SMe,
SACN, SNM, and also SEt and NSH was performed, and the
obtained crystallographic data are given in Tables 1 and S3,
Supporting Information. The crystal structures of NSH and SEt
were consistent with those already reported,40,44 and the newly
prepared solvates SMe, SACN, and SNM were isostructural to
NSH and SEt as already suggested by the PXRD patterns (a
more detailed discussion is given further). In this study the
NSH was determined to be of monohydrate stoichiometry (the
previously published hemihydrate stoichiometry40 is explained
by its nonstoichiometric behavior43), whereas SEt, SMe, SACN,
and SNM crystallized as hemisolvates (although monoethanol
solvate was reported,44 both the published44 and our
Figure 3. The DTA and TG curves of the droperidol isostructural solvates showing (a) the melting of solvate and/or ISD, (b) recrystallization, and
(c) melting of the resulting polymorph I.
Figure 4. PXRD patterns of the desolvation products of the droperidol solvates.
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determined crystal structures corresponded to a hemiethanol
solvate).
An overlay of the PXRD patterns obtained experimentally
and simulated from crystal structure data (see Figure S1,
Supporting Information) conﬁrmed the identity of the
polycrystalline phases.
Thermal Characterization. The DTA/TG curves of all
isostructural solvates were almost the same (see Figure 3 and
Figure S3): desolvation of these solvates occurred over a wide
temperature range, which started at ambient temperature
without a characteristic sharp endothermic eﬀect associated
with the desolvation process, thus suggesting that all of these
solvates are nonstoichiometric. When the temperature was
increased to 115−130 °C, melting occurred as conﬁrmed by
hot stage microscopy (HSM) (see Figure S4). Desolvation of
these solvates occurred at diﬀerent rates, and at the heating rate
5°·min−1 the forms SEt, SACN, SNM, and SCLF were not
completely desolvated before melting, and thus the melting
endotherm appeared together with a rapid loss of the rest of
solvent. After the melting, recrystallization occurred by forming
polymorph I as identiﬁed by the melting point in the DTA
curves. The recrystallization was also observed in the HSM
study (see Figure S4, Supporting Information).
Desolvation products of all the solvates were analyzed with
PXRD, and the obtained diﬀraction patterns are given in Figure
4. By combining the PXRD and DTA/TG data, it was
determined that all of the isostructural solvates can be
desolvated before melting (by heating at 100 °C for a
maximum of 2 days).
From Figure 4 it can be identiﬁed that desolvation of
isostructural solvates produced a phase with only a slightly
diﬀerent PXRD pattern: the isostructural desolvate (ISD). This
was conﬁrmed also by the structure determination of
completely dehydrated NSH crystals (see Table 1). The
formation of isostructural desolvate supports the fact that
isostructural solvates are nonstoichiometric.
Solvent stoichiometry was determined from TG curves (see
Figures 3 and S3, Supporting Information), and the obtained
results are given in Table 2. The obtained results were
consistent with the solvent stoichiometry determined by
SCXRD. The diﬀerences between the observed and calculated
solvent content in isostructural solvates are associated with
their nonstoichiometric behavior. The stoichiometry of SDCM
and SCLF was determined only from TG data. On the basis of
measurements from at least three diﬀerent samples, SDCM was
found to be a hemisolvate, whereas the stoichiometry of SCLF
was unclear because the highest obtained solvent/droperidol
ratio was only 1:3.
Desolvation of STCC and SDIOX produced the polymorph I,
STOL produced a new polymorph IV and that of DH depended
on the sample and produced either the polymorph II or a new
polymorph III. Results from thermal analysis of these solvates
are given in the Supporting Information.
Schematic representation of solvate preparation and phase
transformations upon heating is given in Figure 5.
Crystal Structures of Isostructural Solvates. NSH, SEt,
and SMe crystallize in P1̅ space group (see Table 1 and Table
S3, Supporting Information) with one droperidol molecule and
a water molecule or half of a disordered alcohol molecule
respectively, in agreement with the already reported struc-
tures.35,36 However, SACN and SNM crystallize in the P1 space
group with two droperidol molecules and a solvent molecule in
the unit cell. Both droperidol molecules in these two solvates
are inversion related; thus only the asymmetric solvent
molecule breaks centrosymmetry of the whole crystal structure.
Therefore, the conformation of both droperidol molecules in
the unit cell is the same (by taking into account the inversion
symmetry, see Figure S6 and Table S4, Supporting
Information). As already mentioned, despite the diﬀerent
space groups, all these droperidol solvates are isostructural (see
Figure 6 and Figures S8 and S9, Supporting Information), and
the solvent molecules are situated in the channels positioned
along the a-axis (see Figure S7, Supporting Information).
In these solvates all of the acetonitrile and nitromethane
molecules pointed in only one direction. Although the
methanol and ethanol molecules are asymmetric, the disorder
of these solvent molecules allowed description of SEt and SMe in
the P1 ̅ space group. The type of structural disorder with regard
to the solvent molecules and its causes were further investigated
using solid-state NMR and theoretical calculations and is a
topic for our next study.
The 2D ﬁngerprint plots (calculated from the Hirshfeld
surfaces59,60 in CrystalExplorer 3.161) of droperidol molecules
from all of the solvates were almost the same and were
dominated by the interactions between the droperidol
molecules themselves (see Figure S11, Supporting Informa-
tion). Thus, the solvent had only a minor role in the crystal
structure, and therefore it was reasonable that isostructural
solvates with quite diﬀerent solvent molecules could form.
The Interactions of Solvent Molecules in Isostructural
Solvates. In order to understand the diﬀerences between the
isostructural solvates, as well as the reasons for their stability,
intermolecular interactions of solvent molecules were analyzed.
Solvates can be divided based on the presence (in NSH, SMe,
and SEt) or absence (in SACN and SNM) of strong hydrogen
bonds between the solvent and the droperidol molecule oxygen
atom O1 in the benzimidazolone moiety. Although the disorder
of solvent molecules complicated the characterization of this
interaction in SMe and SEt, hydrogen bond parameters were
characteristic to a strong hydrogen bond with the O1···O3
distance of 2.81−2.91 Å, where the longest distance was in SMe
(see Tables 3 and S5). There were slightly diﬀerent interactions
between alkyl residues of alcohol molecules and droperdiol
molecules: in both solvates the O3 atom was an acceptor of
hydrogen bond from diﬀerent droperidol hydrogen atoms, and
the methyl group of the methanol was a hydrogen bond donor
for a much shorter interaction than in ethanol (see Table 3).
There was no strong hydrogen bond between droperidol and
acetonitrile or nitromethane. Nevertheless, these molecules
Table 2. Physicochemical Data for the Droperidol
Isostructural Solvates
solvate
calculated weight
loss, %
observed weight
loss, %
Tdesolvatation
a,°C
(peak)
resulting
phase
NSH 4.5b 2.5−4.8c 124 ISD
SMe 4.2
d 3.5−4.5 124 ISD
SEt 6.1
d 5.1−6.6 125−127 ISD
SACN 5.4
d 4.9−6.0 124−129 ISD
SNM 8.0
d 8.2−8.9 113−115 ISD
SDCM 11.2
d 5.5−11.0 123−124 ISD
SCLF 15.7
d 5.5−9.5 123−126 ISD
aMelting peak of the solvate or resulting ISD. bFor monosolvate
stoichiometry. cDepended on the storage conditions. dFor hemisolvate
stoichiometry.
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formed numerous weak hydrogen bonds and dispersion
interaction with droperidol molecules (see Table 3), therefore
providing suﬃcient interactions to allow the formation of a
stable solvate.
The only strong intermolecular interaction between solvent
molecules was observed in NSH where two water molecules
formed hydrogen bond by connecting two droperidol
molecules via an O1···O3···O3···O1 linkage40 across the
channel.
Hirshfeld surface 2D ﬁngerprint plots of the solvent
molecules representing the intermolecular interactions are
given in Figure 7. For this analysis crystal structures of SMe
and SEt with ordered solvent molecules after optimization of
hydrogen atom positions were used.
From the solvent molecule 2D ﬁngerprint plots, it was
possible to determined that interactions of both alcohol
molecules were diﬀerent, although both were dominated by
Figure 5. Schematic representation of the droperidol solvate preparation and phase transformations upon their heating.
Figure 6. Overlay of the crystal structures of isostructural droperidol
solvates.
Table 3. Geometrical Parameters for the Intermolecular
Interactions of Solvent Molecules in Droperidol Solvates
SMe, SEt, SACN, SNM, and NSH
a
interactionb
X−H
(Å)
H···A
(Å)
D···A
(Å)
D−H···A
(deg)
SMe O3−H···O1b 1.13 1.87 2.91 150
O3···H−C9c 0.97 2.80 3.51 130
C23−H···O1d 0.96 2.46 3.36 156
SEt O3−H···O1d 0.82 2.53 2.81 102
O3···H−C5e 0.93 2.64 3.41 140
C24−H···C9f 0.95 2.99 3.85 151
C24−H···O1f 0.97 2.92 3.51 120
SACN C23−H···O1Ag 0.96 2.68 3.41 133
C23−H···C9Bb 0.96 2.97 3.92 169
N4···H−C5Ac 0.93 2.80 3.70 162
N4···H−C5Bg 0.93 2.83 3.60 140
SNM C23−H···O1Ah 0.96 2.44 3.31 150
C23−H···C9Bb 0.96 2.90 3.86 178
O3···H−C5Ab 0.93 2.70 3.42 135
O3···H−C10Ah 0.97 2.52 3.29 135
O3···H−C11Ah 0.97 2.66 3.51 147
O3···H−C4Ae 0.93 2.64 3.42 143
O4···H−C9Bc 0.93 2.66 3.16 115
O4···H−C10Bc 0.97 2.72 3.13 106
O4···H−C4Bg 0.93 2.67 3.28 124
O4···H−C5Bg 0.93 2.66 3.26 123
NSH O3−H···O1b 0.85 1.99 2.83 171
O3−H···O3i 0.85 2.22 2.86 131
O3···H−C9c 0.95 2.73 3.38 127
aSymmetry codes: (b) x, y, z. (c) 1 + x, y, z. (d) 1−x, 1−y, −z. (e) −1
+ x, y, z. (f) −1 + x, −1 + y, z. (g) 1 + x, 1 + y, z. (h) x, 1 + y, z. (i) 2 −
x, −y, −z. bCutoﬀ parameter: van der Waals radii +0.1 Å.
Figure 7. Hirshfeld surface 2D ﬁngerprint plots of solvent molecules in
droperidol isostructural solvates, where de is the distance from a point
on the surface to the nearest nucleus outside the surface and di
represents the distance from a point on the surface to the nearest
nucleus inside the surface.57,58
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the strong hydrogen bond O3−H...O1. Despite the diﬀerent
functional groups in acetonitrile and nitromethane, and the
seemingly diﬀerent interactions of nitrile and nitro groups (see
Table 3), the interactions represented in 2D ﬁngerprint plots,
although diﬀerently shaped, were very similar. This suggests
that the properties of SACN and SNM could be similar. Therefore,
besides a strong hydrogen bond connecting alcohols in SMe and
SEt, the stability of these solvates and that of SACN and SNM was
provided by weak hydrogen bonds and dispersion interactions.
As could be expected, interactions of water molecules in NSH
were dominated only by strong hydrogen bonds. However,
unusual relative arrangement of water molecules (see Figure
S14, Supporting Information) introduced unusually shaped
broad representation of hydrogen−hydrogen interactions
between both water molecules.
Fourier-Transform Infrared Spectroscopy. ATR-FTIR
spectra of the solvates are presented in Figure 8. Besides the
few peaks appearing due to the presence of diﬀerent solvent
molecules, the spectra of these solvates were almost identical,
conﬁrming their isostructurality. However, noticeable diﬀer-
ences characterizing the structure of solvates appeared in the
carboxyl group stretching and O−H stretching regions. There
were two distinct peaks with almost the same intensity in the
carboxyl group stretching region for SNM, SACN, and SDCM (see
Figure S17a, Supporting Information). However, the higher
frequency peak (∼1692 cm−1) was observed as a shoulder on
the lower frequency peak (∼1682 cm−1) for SMe, SCLF, SEt, and
NSH. At the same time there was sharp peak at 3468−3475
cm−1 for SEt, SMe, and SCLF, and at 3499 cm
−1 for NSH
corresponding to the O−H (in alcohols and water) and C−H
(in chloroform) stretching bands, respectively.
Thus, based on the similarities in IR spectra in the O−H and
C−H stretching regions and in the CO stretching region, it
can be concluded that chloroform molecule also forms
hydrogen bond with droperidol molecules similarly to water
and alcohol molecules, whereas the solvent interactions in SDCM
are more similar to those in SNM and SACN.
Characterization of Solvent Content in Isostructural
Solvates at Diﬀerent Solvent Activity. The nonstoichio-
metric behavior of the solvates and the presence of solvent
channels suggested that solvent content in the structure (ε)
should be dependent on the solvent activity.62 To investigate
this, NSH, SEt, SMe, SACN, and SNM were stored under
atmosphere with diﬀerent solvent activity, obtaining the
sorption−desorption isotherms of the corresponding solvents.
Water sorption−desorption isotherm of NSH is shown in
Figure 9. The highest water content corresponds to
monohydrate stoichiometry and lowering of the RH gradually
decreased the water content ε by completely dehydrating the
NSH and obtaining ISD at ≈0% RH.
A study of the other four solvate sorption−desorption
isotherms revealed that uptake of the solvent also was gradual
but occurred at much lower solvent activity: most of the solvent
uptake had already had taken place when solvent activity
reached 0.02 and maximum solvate stoichiometry (ε ≈ 0.5) was
reached at solvent activity 0.1. The resulting sorption−
desorption isotherm of SMe is given in Figure 10, but those
of SEt, SACN, and SNM are in Figures S20 and S23, Supporting
Information. The initial parts of the isotherms for all solvates
are given in Figure 11.
Figure 8. FTIR spectra of the droperidol isostructural solvates with dashed rectangle highlighting the most diﬀering spectral regions and asterisks
marking the bands due to the solvent molecules.
Figure 9. Water sorption−desorption isotherm of NSH from two
sample sorption and desorption cycles, and localized water model
describing the experimental points.
Figure 10. Methanol sorption−desorption isotherm of SMe. The black
line corresponds to global isotherm model formed by combination of
Langmuir isotherm (red line) and disordered solvent model63 (green
line).
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In order to compare the obtained isotherms, thermodynamic
models were used to describe the obtained data points, thus
characterizing the thermodynamics of the solvates themselves.63
The sorption−desorption isotherm of NSH was ﬁtted with
general localized water model with constant activity coeﬃcients
(see Figure 9, parameters used for all the ﬁttings are given in
Tables S5−S8), whereas those of all organic solvates were
described as a combination of (a) localized solvent model
describing solvent in the structural channels and (b) disordered
solvent model describing the adsorbed solvent63 (see
Supporting Information). Localized solvent in the sorption−
desorption isotherm of SMe was ﬁtted with Langmuir isotherm
and that in SEt with general localized solvent model with
constant activity coeﬃcients. The sorption−desorption iso-
therms of SACN and SNM clearly did not correspond to
Langmuir isotherm because of the hindered solvent absorption
at very low solvent activity and thus sigmoidal shape (see
Figure 11). The SACN isotherm was ﬁtted with a general
localized solvent model (usage of variable activity coeﬃcients
only slightly improved the ﬁt), whereas that of SNM could be
ﬁtted only using localized solvent model with variable activity
coeﬃcients described by Margules equations (see Figure S24,
Supporting Information). The diﬀerences between the
isotherms are associated with the presence or absence of
interactions between solvent molecules in two adjacent solvent
sites positioned along the a-axis as well as the solvent molecule
size diﬀerences (see Supporting Information). As the solvent
molecules have well located crystallographic sites, the use of the
Langmuir model or localized solvent model for describing the
change of these molecules in the channels is in accordance with
the assumptions for these models.
Characterization of Changes in Isostructural Solvate
Structure at Various Solvent Content. The PXRD patterns
of solvates with various solvent content were recorded. By
increasing the solvent content, continuous displacement of
diﬀraction peaks to mostly lower 2θ values occurred (insertion
of the solvent molecules increased the cell volume and thus the
interplanar spacing), and continuous intensity changes of some
peaks were observed. The peak positions changed gradually,
thus conﬁrming the continuity of structural changes (see
Figures S25−S29, Supporting Information), and it was possible
to calculate the dependence of lattice parameters on the solvent
content (ε) for these solvates. The obtained results conﬁrmed
gradual changes of the crystal structure (see Figure 12). The
diﬀerences between NSH and other solvates already observed
from changes of the diﬀraction peak positions (see Supporting
Information) were reﬂected in the calculated lattice parameters:
the direction and amplitude of the lattice parameter changes
was almost identical for all solvates except for the NSH (see
Figure 12).
These diﬀerences of the lattice parameter change clearly
could be associated with the formation of hydrogen bonds
mediated by water molecules, with these bonds providing links
between droperidol molecules situated across structural
channels. Therefore, the decrease of the cell length c and the
angle α, with concurrent increase of the angle γ in NSH was
due to the geometric eﬀects driven by the formation of this
linkage. The decrease of the cell length a for other solvates
most probably can be associated with the presence of solvent−
solvent interactions in the channels, but the size of the solvent
molecules caused the increase of the cell lengths b and c.
Water Arrangement in a Partially Filled NSH
Structure. In this study the crystal structures of NSH with
three diﬀerent levels of water content were determined: the
monohydrate (120 K, obtained from synthesis), the hemi-
hydrate (120 K, obtained by storing a sample at 30−40% RH),
and the anhydrous form or ISD (333 K, obtained by storing a
sample at 0% RH, or heating the sample). As can be seen in
Table S12, Supporting Information, the intermolecular
Figure 11. Initial part of the droperidol isostructural solvate sorption−
desorption isotherms where circles indicate experimental solvent
content ε and lines represent the best theoretical model (Langmuir
isotherm (SMe) and general localized solvent model
63 with constant
activity coeﬃcients (NSH, SEt, and SACN) or activity coeﬃcients
described by third-order Margules equation (SNM)). For NSH a 10
times larger solvent activity region is shown.
Figure 12. Lattice parameter dependence on the solvent content (ε)
in the isostructural solvates of droperidol.
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interaction geometry of droperidol molecules was only slightly
aﬀected by the water content.
The hydrogen bonding parameters determined for water
mediated hydrogen bond linkage O1···O3···O3···O1 are given
in Table 4. In this study, both of the hydrogen atoms were
located for the case of monohydrate stoichiometry, therefore
conﬁrming that between two water molecules there is a
hydrogen bond with unusual geometry (see Figure S14,
Supporting Information).
The geometrical parameters for the O3−H···O1 and O3−
H···O3 hydrogen bonds were the same for both stoichiome-
tries. Therefore, the removal of water occurred by simulta-
neously losing both hydrogen bonded water molecules from
some of the channel sites instead of losing water molecules
from one of the O3 positions and thus losing hydrogen bond
linkage across the channel. This water molecule arrangement in
NSH with stoichiometry below 1 was also supported by the
absence of a signiﬁcant increase in the equivalent isotropic
displacement parameter of water oxygen for hemihydrate
stoichiometry (thus conﬁrming that water retains two hydrogen
bonds also for this stoichiometry), by the energy calculations
(hemihydrate structure with hydrogen bonded water molecules
was energetically favorable by 2−4.5 kJ per mole of water),
lattice parameter changes (this arrangement explained the
observed lattice parameter changes), and the recorded
sorption−desorption isotherms corresponding to the presence
of only equivalent water absorption sites in the structure. More
details are given in the Supporting Information.
We therefore conclude that the diﬀerence observed in the
solvent uptake at a given solvent activity in the NSH sorption−
desorption isotherm (see Figure 11) can be associated with the
absorption of water through an insertion of two hydrogen-
bonded molecules at one site, which theoretically is a lower
probability process compared to the absorption of one solvent
molecule, as in the rest of the solvates.
Analysis of the Droperidol Solvate Formation. While it
should not be assumed that all of the potentially existing
solvates have been identiﬁed, the crystallization from 30
solvents selected from various solvent classes should ensure
the discovery of most of the stable solvated forms. Interestingly,
ﬁve of the newly prepared solvated phases were isostructural to
the already known NSH and SEt. Thus, although droperidol
solvates can be obtained with 10 solvents, only ﬁve distinct
solvated crystal structures were obtained: DH, STCC, SDIOX,
STOL, and the “isostructural solvate”, where the latter one
formed from a variety of diﬀerent solvents. Therefore, three
questions can be raised to understand the solvate formation of
droperidol: (a) what is the reason for the formation of only
these ﬁve structures, (b) why were the isostructural solvates
obtained from such a wide range of solvents, and (c) which
solvents can form isostructural solvates?
Unfortunately, the lack of information regarding the STCC,
SDIOX, and STOL crystal structures prevents a thorough answer
to the ﬁrst question. It is stated that one of the driving forces
for solvate formation can be a mismatch of the hydrogen bond
donors and acceptors in a molecule.64 Although the molecule of
droperidol contains three strong hydrogen bond accepotors
(HBA) and only one hydrogen bond donor (HBD), this HBD
deﬁciency was compensated only in the DH structure. In
isostructural solvates, the solvent molecules did not compensate
the HBD deﬁciency, and it is not theoretically possible also in
the structures of STCC, SDIOX, and STOL. Therefore, it can be
concluded that the formation of droperidol solvates can be
associated with the fact that molecules cannot pack with a
suﬃcient eﬃciency and solvent molecules act as void ﬁllers in
these structures. This is supported by the fact that the packing
index of the thermodynamically stable polymorph II is 0.675,
which is only slightly higher than that of ISD at 333 K (0.659)
where there are empty channels, but signiﬁcantly lower than
that of the isostructural solvates (0.704−0.717).
The reason for the formation of isostructural solvates is the
stability of this structure. The calculation of both the total and
lattice energy showed that the structures of II and ISD have
almost the same energy at 0 K (the energy of ISD is even
slightly favorable, see Table S13, Supporting Information), and
only the higher density of the polymorph II makes it
thermodynamically stable at elevated temperature. Therefore,
this structure is not necessarily characterized by a high solvent
selectivity, and the criteria for solvate formation most probably
are (a) the ability to form suﬃciently eﬃcient droperidol−
solvent interactions, and (b) the solvent molecules should ﬁt
into the channels by not signiﬁcantly disturbing the packing of
droperidol molecules.
By evaluating the properties of solvents forming isostructural
solvates, it was noticed that three solvates formed with aprotic
polar solvents (acetonitrile, nitromethane, and dichloro-
methane), three formed with hydrogen bond donors (water,
methanol, and ethanol), and the last one formed with
chloroform that can be classiﬁed both as a hydrogen bond
donor and aprotic polar solvent, depending on the classiﬁcation
scheme.45 However, the classiﬁcation of solvents according to
these two groups clearly is not the main factor aﬀecting the
formation of the solvates (see Table S1, Supporting
Information), although the formation of strong hydrogen
bonds apparently is one of the driving forces. A better
explanation of isostructural solvate formation can be achieved
by taking into account a more detailed solvent classiﬁcation
based on various physical and physicochemical properties.46
Isostructural solvates were obtained from solvents belonging to
groups 3 (mostly alcohols), 7 (mostly halocarbons), 9 (nitriles
and nitromethane), and 15 (water).46 Therefore, only solvents
from these groups were able to form energetically favorable
interactions with the functional groups of droperidol molecules
located around the structure channel.
Nevertheless, the second important factor for the formation
of isostructural solvates clearly is the size (and shape) of solvent
molecules. Thus, only the smallest molecules from the solvent
groups 3, 7, and 9 formed isostructural solvates, which was
conﬁrmed by the calculation of molar volume (see Table S14,
Supporting Information). The largest solvent molecule forming
an isostructural solvate with droperidol is chloroform (the size
of which is even higher than that of some solvents not able to
form isostructural solvates with droperidol), explaining the
solvent content in the SCLF phase observed by TG measure-
Table 4. Geometrical Parameters for the Hydrogen Bond
Linkage Provided by Water Molecules in NSH with Mono-
and Hemihydrate Stoichiometry
ε temp, K O1···O3, Å O3···O3, Å O1−O3−O3, ° O1···O1, Å
1 120 2.83 2.86 109 7.11
173 2.85 2.83 109 7.14
0.5 120 2.85 2.86 108 7.13
29840 2.85 2.76 111 7.16
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ments to be below 0.5 stoichiometry. In contrast, the small size
of water molecule and its ability to form interwater hydrogen
bonds enabled the formation of a monohydrate.
■ CONCLUSIONS
Crystallization of droperidol from 30 diﬀerent solvents
produced eight new solvates from methanol, acetonitrile,
nitromethane, chloroform, dichloromethane, carbon tetrachlor-
ide, 1,4-dioxane, and toluene, while the desolvation of
droperidol solvates produced two new polymorphs III and
IV. Droperidol solvates obtained from methanol, ethanol,
acetonitrile, nitromethane, dichloromethane, chloroform, and
water are nonstoichiometric and isostructural. The solvent
content in these solvates can reach up to 0.5 equiv (with the
exception of NSH, that can reach monohydrate stoichiometry),
and desolvation of these solvates produces an isostructural
desolvate.
The crystal structures of ﬁve of these solvates were
determined, proving that the droperidol molecule arrangement
was isostructural despite the crystal structure description in
both the centrosymetric P1 ̅ (NSH, SMe, and SEt) and non-
centrosymetric P1 (SACN and SNM) space group. The diﬀerent
space group determined for solvates with organic solvents was
due to the disorder of methanol and ethanol molecules. The
stability of isostructural solvates was mainly provided by the
interactions between droperidol molecules themselves, while
the solvent molecules were located in the structural channels
and formed strong and/or weak hydrogen bonds with the
droperidol molecules. On the basis of the IR spectra, it was
concluded that the chloroform molecules in SCLF formed
hydrogen bonds with droperidol molecules.
The solvent sorption−desorption isotherms of NSH, SMe,
SEt, SACN, and SNM showed that the solvent molecule content in
the solvate could be described with a localized solvent model
and there was no interaction between the solvent sites in SMe.
For NSH, SEt, SACN, and SNM the solvent interactions and the
larger molecule size complicated the shape of the sorption
isotherm. It was proved that the solvent content variation in the
channels resulted in linear changes of the lattice parameters;
therefore the transformation of the crystal structure was
gradual. The lattice parameter changes and the solvent uptake
at a given solvent activity in NSH signiﬁcantly diﬀered from
those in the rest of the solvates. This was due to the formation
of water molecule mediated hydrogen bond linkage across the
structural channels and the simultaneous occupation of both of
these hydrogen bonded water molecule positions.
The analysis of the solvate formation revealed that the
driving force for droperidol solvate formation was the inability
of droperidol molecules to pack eﬃciently; thus the solvent
molecules acted as a void ﬁllers, with the exception of DH,
where water molecules provided an HBD function matching
the excess HBA functions in the molecule of droperidol. The
stability of the isostructural solvate structure was rationalized by
the very eﬀective interactions between droperidol molecules,
explaining the fact that no speciﬁc interaction with solvate was
necessary to maintain the crystal structure of the isostructural
solvate. Therefore, isostructural solvates can be obtained with
solvents ﬁtting in the channels and providing suﬃciently
eﬀective intermolecular interactions with droperidol. By
analyzing the solvent classiﬁcation, it was concluded that
these solvates can be obtained with the smallest solvent
molecules from the solvent groups 3, 7, and 9, as well as from
water,46 and the formation of strong hydrogen bonds is one of
the driving forces for solvate formation.
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ABSTRACT: In order to ﬁnd a tool for comparison of solvate
stability and to rationalize their relative stability, droperidol
nonstoichiometric isostructural solvates were characterized
experimentally and computationally. For the experimental
evaluation of stability, three comparison tools were considered:
thermal stability characterized by the desolvation rate,
desolvation activation energy, and solvent sorption−desorp-
tion isotherms. It was found that the desolvation process was
limited by diﬀusion, and the same activation energy values
were obtained for all of the characterized solvates, while the
solvent content in the sorption isotherm was determined by the steric factors. Therefore, the only criterion characterizing the
solvate stability in this particular system was the thermal stability. It was found that computationally obtained solvent−droperidol
and solvent−solvent interaction energies could be used for the rationalization of the isostructural solvate stability in this system
and that the solvent−solvent interaction energy has a crucial role in determining the stability of solvates.
1. INTRODUCTION
The investigation of solid phase diversity of pharmaceutical
molecules has frequently shown the formation of diﬀerent
phases, including polymorphs and solvates.1,2 The fact that
diﬀerent polymorphs and solvates have diﬀerent stability,3
mechanical properties,4−6 and bioavailability (because of
diﬀerent solubility7) makes understanding the solid form
stability and phase transitions a crucial step for the character-
ization of drug compounds. Determination of the relative
stability of polymorphs is relatively simple, and there are
numerous reports employing diﬀerent techniques,8−11 with a
growing number of computational stability predictions,10−12
including the calculation of crystal energy landscape where the
stability of theoretical structures is also calculated.13−17 The
same experimental and computational methods can also be
used for the identical stoichiometry solvates17−19 with the same
solvent, although the desolvation temperature predictions are
not straightforward. The comparison of solvate stability with
diﬀerent solvents is cumbersome because of the lack of an
unambiguous comparison parameter. The stability of solvates
can be assessed by comparing the thermal stability, desolvation
activation energy, or solvent sorption−desorption isotherms.
Most commonly, the thermal stability is compared by using
the desolvation onset temperature or the desolvation rate at a
given temperature or heating rate. In general, thermal stability
should be a function of all the host−guest interactions, host−
host interactions, and the intrinsic properties of the guest
itself.20 Surely, the ﬁrst aspect is avoided if the host structure is
identical for all the compared solvates. Although it is stated20
and shown experimentally21,22 that the thermal stability
correlates with the normal boiling point of the solvent, this
can be true only if the solvent molecules are weakly bound to
the host material and situated in open voids. In other cases, the
solvate stability should strongly depend on the solvent
molecule accommodation in the host structure: the interaction
energy between solvent and host molecules and the spatial
characteristics.21 This is supported by the experimentally
obtained order of the isostructural solvate thermal stability
not matching the order of solvent boiling points23,24 and
explained by the presence of diﬀerent solvent−host inter-
molecular interactions,25−28 tight binding of the solvent
molecules in the crystal cavities,29,30 or steric eﬀects hindering
the desolvation.31
The desolvation activation energy could also be used as a
comparison tool if the desolvation mechanism of all the
compared solvates is identical. However, this approach is rarely
employed.32 In principle, also the solvent sorption−desorption
isotherms could be compared by evaluating the phase
composition at a given solvent activity. However, we have
not found any example where this approach has been applied to
pharmaceutical molecules, probably due to the possible
experimental diﬃculties and the relatively complicated
experimental procedure.
Here, we have tried to rationalize the solvate stability with
respect to the desolvation based on their crystal structures and
to select an appropriate tool for experimental comparison of the
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solvate stability. Solvate stability was compared theoretically by
calculating the intermolecular interactions in the solvate
structure and experimentally by determining the solvate
thermal stability and desolvation kinetics and by analyzing
previously reported solvent sorption−desorption isotherms.33
In order to avoid the eﬀects of any other factors on the solvate
stability and desolvation process, for this study, we selected
isostructural solvates of droperidol that retain the crystal
structure after the desolvation.
Droperidol, 1-{1-[4-(4-ﬂuorophenyl)-4-oxobutyl]-1,2,3,6-tet-
rahydro-4-pyridyl}-1,3-dihydro-2H-benzimidazol-2-one (Figure
1), is a neuroleptic pharmaceutical. It is reported to exist in four
polymorphic forms, I−IV,33−35 and 11 solvated forms:
dihydrate DH,35,36 nonstoichiometric hydrate NSH,34,35,37
and solvates with ethanol,38 methanol, acetonitrile, nitro-
methane, chloroform, dichloromethane, carbon tetrachloride,
1,4-dioxane, and toluene33 (SEt, SMe, SACN, SNM, SCLF, SDCM,
SCTC, SDIOX, and STOL, respectively). It is determined that the
NSH, SEt, SMe, SACN, SNM, SCLF, and SDCM are non-
stoichiometric isostructural solvates,33,37 but the crystal
structures have been determined only for the ﬁrst ﬁve of
them (see Table S1, Supporting Information).33,34,38 The unit
cell of these solvates consists of two droperidol molecules and
one (for organic solvates) or two (for NSH) solvent
molecules.33,34,38 The solvent molecules are situated in the
structural channels oriented along the a axis (see Figure S1,
Supporting Information) and in NSH, SEt, and SMe form strong
hydrogen bonds with the droperidol molecule, while the
solvent and droperidol molecules in SACN and SNM are
connected by weak hydrogen bonds and dispersion inter-
actions.33 It is also reported that the desolvation of all of these
droperidol solvates occurs without changes of the droperidol
molecule structure and produces the isostructural desolvate
ISD.33
Although nonstoichiometric in that the solvent content is
dependent on the partial pressure of solvent in the
atmosphereup to 1 equiv of water per droperidol for NSH,
and 0.5 equiv of solvent for the other solvatessamples
produced from crystallization are always fully solvated and are
relatively stable with respect to desolvation if stored in the
mother liquor or in a desiccator with the relative vapor pressure
of the corresponding solvent above 20%.33
2. EXPERIMENTAL SECTION
2.1. Materials and Preparation of Solvates. Droperidol (purity
> 99%) was obtained from JSC Grindeks (Riga, Latvia). The sample
consisted of polymorph II, as determined by powder X-ray diﬀraction
(PXRD) pattern.34,35 Organic solvents of analytical grade were
purchased from commercial sources and used without further
puriﬁcation.
2.2. Preparation of Solvate Samples. For studying the thermal
stability of solvates, samples were prepared as follows: saturated
solutions of droperidol in methanol, ethanol, acetonitrile, and
nitromethane were prepared at 60−90 °C depending on the boiling
point of the solvent. The solutions were then cooled down to −5 °C,
giving SMe, SEt, SACN, and SNM, respectively. A small amount of water
(5−10%) was added to droperidol solution in acetone, and the
resulting solution was slowly partially evaporated at 50 °C temper-
ature, giving NSH. Solvates were stored in the mother liquor, ﬁltered,
dried, and ground in a mortar for 30 s immediately before the analysis.
For a study of the desolvation kinetics, diﬀerent sample preparation
procedures were used. Four diﬀerent types of NSH samples were
obtained similarly as described above by adding 5−50% of water
(relative to the ﬁnal volume). Samples labeled as Crystals I−IV (the
size of all of the dimensions was higher than 100 μm) were obtained
by slowly evaporating the solution in a 100 mL conical ﬂask, and
samples labeled Small crystals I−III (with the size below 100 μm for at
least one of the dimensions) were obtained by evaporating the
solution in a 250 mL conical ﬂask, while samples labeled Powder I−II
(with the size below 40 μm for all of the dimensions) were obtained
when the solution was evaporated at 25 °C temperature from a Petri
dish. The fourth type of samples was obtained by grinding the Crystals
II in a mortar. More details on the preparation of each sample are
given in Table S2 (Supporting Information).
Organic solvates used for the kinetic study were prepared by
obtaining saturated solutions of droperidol in the respective solvents at
60−90 °C (depending on the boiling point of the solvent) and then
cooling to −10 °C either slowly (obtaining crystals with the size of at
least one of the dimensions below 100 μm, labeled Small crystals) or
rapidly (obtaining powder samples with the particle size below 40 μm
for all of the dimensions, and labeled Powder). Alternatively, well-
ground polymorph II was suspended in the corresponding solvent at
50 °C for 24 h, producing powdered solvate samples labeled
Suspension. For the study of the desolvation kinetics of organic
solvates under nonisothermal conditions, Small crystals were ground in
a mortar for 1 min.
Prior to the analysis, samples were stored at ambient temperature in
desiccators above saturated solution of K2SO4 (97% relative humidity)
for NSH and 90% solution (mole fraction) of the corresponding
solvent with glycerol (for alcohol solvates) or DMF (for acetonitrile
and nitromethane solvates). The identity of all droperidol solvates was
conﬁrmed using PXRD33 (see Figure S2, Supporting Information).
2.3. Diﬀerential Thermal Analysis/Thermogravimetry (DTA/
TG). DTA/TG analysis was performed with Exstar6000 TG/
DTA6300 (SII). Open aluminum pans were used. Samples of 7.0 ±
0.5 mg in mass were used. For studying the thermal stability of the
solvates, heating of samples from 30 to 180 °C was performed at a 5°·
min−1 heating rate. The nitrogen ﬂow rate was 100 ± 10 mL·min−1.
For studying the desolvation kinetics in nonisothermal mode,
samples were heated with variable heating rates in the range from 0.1
to 3 °C·min−1. The nitrogen ﬂow rate was 300 ± 20 mL·min−1.
Desolvation kinetics were studied also in the isothermal mode at 20−
125 °C temperatures with an average step of 5 °C. The heater unit was
preset to the required temperature before the insertion of the sample.
For each sample, desolvation was performed at four to eight diﬀerent
temperatures selected according to the dehydration rate, which
depended on the analyzed solvate and the particle size; see Tables
S2 and S3 (Supporting Information). The nitrogen ﬂow rate was 100
± 10 mL·min−1.
2.4. Powder X-ray Diﬀraction (PXRD). PXRD patterns were
measured on a D8 Advance (Bruker) diﬀractometer equipped with a
LynxEye position sensitive detector, using copper radiation (Cu Kα) at
the wavelength of 1.54180 Å. The tube voltage and current were set to
40 kV and 40 mA. The divergence slit was set at 0.6 mm, and the
antiscattering slit was set at 8.0 mm. The diﬀraction patterns were
recorded using a 0.2 s/0.02° scanning speed from 3° to 35° on a 2θ
scale. To prevent the atmospheric humidity eﬀect, the samples were
covered during the analysis with a 10 μm polyethylene ﬁlm.
2.5. Hot-Stage Microscopy (HSM). For HSM, a Laborlux 12
PolS (Leitz) polarized light microscope equipped with a heating stage
and a Newtronic heating control module was used. The heating rate
was 5 °C·min−1. Images were acquired with Leica Application Suite
software from a DFC450 (Leica) digital microscope camera.
Figure 1. Molecular structure of droperidol.
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2.6. Methods for Kinetic Parameter Determination. The
desolvation activation energy and kinetic model were determined
using a model-free approach.39 The data sets of fraction desolvated (α)
− time (for isothermal experiments) and α − temperature (for
nonisothermal experiments) were obtained with Δα = 0.02 for each
temperature or heating rate. By using results from both experimental
modes, Ea was calculated from the Arrhenius equation with
isoconversional methods:40−42 Friedman (FR)43 and average linear
integral method (ALIM).44 The Ea was calculated from the slope of
the line in the corresponding coordinates for α values with a step size
of 0.02,43,44 and identical Ea values were obtained. The conﬁdence
intervals for the calculated Ea values were evaluated from the slope
error of the line used for calculation of Ea with the FR method. Kinetic
model determination was performed with ALIM44 and also with the
reaction progress reconstruction in the coordinates g(α) − α45,46 and
f(α) − α.42,45,46 Besides, kinetic model determination for isothermal
experiments was performed with reduced time plots.47 The most often
used solid-state kinetic models were included in the analysis (see Table
S4, Supporting Information).40−42,48−50
For isothermal experiments, the selection of the kinetic model was
also evaluated by plotting the experimental data points in the
coordinates α − time and ﬁtting the theoretical lines modeled from the
selected kinetic models to these experimental points. The sum of
squared diﬀerences between experimental and theoretically calculated
α values was minimized with MS Excel Solver. The best model was
identiﬁed by the smallest sum of least-squares.
2.7. Geometry Optimization of the Crystal Structures. The
starting geometries of droperidol solvates were obtained from a
previously published crystal structure report.33 Since the solvent
molecules in SMe and SEt are disordered over two orientations related
by inversion symmetry,33 the starting geometries of SMe and SEt
without disorder were prepared by discarding one of the solvent
molecule orientations. The starting geometry for ISD was obtained by
removing the water molecules from the NSH structure. Geometry
optimization of these crystal structures were performed in
CRYSTAL0951 and in CASTEP.52 Calculations in CRYSTAL09
were performed at the B3LYP-D*53,54 level using the 6-31G(d,p)
basis set,55,56 and dispersion was corrected by the Grimme dispersion
correction model57 modiﬁed as described in the literature.54,58,59 The
calculations in CASTEP were performed with the PBE60 functional
using on-the-ﬂy generated ultrasoft pseudopotentials and a cutoﬀ
energy of 600 eV. Dispersion interactions were treated using
semiempirical dispersion correction schemes G0657 and TS.61 Crystal
structure optimization was performed by employing three diﬀerent
proceduresby relaxing only the hydrogen atoms (HO), by relaxing
all atoms (ALL), and by relaxing all atoms and the unit cell parameters
(UC)for three diﬀerent calculation methods: PBE+TS (HO, ALL,
and UC) and PBE+G06 (UC) in CASTEP, as well as B3LYP-D*
(UC) in CRYSTAL09. Identical input geometries were used for all of
the calculation methods.
The validity of the ordered model of SMe and SEt structures was
conﬁrmed by optimizing the geometry of SMe and SEt structures where
adjacent alcohol molecules were oriented in opposite directions and
calculating the intermolecular interaction energy of the solvent
molecules (see the Supporting Information).
2.8. Calculation of the Intermolecular Interaction Energy.
The interaction energies between pairs of molecules were calculated in
Gaussian 0962 using the B3LYP and M06-2X63 functionals and the 6-
311G(d,p) basis set to molecular geometries directly extracted from
the crystal structures after the geometry optimization. The basis set
superposition error was corrected using the counterpoise method. For
B3LYP calculations, the Grimme dispersion correction method was
used.64 The interaction energy was calculated as the diﬀerence
between the total energy of the dimer and the corresponding isolated
molecules. The total solvent interaction energy was calculated as a sum
of all solvent−droperidol and solvent−solvent interaction energies.
3. RESULTS AND DISCUSSION
3.1. Desolvation Kinetics of Droperidol Solvates. First,
the stability of droperidol isostructural solvates was compared
by determining their desolvation kinetic parameters. The
desolvation kinetics was studied in both isothermal and
nonisothermal modes. Various samples were analyzed in the
isothermal mode (including the crystals of NSH, SMe, and SEt),
whereas, in the nonisothermal conditions, only a well-ground
sample was analyzed for each solvate. The Ea values were
calculated by using an isoconversional method only, to allow
the identiﬁcation and characterization of possible complexity of
the desolvation process39 and to identify the possible
complications and errors associated with the experimental
variables (most importantly, the sample, its mass and
packing),40 which can easily aﬀect the results, especially for
the desolvation process of nonstoichiometric solvates.
3.1.1. Desolvation Activation Energy. A total of 11 diﬀerent
NSH samples were analyzed in isothermal mode, and the
calculated activation energy values had a relatively high
dispersion (see Table 1). However, no direct relationship
between the dehydration Ea (or kinetic model) and the sample
particle size was observed. It was conﬁrmed that the samples
with smaller particle size dehydrated faster at a given
temperature (see Figure S3, Supporting Information, and
Table 1), and it was determined that unground samples showed
higher variation of apparent Ea with α, while the average Ea
values were in the same range as those determined for samples
without Ea variation (see Table S2 and Figure S5, Supporting
Information). The average dehydration Ea of NSH was
calculated to be 56 ± 10 kJ·mol−1.
The determination of the desolvation Ea was less
straightforward for the organic solvates of droperidol. First,
for some of the samples, complications arose due to almost
identical desolvation rates at each temperature in the beginning
of the reaction. This was observed for the samples with the
smallest particles and could be due to the rapid escape of the
solvent molecules close to the surface and with only minor
temperature dependence, and for small particles, there were
many such solvent molecules. Second, a higher Ea variation
from sample to sample and also higher apparent variation by
the fraction desolvated was observed (see Table S3 and Figure
Table 1. Summary of the NSH Desolvation Kinetic
Parameters in Isothermal Mode
sample Ea, kJ·mol
−1 kinetic modela temperatures used, °C
Crystals I 38 ± 20 F3/2, D5 60−100
Crystals II 55 ± 20 D5, D3 70−110
Crystals III 47 ± 13 F1 40−90
Crystals IV 49 ± 10 F3/2, D3, D5 50−100
Small crystals I 54 ± 11 F2, D5 60−120
Small crystals II 66 ± 7 F3/2, F1 25−50
Small crystals III 60 ± 20 F1 35−60
Crystals II ground
for 10 s
68 ± 7 D5, F2 25−70
Crystals II ground
for 1 min
65 ± 10 F3/2, F2 25−70
Powder I 54 ± 12 F2, F3/2 25−50
Powder II 56 ± 10 F3/2, F1 20−60
summary 56 ± 10 modiﬁed D5 20−120
aFor each individual sample, only commonly used kinetic models were
included in the selection (see Table S4, Supporting Information).
Crystal Growth & Design Article
dx.doi.org/10.1021/cg500616t | Cryst. Growth Des. 2014, 14, 3639−36483641
S6, Supporting Information). This most probably was a result
of lower reproducibility of the sample conditions and a stronger
eﬀect of diﬀerent sample and experimental factors on the
obtained results. Third, the desolvation of SACN and SNM in the
selected conditions could be analyzed only at temperatures very
close to the melting point of these solvates.33 This resulted in a
very high desolvation rate dependence on the temperature,
which produced unexpectedly high calculated Ea values. This
most probably was a result of the change of the desolvation
mechanism at temperatures close to the melting point;
therefore, the calculated Ea values most probably did not
actually represent the activation energy of the desolvation
process. This assumption was supported by the relatively lower
Ea values obtained for the SACN sample that was analyzed at
slightly lower temperatures (see Table S3). The average
desolvation Ea values for all droperidol solvates are given in
Table 2.
In order to bring more clarity about the desolvation kinetics
of droperidol solvates with organic molecules, these solvates
were studied also in nonisothermal mode using well-ground
samples and a higher nitrogen ﬂow rate. Although these results
were also complicated by the apparent variation of Ea with the
fraction desolvated and by the high uncertainty of the Ea values
(see Figure S10, Supporting Information), the determined
average desolvation Ea value for all four solvates was similar
(50−65 kJ·mol−1) and almost the same as that of NSH in the
isothermal mode (see Table 2). Therefore, it was concluded
that (a) the desolvation activation energy of all the droperidol
solvates is almost the same and is 57 ± 15 kJ·mol−1, and (b) in
isothermal mode, very high Ea calculated for desolvation of
SACN and SNM was due to the analysis at the temperatures close
to the melting point and not because of actually higher
desolvation Ea.
The identical desolvation Ea values did not allow us to use
this parameter for the comparison of solvate stability.
3.1.2. Kinetic Model. Determination of the desolvation
kinetic model of droperidol solvates was not straightforward,
and none of the commonly cited41,48−50,65 kinetic models (see
Table S4, Supporting Information) derived from the rate
dependence on the nuclei formation and growth, interface
advance, diﬀusion, and/or geometrical shape of the particles
were able to convincingly and satisfactorily describe the
desolvation kinetic curves recorded in isothermal mode.
However, the shape of the desolvation kinetic curves was
similar to those of diﬀusion (D5 and D3) and reaction order
(F3/2, F1, and F2) models. The arrangement of the solvent
molecules in the structural channels, the absence of structural
changes during the desolvation,33 and the similarity of the
shape of diﬀusion and reaction order model kinetic curves
suggested that the rate-limiting step in the desolvation process
for all droperidol solvates was the diﬀusion of the solvent
molecules out of the crystals. However, the exact diﬀusion
mechanism appeared to be slightly diﬀerent for diﬀerent
solvates, diﬀerent samples, or even diﬀerent conditions used.
The deviation from the classical diﬀusion mechanisms could be
due to the lattice parameter shrinkage during the loss of the
solvent, resulting in the reduction of the channel cross-sectional
area, which could change the diﬀusion coeﬃcient during the
desolvation process.
Besides, it was observed that the desolvation kinetic curves of
SACN and SNM at the highest used temperatures were
signiﬁcantly diﬀerent from diﬀusion-controlled kinetic curves
and could be ﬁtted by the nucleation and nuclei growth models
(see Table S3, Supporting Information). This observation
Table 2. Kinetic Parameters for the Desolvation of
Droperidol Solvates
isothermal mode nonisothermal mode
solvate Ea, kJ·mol
−1 model Ea, kJ·mol
−1 model
NSH 56 ± 10
SMe 50 ± 13 65 ± 10 D5
SEt 53 ± 15 modiﬁed D5 51 ± 15 D1, D4
SNM
a 57 ± 5 D5
SACN
a 60 ± 15 D5
aDesolvation mechanism changed at a temperature close to the
melting point of the solvate.
Figure 2. Desolvation kinetic curves of droperidol isostructural solvate samples at various temperatures (in °C) in the isothermal mode. Theoretical
curves calculated using the modiﬁed D5 model (eq 1) are shown with black lines.
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conﬁrmed the already stated hypothesis that, at temperatures
close to the melting point, the desolvation mechanism of these
solvates diﬀered from that at the lower temperatures. Moreover,
at temperatures close to the melting temperature, partial
melting of the sample and desolvation from the melt could
occur, thus changing the desolvation mechanism.
Nevertheless, the most appropriate kinetic model ﬁtting most
of the kinetic curves was the Zhuravlev equation D5.66,67 This
kinetic model has been modiﬁed68,69 based on the changing
diﬀusion activation energy during the reaction, giving eq 1.
α· − − =−N kt[(1 ) 1] n1/3 2 (1)
This modiﬁcation, however, could as well represent the
changing diﬀusion coeﬃcient during the reaction or even the
eﬀect of a hindered conversion of the largest particles appearing
due to a broad particle size distribution. It was found that all of
the kinetic curves describing the desolvation of droperidol
solvates in isothermal mode could be ﬁtted with this modiﬁed
Zhuravlev equation (see Figure 2 and Figure S13 with the
corresponding ﬁtting parameters given in Tables S6 and S7; see
the Supporting Information). Note that an additional normal-
ization constant N was introduced in this equation in order to
compensate for the possible eﬀects from either slight
absorption of the solvent at the surface or a very slow approach
to complete conversion due to the presence of a few very large
particles.
Although the ﬁt of the data with eq 1 could as well be
empirical, the obtained description of desolvation of all
droperidol solvates cannot be a coincidence, proving that the
rate-limiting step in this desolvation process is the diﬀusion.
This conclusion is also supported by the fact that the
desolvation Ea of all of the solvates was the same, which can
easily be true for diﬀusion limited desolvation, but is less likely
to be true for other rate controlling mechanisms, because of the
diﬀerent interaction energy between the solvent and the
droperidol molecules. Furthermore, also in the nonisothermal
mode, the desolvation process was best described by diﬀusion
models, with the most appropriate one being D5, in particular.
Moreover, the diﬀusion as the rate-limiting step was also
conﬁrmed by analyzing the desolvation of NSH, SMe, and SEt
crystals by HSM (see Figures S14−S16, Supporting Informa-
tion), as the desolvation before melting (up to 120 °C) did not
introduce any apparent changes to the crystal, except for the
appearance of defects due to the cracking of the crystals or
slight distortion of the molecular layers close to the crystal
surface, which was most probably associated with the reduction
of the unit cell size.
3.2. Thermal Stability of Droperidol Solvates. Although
the desolvation kinetic parameters were almost the same for all
droperidol isostructural solvates, the solvate thermal stability
was not equal. It was not possible to compare the desolvation
onset temperature as the desolvation occurred over a wide
temperature range and the nonstoichiometric behavior
produced a very broad and indistinct desolvation endotherm
(see Figure 3). Therefore, the thermal stability of the
droperidol solvates was evaluated from the experimental results
characterizing the desolvation rate of the solvates in both
isothermal and nonisothermal modes using TG curves and
PXRD patterns recorded during the desolvation. The
determination of the solvate stability in nonisothermal mode
was complicated by the solvate melting due to the relatively
slow desolvation process, during which a complete rapid
desolvation from the melt occurred (see Figure 3). In this
study, it was possible to identify separate melting peaks for the
solvates (a in Figure 3) and the melting or phase transition
peak of ISD (b in Figure 3). Although, in our previous study,
both of these processes were not distinguishable, the reported
melting points were consistent with those determined in this
study.33 It was observed that SNM had the lowest melting point,
whereas SMe had the highest melting point. Therefore, the
thermal stability of the solvates was evaluated from the
desolvation curves before the melting point of solvate, as the
Figure 3. DTA and TG curves of the droperidol isostructural solvates showing (a) the melting of solvate, (b) the melting of ISD or its phase
transition to I, and (c) the melting of the resulting polymorph I.
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melting point did not characterize the thermal stability of
solvate with respect to the desolvation.
Although the criteria for evaluation of the thermal stability
were straightforward (see the Supporting Information), the
sample preparation appeared to be the crucial aspect to
determine the thermal stability (as can be identiﬁed from the
dehydration kinetic curves of diﬀerent NSH samples at 60 °C
in Figure S3, Supporting Information). Thus, the obtained
results were not completely unambiguous, although identical
sample preparation was used to obtain all of the data for this
comparison. Nevertheless, the presented conclusions are based
on separate experiments using diﬀerent samples and, therefore,
are reliable.
Nonisothermal (Figure 4) and isothermal (Figure S17,
Supporting Information) heating of ground droperidol
isostructural solvates showed that it is possible to rationalize
their thermal stability: the least stable was NSH, whereas the
most stable was SNM. Although the thermal stability of SMe, SEt,
and SACN was more similar and the established stability order
slightly diﬀered in some of the experiments, most of the
experiments showed that, from these three phases, the least
stable was SMe and the most stable was SACN.
The same order of thermal stability was conﬁrmed also by
monitoring the PXRD patterns during the isothermal solvate
desolvation and by analyzing the curves recorded during the
study of the desolvation kinetics in the nonisothermal mode
(see the Supporting Information). Therefore, on the basis of
the data obtained from all of the performed experiments, it was
possible to determine the relative thermal stability of droperidol
isostructural solvates, which increased in the following order:
< < < <NSH S S S SMe Et ACN NM
3.3. Quantitative Comparison of Solvate Stability
Based on the Crystal Structure. In the crystal structure of
droperidol solvates, the solvent molecules and droperidol
molecules are connected with strong and/or weak hydrogen
bonds. It is clear that the stability of the solvates cannot be
associated with the presence of strong hydrogen bonds,
because, in the most stable solvates SACN and SNM, the
acetonitrile and nitromethane molecules form only weak
hydrogen bonds with the droperidol molecules. Therefore, in
order to rationalize the relative stability of the droperidol
solvates, solvent−droperidol, solvent−solvent, and also droper-
idol−droperidol intermolecular interaction energy values were
calculated in Gaussian 09. Before the calculation of the
interaction energy, geometry optimization of the crystal
structures was performed. To obtain comparable results, crystal
structures of all ﬁve solvates determined at 173 K were used for
the calculations. As it is not possible to take into account the
degree of disorder, the alcohol molecules in the crystal
structures of SMe and SEt were oriented in one of their two
possible positions for crystal structure optimization and
calculation of the interaction energy.
3.3.1. Characterization of the Droperidol−Droperidol
Intermolecular Interaction Energy. Droperidol−droperidol
interaction energy in all solvates was evaluated based on
droperidol molecule interactions with 10 closest droperidol
molecules designated by the letters A−G (see Figure 5;
symmetrically equivalent interactions were designated with the
same letter). The calculated interaction energy for these
droperidol molecule pairs, as well as the total droperidol−
droperidol interaction energy from these 10 interactions, is
given in the Supporting Information. From these calculations, it
was concluded that the intermolecular interactions between
droperidol molecules as well as their energy were almost the
same in all of these solvates and did not depend on the crystal
structure optimization method. Therefore, diﬀerent solvent
molecules in the channels did not introduce signiﬁcant changes
in the droperidol−droperidol molecule arrangement, although
some minor diﬀerences of the interaction energy values
occurred (see the Supporting Information).
3.3.2. Characterization of the Intermolecular Interaction
Energy of Solvent Molecules. The presence of various
functional groups in the solvent molecules and diﬀerent
arrangements of these molecules in the crystal structure
prevented a direct comparison of the intermolecular interaction
energy for solvent−droperidol molecule pairs in diﬀerent
solvates. Nevertheless, the interaction energy was calculated
between the solvent molecule and up to 8 droperidol
molecules, as well as the closest solvent molecules. These
interactions with droperidol molecules were designated by
Greek alphabet letters α to θ, and solvent−solvent interactions
were designated by ι and κ (see Figure 6), and the calculated
values are given in the Supporting Information.
Most of the molecule pairs were characterized by negative
interaction energy and, therefore, corresponded to energetically
favorable interactions, whereas few pairs were characterized by
slightly positive interaction energy and corresponded to
energetically unfavorable interactions, which was shown to be
a common phenomenon and was explained by the existence of
a crystal structure in a state where the energy minimum was
reached for the whole multimolecular system, and not
individual molecule pairs.70
It was observed that the calculated interaction energy for all
of the molecule pairs at the B3LYP-D level was more negative
Figure 4. Desolvation kinetic curves of droperidol isostructural
solvates in nonisothermal mode at the heating rate of 5°·min−1.
Figure 5. Arrangement of the central droperidol molecule and 10
closest droperidol molecules surrounding it, which was used for the
evaluation of pairwise droperidol−droperidol interaction energy values
in the droperidol isostructural solvates.
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than that calculated at the M06-2X level. This diﬀerence for
interactions between droperidol and solvent molecules was less
than 6.5 kJ·mol−1 with no direct correlation with the magnitude
of the interaction energy (although it was noticed that B3LYP-
D typically overestimated the magnitude of the interaction
energy for pairs in which it was small). Therefore, the total
solvent interaction energy (a sum of all solvent−droperidol and
solvent−solvent interaction energies) calculated at the M06-2X
level was also less negative (see Table 3). The results obtained
by using M06-2X are considered to be more accurate, as it has
been shown that this empirical exchange-correlation functional
performs better for the description of the noncovalent
interactions, compared to the more commonly used dispersion
corrected B3LYP-D functional.71,72 Moreover, the better
accuracy of the interaction energies calculated at the M06-2X
level also was supported by a better agreement to the
interaction energy values calculated with PIXEL code (see
the Supporting Information). Unfortunately, it was not possible
to use the PIXEL code for the calculation of the intermolecular
interaction energy in droperidol organic solvates due to the
presence of three symmetry independent molecules in the unit
cell.
The diﬀerences in crystal structure geometry obtained after
diﬀerent optimization methods (see the Supporting Informa-
tion) were also reﬂected in the calculated interaction energy
values. Therefore, there were only slight diﬀerences of
interaction energy values for the individual molecule pairs
(typically below 2.0 kJ·mol−1; see the Supporting Information)
and for total solvent interaction energy (below 6.4 kJ·mol−1) in
SACN, SNM, and SEt structures after all structure optimization
methods (see Table 3). The same applied also to the diﬀerently
optimized structures of SMe, except for that optimized at the
B3LYP-D* level. The diﬀerent water molecule arrangements in
NSH after diﬀerent geometry optimization methods also
showed up as diﬀerences in the water interaction energy
values. Further discussion is given in the Supporting
Information.
From all three optimization procedures at the PBE+TS level
in CASTEP, the calculated average total solvent interaction
energy per 1 mol of solvent for all droperidol solvates is
presented in Figure 7. From these results, it follows that the
total solvent interaction energy becomes more negative in the
following order
> > >NSH S S S S( , )Me Et ACN NM
where the sequence between the SEt and SACN depended on the
interaction energy calculation level (at the B3LYP-D level, the
calculated total solvent intermolecular interaction energy was
higher in SEt, whereas, at the M06-2X level, the calculated
energy was higher in SACN), but not on the crystal structure
optimization method (although full relaxation of the crystal
structure reduced at the B3LYP-D level calculated energy
diﬀerence between SEt and SACN). Therefore, the SNM was
predicted to be the most stable solvate with respect to the loss
of the solvent molecule, as this process would require
disruption of energetically favored interactions, while the
NSH was predicted to be the least stable one.
It was also noticed that, in SNM and SACN, an important
contribution to the total solvent interaction energy was
Figure 6. Arrangement of (a) solvent−droperidol molecule pairs and solvent−solvent molecule pairs in (b) organic solvates and (c) NSH,
corresponding to all energetically relevant solvent interactions in the droperidol isostructural solvates.
Table 3. Total Solvent Interaction Energy (in kJ·mol−1)
Values Calculated in Gaussian 09 after Diﬀerent Structure
Optimization Methods for Isostructural Solvates of
Droperidola
SNM SACN SEt SMe NSH
B3LYP-D 1 −104.4 −92.9 −96.5 −81.3 −71.1
2 −101.6 −94.1 −95.6 −82.3 −75.7
3 −103.3 −95.1 −95.7 −81.4 −77.3
4 −97.4 −90.3 −91.1 −82.8 −72.0
5 −98.9 −92.6 −96.2 −76.4 −69.4
M06-2X 1 −82.8 −72.0 −69.3 −64.6 −59.7
2 −80.4 −74.3 −68.0 −64.6 −65.1
3 −82.9 −76.1 −68.8 −65.6 −66.6
4 −76.6 −71.0 −67.6 −67.6 −57.0
5 −75.4 −70.7 −69.2 −50.5 −62.6
a1: PBE+TS HO in CASTEP; 2: PBE+TS ALL in CASTEP; 3: PBE
+TS UC in CASTEP; 4: PBE+G06 UC in CASTEP; and 5: B3LYP-
D* UC in CRYSTAL09.
Figure 7. Average total solvent interaction energy calculated in
Gaussian 09 after geometry optimization at the PBE+TS level in
CASTEP for all isostructural solvates of droperidol.
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provided by the solvent−solvent interactions, whereas they had
only a minor contribution for the alcohol solvates (see Table
4). This is logical, as the acetonitrile and nitromethane
molecules have the greatest length and do not have a speciﬁc
orientation of the polar end (in alcohol molecules, this end is
hydrogen-bonded to the benzimidazolone moiety of droper-
idol). Besides, the contribution from the interactions with other
solvent molecules in the total interaction energy increased
when the interaction energy calculation level was changed from
B3LYP-D to M06-2X, which appeared to be one of the main
factors aﬀecting the change of the order of the total solvent
interaction energy for SACN and SEt.
Logically, due to the presence of a strong hydrogen bond
between two water molecules, water−water interaction energy
had a relatively high contribution to the total interactions
involving water molecules.
3.3.3. Summary and Comparison to the Experimental
Results. The calculated total solvent interaction energy at the
M06-2X level became more negative in the following order:
> > > >NSH S S S SMe Et ACN NM
Thus, the theoretically predicted order of the stability of
solvates based on the total solvent interaction energy at the
M06-2X level is opposite, compared to this sequence. This
order is identical to that observed for the thermal stability of
these solvates, which should not come as a surprise, as, during
the desolvation, only solvent−droperidol and solvent−solvent
interactions are disrupted, while the rest of the crystal structure
is maintained. Therefore, the calculation of the total solvent
interaction energy at the M06-2X level in this system can be
used to rationalize and predict the thermal stability of solvates.
Although the total solvent interaction energy in NSH was
very similar to that of SMe, the thermal stability of these two
solvates was quite diﬀerent. This most probably could be
associated with the small size of water molecules allowing an
easier dehydration and the fact that the dehydration occurs by
simultaneously losing the hydrogen-bonded molecule pair;33
therefore, the water−water interaction between the hydrogen-
bonded water molecules actually did not stabilize the NSH
against the dehydration.
Interestingly, it was noted that the order of the solvate
melting points correlated with the calculated total droperidol−
droperidol interaction energy values (see Table S18, Support-
ing Information). Although such a small interaction energy
value diﬀerence (8−9 kJ·mol−1) is unlikely to introduce
signiﬁcant melting point diﬀerences (>20 °C), it would be
reasonable that the solvate melting point would be associated
with the droperidol−droperidol interactions and, therefore, the
stability of the crystal lattice.
Although the thermal stability of the organic solvates
increased in the same order as the boiling points of the
respective solvents, this should be considered only a
coincidence as the interactions of solvent molecules in the
solvates are completely diﬀerent than those in their liquid
states.
Although the experimental stability of the solvates can also
be compared using the sorption−desorption isotherms, which
would provide an information about the thermodynamic
stability, the solvent content in the initial part of the isotherm
representing the solvent sorption at a given solvent vapor
activity increased in the order NSH < SNM < SACN < SEt <
SMe
33(see Figure S22, Supporting Information). Therefore, it
appeared that the solvent content was determined by the steric
factors of solvent molecules, and not by the intermolecular
interactions. The only exception was the NSH, which had the
lowest solvent content at any given activity, although the
signiﬁcant diﬀerence, if compared to other solvents, cannot be
explained exclusively by the lower total energy of intermo-
lecular interactions involving water molecules.
4. CONCLUSIONS
The study of the desolvation kinetics of droperidol isostructural
solvates revealed that the desolvation activation energy of all of
these solvates was almost the same (57 ± 15 kJ·mol−1) and the
desolvation process was diﬀusion limited, and the desolvation
curves could be ﬁtted using the modiﬁed Zhuravlev equation.
The thermal stability of the solvates determined from the
desolvation rate in both isothermal and nonisothermal modes
could be successfully used as a solvate stability comparison and
ranging tool for the droperidol solvates. The calculation of the
intermolecular interaction energies in droperidol solvates
showed that it was possible to rationalize and predict the
thermal stability order of solvates by using a sum of the
solvate−droperidol and solvate−solvate interaction energies.
Although this solvate system can be used to understand the
general trends in the characterization and rationalization of the
solvate stability, we conclude that (a) crystal structure does not
substantially change during the desolvation, and (b) droper-
idol−droperidol interaction energy in all solvates is almost the
same, which makes this system a relatively simple model.
Complications associated with (a) diﬀerent host−host
interaction energy and (b) the energy necessary for the crystal
structure change during the desolvation will arise when a
general stoichiometric solvate system is considered. Therefore,
additional studies are necessary to obtain a more general
understanding of the solvate stability.
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a b s t r a c t
13C, 15N and 2H solid-state NMR spectroscopy have been used to rationalize arrangement and dynamics
of solvent molecules in a set of isostructural solvates of droperidol. The solvent molecules are
determined to be dynamically disordered in the methanol and ethanol solvates, while they are ordered
in the acetonitrile and nitromethane solvates. 2H NMR spectra of deuterium-labelled samples allowed
the characterization of the solvent molecule dynamics in the alcohol solvates and the non-stoichiometric
hydrate. The likely motion of the alcohol molecules is rapid libration within a site, plus occasional
exchange into an equivalent site related by the inversion symmetry, while the water molecules are more
strongly disordered. DFT calculations strongly suggest that the differences in dynamics between the
solvates are related to differences in the energetic penalty for reversing the orientation of a solvent
molecule.
& 2014 Elsevier Inc. All rights reserved.
1. Introduction
Solid-form screening of pharmaceutical molecules has demon-
strated their propensity to adopt different forms, including poly-
morphs and solvates [1,2]. It is not unusual for a pharmaceutical
molecule to form more than ﬁve polymorphs [3–5] and, as
reported, even in excess of one hundred solvates [2]. Under-
standing and characterizing these forms is essential for the
pharmaceutical industry.
Solvates are typically divided in stoichiometric or non-
stoichiometric solvates [6]. It is common that the same host
structure can incorporate different solvent molecules to form a
set of isostructural solvates. This phenomenon is typical for non-
stoichiometric channel solvates [7,8], but is not limited to non-
stoichiometric solvates [9–11] nor to channel solvates [12]. The
formation of isostructural solvates is typically driven by the
presence of speciﬁc solvent–host interactions [9,12] or by the
speciﬁc shape of the solvent molecule [7]. It is also possible to
form mixed isostructural solvates, where solvent molecules can be
exchanged in only a subset of the crystallographic sites [13,14].
Although empty host structures can be stable [15], they are
typically unstable [16] or collapse immediately after the removal
of the guest, despite the weak nature of the host–guest interac-
tions [17].
Droperidol, 1-[1-[4-(4-ﬂuorophenyl)-4-oxobutyl]-1,2,3,6-tetra-
hydro-4-pyridyl]-1,3-dihydro-2H-benzimidazol-2-one, Fig. 1, is a
neuroleptic pharmaceutical. It is reported to exist in four poly-
morphic forms I–IV [18–20] and eleven solvated forms [18–23].
The solvates with methanol, ethanol, acetonitrile, nitromethane,
chloroform, dichloromethane as well as the nonstoichiometric
hydrate (SMe, SEt, SACN, SNM, SCLF, SDCM and NSH respectively) are
isostructural, as observed by PXRD, and crystallize in the P1 or P1
space group (depending on the solvent symmetry and ordering),
with two droperidol molecules in the unit cell. It has not, however,
been possible to obtain diffraction quality crystals for SCLF and
SDCM [20]. Although non-stoichiometric in that the solvent content
is dependent on the partial pressure of solvent in the atmosphere
– up to one equivalent of water per droperidol for NSH, and
0.5 equivalents of solvent for the other solvates – samples
produced from crystallization are always fully solvated and are
relatively stable with respect to desolvation if stored in closed
containers.
Although isostructural in terms of the host droperidol struc-
ture, these solvates are unusual in that they fall into three
categories. Firstly, the NSH crystal structure is centrosymmetric
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with one droperidol and one water molecule in the asymmetric
unit. The water molecules occupy two nearby hydrogen-bonded
positions in the channel, forming hydrogen bonds with the
carboxyl group in the benzimidazolone moiety of droperidol. The
isotropic displacement parameter for the water oxygen at 120 K is
three times higher than for other non-hydrogen atoms, and it was
not possible to locate all the water hydrogen atoms for structures
determined at 173 K or above [20], suggesting that the water
molecules are slightly disordered. Secondly, the SMe and SEt
structures reﬁne with centrosymmetry, with one droperidol and
half a disordered alcohol molecule in the asymmetric unit. The
alcohol molecule has the same hydrogen bond arrangement with
droperidol as the water does in NSH. In contrast to the NSH,
however, only one of the two droperidols in the unit cell is
hydrogen bonded to the alcohol molecule, and taking into account
disorder between two orientations related by inversion symmetry
is necessary for a satisfactory reﬁnement within the P1 space
group. Thirdly, the SACN and SNM are non-centrosymmetric, with
two droperidol and one ordered solvent molecules in the asym-
metric unit, and there are no strong hydrogen bonds between the
solvent and droperidol.
Solid-state NMR is nowwidely used in the ﬁeld of pharmaceutical
molecule characterization [24]. The main advantage of this method is
its ability to characterize the molecular-level structure and identify
possible dynamics using powdered rather than single-crystal sam-
ples [25–31]. It can be used to support or complement the informa-
tion from X-ray diffraction methods [32,33]. Although organic
solvates [32,34–36], including isostructural solvates [13,17,37], have
been previously studied using solid-state NMR, the behaviour and
dynamics of solvent molecules in isostructural solvates has not been
the subject of detailed research. Typically, the NMR spectra of
isostructural channel solvates are only slightly affected by changing
the solvent molecules [13], as the solvent molecules introduce only
minor differences in chemical environment of the host molecules,
although such spectra can still be used for solvate identiﬁcation [38].
Similarly, only slight changes are typically observed in NMR spectra
of non-stoichiometic hydrates as function of water content [39–41],
although some structural variations can be inferred [42–44].
In this study we use 13C, 15N and 2H solid-state NMR to determine
and characterize the differences between these ﬁve droperidol
isostructural solvates. This includes the identiﬁcation and character-
ization of the molecular motion in NSH, SMe and SEt, to explain the
slight disorder of water molecule in NSH and to distinguish between
static vs. dynamic disorder in the alcohol solvates. Theoretical
calculations are used to rationalize the differences in the molecular
motion of the solvent molecules.
2. Experimental
2.1. Sample preparation
Droperidol (purity499%) was obtained from JSC Grindeks (Riga,
Latvia). Droperidol NSH was obtained by dissolving droperidol in
acetone at 50 1C, adding a small amount of water and then slowly
partially evaporating the resulting solution at 50 1C [20]. Droperidol
solvates SMe, SEt, SACN and SNM were obtained by dissolving
droperidol in the corresponding solvent at 60–75 1C (depending
on solvent boiling point) and then cooling the solution to 20 1C
[20]. Solvates were stored in the mother liquor and ﬁltered and
dried immediately before packing into rotors.
Deuterium-labelled solvates were prepared by grinding and
then desolvating the original solvate at 50 1C above P2O5. The
resulting sample was then placed in a closed container with
saturated D2O or d1-alcohol vapour. NSH with different D2O
contents was obtained by storing the deuterium-labelled sample
above D2O to obtain monohydrate stoichiometry or above a
saturated solution of MgCl2 in D2O to obtain approximately
hemihydrate stoichiometry. These stoichiometries were estimated
from previously measured sorption–desorption isotherms [20].
All of the solvents, MgCl2 and P2O5 were purchased from
commercial suppliers and used without further puriﬁcation. The
identity of all droperidol solvates was conﬁrmed using PXRD [20].
2.2. Solid-state NMR
High-resolution solid-state NMR spectra were obtained using
either a Bruker Avance III HD spectrometer (Bruker, Germany)
operating at 125.67 MHz for 13C (499.72 MHz for 1H) and
76.71 MHz for 2H with a 4.0 mm (rotor o.d.) MAS probe, or a
Varian VNMRS 400 spectrometer (Varian Inc., USA), operating at
40.53 MHz for 15N (399.88 MHz for 1H) with a 6.0 mm (rotor o.d.)
MAS probe. 15N spectra were recorded at ambient temperature,
whereas 13C and 2H spectra were recorded at controlled tempera-
tures from 20 1C down to 45 1C. Note that these are set
temperatures that do not attempt to correct for sample heating
under magic-angle spinning; these are estimated to be of the
order of þ5, þ8 and þ15 1C for the 2H, 15N and 13C spectra
respectively.
13C and 15N spectra were obtained under MAS conditions using
cross polarization (CP) with the following conditions: recycle delay
7–30 s for NSH, SMe and SEt, and 120–180 s for SACN, and SNM,
contact time 0.5–2 ms, a sample spin rate of 13 kHz for 13C and
6.8 kHz for 15N spectra, and acquiring 300–1000 transients for 13C
and 440–3600 transients for 15N (depending on relaxation delays).
SPINAL64 with 78 kHz 1H nutation rate and TPPM with 55.6 kHz
nutation rate were used for heteronuclear decoupling of the 13C
and 15N spectra respectively. Spectra were referenced with respect
to external neat TMS for 13C or neat nitromethane for 15N by
setting the high-frequency signal from a replacement sample of
adamantane to 38.4 ppm or the nitrate signal from a replacement
sample of solid ammonium nitrate to 5.1 ppm, and typically
processed with an apodisation function corresponding to a 20 Hz
Lorentzian line-broadening prior to Fourier transformation. 13C
linewidths were determined by ﬁtting the peaks to a mixed
Lorentzian/Gaussian lineshape in the Bruker TopSpin software.
Carbon-13 T1 values were estimated from direct-excitation
spectra with recycle delays of 0.2–180 s, while more accurate
measurements were made using saturation-recovery experiments
with recovery delays of 0.1 ms to 90 s. 12 Pulses separated with a
10 ms delay were used for saturation of the 13C magnetization. 200–
240 Repetitions were accumulated, with a spinning rate of 13 kHz
and 1H decoupling nutation rate of 71 kHz. T1 values from variable
recycle delay experiments were calculated by ﬁtting peak heights to
a simple rising exponential function using Excel Solver. T1 values
from saturation-recovery experiments were determined in TopSpin
by ﬁtting integrated peak areas to a rising exponential. Note that
measurement of the relaxation times for the CH3 of SEt in particular
was complicated by transient Nuclear Overhauser effects [45]; this
is discussed further in the Supplementary information.
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Fig. 1. Molecular structure of droperidol with the numbering of non-hydrogen atoms.
A. Bērziņš, P. Hodgkinson / Solid State Nuclear Magnetic Resonance 65 (2015) 12–20 13
2H MAS spectra were acquired without proton decoupling with
10 kHz spinning rate and 10 s recycle delay, acquiring 1000–
10,000 transients (depending on time available). T1 relaxation
times were estimated with short experiments (50–100 repetitions)
with the recycle delay varying up to 10 s or 30 s using 7–9
increments. T1 values were estimated by ﬁtting peak heights to a
simple rising exponential function as above. Bandshape analysis of
the spinning sidebands was performed in Gsim [46]/pNMRsim
[47] by simultaneously ﬁtting the peak linewidths (using a
Lorentzian lineshape function) and quadrupolar coupling para-
meters from both ND and solvent sites. Flat baselines, which are
signiﬁcant for ﬁtting, were typically obtained by discarding the
data points before the ﬁrst rotary echo for signals obtained on-
resonance. Alternatively, the baseline roll was suppressed using
spline ﬁtting in TopSpin.
2.3. First-principles computation
Chemical shift calculations were carried out using the GIPAW
method implemented in CASTEP 6.0 [48–51], after geometry opti-
mization of the droperidol crystal structures determined at 173 K
[20]. Since the ﬁrst principles calculations cannot be applied to
disordered structures, starting structures of SMe and SEt without
disorder were prepared in two ways: (a) both structures were solved
in the P1 space group with ordered solvent and (b) P1 structures
were derived from the reported P1 structures by discarding one of
the solvent molecule orientations. Calculations were performed with
the PBE [52] functional using on-the-ﬂy generated ultrasoft pseu-
dopotentials and a cut-off energy of 600 eV, with integrals taken
over the Brillouin zone using a Monkhorst-Pack grid of a minimum
k-point sampling of 0.05 Å1. Two approaches were used for
geometry optimization: optimization of hydrogen atom positions
only and optimization of all atomic positions. Unit cell parameters
were ﬁxed to the values determined from X-ray diffraction studies in
both cases. The computed 13C and 15N chemical shifts were
referenced by linear regression of computed shielding values to
the experimental shifts [50]. Geometry optimizations of doubled
unit cells (see below) with adjacent solvent molecules in the same
or opposing directions were performed both with the pure PBE
functional and also using the Tkatchenko–Schefﬂer (TS) dispersion
correction scheme [53]. The orientation of the solvent molecule was
inverted by manually adjusting the atomic coordinates on one
solvent molecule prior to full geometry optimization.
Interaction energies between pairs of molecules were calcu-
lated in Gaussian 09 [54] using the M06-2X [55] functional for
molecular geometries directly extracted from the crystal struc-
tures after optimization of all atom positions in CASTEP. Basis set
superposition error was corrected using the counterpoise method.
The pairs involved a given solvent molecule and either adjacent
solvent molecules in the channels or adjacent droperidol mole-
cules (see further Section 3.4).
3. Results and discussion
3.1. Solvate characterization using 13C CPMAS spectra
Fig. 2 shows the 13C CPMAS spectra of the solvates, with the
peak positions given in Table 1. The resonances of the solvent
molecules are readily identiﬁed (see labels), except for the methyl
group signal of ethanol and the quaternary carbon of acetonitrile,
as these overlap with the peaks of droperidol. Bearing in mind that
the spectra were recorded under CP conditions, and so are not
strictly quantitative, the intensity of the solvent peaks is consis-
tently around two times lower than that of the droperidol CH2
peaks, consistent with a 0.5 solvate stoichiometry. CP spectra with
short (10–50 ms) contact times were recorded (see Fig. S3) to
identify the carbon atoms directly attached to hydrogen; the peaks
absent in these spectra and thus associated with quaternary
carbon atoms are marked with arrows in Fig. 2.
As would be expected, the NSH spectrum is consistent with one
unique droperidol molecule in the asymmetric unit. However, the
SMe and SEt spectra also do not show clear evidence of distinct
droperidol molecules in the crystal structure, one hydrogen-
bonded to the solvent, and one not. Only slight splitting of some
peaks, circled in Fig. 2, is observed in the spectra of SACN and SNM,
which would be consistent with having two slightly different
droperidol molecules in the asymmetric unit.
To help assign the peaks, GIPAW calculations of the NMR
parameters were performed for all solvates after geometry opti-
mization. The results, after rescaling each set of the calculated
shieldings against the experimental chemical shifts, are presented
in Table 1. Different isotropic shielding values were calculated for
the same carbon atom where inequivalent droperidol molecules
are present in the asymmetric unit (SMe, SEt, SACN and SNM). It was
observed that these differences were quite large (up to 6.8 ppm,
with an average difference of 2–3 ppm, depending on the solvate)
when only hydrogen atom positions were relaxed for structures
solved in the P1 space group. Relaxing all atomic positions during
the geometry optimization decreased the average difference to
0.5 ppm. Since this is clearly in better agreement with the
experimental results, only the structures obtained by all atom
optimization were used in further calculations, and average values
of the calculated shieldings of corresponding atoms were used
when making comparisons with experimental data. The maximum
difference of up to 2–3 ppm is observed for C9 and C10, which is
consistent with their proximity to the solvent molecules, see
Fig. S1. These results imply that solution of the XRD results in P1
has “exaggerated” the asymmetry between the droperidol mole-
cules; relaxing all the atomic positions results in increased local
symmetry and better agreement with the experimental NMR data.
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Fig. 2. 50–135 ppm region of the 13C CPMAS spectra of the droperidol isostructural
solvates together with peak assignment. Spinning sidebands are marked with
asterisks, signals absent in short CP contact time experiments are marked with
arrows, and signals in the SACN and SNM spectra showing evidence of splitting are
circled. Full spectra are given in Fig. S2.
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As might be expected, the situation was reversed for the
structures originally solved in P1 space group (SMe and SEt). With
only optimization of the hydrogen atom positions, the droperidol
environments remain essentially identical and only small maximal
(1.6–2.2 ppm) and average (0.3–0.45 ppm) differences were
observed for equivalent carbon shifts in the two droperidol
molecules. Several of these shifts, both for solvent and droperidol
sites, however, deviated signiﬁcantly from the experimentally
observed values. Relaxation of all atoms resulted in almost
identical chemical shifts to those calculated after all-atom optimi-
zation of structures solved in P1.
The most signiﬁcant differences between the 13C spectra are
observed for the C4 and C9, marked by a dashed rectangle in Fig. 2;
these again are close to the solvent molecules. This observation
was consistent with the GIPAW calculations, where the highest
difference between the average chemical shifts for different
solvates were predicted to be for C9 (2.7 ppm), C4 (1.8 ppm) as
well as for C8 (3.0 ppm), see Table 1. Overall, however, the spectra
of solvates are very similar, showing that the different solvent
molecules introduce signiﬁcant changes in the local chemical
environment of the droperidol molecules.
Taking into account the previously identiﬁed signals from quatern-
ary carbons and solvent atoms, the obtained shielding values after all
atom optimization were plotted versus the observed chemical shifts,
illustrated in Fig. 3 for SEt. As observed previously [37,50] and justiﬁed
theoretically [56], these plots had a non-unity slope. Linear regression
was used to reference the mean experimental shift to the mean
computed shielding, and to rescale the calculated shifts. These plots
allowed the majority of the signals to be assigned, as indicated in
Fig. 2, with the exceptions of strongly overlapped peaks in the region
127–135 ppm, indicated by the rectangle in Fig. 3. These ambiguities
are not, however, signiﬁcant for the purposes of this study. Further
details of the assignment are given in Table 1. In each case, a smaller
RMS deviation between calculated and experimental values was
observed when all atomic positions were reﬁned, see Tables 1 and S1.
Table 1
Assigned experimental peak maxima (in ppm) in 13C CPMAS spectra and (rescaled) average calculated 13C chemical shifts after all atom optimization.
Carbon NSH SMe SEt SACN SNM ΔδCalcb
δExp δall δExp δall Diff.a δExp δall Diff.a δExp δall Diff.a δExp δall Diff.a
C16c 197.6 199.9 197.5 199.9 0.1 197.5 199.8 0.1 197.6 200.2 0.2 197.5 199.7 0.0 0.5
C20c,d 167.5 171.5 167.7 171.7 0.0 167.7 171.6 0.1 167.7 171.9 0.0 167.6 171.6 0.0 0.4
C1c 154.0 149.2 154.1 149.5 0.3 154.1 149.3 0.1 154.1 149.8 0.2 154.2 149.7 0.4 0.6
C17/C8c,e 133.6 131.4f 133.6 131.4g 1.4 133.8 132.1g 0.6 133.7 131.4f 0.0 133.9 132.9g 0.8 0.1f
C18 132.2 132.7 132.4h 133.0 0.2 132.4 132.9 0.2 132.3 132.8 0.0 132.7h 133.3 0.1 0.5
C22 132.4 132.6 0.1 132.7 0.4 133.3 0.0 132.6 0.2 0.9
C17/C8c,e 130.1 130.0g 130.2 131.3f 0.1 130.4 131.4f 0.0 129.8 131.3g 0.2 130.7 131.5f 0.0 3.0g
C6c 127.9 127.1 128.3 127.1 0.4 128.3 127.0 0.4 128.6 127.2 0.5 128.6 127.4 0.2 0.4
C7c 126.3 126.6 0.1 126.7 0.3 127.2 0.3 127.3 0.3 1.1
C9 124.7 130.0 125.0 128.4 3.2 125.1 128.2 1.2 124.8 128.0 1.3 124.6h 127.3 2.1 2.7
C4 123.7 122.9 123.1 122.0 1.3 123.0 122.1 0.9 122.1 121.0 0.2 122.9 122.3 0.3 1.8
C3 119.8 118.1 119.4 118.0 0.3 119.3 117.9 0.3 118.9 117.4 0.1 119.0 117.5 0.0 0.6
C19 117.2 117.3 117.2 117.6 0.5 117.3 117.4 0.5 117.3 117.6 0.0 117.3 117.6 0.3 0.3
C21 116.5 116.7 0.0 116.7 0.4 116.8 0.0 116.8 0.0 0.4
C2i 110.9 108.7 110.5 108.9 0.6 110.8 109.2 0.6 110.3 108.6 0.1 110.4 108.8 0.2 0.6
C5i 109.4 109.0 108.9 107.5 1.3 109.2 108.3 1.1 109.0h 107.7 0.7 108.9h 107.7 0.9 1.5
C13 59.8 60.3 60.1 60.1 0.0 60.0 60.1 1.2 60.3 60.2 0.5 60.3 60.5 1.1 0.4
C11i 52.4 53.8 53.3 53.6 1.0 52.3 53.4 0.6 53.7 53.9 0.4 52.6h 53.2 1.2 0.7
C10i 53.2 52.1 53.0 0.6 51.7 53.2 2.1 51.8h 51.8 1.0 52.9 2.1 1.5
C15 35.3 36.1 35.5 36.1 0.0 35.6 36.6 0.0 35.6 36.5 0.0 35.9 37.2 0.1 1.1
C12 28.4 28.2 28.4 28.8 0.2 28.3 28.7 0.2 28.0 28.0 0.2 28.4 29.1 0.3 1.1
C14 21.3 21.0 21.3 21.0 0.2 21.1 21.1 0.0 21.2 20.9 0.0 21.1 21.2 0.0 0.3
CH3 solv 50.8 52.2 21.1 19.8 4.2 6.0 63.1 62.5
CH2/CNsolv 58.3 60.9 128.6/129.8j 128.3
RMSDk 2.06 1.83 1.79 1.81 1.65
a Difference in calculated chemical shift between two chemically equivalent atoms in the unit cell. Signiﬁcant differences greater than 0.7 ppm are in italics and those
larger than 2 ppm are in bold.
b Difference between the highest and lowest calculated chemical shifts from the same atom in all ﬁve solvates.
c Non-protonated carbons identiﬁed from short contact time CP spectrum.
d Signal split by J-coupling to 19F, with 1JCF¼278–280 Hz in NSH, SMe, SEt and SACN and 1JCF¼265 Hz in SNM.
e High variation in CASTEP calculated chemical shifts for these two atoms in different solvates prevents unambiguous assignment.
f Given value is for C17 (calculated).
g Given value is for C8 (calculated).
h Signal is slightly split.
i Peak separation of C2 and C5, as well as that of C10 and C11 is too small for unambiguous assignment, but consistent relative position in GIPAW calculations for all
solvates (with the exception of C2 and C5 in NSH) and the splitting of C5 and C10 peaks support this assignment.
j Experimental peak position uncertain, but peak intensities and GIPAW calculations suggest that nitrile carbon corresponds to one of these peaks.
k Root mean square difference between experimental and calculated chemical shifts.
σcalc = –1.056 δexp + 174.4 ppm  
-40
10
60
110
160
20
δexp / ppm
σ c
al
c /
 p
pm
70 120 170
Fig. 3. Calculated 13C isotropic shielding (averaged over equivalent carbons) values
versus observed chemical shifts in droperidol SEt. The dashed rectangle marks the
region where the peak assignment is ambiguous.
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The experimental spectra show only slight evidence of splitting
for a few peaks in SACN and SNM corresponding to carbon atoms C5,
C9 and C10, which are all close to the solvent molecules. The
differences between peak maxima were at most 0.5 ppm, but
these particular carbon atoms also show the highest splitting in
the GIPAW-calculated chemical shifts, see Table 1. Observing the line
splitting is complicated by the relatively broad linewidths; the
widths of the peaks in the spectra of droperidol isostructural
solvates were 0.75–1.15 ppm, whereas peak widths in the 13C
spectra of droperidol dihydrate and form II (see Figs. S5 and S6)
were only 0.32–0.70 ppm under the same conditions. This difference
in linewidths cannot be explained by the presence of two slightly
different droperidol molecules in the unit cell, as the linewidths of
the organic solvates was identical to that of NSH, where there is a
single droperidol molecule in the asymmetric unit. The “line-broad-
ening factors” associated with the anisotropy of the bulk magnetic
susceptibility (ABMS) for powder samples [57] were determined
using the magnetic susceptibility tensor calculated by CASTEP-NMR.
This was found to be 3.6 ppm for the isostructural solvates and
1.7 ppm for both form II and dihydrate, suggesting that the width
of the lines in the solvate spectra is associated with a large ABMS,
making it intrinsically difﬁcult to resolve overlapped resonances.
3.2. Solvate characterization using 15N CPMAS spectra
As shown in Fig. 4, 15N CPMAS spectra were recorded for the SEt,
SMe and SACN solvates, and peaks assigned based on the GIPAW
calculations. Both SEt and SMe show sharp lines from all three
nitrogen atoms, whereas the line from N2 – the only nitrogen atom
close to the solvent – was split (or signiﬁcantly broadened) in SACN,
indicating two distinct local environments. This conﬁrms that the
acetonitrile breaks the local symmetry of droperidol molecules,
consistent with the determined crystal structure [20]. The experi-
mental and GIPAW-calculated 15N chemical shift differences are
almost the same, 1.0 and 0.8 ppm respectively. The alcohol molecules
are strongly hydrogen-bonded with the droperidol O1 atom, thus
affecting the strength of the intermolecular hydrogen bond between
droperidol molecules N2–H⋯O1, and the calculated chemical shift
difference for N2 is signiﬁcantly higher in SMe and SEt, 1.6 and
3.2 ppm respectively. In contrast to SACN, only one, somewhat
broader, line is observed in the 15N spectrum for the alcohol solvates
(45–50 Hz for N2 compared to 35–40 Hz for other nitrogen reso-
nances). This strongly suggests that the alcohol molecules in SMe and
SEt are dynamically disordered, resulting in a single resonance.
Although the 15N spectra were much more demanding to acquire,
they are more sensitive in this case to the very subtle symmetry
breaking involved. It is also worth noting in this context that 14N
shifts can also be very sensitive to changes in local environment as
they are also dependent (via the quadrupolar 2nd order isotropic
shift) on local differences in electric ﬁeld gradient [58].
3.3. Characterization of solvent dynamics in droperidol isostructural
solvates
The evidence from the 13C and 15N CPMAS spectra acquired
at ambient temperature, combined with the crystal structure
determinations, suggests that the solvent molecules are dynamic
in SMe and SEt. The crystal structure of NSH also shows evidence of
disordered water molecules. 13C and 2H MAS spectra of SEt, SMe
and NSH as a function of temperature are used here to try to
characterize the solvent dynamics.
3.3.1. Solvates with organic solvents
It can be seen in Fig. 5 that the ethanol CH2 group signal
(highlighted with an arrow) in the CPMAS spectrum (solid lines) of
SEt broadens when the temperature is reduced to 15 1C and has
lost most of its intensity at 40 1C. These changes are reversible
and consistent with the presence of dynamics. Experiments with
different contact times, see Fig. S3, conﬁrmed that the low
intensity of this peak is related to its broad nature rather than,
for example, rapid T1ρ relaxation. The broad CH2 peak is more
easily observed in the 13C direct-excitation spectra (dashed lines).
The most likely mechanism for the broadening is interference
between the modulation of NMR parameters by dynamics and the
1H decoupling [31,59], implying that the dynamics of the ethanol
CH2 are on the order of 10 s kHz around 40 1C. It was also
noticed that the build-up of the ethanol CH2 group signal during
cross-polarization at 20 1C was signiﬁcantly slower than that of
CH2 carbons of droperidol (see Fig. S8). This implies that the
heteronuclear CH dipolar couplings are partially averaged by
dynamics on the timescale of 10 s of kHz or faster.
The 13C T1 relaxation times measured as a function of tempera-
ture provide further insight into the dynamics of the ethanol
molecules. These are tabulated in Table S2 and plotted in Fig. 6.
The relaxation times of both ethanol carbon atoms are relatively
short e.g. 1.04 s for the CH2 and 0.8 s for the CH3 at 20 1C,
compared to at least 50 s for the carbon atoms in droperidol.
The steady decrease in T1 relaxation time of the CH3 carbon with
decreasing temperature is consistent with the approach towards a
SMe
SEt
SACN
δ(15N) / ppm
N2N1
CN
–130 –250 –300 –350
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Fig. 4. 15N CPMAS spectra of droperidol solvates SEt, SMe and SACN, showing the
splitting of the N2 peak in the spectrum of SACN. The lower signal-to-noise ratio of
the SACN spectrum reﬂects the much longer recycle delay needed for this sample
(120 s, compared to 15 and 25 s for SEt and SMe respectively) and consequently a
much reduced number of acquisitions compared to the alcohol solvates (440
compared to 3628 and 2308 respectively).
204060
20 °C
–15 °C
–40 °C
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Fig. 5. 13C CPMAS (solid lines) and direct-excitation (dashed lines, 20 1C and
40 1C) spectra of SEt at different temperatures. The signal from ethanol CH2 is
marked with an arrow.
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T1 minimum. Assuming Arrhenius-type behaviour, ﬁtting the
linear regime (i.e. excluding the data point at 40 1C) gives an
activation barrier, Ea, of 15.170.6 kJ mol1. This is a typical value
for rotational diffusion of the methyl group [29,30,60], although it
should be noted that a more extensive data set encompassing the
T1 minimum would provide much more robust ﬁgures. The
interpretation of the CH2 carbon data is less straightforward, but
its rapid relaxation implies that there are signiﬁcant local
dynamics of the CH2 over the full temperature range. While 13C
relaxation rates will be dominated by dipolar relaxation driven by
modulations of the CH heteronuclear couplings, there will also be
a contribution from cross-relaxation to any rapidly relaxing 1H
spins. Faster 1H T1 relaxation at lower temperatures allowed the
recycle delays to be reduced from 12 s at 20 1C to 6 s at 40 1C,
suggesting that the decrease in the 13C T1 of the CH2 in the low-
temperature limit may be related to faster cross-relaxation to 1H
(associated with the methyl group re-orientation). The 13C T1 of
the CH2 also decreases in the high temperature limit, where the
methyl group dynamics is not contributing so effectively to T1
relaxation. This suggests that there are additional dynamic pro-
cesses that become more effective at driving the spin–lattice
relaxation in the high temperature regime (and so are likely to
have higher activation barrier than methyl rotation). Such pro-
cesses would need to be of the order of the 13C Larmor frequency
(in this case 125 MHz) at 20 1C, which could also be consistent
with a process that is of the order of 10 s kHz at 40 1C (as
observed via the spectra).
The T1 relaxation times of methyl group carbons in methanol and
acetonitrile molecules are much longer than in the ethanol solvate,
5.1 and 17 s at 20 1C respectively (see Table S2), and show the
opposite temperature dependence (i.e. decreasing with increasing
temperature). Bearing in mind the difﬁculties of interpreting relaxa-
tion data at some distance from the T1 minimum, this suggests that
the barrier for methyl group re-orientation in these solvates (and the
acetonitrile solvate in particular) is signiﬁcantly higher, and that the
T1 minimum is well above ambient temperature. There is also no
evidence for additional high-frequency motions.
The 2H MAS spectra of the alcohol solvates prepared from
d1-alcohols were very similar, showing resonances both from the
deuterated solvent, at about 4.0 ppm, and the labile NH site of
droperidol, at about 10.5 ppm. Fig. 7 shows the spectra for SEt; the
corresponding ﬁgure for SMe can be found in the Supplementary
information (Fig. S10). Fitting the bandshape from both of the
deuterium sites, quadrupolar coupling parameters were determined
in pNMRsim [47]. The quadrupolar couplings for the ND site are
uninformative, but are tabulated in Table S3. The quadrupolar coupling
parameters for the alcohol OD determined from the spectra at 20 1C
were found to be the same within experimental error, χ¼206 kHz,
η¼0.17. The ﬁtted quadrupolar coupling constants were slightly larger
at 45 1C: χ¼211 kHz for SMe and 222 kHz for SEt, with η¼0.17. The
uncertainties on χ and η are estimated to be 2 kHz and 0.02
respectively, on the basis of duplicate measurements and different
processing methods used to obtain ﬂat spectral baselines. These
parameters are consistent with values calculated by the GIPAW
calculations, χ¼244–246 kHz, η¼0.15, but reduced by high frequency
motions of increasing amplitude as the temperature is increased [61].
Note that ﬂipping of the solvent molecules through the inversion
centre will not change the quadrupolar coupling tensor orientation
and so would not have a direct effect on the spectrum.
In contrast to the 2H spectra, which might suggest that the
solvent molecules are essentially static, the 2H T1 relaxation times
for the alcohol OD group were short (estimated to be 0.1–0.3 s) at
both measurement temperatures (45 1C and 20 1C), see Table S4.
Again, a simple ﬂip of solvent molecules through an inversion
centre cannot itself explain the fast relaxation, since the quadru-
polar tensor is left unchanged. This implies that multiple high-
frequency processes are active, resulting in fast relaxation rates that
are not signiﬁcantly temperature dependent, i.e. there is no single
motional process creating a well-deﬁned T1 minimum. We have
previously observed small amplitude motions that are large enough
to drive relaxation but too small to signiﬁcantly average the
quadrupolar coupling constant [30]. The crystal structure solution
and the averaged chemical environments for the droperidol mole-
cules in the unit cell indicate that the solvent molecules are also
ﬂipping orientations, but the 2H NMR data and the 13C relaxation
times are not sensitive to this process. The most likely scenario is
that the alcohol molecules are relatively dynamic within their
lattice sites and also occasionally ﬂip over to the equivalent site
related by the inversion symmetry.
3.3.2. Nonstoichiometric hydrate
Reduction of the temperature to 40 1C noticeably changed
the 13C CPMAS spectra of NSH, Fig. 8. The largest changes are for
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Fig. 6. 13C T1 relaxation times for the ethanol carbons of SEt as a function of inverse
temperature. The one-standard-deviation error bars on the ﬁtting of CH2 T1 values
are of the order of the size of symbols used.
Fig. 7. 2H MAS spectra at a spinning rate of 10 kHz for SEt at 20 and 45 1C, with
the centreband region expanded on the right.
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Fig. 8. 13C CPMAS spectra of NSH at 20 1C (solid line) and –40 1C (dashed line).
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the signals from C9 and C4, both of which are close to the water
molecules – C9 is even weakly hydrogen bonded with the water
[18,20] – suggesting changes in the dynamics and/or average
structure of the water molecules. The relatively short (largely
temperature independent) 1H T1 relaxation time of about 15 s
observed in the 13C CP experiments is consistent with motion of
the water molecules; droperidol phases without mobile solvent
molecules, SACN, SNM, polymorph II and dihydrate, showed T1
values in excess of 2 min, which is more typical of molecular
solids lacking methyl groups to drive relaxation.
Fig. 9 shows 2H MAS spectra of NSH prepared from D2O as a
function of temperature. Very different bandshapes and temperature
dependence are observed compared to the alcohol solvates. The
water signal in NSH has narrower bandshape with partially averaged
quadrupolar coupling parameters: χ was 8473 kHz, while η was
more variable, in the range 0.6–1.0, depending both on water
content and temperature, see Table S3. This dependence on the
water content presumably reﬂects changes in the overall dynamics
with the degree of occupancy of water sites. While the possibility of
distinct populations of static vs. dynamic water molecules can be
ruled out, it is difﬁcult to distinguish whether there is a distribution
of similar water environments or a single averaged water environ-
ment with fast exchange between sites. Reducing the temperature
clearly broadens the lines corresponding to D2O, Fig. 9(b), implying
the water is highly dynamic at ambient temperature and that some
aspect of the dynamics is being slowed to the 10 s kHz frequency
scale at 45 1C. The overall quadrupolar coupling constants are
somewhat lower than those typically reported for water molecules
undergoing rapid C2 ﬂips [62–64], suggesting that the overall
dynamics is more complex. Moreover a simple C2 ﬂip motion would
produce η values of unity and would not explain the relatively high
displacement parameters for water oxygen site observed in XRD
[20]. As would be expected, the 2H T1 relaxation times for the water
sites are very short, estimated to be o0.1 s from experiments with
variable recycle delays. Again, the ND site is relatively uninforma-
tive; ﬁtted quadrupolar parameters are tabulated in Table S3. T1
relaxation times were 1–3 s (see Table S4), comparable to values
observed for deuterium sites without high-frequency dynamics. The
larger intensity of the ND signal in Fig. 9(a) probably reﬂects the fact
that the hemihydrate sample was stored for longer in the D2O
atmosphere than the monohydrate sample.
To quantify the motional broadening seen in Fig. 9, the line-
widths of the D2O peaks (LW) were determined from the
bandshape ﬁtting of the spinning sideband manifold. The motional
broadening was estimated by subtracting the width of the ND
resonance (LWo¼160 Hz), which is assumed to be unaffected by
the water dynamics. The plot of linewidth due to motional broad-
ening [65] against inverse temperature, Fig. 10, is linear over this
temperature range allowing an Arrhenius-type activation barrier
to be determined, Ea¼2573 kJ mol–1. Note that in this fast
exchange limit, the constant of proportionality between the
motional broadening and the rate of dynamics is related in a
non-trivial way to the quadrupolar parameters and motional
mechanism. Moreover, the physical signiﬁcance of the derived
activation parameter is limited given both the non-trivial nature of
the motion and the restricted temperature range covered.
3.4. Theoretical analysis of the differences in solvent molecule
behaviour
In order to rationalize the observed differences in the solvent
molecule dynamics between the different droperidol solvates, the
energy difference was determined between structures where all
the solvent molecules in a channel point in the same direction and
where adjacent solvent molecules point in opposite directions. As
a ﬁrst step, the orientation of the solvent molecule in each
hemisolvate crystal structure was approximately reversed and
geometry optimization in CASTEP used to relax all the atomic
positions. The tiny energy differences of up to 0.3 kJ cell1
(equivalent about 3 107 of the total cell energy) between the
energies of these nominally identical unit cells gives an estimate of
the “error bar” in this type of calculation. The unit cell dimensions
were then doubled in the solvent channel (a-axis) direction and
the orientation of one solvent molecule was reversed. The energy
differences (per unit cell/doperidol molecule) between the “same
direction” and “opposite direction” structures after full geometry
optimization, with and without dispersion correction, are shown
in Table 2. It can be seen that the cell energies are essentially the
same for SEt, particularly when the dispersion-corrected functional
is used. In contrast, the “same direction” structure is slightly
Fig. 9. 2H MAS spectra at a spinning rate of 10 kHz of NSH with (a) hemihydrate
stoichiometry at 20 1C, and (b) monohydrate stoichiometry at different tempera-
tures. The insets show the spinning sideband at about 30 kHz (marked with dashed
rectangle), as the ND signal is clearer here than in the centreband. The spectra have
the same vertical scale.
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Fig. 10. Estimated motional line broadening of the 2H D2O resonance of NSH as a
function of inverse temperature. The “error bar” indicates the maximum and
minimum linewidths observed using different methods for bandshape ﬁtting/
baseline roll suppression (see Section 2).
Table 2
Increase in unit cell total energy (in kJ cell–1) of droperidol solvates when adjacent
solvent molecules are positioned in the opposite direction, with (þTS) and without
dispersion correction.
Solvate SEt SMe SNM SACN
PBE 1.5 2.9 9.9 26.3
PBEþTS 0.4 3.7 12.6 26.9
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energetically more favourable for SMe, and is signiﬁcantly more
energetically favourable for SNM and SACN.
Pairwise interaction energies were also calculated to provide
insight into the energetics of different relative solvent orienta-
tions. Interaction energies (the difference in energy between two
separated molecules and their dimer) were calculated using
Gaussian 09 between one solvent molecule and the two solvent
and eight droperidol molecules that surround the chosen solvent
molecule. The co-ordinates of these ten molecular pairs were
extracted from the optimized “same direction” and “opposite
direction” crystal structures, and the overall interaction energy
approximated as the sum of these ten pairwise interaction
energies. In the case of the “opposite direction” structure, adjacent
solvent molecules can either be oriented “head-to-head” (HH) or
“tail-to-tail” (TT), see Fig. S11, along the a-axis direction. As
required from the inversion symmetry, the total interaction energy
of the solvent with its surroundings is the same, within the
calculation accuracy, for the two solvent arrangements in “oppo-
site direction” structure. As shown in Fig. 11, the total interaction
energy is essentially identical for the “same direction” and
“opposite direction” structures in the case of SEt. In contrast, the
interaction energies are much more favourable for the “same
direction” structure for SNM and SACN. These trends are fully
consistent with the pattern of total unit cell energies as observed
above. As shown in Fig. 11 and tabulated in Table S5, the most
signiﬁcant factor (at least 87%) contributing to the difference in
interaction energies are the solvent–solvent interactions. The
solvent–solvent interactions are always attractive in the “same
direction” structure, whereas the interactions between nitro-
methane and acetonitrile molecules change by 13–18 kJ mol1
from attractive to repulsive in the “opposite direction” structure.
These results provide a straightforward rationalization of the
absence of solvent disorder in the SACN and SNM solvates – where
there is a strong energetic preference for the solvent molecules to
be consistently oriented – and the presence of solvent molecule
disorder in SMe and SEt, where there is little energetic preference
for a consistent orientation.
4. Conclusions
The 13C CPMAS solid-state NMR spectra of a set of isostructural
solvates of droperidol (NSH, SMe, SEt, SACN and SNM) conﬁrm that
the solvent molecules have only minor effect on the chemical
environment of the droperidol molecules. The relatively broad
linewidths, which make it difﬁcult to resolve the inequivalence of
the droperidol molecules in the SACN and SNM solvates, can be
explained by high anisotropy of the bulk magnetic susceptibility.
The nature of the disorder was somewhat easier to resolve in the
15N CPMAS spectra, where dynamic disorder in the SMe and SEt
results a single sharp set of peaks for the droperidol nitrogen sites.
Variable-temperature 13C and 2H spectra and measurements of
spin–lattice relaxation times allow the characterization of the
solvent molecule dynamics in NSH, SMe and SEt. The motion of
the alcohol molecules in SMe and SEt contains dynamics of
relatively high-frequency (on the order of 10 s MHz to drive 2H
and 13C T1 relaxation), but of limited amplitude (given the minimal
averaging of the 2H quadrupolar parameters). The absence of well-
deﬁned T1 minima suggests that this is a complex motion. The
dynamics also includes components on the 10 s kHz frequency
scale (observed via the 13C spectra) and allows for occasional
ﬂipping over to the equivalent state related by the inversion
symmetry, although the rate of this process cannot be estimated
with any precision; the 15N spectra set a lower limit of about 40 Hz
at ambient temperature (corresponding to collapsing a frequency
difference of about 1 ppm at 40.53 MHz 15N Larmor frequency).
The motion of the water molecules in NSH is also expected to be a
composite motion, resulting in greater averaging of the NMR
parameters than a simple C2 ﬂip between equivalent positions,
with an estimated C2 ﬂip rate on the order of 10 s kHz in 45 1C
temperature, although an Arrhenius-type activation barrier of
Ea¼2573 kJ mol–1 could be estimated in this case.
The computational simulations help to rationalize these observa-
tions. There is little energy difference between initial and ﬁnal states
for inverting the orientation of the alcohol molecule in the SMe and SEt
solvates. Although the barrier to inversion may be relatively high, this
means that the solvent molecules appear to be disordered between
the two symmetry-equivalent positions over the timescale of the XRD
and NMR experiments. In contrast, the unfavourable energetics
associated with adjacent acetonitrile and nitromethane molecules
having opposite directions means that the SACN and SNM are strongly
ordered on the NMR and XRD timescales. These unfavourable ener-
getics are mostly associated with solvent–solvent interaction energies.
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ABSTRACT: Experimental and theoretical characterization
and studies of phase transitions and stability of the solvates
obtained in solvate screening of the pharmaceutical compound
benperidol were performed to rationalize and understand the
solvate formation, stability, and phase transitions occurring
during their desolvation. The solvate screening revealed that
benperidol can form 11 solvates, including two sets of
isostructural solvates. The analysis of the solvate crystal
structures and molecular properties indicated that benperidol
solvate formation is mainly driven by the complications during
packing of benperidol molecules in an energetically eﬃcient
way in the absence of solvent molecules, as well as by the compensation of an insuﬃcient number of hydrogen bond donor
moieties. Analysis of solvate structures, particularly those of isostructural solvates, revealed that both the possible interactions and
the size and shape of the solvent molecules were important factors in solvate formation. Stability of the solvate was proved to be
associated with the intermolecular interaction energies in the crystal structure. Desolvation studies of benperidol solvates
identiﬁed two forces determining the polymorph obtained after desolvation: structural similarity with the solvate and the
thermodynamic stability.
1. INTRODUCTION
Benperidol, 1-{1-[4-(4-ﬂuorophenyl)-4-oxobutyl]piperidin-4-
yl}-1,3-dihydro-2H-benzimidazol-2-one (Figure 1), is an
antipsychotic, used for the treatment of schizophrenia and to
control antisocial, hypersexual behavior. It is reported to exist in
three polymorphic forms I−III, a dihydrate DH, and an ethanol
solvate SEt. These phases have been characterized by powder X-
ray diﬀraction (PXRD) peak positions and melting points,1 as
well as by the IR spectra.2 The crystal structure, however, has
been reported only for polymorph I,3 which crystallizes in the
R3̅ space group with Z = 18.
Nevertheless, it has been shown that pharmaceutical
molecules tend to form a range of diﬀerent phases4,5 (up to
10 polymorphs6,7 and more than 100 solvates5), and a recent
study of the similar molecule droperidol shows that it exists as
four polymorphs and 11 solvates.8 Moreover, benperidol has
three strong hydrogen bond acceptors and only one hydrogen
bond donor, suggesting it could be a promiscuous solvate
former.9
Exploration of a solid form landscape is an essential step
during the drug development process, as diﬀerent polymorphs
and, particularly, solvates have diﬀerent stabilities,6 mechanical
properties,10−12 and bioavailability (linked to the diﬀerent
solubility13), and such studies are needed to prevent
unexpected solid form appearance after the approval of a
drug.14,15
The two main structural driving forces leading to the
formation of solvates are4 (a) unsatisﬁed potential intermo-
lecular interactions between the molecules, compensated by the
incorporation of solvent molecules, the most typical scenario
being a misbalance between the hydrogen bond donor and
acceptor sites in the molecule,9 or (b) solvent inclusion in the
crystal decreases the void space and/or leads to more eﬃcient
packing.16 Therefore, only in the ﬁrst scenario the solvate
selectivity is based on their functionality. However, most of the
solvates include contributions from both of these driving forces,
and the resulting eﬀect for solvate formation is a lowering of the
crystal free energy. This principle is well demonstrated by
isostructural solvates, which can form only with solvents having
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Figure 1. Molecular structure of benperidol with the numbering of
non-hydrogen atoms and labeling of ﬂexible dihedral angles.
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some speciﬁc interactions17,18 or molecular shapes,19 although
it is common that such solvates form with diﬀerent solvent
molecules located in structural channels.20−22
A predictable outcome of the desolvation process commonly
is the formation of structurally similar nonsolvated phases,23−25
which then strongly suggests limited molecule rearrangements
caused by the escape of the solvent molecules.26,27 However,
quite often there is no structural similarity between the solvate
and its desolvated form, especially if the solvent molecules have
a crucial role in stabilization of the solvate structure,28 and the
desolvation results in recrystallization or melting of the
desolvated structure.29,30
As it has recently been shown, computational structure
prediction tools are successful in the prediction of polymorphs
and their relative stability,31−40 while the prediction of solvates
and, especially, their stability is a lot more challenging and has
been successful only for some relatively simple hydrate19,41−43
and solvate44 systems. Currently, it would be the most
reasonable to make solvate predictions based on the solvent
and host properties and possible intermolecular interac-
tions.45−47 In the recent literature, systematic and compre-
hensive studies of solvate formation8,45 and their proper-
ties22,48−50 have been reported for some pharmaceutical
molecules. However, a general understanding of theoretical
prediction of solvate formation based on the molecular
structure and prediction of solvate properties based on the
crystal structure data have not yet been achieved. Therefore, in
this study we tried to understand and rationalize the formation,
stability, and phase transformations of benperidol solvates using
a comprehensive approach employing experimental, theoretical,
and computational analysis of molecular and crystal structure
properties. Benperidol was crystallized from solvents belonging
to diﬀerent solvent classes, the obtained solvates were
characterized, and their crystal structures, as well as solvent
and benperidol properties, were used to rationalize their
formation. The desolvation process and products were
rationalized based on crystal structure and relative stability of
nonsolvated forms. Crystal structures of solvates were
compared to rationalize the relative stability of solvates and
the observed frequency of the solvate formation in the
crystallization experiments. Such a study is a step forward to
reaching a general understanding of the solvate formation and
properties.
2. EXPERIMENTAL SECTION
2.1. Materials. Benperidol (purity > 99%) was obtained from JSC
Grindeks (Riga, Latvia). The sample consisted of polymorph I.
Inorganic compounds and organic solvents of analytical grade were
purchased from commercial sources and used without further
puriﬁcation.
2.2. Preparation of Known Polymorphs and the Dihydrate.
Benperidol polymorph I was prepared by recrystallization from
isopropanol, preparing a saturated solution at 70 °C, and rapid cooling
to −5 °C. Polymorph II was prepared by slowly evaporating
benperidol solution in isopropanol at 50 °C. DH crystals were
obtained when a similar volume of water was slowly added to
benperidol solution in acetone, and the resulting solution was slowly
evaporated at 50 °C. Powdered DH was obtained when benperidol
solution in acetone or DMF was poured into a large amount of water,
by stirring the obtained suspension.
2.3. Solvent-Based Polymorph and Solvate Screening. The
most popular solvents chosen from diﬀerent solvent classes51,52
(grouped according to physical and physicochemical properties) were
selected for the crystallization of benperidol. Saturated or concentrated
solutions of benperidol in all of the solvents were prepared at 40−120
°C, depending on the boiling point of the solvent (see Table S1,
Supporting Information). The obtained solutions were then cooled
down to −5 °C. In the cases when no crystallization was observed, the
solutions were slowly evaporated at 40 or 50 °C, while preventing a
complete evaporation. The obtained products were collected by
ﬁltration, air-dried, and characterized.
2.4. Preparation of Solvate Samples. For studying the phase
transitions and desolvation kinetics, all solvates were prepared as in the
solvate screening experiments by obtaining crystals or powders (for
HH and SDIOX). Alternatively, well-ground polymorph I was
suspended for 24 h in the corresponding solvent at 50 °C, producing
powdered SEt, SMe, and SACN solvate samples. Fast cooling of the
ethanol and methanol solutions produced small solvate crystals (the
size of at least one of the dimensions was below 100 μm), while slow
evaporation of these solutions at 50 °C produced large crystals (the
size of all of the dimensions was higher than 200 μm).
2.5. Study of Solvate Stability. Stability of the solvates was
determined at ambient conditions, by storing the solvate sample in a
desiccator over P2O5 at 30 °C, and at elevated temperatures by heating
the samples in air thermostats. The heating temperature was selected
based on the recorded diﬀerential thermal analysis/thermogravimetry
(DTA/TG) curves. Phase transformations were identiﬁed using PXRD
and, if necessary, DTA/TG as well.
2.6. Single Crystal X-ray Diﬀraction (SCXRD). The single-
crystal X-ray diﬀraction data for benperidol polymorph II and solvates
were collected at 173 K (100 K for SEtOAc) on a Nonius Kappa CCD
(Bruker) diﬀractometer, using Mo−Kα radiation (graphite mono-
chromator, λ = 0.71073 Å) and Oxford Cryostream (Oxford
Cryosystems) open-ﬂow nitrogen cryostat for sample temperature
control. The structures were solved by direct method and reﬁned by
full-matrix least-squares on F2 for all data using SHELX-2013 suite53
and OLEX254 software. All nondisordered non-hydrogen atoms were
reﬁned anisotropically. For disordered ethyl acetate molecules, a ﬁxed
value of SOF = 0.5 was used.
The packing coeﬃcients for crystal structures were calculated by
PLATON.55 Mercury 3.3 software56 was used for crystal structure
analysis and simulation of powder X-ray diﬀraction (PXRD) patterns
based on crystal structure data.
2.7. Powder X-ray Diﬀraction. The PXRD patterns were
measured at ambient temperature on a D8 Advance (Bruker)
diﬀractometer using copper radiation (Cu Kα) at the wavelength of
1.54180 Å, equipped with a LynxEye position sensitive detector. The
tube voltage and current were set to 40 kV and 40 mA. The divergence
slit was set at 0.6 mm, and the antiscatter slit was set at 8.0 mm. The
diﬀraction patterns were recorded using a 0.2s/0.02° scanning speed
from 3° to 35° on 2θ scale. To prevent the atmospheric humidity
eﬀects and decomposition of the solvates, the samples were covered
during the analysis with a 10 μm polyethylene ﬁlm, when necessary.
For crystal structure determination, PXRD patterns were measured
on a D8 Discover (Bruker) diﬀractometer at transmission geometry
using Göbel Mirrors and a capillary sample stage. Other settings and
equipment were identical to those used for D8 Advance. Samples were
sealed in rotating (60 rpm) borosilicate glass capillaries of 0.5 mm
outer diameter (Hilgenberg glass No. 10), and data were collected
using 22s/0.01° (III), 25s/0.01° (SBenz), or 36s/0.01° (HH) scanning
speed from 2.5° (SBenz) or 4.5° (III and HH) to 70° on 2θ scale.
2.8. Crystal Structure Determination from PXRD Data. The
PXRD patterns were indexed for the ﬁrst 20−25 peaks, using
DICVOL0457 (implemented in WinPLOTR software58) and SVD
indexing algorithms59 (implemented in TOPAS v4.2). Space group
determination was carried out using a statistical assessment of
systematic absences, and Z′ was determined based on density
considerations. Structure solutions were performed by Monte Carlo/
Simulated annealing technique implemented in Expo2014,60,61 using a
rigid model, ﬂexible about the dihedral angles τ1−6 and τBenz1 and τBenz2
(Figure S7, Supporting Information) for benzyl alcohol molecule by
also determining the center of mass location and molecular
orientation. The initial geometries of benperidol molecule as in
crystal structures of polymorph I (for SBenz) and SACN (for HH and
III) were used. For the structure of HH, oxygen atoms of water
Crystal Growth & Design Article
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molecules were kept in the special positions, and the initial unit cell
with water molecules was taken from the CSD (refcode AMCHCA62).
The initial geometry of benzyl alcohol molecule was taken from the
CSD (refcode FEBCUL63). The ﬁnal reﬁnements were carried out by
the Rietveld method, maintaining the rigid bodies introduced at the
structure solution stage. The background was modeled by a 20th-order
polynomial function of the Chebyshev type; peak proﬁles were
described by the Pearson VII function, and a common (reﬁnable)
isotropic thermal factor was attributed to all non-hydrogen atoms,
while that of hydrogen atoms was assumed to be 1.2 times higher.
2.9. Diﬀerential Thermal Analysis/Thermogravimetry (DTA/
TG). The DTA/TG analysis was performed with Exstar6000 TG/
DTA6300 (SII). Open aluminum pans were used. Heating of the
samples from 30 to 180 °C was performed at a 5°·min−1 heating rate.
Samples of 5−10 mg mass were used, and the nitrogen ﬂow rate was
100 ± 10 mL·min−1.
2.10. Karl Fischer Titration. A 836 Titrando (Metrohm) Karl
Fischer volumetric titrator was used for the determination of water
content in the samples. Approximately 100−200 mg portions of each
sample were weighed on an analytical balance (d = 0.1 mg) and
titrated with Hydranal Composite 5 (Fluka).
2.11. Fourier Transform (FTIR) Infrared Spectroscopy. The
ATR-FTIR spectra were collected for neat solids on a Frontier FTIR
(PerkinElmer) spectrometer equipped with a Universal ATR Sampling
Accessory with a diamond window. The spectra were recorded from
650 to 4000 cm−1 at a 2 cm−1 spectral resolution with 16 scans.
2.12. Theoretical Calculations. The geometry optimization was
performed in CASTEP64 using the PBE65 functional and on-the-ﬂy
generated ultrasoft pseudopotentials and a cutoﬀ energy of 600 eV
(where the lattice parameters and the atom positions were relaxed) or
300 eV (where only the atom positions were relaxed). The
Tkatchenko−Scheﬄer dispersion correction scheme66 was used. For
these calculations, a structure of SEtOAc with one of the possible solvent
orientations was used, thus creating a structure in the P1 space group
with two symmetrically individual benperidol molecules.
The lattice energy calculations were performed using semiempirical
PIXEL67 methodology and classical atom−atom Coulomb−London−
Pauli (CLP) model,67 both developed by Gavezzotti. Crystal structures
were used after geometry optimization in CASTEP.
The interaction energies between pairs of molecules were calculated
in Gaussian 0968 using the M06-2X69 functional and 6-311G(d,p) basis
set to molecular geometries directly extracted from the crystal
structures after the geometry optimization in CASTEP. The basis set
superposition error was corrected using the counterpoise method. The
interaction energy was calculated as the diﬀerence between the total
energy of the dimer and the corresponding isolated molecules. The
total interaction energy values were calculated as a sum of all pairwise
interaction energies (without the correction for double counting of
identical interactions) for molecule pairs having contacts shorter than
the given cutoﬀ distance, see Table 5.
The molecular volumes of selected solvent molecules were
calculated in Gaussian0968 after the geometry optimization at the
B3LYP/6-311G(d,p) level using Grimme’s dispersion correction.70
Simulation of IR spectra was performed by extracting a character-
istic molecular fragment representing the intermolecular interactions
(amide homodimers for II and SACN, a ring of six benperidol molecules
for I, a chain consisting of three benperidol and two alcohol molecules
for SMe and SBenz, and a fragment of three benperidol and one water
molecule for HH). Geometry optimization and frequency calculation
were performed at the PM6 level, and the obtained frequencies were
multiplied by a scale factor of 0.953.71
3. RESULTS AND DISCUSSION
3.1. Crystallization. Benperidol was crystallized from a
range of solvents selected to represent diﬀerent solvent classes
based on classiﬁcation according to statistical analysis of four
molecular descriptors,51 as well as hydrogen bond acceptor and
donor propensity, polarity/dipolarity, dipole moment, and
dielectric constant.52 In these experiments no new benperidol
polymorphs were obtained; see Table S1, Supporting
Information. Moreover, in our experiments it was not possible
to obtain polymorph III from n-heptane as described in the
literature1 nor from any other solvent. From most of the
solvents, polymorph I was obtained. In accordance to previous
studies,1,2 it was possible to crystallize polymorph II from
isopropanol. However, the precipitation of the solid product
from isopropanol usually initiated shortly after cooling the
solution, and polymorph I was obtained instead.
Nevertheless, besides the already reported solvates DH and
SEt,
1,2 nine new solvates were obtained in crystallization
experiments from methanol, acetonitrile, ethyl acetate, nitro-
methane, 1,4-dioxane, toluene/o-xylene, benzyl alcohol, carbon
tetrachloride, and chloroform (labeled as SMe, SACN, SEtOAc,
SNM, SDIOX, HH, SBenz, STCC, and SCLF, respectively). In this
study, the ﬁrst seven of these solvates, as well as the poorly
explored solvated forms SEt and DH were characterized using
PXRD patterns, DTA/TG analysis, and IR spectra, while their
desolvation products were also identiﬁed, and the desolvation
process was characterized. Preparation of solvates STCC and
SCLF was complicated by the formation of side-products and
poor reproducibility, so these solvates were characterized only
using PXRD and DTA/TG analysis. Crystals suitable for
SCXRD measurements were obtained for polymorph II and
solvates DH, SEt, SMe, SACN, and SEtOAc. Additionally, attempts
were made to solve the crystal structures of the rest of the
phases by using the recorded PXRD patterns, with success for
HH, SBenz, and the polymorph III.
3.2. X-ray Diﬀraction and Thermal Characterization of
Benperidol Solvates. PXRD patterns of all the obtained
solvated forms are given in Figure 2.
It can be seen that the diﬀraction peak positions of solvates
SMe and SEt were very similar. The same was found also for
solvates SACN, SEtOAc, and SNM. These similarities suggest the
formation of two sets of benperidol isostructural solvates: type
1 solvates (SMe and SEt) and type 2 solvates (SACN, SEtOAc, and
SNM). The PXRD patterns of HH, SBenz, SDIOX, and STCC,
however, exhibited diﬀerent characteristic features, which also
diﬀered from those in PXRD patterns of all other known
benperidol forms. The PXRD pattern of SCLF, however, was
similar to that of type 2 solvates, suggesting that this solvate
probably also belongs to this type, although the poor quality of
the pattern did not allow us to draw an absolute conclusion.
Figure 2. PXRD patterns of the benperidol solvates.
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The DTA/TG curves of the benperidol solvates are shown in
Figure 3. Although this method allowed us to conﬁrm STCC and
SCLF as solvates, the obtained curves cannot be assured to be
characteristic for pure phases. Nevertheless, for informative
purposes they are given in Figure S1, Supporting Information.
The desolvation of DH and HH appeared to be a simple
one-step process with a characteristic desolvation endothermic
peak associated with the weight loss. The curves of other
solvates, however, showed a complex desolvation process. Type
1 and type 2 solvates usually showed two endothermic peaks
associated with the weight loss (with larger particle size and
faster heating rate increasing the contribution of the second
peak; see Section 3.5). This suggests that the desolvation
occurred in two stages, or other complications were
encountered during the desolvation. It was shown that the
second desolvation peak corresponded to peritectic desolvation
and/or melting; see Section 3.5. Although the desolvation of
SBenz most probably was also a one-step process, it appeared to
be complicated by the diﬃcult evaporation of benzyl alcohol
(Tb = 205.3 °C).
Desolvation products of the solvates were analyzed using
PXRD and are given in Table 1.
Figure 3. DTA and TG curves of benperidol solvates. d − desolvation, dp − peritectic desolvation and/or melting, mI−IV − melting of polymorphs
I−IV, and evapBenz − evaporation of benzyl alcohol.
Table 1. Weight Loss Observed during the Desolvation of Benperidol Solvates and the Obtained Desolvation Products
solvate ratio calculated weight loss, % observed weight loss, % Tdesolvation, °C (peak) resulting phase
DH 1:2 8.6 8.8 (9.0)a 77 (V, IV)/(II, I)c
SMe 1:1 7.8 7.9 89, 129
b II/Ic
SEt 1:1 10.8 11.6 87, 137
b
SACN 1:1 9.7 8.1−9.5d 86, 106b III/Ic
SNM 1:0.5 7.4 6.9−9.0d 82, ∼95b
SEtOAc 1:0.5 10.4 8.5−9.8d 88
HH 1:0.5 2.3 2.0−2.5 (2.1)a 89 III/Ic
SBenz 1:1 22.1 21.8 109 I
SDIOX 1:1.5 25.7 24.5 69 III/I
c
STCC 1:1 16.8 16−22 66, 88 IV, V, II, I
SCLF 1:0.5 13.5 10−17 76 III/I
aThe water content determined by Karl Fischer titration is given in parentheses. bThe second value is peritectic decomposition and/or melting
temperature. cSee discussion in Section 3.5. dThe ﬁrst number is the weight loss after the appearance of the desolvation peak in the DTA, and the
second number is the total weight loss.
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Besides the polymorphs I and II obtained in the
crystallization, desolvation of type 2 solvates, HH, SDIOX, and
SCLF produced the polymorph III described in the literature,
1
whereas the desolvation of DH produced new polymorphs IV
and V. The PXRD patterns of benperidol polymorphs are given
in Figure S2, while the DTA curves are given in Figure S3,
Supporting Information.
Therefore, the existence of polymorph III as described in the
literature1 has been conﬁrmed,2 although it is not clear whether
it is possible to obtain it as described,1 because in our study it
was obtained only in the desolvation process.
The stoichiometry of the solvates was calculated from the
weight loss in TG curves. The DH phase was conﬁrmed to be a
dihydrate, whereas SEt was determined to be an ethanol
monosolvate, in contrast to the reported ethanol disolvate
stoichiometry.1 With regard the isostructural type 2 solvates,
the SACN phase was monosolvate, whereas SNM and SEtOAc
appeared to be hemisolvates. Both TG and KF titration
conﬁrmed that HH is a hemihydrate. Repeated measurements
suggested that SDIOX is a sesquisolvate, although this should be
interpreted cautiously.
Crystal structures of benperidol polymorph II, and solvates
DH, SEt, SMe, SACN, and SEtOAc were determined from SCXRD
measurements at 173 or 100 K (SEtOAc), while those of
polymorph III, as well as solvates HH and SBenz, were
determined from PXRD data collected in transmission mode at
ambient temperature. The obtained crystallographic data are
given in Table 2. An overlay of the experimental data and
PXRD patterns simulated from crystal structure data (see
Figure S8, Supporting Information) conﬁrmed the identity of
the polycrystalline phases. The correctness of the structures
calculated from PXRD patterns was conﬁrmed by the good
agreement between experimental and calculated diﬀraction
patterns (see Figure 4), as well as by the geometry optimization
in CASTEP introducing only small changes in the crystal
structure (see Figure S9, Supporting Information). Polymorphs
II and III crystallized in the space group P1 ̅ with three
molecules or one molecule in the asymmetric unit, respectively.
The DH form crystallized in the P21/n space group, SEt and SMe
were isostructural and crystallized in the P21/c space group,
SACN and SEtOAc were isostructural and crystallized in the P1 ̅
space group, HH crystallized in the C2/c space group, and SBenz
crystallized in the Pbca space group. The asymmetric units of all
solvated forms contained one benperidol molecule and two
(DH), one (SMe, SEt, SACN, and SBenz), or one-half (HH and
SEtOAc) solvent molecules. In the HH form, the oxygen atom of
water molecule was at a special position, and the ethyl acetate
molecule in SEtOAc was disordered over two symmetrically
related positions. The solvent stoichiometry determined from
this analysis was consistent with that determined from TG
analysis.
3.3. Characterization of Benperidol Solvate Crystal
Structures. Analysis of the crystal structures revealed that the
conformation diﬀerences appear as diﬀerent values of the
dihedral angles τ1−τ6, although the oxobutyl side chain (τ3−τ6)
tends to be linear. Interestingly, molecular conformation of
benperidol in polymorphs I and III, as well as that in all of it
solvates, is quite similar, but diﬀerent from all three benperidol
molecules in the polymorph II, with the most apparent
diﬀerence observed for the value of τ1 (see Figure 5a and Table
3). The molecular conformation of all three symmetrically
independent molecules in II (designated as A, B, and C) was
diﬀerent, with slight variations in the conformations of A and C,
and signiﬁcant variations in the dihedral angles τ2 and τ4 for
molecule B. As already mentioned, besides the identical
conformations observed in the isostructural solvates SMe and
SEt as well as in SACN and SEtOAc, the conformations of all
Figure 4. Experimental (black), calculated (red), and diﬀerence (dark
blue) PXRD proﬁles from the ﬁnal Rietveld reﬁnement of various
benperidol forms.
Figure 5. An overlay of benperidol molecules in (a) polymorphs (I:
green, IIA: red, IIB: dark gray, IIC: cyan), (b) solvates (DH: dark blue,
SEt: dark green, SACN: orange, SBenz: pink) and polymorph I (green).
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solvates and polymorph III were nearly identical, with the
exception of SBenz, which had a noticeable deviation of the
dihedral angles τ2 and τ4 (see Figure 5b and Table 3). It should,
however, be mentioned that the geometry optimization in
CASTEP changed the geometry of oxobutyl side chain by
making it more similar to that in the rest of the solvates.
Therefore, the overall conformation diﬀerences of benperidol
were small if compared to other molecules with similar
conformational degrees of freedom,72,73 and the observed
structural diversity resulted from diﬀerent intermolecular
interaction possibilities producing diﬀerent molecular packing.
Table 3. Dihedral Angles (in Degrees) of Benperidol in Its Polymorphs and Solvates
I3 IIA IIB IIC DH SEt SACN HH SBenz III
τ1 −124.03 74.00 92.67 64.60 −108.82 −108.29 −113.17 −114.21 −123.07 −108.93
τ2 −60.75 −157.37 −68.78 −156.47 −60.65 −72.75 −71.46 −72.09 −21.19 −75.32
τ3 −172.82 175.51 −177.09 −177.98 −167.59 −176.74 −169.39 −148.24 −165.54 −162.38
τ4 −166.14 171.94 74.07 175.18 −175.91 −179.91 −174.13 −152.45 138.78 −165.18
τ5 −176.79 −179.31 −172.78 −173.37 179.6 −179.58 −175.07 163.25 172.75 177.45
τ6 −177.47 155.52 161.46 −177.79 −178.83 178.82 −178.18 169.07 −149.71 170.13
Figure 6. Hydrogen bond patterns observed in crystal forms of benperidol.
Table 4. Geometrical Parameters of the Strong Hydrogen Bonds in Benperidol Polymorphs and Solvates
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The analysis of the strong hydrogen bonding pattern showed
that benperidol molecules in the polymorph I formed N2−H···
N3 bonds creating a ring of six molecules characterized by
R6
6(48) graph set, whereas all three molecules in II formed
amide homodimers linked by N2−H···O1 bonds and
characterized by R2
2(8) graph set (see Figure 6 and Table 4).
However, the observed conformation diﬀerences in benperidol
polymorphs could not be purely associated with the diﬀerence
in strong hydrogen bonds, as benperidol molecules were
arranged in amide homodimers also in the form III.
Nevertheless, other intermolecular interactions in this form
were completely diﬀerent from those in both II and I (see
Table S4, Supporting Information).
Although the incorporation of proton donating alcohol
molecules in the crystal lattice can provide a possibility for the
formation of additional strong hydrogen bonds, only one
hydrogen bond acceptor N3 in both type 1 solvates and in SBenz
is employed in similar hydrogen bonding connection with N2−
H as observed in form I, with alcohol O−H group inserted
between the benperidol molecules, and therefore creating two
strong hydrogen bonds. However, inﬁnite hydrogen bonded
chains C2
2(10) are formed in these structures. The alcohol
molecules in these solvates are positioned in structural voids
which can be joined in zigzag-shaped channels. However, the
diameter of the channel in the narrowest place is smaller than
that of the solvent molecules, and alcohol molecules are
involved in the formation of the main hydrogen bonding
pattern, so these solvates cannot be classiﬁed as channel
solvates.
In the HH and DH forms, however, the presence of the
water molecules provided for the formation of one additional
hydrogen bond in HH by employing an additional hydrogen
bond acceptor of benperidol molecule, and an eﬃcient
hydrogen bonding in DH by employing all hydrogen bond
acceptors of benperidol. In the HH form, benperidol molecules
existed as amide homodimers, whereas in the DH form
benperidol molecules were linked to each other by strong
hydrogen bonds via water molecules, and directly interacted
only by weak interactions. In these structures, the water
molecules were situated in isolated structural cavities, so both
the hydrates were isolated site hydrates.
The insertion of acetonitrile and ethyl acetate molecules,
however, could not provide a basis for the emergence of
additional strong hydrogen bonds. Also, benperidol molecules
in type 2 solvates formed amide homodimers characterized by
R2
2(8) graph set. The solvent molecules were located in
structural channels and interacted with benperidol molecules
only by weak hydrogen bonds (see Table S4, Supporting
Information) and dispersion forces. The type 2 solvates thus
were typical channel solvates. As ethyl acetate (81.4 cm3·mol−1)
Figure 7. 2D ﬁngerprint plots of Hirshfeld surfaces for selected molecules in benperidol polymorphs and solvates (the remaining plots are given in
the Supporting Information).
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molecules are much larger than acetonitrile (37.9 cm3·mol−1)
molecules, the size of the channel apparently is too small to
accommodate 1 equiv of ethyl acetate, explaining the diﬀerent
stoichiometry observed in type 2 solvates. Ethyl acetate
molecules, however, did not occupy the two adjacent solvent
sites in one channel but rather two sites from the nearby
partially connected channels; see Figure S18, Supporting
Information. Interestingly, the molecular size calculation and
computational simulation showed that the crystal structure of
SNM should be identical to that of SACN with monosolvate
stoichiometry (see Supporting Information). This could be
explained by a partial desolvation before the experiment, which
is supported by the slow desolvation at the beginning of the TG
curve for type 2 solvates (particularly for SNM, see Figure 3) and
can be explained by the fact that solvent molecules are located
in the channel and their escape is therefore relatively easy.
A more detailed comparison of the intermolecular inter-
actions was performed through the analysis of weak interactions
and 2D ﬁngerprint plots of Hirshfeld surfaces, which
summarized the information about intermolecular interac-
tions.74,75 The program Crystal Explorer 3.176 was used for
calculations; see Figure 7, Table S4, and Figures S13−S16,
Supporting Information. Overall, weak hydrogen bonds were
the most typical weak intermolecular interactions in crystal
structures of benperidol forms, and mostly were formed by O2
(in all structures except type 1 solvates and DH), O1 (in I, type
1 solvates, II, SBenz, and DH), and F1 (in II, III, type 1 solvates,
SBenz, and HH), while not by N3 (probably because of the
shape and packing of the molecules). In the crystal structure of
I, II, DH, and SBenz a noticeable role was played also by other
weak interactions (mainly CH···π). In the Hirshfeld surface
ﬁngerprint plots, a similarity was observed between the
benperidol molecules forming amide homodimers in II, III,
type 2 solvates, and HH (except for the spike associated with
the O3−H···N3 bond). The plot of SBenz is diﬀerent from those
of type 1 solvates, clearly identifying structural diﬀerences,
whereas it is similar to that of polymorph I, suggesting a
structural similarity with it. The structural similarity between I
and SBenz is also identiﬁed from the presence of similar weak
intermolecular interactions. Because of the dominance of strong
hydrogen bonding pattern involving water molecules in DH, its
plot completely diﬀers from that of all other phases.
Interestingly, a common feature of the ﬁngerprint plots of
polymorphs I and II is the presence of a number of longer
contacts (notice the points at high di and de values in Figure 7)
if compared to the solvates, indicating less eﬃcient packing.
This is also supported by the presence of small structural voids
(2.2% and 1.4% of the volume, respectively, but too small to
accommodate residual solvent molecules) in the structure of
both of these polymorphs, as determined using PLATON and
visualized in Mercury (see Figure S17, Supporting Informa-
tion).
Analysis of the molecular packing was performed in Mercury
and using XPac code.77,78 It was determined that the only forms
showing clear similarity of molecular packing (except for the
isostructural solvates) were III with HH and type 2 solvates, in
which the benperidol molecules were packed in a similar
manner (see Figure 8) by forming identical 2D supramolecular
constructsinﬁnite layers of molecules parallel to (110) in III,
(011) in type 2 solvates, and (201) in HH; see blue and green
layers in Figure 8. The similarity of HH and type 2 solvates,
however, is lower, and only identical 1D supramolecular
construct (ﬁnite layers formed from amide homodimers as
shown with red in Figure 8) was identiﬁed because of the
presence of solvent molecules distorting the molecular packing.
Similarly formed hydrogen bonded molecular chains forming
similar double layers were observed also in all alcohol solvates,
with small diﬀerences due to diﬀerent molecular conformations.
However, these double layers were stacked diﬀerently in SBenz,
therefore making these structures diﬀerent from those of type 1
solvates. Despite the similarity of intermolecular interactions
and Hirshfeld surfaces when comparing I and SBenz, no obvious
similarity in the molecular packing of these two forms could be
identiﬁed. All other benperidol forms did not show identiﬁable
Figure 8. Molecular packing in benperidol polymorphs and solvates. Benzimidazolone moiety is in blue, and ﬂuorophenyl moiety is in green. Green,
blue, and red layers represent identical supramolecular constructs identiﬁed in the crystal structures. Hydrogen atoms have been omitted for clarity.
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packing similarities; see Figures 8 and S19, Supporting
Information.
Interestingly, it was noticed that benperidol molecule layers
could be identiﬁed in all solvated forms, whereas molecular
packing of the two stable polymorphs I and II was more
complex.
3.4. Fourier-Transform Infrared Spectroscopy. The
FTIR spectra conﬁrmed the already identiﬁed isostructurality
within type 1, as well as type 2 solvates. Individual solvates,
however, could be identiﬁed by the presence of particular bands
from diﬀerent solvent molecules; see Figure 9. Also, the already
identiﬁed similarity of molecular packing in the polymorph III,
hydrate HH, and less explicitly in type 2 solvates, as well
similarity between the polymorph I and SBenz identiﬁed by
intermolecular interaction analysis was reﬂected as similarity of
their IR spectra. No clear similarities, however, were observed
between DH and polymorph V (see Figure S5, Supporting
Information), suggesting that there is no direct structural
relation between these forms, although this can also be
explained by the signiﬁcant changes introduced in benperidol
molecular environment by removal of the water molecules.
Interestingly, the IR spectra of polymorphs IV and V are
similar, suggesting that structural rearrangements during the
transition from V to IV could be quite limited in magnitude;
see Figure S5, Supporting Information.
The most easily noticeable diﬀerence in the IR spectra was
the position of the carbonyl group stretching bands, as two
peaks (at ∼1708 and ∼1684 cm−1) appearing for the
polymorph I and SBenz, whereas two indistinguishable or
slightly split peaks (at ∼1696−1683 cm−1) appeared for other
polymorphs and solvates. By using computational methods, it
was shown that the position of the amide carbonyl stretching
band was signiﬁcantly aﬀected by the hydrogen bonding, with
the N2−H···N3 and N2−H···O3 hydrogen bonds in I and SBenz
observed at ∼1710 cm−1, while the N2−H···O1 and N2−H···
O3 hydrogen bonds in other benperidol phases were observed
at ∼1695 cm−1 vibrational frequency (see Table S6, Supporting
Information).
3.5. Characterization and Rationalization of Benper-
idol Solvate Desolvation. Dihydrate. The TG analysis and
PXRD patterns showed that the dehydration of DH occurred in
one stage. However, the dehydration products of DH depended
on the sample and its preparation. Dehydration of ﬁne DH
powder at 30 °C over P2O5 resulted in the formation of
polymorph V. At elevated temperature (above 40 °C),
polymorph V transformed to polymorph IV. However, when
DH crystals (the size above 100 μm for all of the dimensions)
were dehydrated, polymorph II or a mixture of II and I was
obtained. This could be explained by slower water escape from
the crystal, which could lead to recrystallization of the product
in thermodynamically preferred polymorphs II and I (see
Supporting Information). These polymorphs also typically
appeared when powdered DH obtained by grinding its crystals
was dehydrated and could be explained by the nucleation of
polymorphs II and I during grinding. The fact that water
molecules had a crucial role in the stabilization of the crystal
structure implies that the dehydration most probably involved
complete structural collapse, followed by recrystallization to a
completely diﬀerent crystal structure, which explains the
possibility of forming diﬀerent dehydration products.
Type 1 Solvates. The PXRD measurements and crystal
structure analysis indicated that the presence of two
endothermic peaks in the desolvation process of SMe and SEt
Figure 9. FTIR spectra of the benperidol solvates and polymorphs I
and III. Asterisks mark the most characteristic bands from the solvent
molecules in isostructural solvates. An enlarged version is given in
Figure S4, Supporting Information.
Figure 10. Eﬀect of particle size (on the left, solid lines − large crystals, dashed − small crystals, dotted − well ground powder) and the heating rate
(on the right, solid lines − 20°·min−1, dashed − 2°·min−1, dotted − 0.2°·min−1) on the desolvation of SEt.
Crystal Growth & Design Article
DOI: 10.1021/acs.cgd.5b00138
Cryst. Growth Des. 2015, 15, 2337−2351
2346
(Figure 3) cannot be associated with the formation of a
desolvation intermediate. Besides, a change of the sample
particle size aﬀected the contribution from each peak.
Therefore, the appearance of two peaks apparently resulted
from diﬀerent desolvation rates associated with the molecules
located at diﬀerent distances from the surface of the crystals.
The ﬁrst peak was associated with the desolvation of solvate
close to the surface, for which the escape of solvent molecules
was relatively easy. The amount of solvate desolvated in this
way depended on the particle size. The further desolvation,
however, slowed down because of the hindered escape of
solvent molecules through the product phase. Nevertheless, the
desolvation slowly continued at increased temperature. The
second desolvation peak appeared when a fast and complete
desolvation occurred by reaching the peritectic decomposition/
melting point of the solvate at 129 °C for SMe, and at 137 °C
for SEt. Therefore, the desolvation proﬁle depended both on the
particle size and on the heating rate (see Figure 10).
The desolvation product in most cases was the structurally
diﬀerent polymorph II. Nevertheless, when desolvation was
performed with solvates prepared by a suspending technique, or
with large solvate crystals, a mixture of polymorphs II and I was
obtained in both desolvation stages, although it was noticed
that slow desolvation at low temperature facilitated the
formation of polymorph II, while fast desolvation at high
temperature facilitated the formation of I. The formation of
polymorph I can be explained by the presence of small nuclei of
I in the solvates obtained by suspending technique, as well as
the recrystallization from retained or condensed solvent in large
crystals, as I is the thermodynamically stable polymorph at
temperatures required for the desolvation process; see
Supporting Information. This was supported by the observation
that seeding of SMe with 5% of I led to the formation of pure I
after desolvation. Moreover, the crystallization of polymorph I
from ethanol solution, as well as the occurrence of peritectic
decomposition and/or melting was conﬁrmed by a hot-stage
microscopy experiment.
Type 2 Solvates. Similarly to the type 1 solvates, thermal
analysis of SACN with various particle sizes showed that the
second desolvation peak (at 106 °C in Figure 3) corresponded
to the peritectic melting and/or decomposition of this solvate.
The desolvation process of these solvates usually produced a
mixture of polymorphs III and I, with a smaller particle size and
lower temperatures facilitating the formation of III. The
desolvation of these solvates was easy and occurred even by
grinding at ambient conditions in a mortar, producing III with
low crystallinity. This relatively easy desolvation can be
explained by the presence of solvent channels and the absence
of strong benperidol−solvent interactions facilitating the
solvent removal process. The appearance of polymorph I as a
desolvation product most probably occurred in the presence of
nuclei of this thermodynamically stable polymorph or in a
recrystallization process from acetonitrile solution in the case
when large crystals were desolvated.
Other Solvates. Dehydration of HH over P2O5 at 30 °C
produced pure III, while dehydration at elevated temperature
produced besides III also the polymorph I. Desolvation of SBenz
both at elevated temperature and at ambient temperature
produced only the polymorph I. Desolvation of SDIOX produced
the polymorph III or HH, depending on the conditions (see
Supporting Information).
Structural Characterization of Benperidol Solvate Desol-
vation. A summary of the most characteristic phase transitions
occurring during the desolvation of solvates is given in Figure
11.
By analyzing these phase transitions in association with the
crystal structure data and phase stability of polymorphs, it was
concluded that two driving forces determined the obtained
desolvation product: (a) structural similarity between the
solvate and the obtained polymorph and (b) thermodynamic
stability of the resulting polymorph. The only solvate clearly
producing only one desolvation product was SBenz, which
formed only the thermodynamically stable polymorph I (see
Supporting Information). Besides, a strong similarity of
intermolecular interactions was observed in both of these
phases. Although type 2 solvates and HH showed clear
structural similarity with polymorph III, which usually was their
main desolvation product, it hardly ever appeared without
polymorph I as a minor component. The formation of
polymorph I was enhanced in situations facilitating the
formation of thermodynamically stable polymorph: at high
temperatures and in the case of large solvate crystals, when
recrystallization from trapped solvent was possible. Similar
eﬀects facilitating the formation of I were observed also in the
desolvation of type 1 solvates, and in that case further
supported by the observation that seeding with I produced I
as the only desolvation product. For type 1 solvates, however,
no structural similarities with the main desolvation product II
could be observed.
Similar observations as for type 2 solvates were made also for
the desolvation of DH, although in that case the main
desolvation product was the unstable polymorph V, and the
thermodynamically stable byproducts were polymorphs II and
I. In this case, however, a structural similarity between DH and
V could not be determined.
3.6. Rationalization of Solvate Stability and Fre-
quency of Solvate Formation in Crystallization. The
solvate stability was compared using the lattice energies and
pairwise intermolecular interaction energies. The results
obtained for structures where atom positions were relaxed in
Figure 11. A schematic representation of benperidol solvate preparation and the phase transformations occurring during their desolvation.
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CASTEP are given in Table 5. As shown previously, the results
from the semiempirical PIXEL code had accuracy similar to
those from DFT-D methods,79 while results from empirical AA-
CLP are less accurate and are given only to compare the lattice
energy of solvates with more than two molecules in the
asymmetric unit. Total pairwise interaction energy values were
less conclusive than the lattice energies, especially those
calculated for benperidol−benperidol interactions, as they did
not take into account the energetically relevant long-range
interactions. However, they allowed an approximate evaluation
of the contribution from benperidol and solvent molecule
interactions in the lattice energies and gave a fast insight into
the relative stability of solvates with similar structures.
The higher lattice energy of SEt compared to that of SMe
apparently explains the higher stability of this solvate, as
observed by its higher peritectic desolvation and/or melting
point (see Table 1) and higher desolvation Ea, see Supporting
Information.
Logically, by comparing the interaction energies in type 1
solvates with those in SBenz, it is observed that an increase in the
size of the solvent molecule increases the contribution of the
total pairwise solvent interaction energy to the lattice energy,
while the contribution from the total pairwise benperidol
interaction energy decreases due to the larger separation of
these molecules.
Although the thermal stability of type 2 solvates is very
similar, crystallization from acetonitrile always resulted in the
formation of SACN, whereas crystallization from ethyl acetate
mainly produced pure polymorph I. Moreover, SNM was
obtained only once. Besides, SACN was obtained also in slurry
experiments, whereas preparation of the other two solvates
using this approach was not possible. The lattice energy of SACN
was slightly more negative than that of SNM, and the pairwise
interaction energies between benperidol molecules in the
crystal structure of SNM were less eﬃcient (due to the larger size
of nitromethane molecule). This theoretically can lead to
hindered formation of SNM, as the formation of its crystals is
energetically less favored, compared to the formation of SACN
crystals. Because of the diﬀerent stoichiometries, reliable
comparison with SEtOAc was possible only using pairwise
interaction energies, which showed that the ethyl acetate
molecule in this structure did not form as eﬃcient interactions
as acetonitrile or nitromethane molecules, explaining the
complications with its crystallization. Nevertheless, it should
not be forgotten that the crystallization product can also be
associated with the molecular interactions in the solution, and it
is theoretically possible that ethyl acetate and nitromethane
somehow facilitate the crystallization of polymorph I.
The easier desolvation of type 2 solvates, compared to the
type 1 solvates, is explained by the presence of solvent channels
and weaker interaction energies experienced by the solvent
molecules.48,49
Although all the strong hydrogen bonds in DH structure are
formed with or between water molecules, interactions between
benperidol molecules in the form of weak hydrogen bonds and
dispersion forces contributed more to the lattice energy.
Nevertheless, the overall interactions in DH were energetically
more favored than those in HH, which apparently explain the
fact that this is the most stable of benperidol hydrates.
Therefore, the facile crystallization of DH can be explained by a
more eﬃcient hydrogen bond network, while the formation of
HH was possible only under the conditions with a very low
water activity and in the presence of speciﬁc solvent molecules,
probably providing for the formation of favorable benperidol
molecule associates.
3.7. Analysis of Benperidol Solvate Formation.
Crystallization of benperidol from a range of 31 solvents
selected from various solvent classes resulted in the formation
of 11 solvates. Nevertheless, SEtOAc and SNM were obtained only
in some crystallization experiments from the respective
solvents, hemihydrate crystallized only from xylene and toluene
containing traces of water, and repeated preparation of SCLF
and STCC was complicated. These observations suggest that
discovery of additional benperidol solvates with the studied
solvents is theoretically possible. Nevertheless, the obtained
amount of solvates and the knowledge of benperidol and
solvent properties, as well as the elucidation of solvate crystal
structure, allowed us to rationalize the formation of benperidol
solvates.
Generally it was concluded that solvates formed with solvent
molecules representing diﬀerent solvent classes: hydrogen bond
donors (type 1 solvates, HH, and DH), aprotic polar solvents
(type 2 solvates, SCLF), aromatic apolar or lightly polar solvents
(SBenz; although benzyl alcohol is a hydrogen bond donor, its
ability to form dispersion interactions appeared to be even
more important for the formation of this solvate), and aprotic
polar electron pair donor (SDIOX). Even though the crystal
structures of some of the solvates are not known, it was possible
to conclude that the solvent molecules in all solvates employed
features (strong or weak hydrogen bonds, dispersion
interactions) characteristic of the corresponding solvent class.
More detailed classiﬁcation of solvents did not provide
additional clariﬁcation for the solvate formation of benperidol,
as type 1 solvates formed from solvents belonging to group 3,
type 2 solvates from solvents from groups 2 and 9, and other
solvates were obtained from solvents belonging to groups 1, 7,
10, 11, and 1552 (see Table S1, Supporting Information).
As already mentioned, although the solvates were obtained
with four diﬀerent hydrogen bond donors, only in both
hydrates the additional hydrogen bond acceptor sites of
benperidol molecule were employed. Therefore, the formation
of hydrates was directly explained by the advantages of a more
eﬃcient hydrogen bonding network. The formation of alcohol
Table 5. Lattice Energy and Total Pairwise Interaction
Energy (in kJ·mol−1) for Benperidol Solvates
lattice energy total pairwise interaction energy
solvate PIXEL AA-CLP benperidola solventb
DH −99.3 −227.1 −86.1/−79.4c
HH −84.3 −65.6 −269.7 −44.7
SBenz −130.7 −109.5 −167.8 −151.9
Type 1
SMe −119.9 −107.4 −245.7 −92.9
SEt −124.3 −121.9 −223.0 −104.9
Type 2
SACN −110.7 −116.0 −295.6 −53.5
SEtOAc −137.6 −301.1/−301.8c −60.9
SNM −108.2 −119.7 −273.5 −75.8
aThe sum of all pairwise benperidol-benperidol interaction energies
with cutoﬀ distance equal to the sum of vdW radii +0.3 Å. bThe sum
of all pairwise solvent-benperidol and solvent−solvent interaction
energies with cutoﬀ distance equal to the sum of vdW radii +1.6 Å.
cFor each water molecule (in DH) or benperidol molecule (in SEtOAc)
in the asymmetric unit.
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solvates, however, was not driven purely by this feature,
although the presence of strong benperidol−solvent hydrogen
bonds deﬁnitely provided stability for these structures. The
solvent molecules in other solvates could not participate in
strong hydrogen bonds, but provided new, weak interactions
and allowed energetically favorable packing of benperidol
molecules with the solvent molecules. Interestingly, although
there were some voids in the crystal structures of both
polymorphs I and II, which were not observed in any of the
solvate structures, the packing index of solvates was generally
the same as that in the polymorphs; see Table 2. Nevertheless,
the presence of voids and complex structural patterns in the
crystals of stable benperidol polymorphs (six-molecule rings in
I, see Figure 6, and Z′ = 3 for II) suggested that energetically
eﬃcient packing is complicated for phases consisting of
benperidol molecules only. The presence of certain functional
groups in the benperidol molecule, however, provides
possibilities for eﬃcient interactions with solvent molecules
containing diﬀerent functional groups. These appear to be the
two main reasons for the formation of such a wide range of
benperidol solvates with various solvent molecules.
The appearance of two isostructural solvate groups suggests
that in the case of some particular solvent properties, solvent
molecules are incorporated in identical crystal structures. The
comparison of these structures shows that both the speciﬁc
interactions provided by solvent, as well as the size of the
solvent molecules are important factors. Therefore, small
hydrogen bond donating alcohol molecules form type 1
solvates, whereas aprotic polar donors and acceptors of weak
hydrogen bonds with appropriate molecular size and shape
form type 2 solvates.
4. CONCLUSIONS
Crystallization of benperidol from various solvents produced
nine new solvates containing methanol, acetonitrile, ethyl
acetate, nitromethane, 1,4-dioxane, water, benzyl alcohol,
carbon tetrachloride, and chloroform, while the desolvation of
benperidol solvates produced two new polymorphs IV and V. It
was determined that benperidol forms two sets of isostructural
solvates: type 1 (with methanol and ethanol) and type 2 (with
acetonitrile, nitromethane, and ethyl acetate). Infrequent
formation of some of the solvates, however, showed that the
existence of a certain solvate cannot guarantee its facile
formation and discovery, even if there are isostructural solvates
forming easily.
It was determined that the main reason for the formation of
various benperidol crystal structures was the diverse possibil-
ities of molecular packing, resulting in diﬀerent intermolecular
interactions, whereas the molecular conformation of benperidol
was typically very similar. A comparison of the crystal structures
of benperidol phases showed that the only structures showing
clear similarities were the polymorph III, hemihydrate HH, and
type 2 solvates, while similarities of intermolecular interactions
were observed also for SBenz and polymorph I.
Desolvation studies of benperidol solvates showed that the
stability of solvates can be associated with the intermolecular
interactions in the crystal structure, while the structures of
desolvation products were determined through an interplay of
structural similarity and thermodynamic stability of the
resulting polymorphs, and each of these factors could become
dominant due to sample preparation procedures or exper-
imental conditions.
The inability of benperidol molecules to pack eﬃciently
without solvent was found to be the main reason for solvate
formation, whereas the presence of speciﬁc functional groups in
benperidol molecule enabled the formation of a wide range of
stable solvate structures containing various solvent molecules.
This is similar to the properties for droperidol solvates,
although less structural variation was observed in the case of
droperidol solvates.8 Nevertheless, theoretical prediction of
benperidol solvates would be quite complicated as it would be
diﬃcult to predict the energetically favorable packing for each
particular solvate. The formation of both benperidol hydrates,
however, was driven by the compensation for hydrogen bond
donor deﬁciency.
By using both sets of isostructural solvates it was proved that
both the possible interactions and the size of the solvent
molecules were important factors in solvate formation. The
solvate structures of benperidol, however, were more
interaction-speciﬁc, if compared to those of droperidol, which
formed only one set of isostructural solvates with at least seven
very diﬀerent solvents.8 In the formation of type 2 solvates,
both the size and shape of the solvent molecules appeared to be
relevant, as two nearby partially connected channels could be
occupied by smaller molecules in each of the channel (as in
SACN and SNM), or by larger molecules occupying both of the
channels (SEtOAc).
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(7) Loṕez-Mejías, V.; Kampf, J. W.; Matzger, A. J. J. Am. Chem. Soc.
2012, 134, 9872.
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C.; Edwards, A. J.; Howard, J. A. K.; Steed, J. W. Chem.Eur. J. 2015,
21, 1036.
(46) Iwata, K.; Kojima, T.; Ikeda, Y. Cryst. Growth Des. 2014, 14,
3335.
(47) Infantes, L.; Fabian, L.; Motherwell, W. D. S. CrystEngComm
2007, 9, 65.
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